<SEC-DOCUMENT>0001171843-18-001818.txt : 20180309
<SEC-HEADER>0001171843-18-001818.hdr.sgml : 20180309
<ACCEPTANCE-DATETIME>20180309160622
ACCESSION NUMBER:		0001171843-18-001818
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		86
CONFORMED PERIOD OF REPORT:	20171231
FILED AS OF DATE:		20180309
DATE AS OF CHANGE:		20180309

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOINT Corp
		CENTRAL INDEX KEY:			0001612630
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				900544160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36724
		FILM NUMBER:		18680111

	BUSINESS ADDRESS:	
		STREET 1:		16767 N PERIMETER DRIVE
		STREET 2:		SUITE 240
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260
		BUSINESS PHONE:		480 245 5960

	MAIL ADDRESS:	
		STREET 1:		16767 N PERIMETER DRIVE
		STREET 2:		SUITE 240
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>f10k_030918p.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<HTML><HEAD>
     <TITLE></TITLE>
</HEAD><BODY STYLE="font: 10pt Times New Roman, Times, Serif">





<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><font style="font-size: 12pt"><b>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</b></font></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><font style="font-size: 12pt">Washington, D.C. 20549</font></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><font style="font-size: 12pt">&nbsp;</font></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><font style="font-size: 12pt"><b>FORM 10-K</b></font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&#9746; <b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)&nbsp;OF
THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>For the fiscal year ended December 31, 2017</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>OR</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&#9744; &nbsp;&nbsp;TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>For the transition period from _______ to ________</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Commission File Number: 001-36724</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 18pt; text-align: center; margin: 0pt 0"><b><u>The Joint Corp.</u></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>(Exact name of registrant as specified in its charter)</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 50%; text-align: center"><font style="font-size: 10pt"><b>Delaware</b></font></td>
    <td style="width: 50%; text-align: center"><font style="font-size: 10pt"><b>90-0544160</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><font style="font-size: 10pt"><i>(State or Other Jurisdiction of</i></font></td>
    <td style="text-align: center"><font style="font-size: 10pt"><i>(I.R.S. Employer</i></font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><font style="font-size: 10pt"><i>Incorporation)</i></font></td>
    <td style="text-align: center"><font style="font-size: 10pt"><i>Identification No.)</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 50%">
        <p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>16767 N. Perimeter Drive, Suite 240, Scottsdale</b></p>
        <p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Arizona</b></p></td>
    <td style="width: 50%; font-size: 10pt; text-align: center"><font style="font-size: 10pt"><b>85260</b></font></td></tr>
<tr>
    <td style="font-size: 10pt; text-align: center"><font style="font-size: 10pt"><i>(Address of Principal Executive Offices)</i></font></td>
    <td style="font-size: 10pt; text-align: center"><font style="font-size: 10pt">(Zip Code)&nbsp;</font></td></tr>
</table>
<p style="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(480) 245-5960</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>(Registrant&#8217;s Telephone Number, Including Area Code)</i></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><i>&nbsp;</i><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 50%; text-align: center"><font style="font-size: 10pt"><u>Title Of Each Class</u></font></td>
    <td style="width: 50%; text-align: center"><font style="font-size: 10pt"><u>Name Of Each Exchange On Which Registered</u></font></td></tr>
<tr>
    <td style="text-align: center"><font style="font-size: 10pt">Common Stock, $0.001 Par Value Per Share</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">The NASDAQ Capital Market LLC</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">Securities Registered Pursuant to Section 12(g) of the Act:</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>None</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark if the registrant is
a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp; &#9744; &nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&nbsp;
&#9745;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark if the registrant is
not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&nbsp;&nbsp;Yes&nbsp;&nbsp; &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;
&#9745;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant:
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.&nbsp;&nbsp;Yes&nbsp;&nbsp; &#9745; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;
&#9744;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes&nbsp;&nbsp; &#9745; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp; &#9744;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark if disclosure of delinquent
filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant&#8217;s
knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment
of this Form 10-K.&nbsp;&nbsp;&nbsp; &#9744;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions
of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging
growth company&#8221; in Rule&nbsp;12b-2 of the Exchange Act.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 55%"><font style="font-size: 10pt">Large accelerated filer&nbsp;&#9744;</font></td>
    <td style="width: 45%"><font style="font-size: 10pt">Accelerated filer&nbsp;&#9744;</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 10pt">Non-accelerated filer&nbsp;&#9744;&nbsp;(Do not check if a smaller reporting company)</font></td>
    <td><font style="font-size: 10pt">Smaller reporting company&nbsp;&#9745;</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">Emerging growth company &#9745;</font></td></tr>
</table>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant has elected not
to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. &#9745;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Act).&nbsp;&nbsp;Yes&nbsp;&nbsp; &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;
&#9745;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The aggregate market value of the voting and
non-voting common equity held by non-affiliates of the registrant was approximately $46.5 million as of June 30, 2017 based on
the closing sales price of the common stock on the NASDAQ Capital Market.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">There were&nbsp;13,586,254 shares of
the registrant&#8217;s common stock issued and outstanding as of March 2, 2018.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Documents Incorporated by Reference</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Portions of the registrant's Proxy Statement
relating to its 2018 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission (&#8220;SEC&#8221;)
pursuant to Regulation&nbsp;14A within 120 days after the registrant&#8217;s fiscal year ended December 31, 2017, are incorporated
by reference in Part&nbsp;III of this Form&nbsp;10-K.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><br>
</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;<b>TABLE OF CONTENTS</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 6%">&nbsp;</td>
    <td style="width: 88%">&nbsp;</td>
    <td style="width: 6%; text-align: center"><font style="font-size: 10pt"><b>Page</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b><u>Numbers</u></b></font></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><a href="#a_001"><font style="font-size: 10pt"><b>PART I</b></font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_002"><font style="font-size: 10pt">Item&nbsp;1.</font></a></td>
    <td><a href="#a_002"><font style="font-size: 10pt">Business</font></a></td>
    <td style="text-align: center"><a href="#a_002"><font style="font-size: 10pt">1</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_003"><font style="font-size: 10pt">Item&nbsp;1A.</font></a></td>
    <td><a href="#a_003"><font style="font-size: 10pt">Risk Factors&nbsp;</font></a></td>
    <td style="text-align: center"><a href="#a_003"><font style="font-size: 10pt">12</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_004"><font style="font-size: 10pt">Item&nbsp;1B.</font></a></td>
    <td><a href="#a_004"><font style="font-size: 10pt">Unresolved Staff Comments</font></a></td>
    <td style="text-align: center"><a href="#a_004"><font style="font-size: 10pt">30</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_005"><font style="font-size: 10pt">Item&nbsp;2.</font></a></td>
    <td><a href="#a_005"><font style="font-size: 10pt">Properties</font></a></td>
    <td style="text-align: center"><a href="#a_005"><font style="font-size: 10pt">30</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_006"><font style="font-size: 10pt">Item&nbsp;3.</font></a></td>
    <td><a href="#a_006"><font style="font-size: 10pt">Legal Proceedings</font></a></td>
    <td style="text-align: center"><a href="#a_006"><font style="font-size: 10pt">30</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_007"><font style="font-size: 10pt">Item&nbsp;4.</font></a></td>
    <td><a href="#a_007"><font style="font-size: 10pt">Mine Safety Disclosures</font></a></td>
    <td style="text-align: center"><a href="#a_007">30</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><a href="#a_008"><font style="font-size: 10pt"><b>PART II</b></font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_009"><font style="font-size: 10pt">Item&nbsp;5.</font></a></td>
    <td><a href="#a_009"><font style="font-size: 10pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</font></a></td>
    <td style="text-align: center"><a href="#a_009"><font style="font-size: 10pt">31</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_010"><font style="font-size: 10pt">Item&nbsp;6.</font></a></td>
    <td><a href="#a_010"><font style="font-size: 10pt">Selected Financial Data</font></a></td>
    <td style="text-align: center"><a href="#a_010"><font style="font-size: 10pt">32</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_011"><font style="font-size: 10pt">Item&nbsp;7.</font></a></td>
    <td><a href="#a_011"><font style="font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></a></td>
    <td style="text-align: center"><a href="#a_011"><font style="font-size: 10pt">33</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap><a href="#a_012"><font style="font-size: 10pt">Item 7A.</font></a></td>
    <td><a href="#a_012"><font style="font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk</font></a></td>
    <td style="text-align: center"><a href="#a_012"><font style="font-size: 10pt">41</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_013"><font style="font-size: 10pt">Item&nbsp;8.</font></a></td>
    <td><a href="#a_013"><font style="font-size: 10pt">Financial Statements and Supplementary Data</font></a></td>
    <td style="text-align: center"><a href="#a_013"><font style="font-size: 10pt">42</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_020"><font style="font-size: 10pt">Item&nbsp;9.</font></a></td>
    <td><a href="#a_020"><font style="font-size: 10pt">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</font></a></td>
    <td style="text-align: center"><a href="#a_020"><font style="font-size: 10pt">69</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_021"><font style="font-size: 10pt">Item&nbsp;9A.</font></a></td>
    <td><a href="#a_021"><font style="font-size: 10pt">Controls and Procedures</font></a></td>
    <td style="text-align: center"><a href="#a_021"><font style="font-size: 10pt">70</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_022"><font style="font-size: 10pt">Item&nbsp;9B.</font></a></td>
    <td><a href="#a_022"><font style="font-size: 10pt">Other Information</font></a></td>
    <td style="text-align: center"><a href="#a_022"><font style="font-size: 10pt">71</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><font style="font-size: 10pt"><b><a href="#a_031">PART&nbsp;III</a></b></font></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_023"><font style="font-size: 10pt">Item&nbsp;10.</font></a></td>
    <td><a href="#a_023"><font style="font-size: 10pt">Directors, Executive Officers and Corporate Governance</font></a></td>
    <td style="text-align: center"><a href="#a_023"><font style="font-size: 10pt">71</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_024"><font style="font-size: 10pt">Item&nbsp;11.</font></a></td>
    <td><a href="#a_024"><font style="font-size: 10pt">Executive Compensation</font></a></td>
    <td style="text-align: center"><a href="#a_024"><font style="font-size: 10pt">71</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_025"><font style="font-size: 10pt">Item&nbsp;12.</font></a></td>
    <td><a href="#a_025"><font style="font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</font></a></td>
    <td style="text-align: center"><a href="#a_025"><font style="font-size: 10pt">71</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_026"><font style="font-size: 10pt">Item&nbsp;13.</font></a></td>
    <td><a href="#a_026"><font style="font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence</font></a></td>
    <td style="text-align: center"><a href="#a_026"><font style="font-size: 10pt">71</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_027"><font style="font-size: 10pt">Item&nbsp;14.</font></a></td>
    <td><a href="#a_027"><font style="font-size: 10pt">Principal Accountant Fees and Services</font></a></td>
    <td style="text-align: center"><a href="#a_027"><font style="font-size: 10pt">71</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><font style="font-size: 10pt"><b><a href="#a_032">PART IV</a></b></font></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_028"><font style="font-size: 10pt">Item&nbsp;15.</font></a></td>
    <td><a href="#a_028"><font style="font-size: 10pt">Exhibits, Financial Statement Schedules</font></a></td>
    <td style="text-align: center"><a href="#a_028"><font style="font-size: 10pt">71</font></a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2"><a href="#a_029"><font style="font-size: 10pt">SIGNATURES</font></a></td>
    <td style="text-align: center"><a href="#a_029"><font style="font-size: 10pt">72</font></a></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;<b>Forward-Looking Statements and Terminology</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>The information in this Annual Report on
Form 10-K, or this Form 10-K, including this discussion under the headings &#8220;Business&#8221; and &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations,&#8221; contains forward-looking statements and information
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended, or the Exchange Act, which are subject to the &#8220;safe harbor&#8221; created by those sections. All statements,
other than statements of historical facts, included or incorporated in this Form 10-K could be deemed forward-looking statements,
particularly statements about our plans, strategies and prospects under the headings &#8220;Business&#8221; and &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations.&#8221; In some cases, you can identify forward-looking
statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expects,&#8221;
&#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221;
&#8220;continue,&#8221; &#8220;intend&#8221; or the negative of these terms or other comparable terminology. All forward-looking
statements in this Form 10-K are made based on our current expectations, forecasts, estimates and assumptions, and involve risks,
uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking
statements. In evaluating these statements, you should specifically consider various factors, uncertainties and risks that could
affect our future results or operations as described from time to time in our SEC reports., including those risks outlined under
&#8220;Risk Factors&#8221; in Item 1A of this Form 10-K. These factors, uncertainties and risks may cause our actual results to
differ materially from any forward-looking statement set forth in this Form 10-K. You should carefully consider the trends, risks
and uncertainties described below and other information in this Form 10-K and subsequent reports filed with or furnished to the
SEC before making any investment decision with respect to our securities. All forward-looking statements attributable to us or
persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.&nbsp;&nbsp;Some of the important
factors that could cause our actual results to differ materially from those projected in any forward-looking statements include,
but are not limited to, the following:</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to successfully implement our growth strategy if we or our franchisees are unable to locate and secure appropriate sites for clinic locations, obtain favorable lease terms, and attract patients to our clinics;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>in operating company-owned or managed clinics, we may not be able to duplicate the success of some of our franchisees, and in the case of certain company-owned or managed clinics that we have closed or may close, we were not able to duplicate the success of our most successful franchisees;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to acquire operating clinics from existing franchisees or develop company-owned or managed clinics on attractive terms;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>any acquisitions that we make could disrupt our business and harm our financial condition;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to continue to sell regional developer licenses to qualified regional developers&nbsp;&nbsp;or sell franchises to qualified franchisees, and our regional developers and franchisees may not succeed in developing profitable territories and clinics;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to identify, recruit and train enough qualified chiropractors to staff our clinics;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>new clinics may not reach the point of profitability, and we may not be able to maintain or improve revenues and franchise fees from existing franchised clinics;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>the chiropractic industry is highly competitive, with many well-established competitors, which could prevent us from increasing our market share or result in reduction in our market share;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>administrative actions and rulings regarding the corporate practice of medicine and joint employer responsibility may jeopardize our business model;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may face negative publicity or damage to our reputation, which could arise from concerns expressed by opponents of chiropractic and by chiropractors operating under traditional service models;</i></font></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>our security systems may be breached, and we may face civil liability and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract and retain patients;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>legislation, regulations, as well as new medical procedures and techniques could reduce or eliminate our competitive advantages; and</i></font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we face increased costs as a result of being a public company.</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Additionally, there may be other risks that
are otherwise described from time to time in the reports that we file with the Securities and Exchange Commission. Any forward-looking
statements in this report should be considered in light of various important factors, including the risks and uncertainties listed
above, as well as others.</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As used in this Form 10-K:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">&#8220;we,&#8221;&nbsp;&nbsp;&#8220;us,&#8221; and &#8220;our&#8221; refer to The Joint Corp.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">a &#8220;clinic&#8221; refers to a chiropractic clinic operating under our &#8220;Joint&#8221; brand, which may be (i) owned by a franchisee, (ii) owned by a professional corporation or limited liability company and managed by a franchisee; (iii) owned directly by us; or (iv) owned by a professional corporation or limited liability company and managed by us.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">when we identify an &#8220;operator&#8221; of a clinic, a party that is &#8220;operating&#8221; a clinic, or a party by whom a clinic is &#8220;operated,&#8221; we are referring to the party that operates all aspects of the clinic in certain jurisdictions, and to the party that manages all aspects of the clinic other than the practice of chiropractic in certain other jurisdictions.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">when we describe our acquisition or our opening of a clinic, we are referring to our acquisition or opening of the entity that operates all aspects of the clinic in certain jurisdictions, and to our acquisition or opening of the entity that manages aspects of the clinic other than the practice of chiropractic in certain other jurisdictions.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_001"></a>PART&nbsp;I</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><a name="a_002"></a>ITEM 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
BUSINESS</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><img src="mission.jpg" alt="">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Overview</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our principal business is to develop, own,
operate, support and manage chiropractic clinics through direct ownership, management arrangements, franchising and the sale of
regional developer rights throughout the United States.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We are a rapidly growing franchisor and operator
of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We seek to be the leading provider of chiropractic
care in the markets we serve and to become the most recognized brand in our industry through the rapid and focused expansion of
chiropractic clinics in key markets throughout North America and abroad. We strive to accomplish our mission by making quality
care readily available and affordable in a retail setting. We have created a growing network of modern, consumer-friendly chiropractic
clinics operated by franchisees and by us that employ licensed chiropractors. Our model enables us to price our services below
most competitors&#8217; pricing for similar services and below most insurance co-payment levels (i.e., below the patient co-payment
required for an insurance-covered service).&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Since acquiring the predecessor to our company
in March, 2010, we have grown our enterprise from eight to 399 clinics in operation as of December 31, 2017, with an additional
104 franchise licenses sold but not yet developed across our network, and eight letters of intent for future clinic licenses. As
of December 31, 2017, 352 of our clinics were operated by franchisees and 47 clinics were operated as company-owned or managed
clinics. We reached 400 open clinics system-wide in January, 2018, having opened 41 new franchised clinics during 2017. In the
year ended December 31, 2017, our system registered nearly five million patient visits and generated system-wide sales of $126.8
million. Our future growth strategy remains focused on accelerating the development of our franchise base through the sale of additional
franchises and through a robust regional developer network. Additionally, this year we plan to opportunistically acquire select
operating clinics or develop in areas in which we already support company-owned or managed clinics. We collect a royalty of 7.0%
of revenues from franchised clinics. We remit a 3.0% royalty to our regional developers on the gross sales of franchises opened
within certain regional developer protected territories. We also collect a national marketing fee of 2.0% of gross sales of all
franchised clinics. We receive a franchise sales fee of $39,900 for each franchise we sell directly and a franchise fee ranging
from $19,950 to $25,400 for each franchise sold through our network of regional developers. If a franchisee purchases additional
franchise licenses, the initial franchise fee is reduced by $10,000 per additional license.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 14, 2014, we completed our initial
public offering, or the IPO, of 3,000,000 shares of common stock at an initial price to the public of $6.50 per share, and we received
net proceeds of approximately $17.1 million. Our underwriters exercised their option to purchase 450,000 additional shares of common
stock to cover over-allotments on November 18, 2014, pursuant to which we received net proceeds of approximately $2.7 million.
Also, in conjunction with the IPO, we issued warrants to the underwriters for the purchase of 90,000 shares of common stock, which
can be exercised between November 10, 2015 and November 10, 2018 at an exercise price of $8.125 per share.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 25, 2015, we closed on our follow-on
public offering of 2,272,727 shares of common stock, at a price to the public of $5.50 per share. We granted the underwriters a
45-day option to purchase up to 340,909 additional shares of common stock to cover over-allotments, if any. On December 30, 2015,
our underwriters exercised their over-allotment option to purchase an additional 340,909 shares of common stock at a price of $5.50
per share. After giving effect to the over-allotment exercise, the total number of shares offered and sold in our follow-on public
offering increased to 2,613,636 shares. With the over-allotment option exercise, we received aggregate net proceeds of approximately
$13.0 million.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We deliver convenient, appointment-free chiropractic
adjustments in an inviting, open bay environment at prices that are approximately 66% lower than the average industry cost for
comparable procedures offered by traditional chiropractors, according to 2017 industry data from Chiropractic Economics. In support
of our mission to offer quality, affordable and convenient care and value for our patients, our clinics offer a variety of customizable
membership and wellness treatment plans which provide additional value pricing even as compared with our single-visit pricing schedules.
These flexible plans are designed to attract patients and encourage repeat visits and routine usage as part of an overall health
and wellness program.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2017, we had 399 franchised
or company-owned or managed clinics in operation in 30 states. The map below shows the states in which we or our franchisees operate
clinics and the number of clinics open in each state as of December 31, 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&nbsp;<img src="clinic_map.jpg" alt=""></font></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our retail locations have been selected to be
visible, accessible and convenient. We offer a welcoming, consumer-friendly experience that attempts to redefine the chiropractic
doctor/patient relationship. Our clinics are open longer hours than many of our competitors, including weekend days, and our patients
do not need appointments. We accept cash or major credit cards in return for our services. We do not accept insurance and do not
provide Medicare covered services. We believe that our approach, especially our commitment to affordable pricing and our ready
service delivery model, will attract existing consumers of chiropractic services and will also appeal to the growing market of
consumers who seek alternative or non-invasive wellness care, but have not yet tried chiropractic. According to our patient survey
conducted in 2017 by WestGroup Research, 22% of our new patients had never tried chiropractic care before they came to The Joint.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our patients arrive at our clinics without appointments
at times convenient to their schedules. Once a patient has joined our system and is returning for treatment, they simply swipe
their membership card at a card reader at the reception desk to announce their arrival. Typically, within three to five minutes
(the average throughout our system), the patient is escorted to our open adjustment area, where they are required to remove only
their outerwear to receive their adjustment. Each patient&#8217;s records are digitally updated for retrieval in our proprietary
data storage system by our chiropractors in compliance with all applicable medical records security and privacy regulations. The
adjustment process, administered by a licensed chiropractor, takes approximately 15&nbsp;&#8211;20 minutes on average for a new
patient and 5&nbsp;&#8211;&nbsp;7 minutes on average for a returning patient.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our consumer-focused service model targets the
non-acute treatment market, which is part of the $15 billion chiropractic services market. As our model does not focus on the treatment
of severe, acute injury, we do not provide expensive and invasive diagnostic tools such as MRIs and X-rays. Instead we refer those
with acute symptoms to alternate healthcare providers, including traditional chiropractors.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Our Industry</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Chiropractic care is widely accepted among individuals
with a variety of medical conditions, particularly back pain. A 2016 Gallup report commissioned by Palmer College of Chiropractic
shows that 35.5 million U.S. adults (11% of the total U.S. population) now seek chiropractic care each year, an increase of 1.9
million as compared to the 33.6 million U.S. adults reported in the inaugural 2015 Gallup-Palmer report. These numbers represent
a marked increase over the 2012 National Health Interview Survey that measured chiropractic use at 20.6 million U.S. adults, or
8% of the population. According to the American Chiropractic Association, 80% of Americans experience back pain at least once in
their lifetime. According to the 2016 Gallup report commissioned by the Palmer College of Chiropractic, over half of adults in
the United States (55%) say they are likely to see a chiropractor if they had significant neck or back pain.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Chiropractic care is increasingly recognized
as an effective treatment for pain and potentially for a variety of other conditions. The American College of Physicians (ACP)
now recommends non-drug therapy such as spinal manipulation as a first line of treatment for patients with chronic low back pain.
The ACP states that treatments such as spinal manipulation are shown to improve symptoms with little risk of harm. The National
Center for Complementary &amp; Alternative Medicine of the National Institutes of Health has stated that spinal manipulation appears
to benefit some people with low-back pain and also may be helpful for headaches, neck pain, upper- and lower-extremity joint conditions
and whiplash-associated disorders. The Mayo Clinic has recognized chiropractic as safe when performed by trained and licensed chiropractors,
and the Cleveland Clinic has stated that chiropractors are established members of the mainstream medical team.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The chiropractic industry in the United States
is large, growing and highly fragmented. The Bureau of Labor Statistics estimates that $90 billion is spent on back pain each year
in the U.S. According to a report issued by IBIS World Chiropractors Market Research in August 2016, expenditures for chiropractic
services in the U.S. are $15.0 billion annually. The United States Bureau of Labor Statistics expects employment in chiropractic
to grow faster than the average for all occupations. Some of the factors that the Bureau of Labor Statistics identified as driving
this growth are healthcare cost pressures, an aging population requiring more health care and technological advances, all of which
are expected to increasingly shift services from inpatient facilities and hospitals to outpatient settings. We believe that the
demand for our chiropractic services will continue to grow as a result of several additional drivers, such as the growing recognition
of the benefits of regular maintenance therapy coupled with an increasing awareness of the convenience of our service and of our
pricing at a significant discount to the cost of traditional chiropractic adjustments and, in most cases, at or below the level
of insurance co-payment amounts.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Today, most chiropractic services are provided
by sole practitioners, generally in medical office settings. The chiropractic industry differs from the broader healthcare services
industry in that it is more heavily consumer-driven, market-responsive and price sensitive, in large measure a result of many treatment
options falling outside the bounds of traditional insurance reimbursable services and fee schedules. According to First Research,
the top 50 companies delivering chiropractic services in the United States generated less than 10% of all industry revenue. We
believe these characteristics are evidence of an underserved market with potential consumer demand that is favorable for an efficient,
low-cost, consumer-oriented provider.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Most chiropractic practices are set up to accept
and to process insurance-based reimbursement. While chiropractors typically accept cash payment in addition to insurance, Medicare
and Medicaid, they continue to incur overhead expenses associated with maintaining the capability to process third-party reimbursement.
We believe that most chiropractors who use this third-party reimbursement model would find it economically difficult to discount
the prices they charge for their services to levels comparable with our pricing.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Accordingly, we believe these and certain other
trends favor our business model. Among these are:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">People, most notably Millennials, have increasingly active lifestyles and are living longer, requiring more medical, maintenance and preventative support; </font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">People are increasingly open to alternative, non-pharmacological types of care; </font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Utilization of more conveniently situated, local-sited urgent-care or &#8220;mini-care&#8221; alternatives to primary care is increasing; and </font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Popularity of health clubs, massage and other non-drug, non-invasive wellness maintenance providers is growing. </font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Our Competitive Strengths</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe the following competitive strengths
have contributed to our initial success and will position us for future growth:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Retail, consumer-driven approach</i>.&nbsp;&nbsp;To
support our consumer-focused model, we use strong, recognizable retail approaches to stimulate brand-awareness and attract patients
to our clinics. We intend to continue to drive awareness of our brand by locating clinics mainly at retail centers and convenience
points, displaying prominent signage and employing consistent, proven and targeted marketing tools. We offer our patients the flexibility
to visit our clinics without an appointment and receive prompt attention. Additionally, most of our clinics offer extended hours
of operation, including weekends, which is not typical among our competitors.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We attracted an average per clinic of 862 new
patients during the year ended December 31, 2017, as compared to the 2017 chiropractic industry average of 390 new patients per
year for traditional insurance-based non-multidisciplinary or integrated practices, according to a 2017 Chiropractic Economics
survey.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Quality Service</i>.&nbsp;&nbsp;Across our
system we have a community of over 1,000 fully licensed chiropractic doctors, who performed nearly five million adjustments last
year. Our doctors provide patient care focused on pain relief and ongoing wellness to promote healthy, active lifestyles. We provide
our doctors one-on-one training, as well as ongoing coaching and mentoring through our partnerships with two of the profession&#8217;s
preeminent instructors in chiropractic technique and adjusting. Our doctors continually refine their skills, as our clinics see
an average of 234 patients per week, as compared to the 2017 chiropractic industry average of 137 patients per week for non-multidisciplinary
or integrated practices, according to a 2017 Chiropractic Economics survey. Our service offerings encourage consumer trial, repeat
visits and sustainable patient relationships.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">By limiting the administrative burdens of insurance
processing, our model helps chiropractors focus on patient service. We believe the time our chiropractors save by not having to
perform administrative duties related to insurance reimbursement allows more time to see more patients, establish and reinforce
chiropractor/patient relationships, and educate patients on the benefits of chiropractic maintenance therapy.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our approach has made us an attractive alternative
for chiropractic doctors who want to spend more time treating patients than they typically do in traditional practices, which are
burdened with greater overhead, personnel and administrative expense. We believe that our model helps us to recruit chiropractors
who want to focus their practice principally on patient care.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Pricing Structure.</i>&nbsp;&nbsp;We believe
that our strongest competitive advantages are our price and convenience. By focusing on non-acute care in an open-bay environment
and by not participating in insurance or Medicare reimbursement, we are able to offer a much less expensive alternative to traditional
chiropractic services. We can do this because our clinics do not have the expenses of performing certain diagnostic procedures
and processing reimbursement claims. Our model allows us to pass these savings on to our patients. According to Chiropractic Economics
in 2017, the average fee for a chiropractic treatment involving spinal manipulation in a cash-based practice in the United States
is approximately $77. By comparison, our average fee as of December 31, 2017, was approximately $26, approximately 66% lower than
the industry average price.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe our pricing and service offering structure
helps us to generate higher usage. The following table sets forth our average price per adjustment as of December 31, 2017, for
patients who pay by single adjustment plans, multiple adjustment packages, and multiple adjustment membership plans. Our price
per adjustment as of December 31, 2017 averaged approximately $26 across all three groups.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: justify">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">The Joint Service Offering</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: justify">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Single Visit</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Package(s)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Membership(s)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; font-size: 10pt">Price per adjustment</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">39</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-size: 10pt">$20&nbsp;&#8211;&nbsp;$33</font></td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-size: 10pt">$15&nbsp;&#8211;&nbsp;$20</font></td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Proven track record of opening clinics and
growing revenue at the clinic level</i>.&nbsp;&nbsp;We have grown our clinic revenue base consistently since we acquired our predecessor
in March 2010. From January 2012 through December 31, 2017, we have increased monthly sales at our clinics from $0.4 million to
$12.0 million. During this period, we increased the number of clinics in operation from 33 to 399.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We continue to be encouraged by the ability of
individual clinics to generate growth. While there is significant variation in results among our system, and the results of our
top-performing clinics are not representative of our system overall, we believe it is worth noting that in January 2012, the highest-performing
clinic in our system was a franchise clinic which had monthly sales of approximately $45,000, and in December 2017, the highest
performing clinic in our system was a franchise clinic which had monthly sales of approximately $108,000.</p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Strong and proven management team.</i>&nbsp;&nbsp;Our
strategic vision is directed by our president and chief executive officer Peter D. Holt, who has more than 30 years of experience
in domestic and international franchising, franchise development and operations. Under his direction we have confirmed our commitment
to the continued strengthening of operations, the continued cultivation and management of our franchise community, as well as a
strong commitment to future clinic development both domestically and internationally. Mr. Holt was most recently president and
chief executive officer of Tasti-D-Lite &amp; Planet Smoothie. He has also served as chief operating officer of 24seven Vending
(U.S), where he directed its franchise system in the U.S., and as executive vice president of development for Mail Boxes Etc. and
vice president of international for I Can&#8217;t Believe It&#8217;s Yogurt and Java Coast Fine Coffees. Mr. Holt directs a team
of dedicated leaders who are focused on executing our business plan and implementing our growth strategy.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">During 2016 and 2017, Mr. Holt assembled a strong
management team including John Meloun as chief financial officer. In addition to valuable institutional memory, Mr. Meloun has
financial and accounting experience from the University of Phoenix, Emerson Network Power and Motorola.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Also joining the team in 2016 was Eric Simon,
vice president of franchise sales and development. Mr. Simon has over 20 years of experience in all aspects of franchising, most
recently as director of franchise development for AAMCO Transmissions. Mr. Simon spent five years as a franchisee and area developer
with Extreme Pita and previously spent 10 years with Mail Boxes Etc. in franchise sales roles.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In 2017, Jorge Armenteros joined as vice president
of operations bringing with him more than 30 years of franchise operations leadership experience. For 10 years prior to joining
the team, Mr. Armenteros was the executive senior vice president of franchise operations and corporate development for Campero
USA, a fast food restaurant chain. Prior to that, he held progressively senior roles up to zone vice president and corporate office
with the Dunkin Donuts, Baskin Robbins, Togo&#8217;s brand. His career also includes a period as a multi-unit franchisee of Dunkin
Donuts..</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Amy Karroum was promoted to vice president of
human resources in 2017, having joined us in 2015. Prior to working at The Joint, Ms. Karroum was director of human resources for
Thermo Fluids, an oil recycling company. And before that she spent five years in homebuilding with both Taylor Morrison and Pulte
Homes.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In 2018, Jason Greenwood joined our management
team as Vice President of Marketing. Mr. Greenwood spent the last 10 years at Peter Piper Pizza in progressively responsible roles,
most recently as chief marketing officer. Prior to that he was a multi-unit franchisee for Robeks Juice.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe that our management team&#8217;s experience
and demonstrated success in building and operating a robust franchise system will be a key driver of our growth and will position
us well for achieving our long-term strategy.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our Growth Strategy</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our goal is not only to capture a significant
share of the existing market but also to expand the market for chiropractic care. We are accomplishing this through the rapid geographic
expansion of our affordable franchising program and the opportunistic addition of company-owned or managed clinics. While we temporarily
suspended our addition of company-owned or managed clinics during 2017 in order to stabilize our corporate clinic portfolio, we
believe that we will be able to resume taking advantage of opportunities for the addition of company-owned or managed clinics during
2018. Accordingly, our long-term growth tactics include:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 2%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="width: 97%; text-align: justify"><font style="font-size: 10pt">the continued growth of system sales and royalty income;&nbsp;</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">accelerating the opening of clinics already in development;</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the sale of additional franchises;</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the sale of additional regional developer protected territories;&nbsp;</font></td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 2%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify; width: 97%"><font style="font-size: 10pt">increasing the capability and capacity of our existing regional developer network;</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">improving operational margins and leveraging infrastructure;</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the opportunistic acquisition of existing franchises&nbsp;&nbsp;&#8211; referred to as &#8220;buybacks&#8221;; and</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the development of company-owned clinics &#8211; referred to as &#8220;greenfields&#8221; &#8211; in clustered geographies.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;Our analysis of data from over 500,000
patient records from 395 clinics across 30 states suggests that the United States market alone can support at least 1,700 of our
clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&nbsp;<img src="support_map.jpg" alt=""></font> </p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Continued growth of system sales. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">System wide comparable same-store sales growth,
or &#8220;Comp Sales,&#8221; for 2017 was 21.0%, reflecting the growing acceptance of The Joint business model. Comp Sales refers
to the amount of sales a clinic generates in the most recent accounting period, relative to the amount of sales it generated in
a similar period in the past. Comp Sales include the sales from both company-owned or managed clinics and franchised clinics that
in each case have been open at least 13 full months, and exclude any clinics that have closed. We believe that the experience we
have gained in developing and refining management systems, operating standards, training materials and marketing and customer acquisition
activities has contributed to our system&#8217;s revenue growth. In addition, we believe that increasing awareness of our brand
has contributed to revenue growth, particularly in markets where the number and density of our clinics has made cooperative and
mass media advertising attractive. We believe that our ability to leverage aggregated and general media digital advertising and
search tools will continue to grow as the number and density of our clinics increases.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;<b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Selling additional franchises. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We will continue to sell franchises. We believe
that to secure leadership in our industry and to maximize our opportunities in our markets, it is important to gain brand equity
and consumer awareness as rapidly as possible, consistent with a disciplined approach to opening clinics. We believe that continued
sales of franchises in selected markets is the most effective way to drive brand awareness in the short term. Our longer-term strategy
includes the resumption of opening or acquiring company-owned or managed clinics, and we believe that a growth strategy that includes
both franchised and company-owned or managed clinics has advantages over either approach by itself.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Selling additional Regional Developer rights. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe that we can achieve scale faster by
using a regional developer model, which is employed by many successful franchisors. We sell a regional developer the rights to
open a minimum number of clinics in a defined territory. They in turn help us to identify and qualify potential new franchisees
in that territory and assist us in providing field training, clinic openings and ongoing support. In return, we share part of the
initial franchise fee and pay the regional developer 3% of the 7% ongoing royalties we collect from the franchisees in their protected
territory. On December 31, 2016 we had eight regional developers operating. In 2017 we sold the rights to an additional 10 regional
developer territories for a combined minimum development commitment of 259 clinics over the lifetime of their regional developer
agreements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Opening clinics in development. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition to our 399 operating clinics, as
of December 31, 2017, we have granted franchises, either directly or through our regional developers, for an additional 104 clinics
that we believe will be developed in the future. We will continue to support our franchisees and regional developers to open these
clinics and to achieve sustainable performance as rapidly as possible.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2017, we
terminated three franchise licenses for undeveloped clinics that were in default.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Continue to improve margins and leverage infrastructure. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe our corporate infrastructure can support
a clinic base greater than our existing footprint. As we continue to grow, we expect to drive greater efficiencies across our operations,
development and marketing programs and further leverage our technology and existing support infrastructure. We believe we will
be able to control corporate costs over time to enhance margins as general and administrative expenses grow at a slower rate than
our clinic base and sales. At the clinic level, we expect to drive margins and labor efficiencies through continued sales growth
and consistently applied operating standards as our clinic base matures and the average number of patient visits increases. In
addition, we will consider introducing selected and complementary branded products such as nutraceuticals or dietary supplements
and related additional services.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Acquiring existing franchises. </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe that we can accelerate the development
of, and revenue generation from, company-owned or managed clinics through the further selective acquisition of existing franchised
clinics. We will seek out the opportunistic acquisition of existing franchised clinics that meet our criteria for demographics,
site attractiveness, proximity to other clinics and additional suitability factors. Following the completion of the IPO through
December 31, 2017, we acquired 34 existing franchises, subsequently closed three, and continue to operate 31 of them as company-owned
or managed clinics.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Development of company-owned or managed clinics. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We acquired our first company-owned or managed
clinic on December 31, 2014. In the first full calendar quarter after that acquisition, total revenue from company-owned or managed
clinics was $0.4 million, growing to approximately $3.0 million in the quarter ended December 31, 2017. From July, 2016, we ceased
additional expansion of our company-owned or managed clinic portfolio to allow our portfolio of clinics to mature and to focus
resources on the growth of our franchise system. In January, 2017, we sold the assets of six of our 11 clinics in the Chicago area
for a nominal amount to a limited liability company that includes existing franchisees as members, and recorded a related impairment
charge. The limited liability company operates the clinics pursuant to a franchise agreement. We closed the remaining five Chicago-area
clinics, as well as three company-managed clinics in upstate New York. Total revenue from our 47 company-owned or managed clinics
was approximately $11.1 million for the year ended December 31, 2017 as compared to $8.6 million from 61 company-owned or managed
clinics for the year ended December 31, 2016. Through December 31, 2017, revenue from company-owned or managed clinics consisted
of revenue earned from 31 franchised clinics that we acquired, as well as 16 clinics that we developed.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">When we resume the acquisition and development
of company-owned or managed clinics, we intend to target geographic clusters where we are able to increase efficiencies through
a consolidated real estate penetration strategy, leverage cooperative advertisement and marketing, and attain general corporate
and administrative operating efficiencies. We also believe that the development timeline and point of break-even for company-owned
or managed clinics can be shortened and that our revenue from company-owned or managed clinics will ultimately exceed revenue that
would be generated through royalty income from a franchise-only system.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Regulatory Environment</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>HIPAA </i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In an effort to further combat healthcare fraud
and protect patient confidentiality, Congress included several anti-fraud measures in the Health Insurance Portability and Accountability
Act of 1996 (HIPAA). HIPAA created a source of funding for fraud control to coordinate federal, state and local healthcare law
enforcement programs, conduct investigations, provide guidance to the healthcare industry concerning fraudulent healthcare practices,
and establish a national data bank to receive and report final adverse actions. HIPAA also criminalized certain forms of healthcare
fraud against all public and private payors. Additionally, HIPAA mandates the adoption of standards regarding the exchange of healthcare
information in an effort to ensure the privacy and security of electronic patient information. Sanctions for failing to comply
with HIPAA include criminal penalties and civil sanctions. In February 2009, the American Recovery and Reinvestment Act of 2009
(ARRA) was enacted. Title XIII of ARRA, the Health Information Technology for Economic and Clinical Health Act (HITECH), includes
substantial Medicare and Medicaid incentives for providers to adopt electronic health records (&#8220;EHR&#8221;) and grants for
the development of health information exchange (&#8220;HIE&#8221;) systems. Recognizing that HIE and EHR systems will not be implemented
unless the public can be assured that the privacy and security of patient information in such systems is protected, HITECH also
significantly expands the scope of the privacy and security requirements under HIPAA. Most notable are the new mandatory breach
notification requirements and a heightened enforcement scheme that includes increased penalties, and which now apply to business
associates as well as to covered entities. In addition to HIPAA, a number of states have adopted laws and/or regulations applicable
in the use and disclosure of individually identifiable health information that can be more stringent than comparable provisions
under HIPAA and HITECH.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe that our operations substantially
comply with applicable standards for privacy and security of protected healthcare information. We cannot predict what negative
effect, if any, HIPAA/HITECH or any applicable state law or regulation will have on our business.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>State regulations on corporate practice of chiropractic. </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In states that regulate the &#8220;corporate
practice of chiropractic,&#8221; our chiropractic services are provided by legal entities organized under state laws as professional
corporations, or PCs or their equivalents. Each of the PCs is wholly owned by one or more licensed chiropractors, and employs or
contracts with chiropractors in one or more offices. We do not own any capital stock of (or have any other ownership interest in)
any such PC. We and our franchisees that are not owned by chiropractors enter into management services agreements with PCs to provide
the PCs on an exclusive basis with all non-clinical administrative services needed by the chiropractic practice. In November, 2015,
the California Board of Chiropractic Examiners commenced an administrative proceeding to which we were not a party, in which it
claimed that the doctor who owns the PC that we manage in southern California violated California&#8217;s prohibition on the corporate
practice of chiropractic, among other claims, because our management of the clinics operated by his PC involved the exercise of
control over certain clinical aspects of his practice. The California Board of Chiropractic Examiners subsequently dismissed those
claims in congruence with findings of the overseeing administrative judge. In June 2015, the New York Attorney General announced
that it had entered into an Assurance of Discontinuance with a provider of business services to independently owned dental practices
in New York, pursuant to which the provider paid a substantial fine and agreed to change its business and branding practices. While
the effect of the proceeding before the California Board of Chiropractic Examiners and the New York Assurance of Discontinuance
is that our business practices in California and New York may be under stricter scrutiny than elsewhere, we believe we are in substantial
compliance with all applicable laws relating to the corporate practice of chiropractic.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Regulation relating to franchising </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are subject to the rules and regulations of
the Federal Trade Commission and various state laws regulating the offer and sale of franchises. The Federal Trade Commission and
various state laws require that we furnish a Franchise Disclosure Document or FDD containing certain information to prospective
franchisees, and a number of states require registration of the FDD at least annually with state authorities. Included in the information
required to be disclosed in our FDD is our business experience, material litigation, all fees due to us from franchisees, a franchisee&#8217;s
estimated initial investment, restrictions on sources of products and services we impose on franchisees, development and operating
obligations of franchisees, whether we provide financing to franchisees, our training and support obligations and other terms and
conditions of our franchise agreement. We are operating under exemptions from registration in several states based on our qualifications
for exemption as set forth in those states&#8217; laws. Substantive state laws regulating the franchisor-franchisee relationship
presently exist in many states. We believe that our FDD and franchising procedures comply in all material respects with both the
Federal Trade Commission guidelines and all applicable state laws regulating franchising in those states in which we have offered
franchises. As of December 31, 2017, we were registered to sell franchises in every state (where registrations are required); and
could sell franchises in all 50 states.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Other federal, state and local regulation </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are subject to varied federal regulations
affecting the operation of our business. We are subject to the U.S. Fair Labor Standards Act, the U.S. Immigration Reform and Control
Act of 1986, the Occupational Safety and Health Act and various other federal and state laws governing such matters as minimum
wage requirements, overtime, fringe benefits, workplace safety and other working conditions and citizenship requirements. A significant
number of our clinic service personnel are paid at rates related to the applicable minimum wage, and increases in the minimum wage
could increase our labor costs. We are continuing to assess the impact of recently-adopted federal health care legislation on our
health care benefit costs. Many of our smaller franchisees will qualify for exemption from the mandatory requirement to provide
health insurance benefits because of their small number of employees. The imposition of any requirement that we or our franchisees
provide health insurance benefits to our or their employees that are more extensive than the health insurance benefits that we
currently provide to our employees or that franchisees may or may not provide, or the imposition of additional employer paid employment
taxes on income earned by our employees, could have an adverse effect on our results of operations and financial position. Our
distributors and suppliers also may be affected by higher minimum wage and benefit standards, which could result in higher costs
for goods and services supplied to us.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In August, 2015, the National Labor Relations
Board (or &#8220;NLRB&#8221;) adopted a more expansive definition of what it means to be a &#8220;joint employer,&#8221; making
it easier for employees of franchisees to organize and bargain collectively. This NLRB action, as well as a July 2014 NLRB action
holding that McDonald&#8217;s Corporation could be held jointly liable for labor and wage violations by its franchisees, may also
make it easier for a franchisor to be held responsible as employer for a franchisee&#8217;s misconduct. In December, 2017, the
NLRB reversed the standard it had set in 2015 and reinstated a narrower definition of what it means to be a &#8220;joint employer.&#8221;
We believe that this recent NLRB action is favorable to us and makes it less likely that we would be held accountable for the actions
of our franchisees. In February 2018, the NLRB reversed its decision to revert to the narrower (and thus more favorable to us)
definition of &#8220;joint employer,&#8221; due to a conflict of interest on the part of one of the NLRB&#8217;s commissioners.
While this action was taken more on procedural than on policy grounds, it effectively reinstates the NLRB&#8217;s 2015 ruling.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are required to comply with the accessibility
standards mandated by the U.S. Americans with Disabilities Act of 1990 and related federal and state statutes, which generally
prohibit discrimination in accommodation or employment based on disability. We may, in the future, have to modify our clinics to
provide service to or make reasonable accommodations for disabled persons. While these expenses could be material, our current
expectation is that any such actions will not require us to expend substantial funds.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are subject to extensive and varied state
and local government regulation affecting the operation of our business, as are our franchisees, including regulations relating
to public and occupational health and safety, sanitation, fire prevention and franchise operation. Each franchised clinic is subject
to licensing and regulation by a number of governmental authorities, which include zoning, health, safety, sanitation, environmental,
building and fire agencies in the jurisdiction in which the clinic is located. We require our franchisees to operate in accordance
with standards and procedures designed to comply with applicable codes and regulations. However, our or our franchisees&#8217;
inability to obtain or retain health or other licenses would adversely affect operations at the impacted clinic or clinics. Although
we have not experienced and do not anticipate any significant difficulties, delays or failures in obtaining required licenses,
permits or approvals, any such problem could delay or prevent the opening of, or adversely impact the viability of, a particular
clinic. In addition, in order to develop and construct our clinics, we need to comply with applicable zoning and land use regulations.
Federal and state regulations have not had a material effect on our operations to date, but more stringent and varied requirements
of local governmental bodies with respect to zoning and land use could delay or even prevent construction and increase development
costs of new clinics.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Competition</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The chiropractic industry is highly fragmented.
According to First Research&#8217;s report, the top 50 providers of chiropractic services in the United States generate less than
10% of industry revenue. Our competitors include approximately 39,000 independent chiropractic offices currently open throughout
the United States, according to a 2017 Kentley Insights market research report, as well as certain multi-unit operators. We may
also face competition from traditional medical practices, outpatient clinics, physical therapists, med-spas, massage therapists
and sellers of devices intended for home use to address back and joint discomfort. Our three largest multi-unit competitors are
HealthSource Chiropractic, AlignLife Chiropractic &amp; Natural Health Centers and ChiroOne Wellness Centers, all of which are
insurance-based models.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We have identified three competitors who are
attempting to duplicate our cash-only, low cost, appointment-free model. Based on publicly available information, these competitors
each operate less than ten clinics as franchises. We anticipate that other direct competitors will join our industry as our visibility,
reputation and perceived advantages become more widely known. We believe our first mover advantage, proprietary operations systems,
and strong unit level economics will continue to accelerate our growth even with the spawning of additional competition.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Employees</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of March 2, 2018, we had 148 employees on
a full-time basis. None of our employees are members of unions or participate in other collective bargaining arrangements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Facilities</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We lease the property for our corporate headquarters
and all of the properties on which we own or manage clinics. As of March 2, 2018, we leased 47 facilities in which we operate or
intend to operate clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our corporate headquarters are located at 16767
North Perimeter Drive, Suite 240, Scottsdale, Arizona 85260. The term of our lease for this location expires on July 31, 2019.
The primary functions performed at our corporate headquarters are financial, accounting, treasury, marketing, operations, human
resources, information systems support and legal.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are also obligated under non-cancellable leases
for the clinics which we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial
term of five years, include one to two options to renew for terms of five years, and require us to pay a proportionate share of
real estate taxes, insurance, common area maintenance charges and other operating costs.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">As of March 2, 2018, our franchisees operated
355 clinics in 29 states. All of our franchise locations are leased.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Intellectual Property</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Trademarks, trade names and service marks</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"><font style="color: #212121">&#8220;The Joint Chiropractic&#8221;
is our trademark, registered in December 2016, under registration number 5095943. We have also registered "Relief Recovery
Wellness" in February 2018, under registration number 5398367,&nbsp;</font>&#8220;Be Chiro-Practical&#8221; in October 2017,
under registration number 5313693,&nbsp;<font style="color: #212121">&#8220;Relief. On so many levels&#8221; in December 2015,
under registration number 4871809, and &#8220;The Joint&#8221; in April 2015, under registration number 4723892.</font></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0; color: #212121">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0; color: #212121">Additional trademarks previously registered include
&#8220;The Joint&#8230; the Chiropractic Place&#8221; registered in February 2011, under registration number 3922558. We also
registered the words, letters, and stylized form of service mark, &#8220;The Joint&#8230; the Chiropractic Place&#8221; in April
2013 under registration number 4323810.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_003"></a>ITEM 1A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RISK
FACTORS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Risks Related to Our Business</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>New clinics, once opened, may not be profitable, and the increases
in average clinic sales and comparable clinic sales that we have experienced in the past may not be indicative of future results.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our clinics continue to demonstrate increases
in comparable clinic sales even as they mature. Our annual Comp Sales for the full year 2017, for clinics that have been open for
greater than 48 months was 13%. However, we cannot assure you that this will continue for our existing clinics or that clinics
we open in the future will see similar results. In new markets, the length of time before average sales for new clinics stabilize
is less predictable and can be longer than we expect because of our limited knowledge of these markets and consumers&#8217; limited
awareness of our brand. New clinics may not be profitable and their sales performance may not follow historical patterns. In addition,
our average clinic sales and comparable clinic sales for existing clinics may not increase at the rates achieved over the past
several years. Our ability to operate new clinics, especially company-owned or managed clinics, profitably and increase average
clinic sales and comparable clinic sales will depend on many factors, some of which are beyond our control, including:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">consumer awareness and understanding of our brand; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">general economic conditions, which can affect clinic traffic, local rent and labor costs and prices we pay for the supplies we use; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">changes in consumer preferences and discretionary spending; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">competition, either from our competitors in the chiropractic industry or our own clinics; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the identification and availability of attractive sites for new facilities and the anticipated commercial, residential and infrastructure development near our new facilities; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">changes in government regulation; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">other unanticipated increases in costs, any of which could give rise to delays or cost overruns. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">If our new clinics do not perform as planned,
our business and future prospects could be harmed. In addition, if we are unable to achieve our expected average clinics sales,
our business, financial condition and results of operations could be adversely affected.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our failure to manage our growth effectively could harm our business
and operating results.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our growth plan includes a significant number
of new clinics, focused currently on franchised clinics, but in the long term, also including company-owned or managed clinics.
Our existing clinic management systems, administrative staff, financial and management controls and information systems may be
inadequate to support our planned expansion. Those demands on our infrastructure and resources may also adversely affect our ability
to manage our existing clinics. Managing our growth effectively will require us to continue to enhance these systems, procedures
and controls and to hire, train and retain managers and team members. We may not respond quickly enough to the changing demands
that our expansion will impose on our management, clinic teams and existing infrastructure which could harm our business, financial
condition and results of operations. We are currently in the process of replacing and upgrading our management information systems,
and we cannot provide assurances that we will accomplish this without delays, difficulties or service interruptions.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our long-term strategy involves opening new, company-owned or
managed clinics, and is subject to many unpredictable factors.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">One component of our long-term growth strategy
will be to open new company-owned or managed clinics and to operate those clinics on a profitable basis. After the sale or closing
of 14 company-owned or managed clinics in Chicago and Upstate New York during 2017, we currently own or manage 47 company-owned
or managed clinics. We suspended the development of new company-owned or managed clinics from July 2016 in order to stabilize our
corporate clinic portfolio, and when we resume development of such clinics in 2018, we may not be able to open new company-owned
or managed clinics as quickly as planned. In the past, we have experienced delays in opening some franchised clinics, for various
reasons, including the landlord&#8217;s failure to turn over the premises to our franchisee on a timely basis. Such delays could
happen again in future clinic openings. Delays or failures in opening new clinics could materially and adversely affect our growth
strategy and our business, financial condition and results of operations. As we operate more clinics, our rate of expansion relative
to the size of our clinic base will eventually decline.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition, one of our biggest challenges is
locating and securing an adequate supply of suitable new clinic sites in our target markets. Competition for those sites is intense,
and other retail concepts that compete for those sites may have unit economic models that permit them to bid more aggressively
for those sites than we can. There is no guarantee that a sufficient number of suitable sites will be available in desirable areas
or on terms that are acceptable to us in order to achieve our growth plan. Our ability to open new clinics also depends on other
factors, including:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">negotiating leases with acceptable terms; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">identifying, hiring and training qualified employees in each local market; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">timely delivery of leased premises to us from our landlords and punctual commencement and completion of construction; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">managing construction and development costs of new clinics, particularly in competitive markets; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">obtaining construction materials and labor at acceptable costs, particularly in urban markets; </font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">unforeseen engineering or environmental problems with leased premises; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">generating sufficient funds from operations or obtaining acceptable financing to support our future development; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">securing required governmental approvals, permits and licenses (including construction permits and operating licenses) in a timely manner and responding effectively to any changes in local, state or federal laws and regulations that adversely affect our costs or ability to open new clinics; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">avoiding the impact of inclement weather, natural disasters and other calamities. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our expansion into new markets may be more costly and difficult
than we currently anticipate which would result in slower growth than we expect.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Clinics we open in new markets may take longer
to reach expected sales and profit levels on a consistent basis and may have higher construction, occupancy, marketing or operating
costs than clinics we open in existing markets, thereby affecting our overall profitability. New markets may have competitive conditions,
consumer tastes and discretionary spending patterns that are more difficult to predict or satisfy than our existing markets. We
may need to make greater investments than we originally planned in advertising and promotional activity in new markets to build
brand awareness. We may find it more difficult in new markets to hire, motivate and keep qualified employees who share our vision
and culture. We may also incur higher costs from entering new markets, particularly with company-owned clinics if, for example,
we hire and assign regional managers to manage comparatively fewer clinics than in more developed markets. For these reasons, both
our new franchised clinics and our new company-owned or managed clinics may be less successful than our existing franchised clinics
or may achieve target rates of patient visits at a slower rate. If we do not successfully execute our plans to enter new markets,
our business, financial condition and results of operations could be materially adversely affected.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Opening new clinics in existing markets may negatively affect
revenue at our existing clinics.</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The target area of our clinics varies by location
and depends on a number of factors, including population density, other available retail services, area demographics and geography.
As a result, the opening of a new clinic in or near markets in which we already have clinics could adversely affect the revenues
of those existing clinics. Existing clinics could also make it more difficult to build our patient base for a new clinic in the
same market. Our business strategy does not entail opening new clinics that we believe will materially affect revenue at our existing
clinics, but we may selectively open new clinics in and around areas of existing clinics that are operating at or near capacity
to effectively serve our patients. Revenue &#8220;cannibalization&#8221; between our clinics may become significant in the future
as we continue to expand our operations and could affect our revenue growth, which could, in turn, adversely affect our business,
financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Any acquisitions that we make could disrupt our business and
harm our financial condition.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">From time to time, we may evaluate potential
strategic acquisitions of existing franchised clinics to facilitate our growth. We may not be successful in identifying acquisition
candidates. In addition, we may not be able to continue the operational success of any franchised clinics we acquire or successfully
integrate any businesses that we acquire. We may have potential write-offs of acquired assets and an impairment of any goodwill
recorded as a result of acquisitions. Furthermore, the integration of any acquisition may divert management&#8217;s time and resources
from our core business and disrupt our operations or may result in conflicts with our business. Any acquisition may not be successful,
may reduce our cash reserves and may negatively affect our earnings and financial performance. We cannot ensure that any acquisitions
we make will not have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Damage to our reputation or our brand in existing or new markets
could negatively impact our business, financial condition and results of operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe we have built our reputation on high
quality patient care, and we must protect and grow the value of our brand to continue to be successful in the future. Our brand
may be diminished if we do not continue to make investments in areas such as marketing and advertising, as well as the day-to-day
investments required for facility operations, equipment upgrades and staff training. Any incident, real or perceived, regardless
of merit or outcome, that erodes our brand, such as failure to comply with federal, state or local regulations including allegations
or perceptions of non-compliance or failure to comply with ethical and operating standards, could significantly reduce the value
of our brand, expose us to adverse publicity and damage our overall business and reputation. Further, our brand value could suffer
and our business could be adversely affected if patients perceive a reduction in the quality of service or staff.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We may be unable to maintain or improve our operating margins,
which could adversely affect our financial condition and ability to grow.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">If we are unable to successfully manage our growth,
we may not be able to capture the efficiencies and opportunities that we expect from our expansion strategy. If we are not able
to capture expected efficiencies of scale, maintain patient volumes, improve our systems and equipment, continue our cost discipline
and retain appropriate chiropractors and overall labor levels, our operating margins may stagnate or decline, which could have
a material adverse effect on our business, financial condition and results of operations and adversely affect the price of our
common stock.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We have experienced net losses and may not achieve or sustain
profitability in the future.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We have experienced periods of net losses, including
consolidated net losses of approximately $3.3 and $15.2 million for the years ended December 31, 2017 and 2016, respectively. Our
revenue may not grow and we may not achieve or maintain profitability in the future. Even if we do achieve profitability, we may
not sustain or increase profitability on a quarterly or annual basis in the future. Our ability to achieve profitability will be
affected by the other risks and uncertainties described in this section and in Management&#8217;s Discussion and Analysis. If we
are not able to achieve, sustain or increase profitability, our business will be materially adversely affected and the price of
our common stock may decline.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our marketing programs may not be successful.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We incur costs and expend other resources in
our marketing efforts to attract and retain patients. Our marketing activities are principally focused on increasing brand awareness
and driving patient volumes. As we open new facilities, we undertake aggressive marketing campaigns to increase community awareness
about our growing presence. We plan to utilize targeted marketing efforts within local neighborhoods through channels such as radio,
digital media, community sponsorships and events, and a robust online/social media presence. These initiatives may not be successful,
resulting in expenses incurred without the benefit of higher revenue. Our ability to market our services may be restricted or limited
by federal or state law.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We will be subject to all of the risks associated with leasing
space subject to long-term non-cancelable leases for clinics that we intend to operate.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We do not own and we do not intend to own any
of the real property where our company-owned or managed clinics will operate. We expect the spaces for the company-owned or managed
clinics we intend to open in the future will be leased. We anticipate that our leases generally will have an initial term of five
or ten years and generally can be extended only in five-year increments (at increased rates). We expect that all of our leases
will require a fixed annual rent, although some may require the payment of additional rent if clinic sales exceed a negotiated
amount. We expect that our leases will typically be net leases, which require us to pay all of the cost of insurance, taxes, maintenance
and utilities, and that these leases will not be cancellable by us. If a future company-owned clinic is not profitable, resulting
in its closure, we may nonetheless be committed to perform our obligations under the applicable lease including, among other things,
paying the base rent for the balance of the lease term. In addition, we may fail to negotiate renewals as each of our leases expires,
either on commercially acceptable terms or at all, which could cause us to pay increased occupancy costs or to close stores in
desirable locations. These potential increases in occupancy costs and the cost of closing company-owned or managed clinics could
materially adversely affect our business, financial condition or results of operations. We have settled disputes over future rent
with landlords at eleven of the fourteen clinics that we either closed or never opened. We are currently negotiating with the remaining
three landlords.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our intended reliance on sources of revenue other than from franchise
and regional developer licenses exposes us to risks including the loss of revenue and reduction of working capital.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">From the commencement of our operations until
we began to acquire or open company-owned or managed clinics, we have relied exclusively on the sale of franchises and regional
developer licenses as sources of revenue until the franchises we have sold begin to generate royalty revenues. While we have determined
to re-emphasize our franchising strategy in the near term, we may place less reliance in the future on these sources of revenue
when we resume acquiring, developing and operating company-owned or managed clinics. Prior to January 1, 2018, we did not recognize
revenues from company-owned or managed clinics until the opening of those clinics, and we will be required to use our working capital
to operate our business and to develop company-owned or managed clinics. If the opening of our company-owned or managed clinics
is delayed or if the cost of developing company-owned or managed clinics exceeds our expectations, we may experience insufficient
working capital to fully implement our development plans, and our business, financial condition and results of operations could
be adversely affected.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our potential need to raise additional capital to accomplish
our objectives of expanding into new markets and selectively developing company-owned or managed clinics exposes us to risks including
limiting our ability to develop or acquire clinics and limiting our financial flexibility.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We intend to resume the selective development
and acquisition of company-owned or managed clinics and related businesses. If we do not have sufficient cash resources, our ability
to develop and acquire clinics and related businesses could be limited unless we are able to obtain additional capital through
future debt or equity financings. Using cash to finance development and acquisition of clinics and related businesses could limit
our financial flexibility by reducing cash available for operating purposes. Using debt financing could result in lenders imposing
financial covenants that limit our operations and financial flexibility. Using equity financing may result in dilution of ownership
interests of our existing stockholders. We may also use common stock as consideration for the future acquisition of clinics and
related businesses. If our common stock does not maintain a sufficient market value or if prospective acquisition candidates are
unwilling to accept our common stock as part of the consideration for the sale of their clinics or businesses, we may be required
to use more of our cash resources or greater debt financing to complete these acquisitions.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Changes in economic conditions and adverse weather and other
unforeseen conditions could materially affect our ability to maintain or increase sales at our clinics or open new clinics.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our services emphasize maintenance therapy, which
is generally not a medical necessity, and should be viewed as a discretionary medical expenditure. The United States in general
or the specific markets in which we operate may suffer from depressed economic activity, recessionary economic cycles, higher fuel
or energy costs, low consumer confidence, high levels of unemployment, reduced home values, increases in home foreclosures, investment
losses, personal bankruptcies, reduced access to credit or other economic factors that may affect consumer discretionary spending.
Traffic in our clinics could decline if consumers choose to reduce the amount they spend on non-critical medical procedures. Negative
economic conditions might cause consumers to make long-term changes to their discretionary spending behavior, including reducing
medical discretionary spending on a permanent basis. In addition, given our geographic concentrations in the West, Southwest and
mid-Atlantic regions of the United States, economic conditions in those particular areas of the country could have a disproportionate
impact on our overall results of operations, and regional occurrences such as local strikes, terrorist attacks, increases in energy
prices, adverse weather conditions, tornadoes, earthquakes, hurricanes, floods, droughts, fires or other natural or man-made disasters
could materially adversely affect our business, financial condition and results of operations. Adverse weather conditions may also
impact customer traffic at our clinics. All of our clinics depend on visibility and walk-in traffic, and the effects of adverse
weather may decrease visits to malls in which our clinics are located and negatively impact our revenues. If clinic sales decrease,
our profitability could decline as we spread fixed costs across a lower level of sales. Reductions in staff levels, asset impairment
charges and potential clinic closures could result from prolonged negative clinic sales, which could materially adversely affect
our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our dependence on the success of our franchisees exposes us to
risks including the loss of royalty revenue and harm to our brand.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">A substantial portion of our revenues comes from
royalties generated by our franchised clinics. We anticipate that franchise royalties will represent a substantial part of our
revenues in the future. As of December 31, 2017, we had franchisees operating 352 clinics. Accordingly, we are reliant on the performance
of our franchisees in successfully opening and operating their clinics and paying royalties to us on a timely basis. Our franchise
system subjects us to a number of risks as described in the next four risk factors, any one of which could impact our ability to
collect royalty payments from our franchisees, may harm the goodwill associated with our brand and may materially adversely affect
our business and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our franchisees are independent operators over whom we have limited
control.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Franchisees are independent operators, and their
employees are not our employees. Accordingly, their actions are outside of our control. Although we have developed criteria to
evaluate and screen prospective franchisees, we cannot be certain that our franchisees will have the business acumen or financial
resources necessary to operate successful franchises in their approved locations, and state franchise laws may limit our ability
to terminate or modify these franchise agreements. Moreover, despite our training, support and monitoring, franchisees may not
successfully operate clinics in a manner consistent with our standards and requirements, or may not hire and adequately train qualified
personnel. The failure of our franchisees to operate their franchises successfully and the actions taken by their employees could
have a material adverse effect on our reputation, our brand and our ability to attract prospective franchisees, and on our business,
financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">A July, 2014 decision by the United States National
Labor Relations Board (or &#8220;NLRB&#8221;) held that McDonald&#8217;s Corporation could be held jointly liable for labor and
wage violations by its franchisees. Also, in August, 2015, the NLRB adopted a more expansive definition of what it means to be
a &#8220;joint employer,&#8221; making it easier for employees of franchisees to organize and bargain collectively. In December,
2017, the NLRB reversed the standard it had set in 2015 and reinstated a narrower definition of what it means to be a &#8220;joint
employer.&#8221; We believe that this recent NLRB action is favorable to us and makes it less likely that we would be held accountable
for the actions of our franchisees, however, if this standard is again expanded, or if the McDonald&#8217;s decision is upheld,
it could result in us having responsibility for damages, reinstatement, back pay and penalties in connection with labor law violations
by our franchisees over whom we have no control, and could have a material adverse effect on our financial condition and results
of operations. In February 2018, the NLRB reversed its decision to revert to the narrower (and thus more favorable to us) definition
of &#8220;joint employer,&#8221; due to a conflict of interest on the part of one of the NLRB&#8217;s commissioners. While this
action was taken more on procedural than on policy grounds, it effectively reinstates the NLRB&#8217;s 2015 ruling.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are subject to the risk that our franchise agreements may
be terminated or not renewed.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Each franchise agreement is subject to termination
by us as the franchisor in the event of a default, generally after expiration of applicable cure periods, although under certain
circumstances a franchise agreement may be terminated by us upon notice without an opportunity to cure. The default provisions
under the franchise agreements are drafted broadly and include, among other things, any failure to meet operating standards and
actions that may threaten our intellectual property. In addition, each franchise agreement has an expiration date. Upon the expiration
of the franchise agreement, we or the franchisee may, or may not, elect to renew the franchise agreement. If the franchise agreement
is renewed, the franchisee will receive a new franchise agreement for an additional term. Such option, however, is contingent on
the franchisee&#8217;s execution of the then-current form of franchise agreement (which may include increased royalty payments,
advertising fees and other costs) and the payment of a renewal fee. If a franchisee is unable or unwilling to satisfy any of the
foregoing conditions, we may elect not to renew the expiring franchise agreement, in which event the franchise agreement will terminate
upon expiration of its term. The termination or non-renewal of a franchise agreement could result in the reduction of royalty payments
we receive.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our franchisees may not meet timetables for opening their clinics,
which could reduce the royalties we receive.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our franchise agreements specify a timetable
for opening the clinic. Failure by our franchisees to open their clinics within the specified time limit would result in the reduction
of royalty payments we receive and could result in the termination of the franchise agreement. As of December 31, 2017, we have
104 active licenses which we believe to be developable, and an additional eight letters of intent for future clinic licenses. Of
these, 66 have not met their development requirements within the time periods specified in their franchise agreements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our franchisees may elect bankruptcy protection and deprive us
of income.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The bankruptcy of a franchisee could negatively
impact our ability to collect payments due under such franchisee&#8217;s franchise agreement. In a franchisee bankruptcy, the bankruptcy
trustee may reject the franchisee&#8217;s franchise agreement pursuant to Section 365 under the United States Bankruptcy Code,
in which case we would no longer receive royalty payments from the franchisee.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our regional developers are independent operators over whom we
have limited control.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our regional developers are independent operators.
Accordingly, their actions are outside of our control. We depend upon our regional developers to sell a minimum number of franchises
within their territory and to assist the purchasers of those franchises to develop and operate their clinics. The failure by regional
developers to sell the specified minimum number of franchises within the time limits set forth in their regional developer license
agreements would reduce the franchise fees we receive, delay the payment of royalties to us and result in a potential event of
default under the regional developer license agreement. Of our total of eighteen regional developers as of December 31, 2017, ten
of which were sold during 2017, three have not met their minimum franchise opening requirements within the time periods specified
in their regional developer agreements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our ability to operate effectively could be impaired if we fail
to attract and retain our executive officers.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our success depends, in part, upon the continuing
contributions of our executive officers and key employees at the management level. Although we have employment agreements with
certain of our key executive officers, there is no guarantee that they will not leave. The loss of the services of any of our executive
officers or the failure to attract other executive officers could have a material adverse effect on our business or our business
prospects. If we lose the services of any of our key employees at the operating or regional level, we may not be able to replace
them with similarly qualified personnel, which could harm our business.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>A lack of qualified employees will significantly hinder our growth
plans and adversely affect our results of operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">As we grow, our ability to increase productivity
and profitability will be limited by our ability to employ, train and retain skilled personnel. There can be no assurance that
we will be able to maintain an adequate skilled labor force necessary to operate efficiently, that our labor expenses will not
increase as a result of a shortage in the supply of skilled personnel or that we will not have to curtail our planned internal
growth as a result of labor shortages.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We may not be able to successfully recruit and retain qualified
chiropractors.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our success depends upon our continuing ability
to recruit and retain qualified chiropractors. In the event we are unable to attract a sufficient number of qualified chiropractors,
our growth rate may suffer.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our clinics and chiropractors compete for patients in a highly
competitive environment that may make it more difficult to increase patient volumes and revenues.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The business of providing chiropractic services
is highly competitive in each of the markets in which our clinics operate. The primary bases of such competition are quality of
care and reputation, price of services, marketing and advertising strategy and implementation, convenience, traffic flow and visibility
of office locations and hours of operation. Our clinics compete with all other chiropractors in their local market. Many of those
chiropractors have established practices and reputations in their markets. Some of these competitors and potential competitors
may have financial resources, affiliation models, reputations or management expertise that provide them with competitive advantages
over us, which may make it difficult to compete against them. Our three largest multi-unit competitors are HealthSource Chiropractic,
which currently operates 295 units; AlignLife Chiropractic &amp; Natural Health Centers, which currently operates 23 units; and
ChiroOne Wellness Centers, which currently operates 41 units. Each of these competitors is currently operating under an insurance
based model. In addition, a number of other chiropractic franchises and chiropractic practices that are attempting to duplicate
or follow our business model are currently operating in our markets and in other parts of the country and may enter our existing
markets in the future.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our success is dependent on the chiropractors who control the
professional corporations, or PC owners, with whom we enter into management services agreements, and we may have difficulty locating
qualified chiropractors to replace PC owners.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In states that regulate the corporate practice
of chiropractic, our chiropractic services are provided by legal entities organized under state laws as professional corporations,
or PCs and their equivalents. Each PC employs or contracts with chiropractors in one or more offices. Each of the PCs is wholly
owned by one or more licensed chiropractors, or medical professionals as state law may require, and we do not own any capital stock
of any PC. We and our franchisees that are not owned by chiropractors enter into management services agreements with PCs to provide
on an exclusive basis all non-clinical services of the chiropractic practice. The PC owner is critical to the success of a clinic
because he or she has control of all clinical aspects of the practice of chiropractic and the provision of chiropractic services.
Upon the departure of a PC owner, we may not be able to locate one or more suitably qualified licensed chiropractors to hold the
ownership interest in the PC and maintain the success of the departing PC owner.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our management services agreements with our affiliated PCs could
be challenged by a state or chiropractor under laws regulating the practice of chiropractic, and some state chiropractic boards
have made inquiries concerning our business model.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The laws of every state in which we operate contain
restrictions on the practice of chiropractic and control over the provision of chiropractic services. The laws of many states where
we operate permit a chiropractor to conduct a chiropractic practice only as an individual, a member of a partnership or an employee
of a PC, limited liability company or limited liability partnership. These laws typically prohibit chiropractors from splitting
fees with non-chiropractors and prohibit non-chiropractic entities, such as chiropractic management services organizations, from
engaging in the practice of chiropractic and from employing chiropractors. The specific restrictions against the corporate practice
of chiropractic, as well as the interpretation of those restrictions by state regulatory authorities, vary from state to state.
However, the restrictions are generally designed to prohibit a non-chiropractic entity from controlling or directing clinical care
decision-making, engaging chiropractors to practice chiropractic or sharing professional fees. The form of management agreement
that we utilize, and that we recommend to our franchisees that are management service organizations, explicitly prohibits the management
service organization from controlling or directing clinical care decisions. However, there can be no assurance that all of our
franchisees that are management service organizations will strictly follow the provisions in our recommended form of management
agreement. The laws of many states also prohibit chiropractic practitioners from paying any portion of fees received for chiropractic
services in consideration for the referral of a patient. Any challenge to our contractual relationships with our affiliated PCs
by chiropractors or regulatory authorities could result in a finding that could have a material adverse effect on our operations,
such as voiding one or more management services agreements. Moreover, the laws and regulatory environment may change to restrict
or limit the enforceability of our management services agreements. We could be prevented from affiliating with chiropractor-owned
PCs or providing comprehensive business services to them in one or more states.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In February, 2015, the Arkansas Board of Chiropractic
Examiners questioned whether our business model might violate Arkansas law in its response to an inquiry we made on behalf of one
of our franchisees. While the Arkansas Board did not thereafter pursue the matter of a possible violation, it might choose to do
so at any time in the future. The Kansas Healing Arts Board, in response to a third-party complaint about one of our franchisees,
sent a letter to the franchisee in February 2015 questioning whether the franchise business model might violate Kansas law regarding
the unauthorized practice of chiropractic care. We and the franchisee have had several communications with the Kansas Board with
respect to modifying the management agreement to address its concerns, but we have no assurance that changes to the agreement will
satisfy these concerns. The Oregon Board of Chiropractic Examiners has made several inquiries since our franchisees began operating
in Oregon. While we have satisfied these past inquiries by providing a brief response or documentation, recently the Oregon Board
has asked to meet with the franchisee&#8217;s PC chiropractor owner to address questions which may relate to our business model.
In February 2018, the Oregon Board asked for clarification regarding ownership of our franchise locations operating in Oregon,
and we intend to respond with the requested clarification.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In November, 2015, the California Board of Chiropractic
Examiners commenced an administrative proceeding to which we are not a party, in which it claimed that the doctor who owns the
PC that we manage in southern California violated California&#8217;s prohibition on the corporate practice of chiropractic, among
other claims, because our management of the clinics operated by his PC involved the exercise of control over certain clinical aspects
of his practice. The claims were subsequently dismissed congruent with the decision of the administrative law judge who conducted
the proceeding; however, we cannot assure you that similar claims will not be made in the future, either against us or our affiliated
PCs.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The New York Attorney General&#8217;s recent
investigation into the practices of a provider of business support services to independently owned dental practices may mean that
our business model will be subject to greater scrutiny in New York. The New York Attorney General concluded that the provider,
Aspen Dental Management, improperly made business decisions impacting clinical matters, illegally engaged in fee-splitting with
dental practices and required the dental practices to use the &#8220;Aspen Dental&#8221; trade name in a manner that had the potential
to mislead consumers into believing that the &#8220;Aspen Dental&#8221;&nbsp;&#8212;- branded offices were under common ownership
with the provider. In June 2015, the New York Attorney General agreed to an Assurance of Discontinuance, pursuant to which Aspen
Dental paid a substantial fine and agreed to change its business and branding practices, including changes to its website and marketing
materials in order to make clear that the Aspen-branded dental offices were independently owned and operated. The New York Attorney
General could similarly choose to challenge our contractual relationships with our affiliated PCs in New York and, in particular,
might question whether use of The Joint trademark by our affiliated PCs misleads consumers, causing them to incorrectly conclude
that we are the provider of chiropractic treatment.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Recent decisions by the United States National Labor Relations
Board expanding the meaning of &#8220;joint employer&#8221; mean that we could have liability for employment law violations by
our franchisees.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">A July, 2014 decision by the United States National
Labor Relations Board, or the NLRB, held that McDonald&#8217;s Corporation could be held liable as a &#8220;joint employer&#8221;
for labor and wage violations by its franchisees. Subsequently, the NLRB issued a number of complaints against McDonald&#8217;s
Corporation in connection with these violations. Additionally, an August 2015 decision by the NLRB held that Browning-Ferris Industries
is a &#8220;joint employer&#8221; obligated to negotiate with the Teamsters union over workers supplied by a contract staffing
firm within one of its recycling plants. In January 2016, Browning-Ferris Industries filed an appeal in a U.S. appellate court
of an unfair labor practices charge arising out of this NLRB decision.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In December, 2017, the NLRB reversed the standard
it had set in 2015 and reinstated a narrower definition of what it means to be a &#8220;joint employer.&#8221; We believe that
this recent NLRB action is favorable to us and makes it less likely that we would be held accountable for the actions of our franchisees,
However, if the expanded definition of &#8220;joint employer&#8221; is upheld in the Browning-Ferris appeal or in an expected appeal
of the McDonald&#8217;s decision, it could result in us having responsibility for damages, reinstatement, back pay and penalties
in connection with labor law violations by our franchisees over whom we have no control and could have a material adverse effect
on our financial condition and results of operations. In February 2018, the NLRB reversed its decision to revert to the narrower
(and thus more favorable to us) definition of &#8220;joint employer,&#8221; due to a conflict of interest on the part of one of
the NLRB&#8217;s commissioners. While this action was taken more on procedural than on policy grounds, it effectively reinstates
the NLRB&#8217;s 2015 ruling.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We and our affiliated chiropractor-owned PCs are subject to complex
laws, rules and regulations, compliance with which may be costly and burdensome.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We, our franchisees and the chiropractor-owned
PCs to which we and our franchisees provide management services, are subject to extensive federal, state and local laws, rules
and regulations, including:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">state regulations on the practice of chiropractic; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the Health Insurance Portability and Accountability Act of 1996, as amended, and its implementing regulations, or HIPAA, and other federal and state laws governing the collection, dissemination, use, security and confidentiality of patient-identifiable health and financial information; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">federal and state laws and regulations which contain anti-kickback and fee-splitting provisions and restrictions on referrals; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the federal Fair Debt Collection Practices Act and similar state laws that restrict the methods that we and third-party collection companies may use to contact and seek payment from patients regarding past due accounts; and</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">state and federal labor laws, including wage and hour laws. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Many of the above laws, rules and regulations
applicable to us, our franchisees and our affiliated PCs are ambiguous, have not been definitively interpreted by courts or regulatory
authorities and vary from jurisdiction to jurisdiction. Accordingly, we may not be able to predict how these laws and regulations
will be interpreted or applied by courts and regulatory authorities, and some of our activities could be challenged. In addition,
we must consistently monitor changes in the laws and regulatory schemes that govern our operations. Although we have tried to structure
our business and contractual relationships in compliance with these laws, rules and regulations in all material respects, if any
aspect of our operations were found to violate applicable laws, rules or regulations, we could be subject to significant fines
or other penalties, required to cease operations in a particular jurisdiction, prevented from commencing operations in a particular
state or otherwise be required to revise the structure of our business or legal arrangements. Our efforts to comply with these
laws, rules and regulations may impose significant costs and burdens, and failure to comply with these laws, rules and regulations
may result in fines or other charges being imposed on us.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We conduct business in a heavily regulated industry and, if we
fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes
to our operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The healthcare industry is heavily regulated
and closely scrutinized by federal, state and local governments. Comprehensive statutes and regulations govern the manner in which
we provide and bill for services, our contractual relationships with our physicians, vendors and customers, our marketing activities
and other aspects of our operations. Failure to comply with these laws can result in civil and criminal penalties such as fines,
damages, overpayment recoupment, loss of enrollment status or exclusion from government healthcare programs. The risk of our being
found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by
regulatory authorities or the courts, and their provisions are sometimes open to multiple interpretations. Any action against us
for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal
expenses and divert our managements&#8217; attention from the operation of our business.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our chiropractors are also subject to ethical
guidelines and operating standards of professional and trade associations and private accreditation agencies. Compliance with these
guidelines and standards is often required by our contracts with our customers or to maintain our reputation. The laws, regulations
and standards governing the provision of healthcare services may change significantly in the future. New or changed healthcare
laws, regulations or standards may materially and adversely affect our business. In addition, a review of our business by judicial,
law enforcement, regulatory or accreditation authorities could result in a determination that could adversely affect our operations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our facilities are subject to extensive federal and state laws
and regulations relating to the privacy and security of individually identifiable information.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">HIPAA required the United States Department of
Health and Human Service, or HHS, to adopt standards to protect the privacy and security of individually identifiable health-related
information, or PHI. HHS released final regulations containing privacy standards in December 2000 and published revisions to the
final regulations in August 2002. The privacy regulations extensively regulate the use and disclosure of PHI. The regulations also
provide patients with significant rights related to understanding and controlling how their health information is used or disclosed.
The security regulations require healthcare providers to implement administrative, physical and technical practices to protect
the security of individually identifiable health information that is maintained or transmitted electronically. The Health Information
Technology for Economic and Clinical Health Act, or HITECH, which was signed into law in February of 2009, enhanced the privacy,
security and enforcement provisions of HIPAA by, among other things, extending HIPAA&#8217;s privacy and security standards to
&#8220;business associates,&#8221; which, like us, are independent contractors or agents of covered entities (such as the chiropractic
PCs and other healthcare providers) that create, receive, maintain, or transmit PHI in connection with providing a service for
or on behalf of a covered entity. HITECH also established security breach notification requirements, created a mechanism for enforcement
of HIPAA by state attorneys general, and increased penalties for HIPAA violations. Violations of HIPAA or HITECH could result in
civil or criminal penalties. In addition to HIPAA, there are numerous federal and state laws and regulations addressing patient
and consumer privacy concerns, including unauthorized access or theft of personal information. State statutes and regulations vary
from state to state. Lawsuits, including class actions and action by state attorneys general, directed at companies that have experienced
a privacy or security breach also can occur. We have established policies and procedures in an effort to ensure compliance with
these privacy related requirements. However, if there is a breach, we may be subject to various penalties and damages and may be
required to incur costs to mitigate the impact of the breach on affected individuals.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are subject to the data privacy, security and breach notification
requirements of HIPAA and other data privacy and security laws, and the failure to comply with these rules, or allegations that
we have failed to do so, can result in civil or criminal sanctions.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">HIPAA required the United States Department of
Health and Human Service, or HHS, to adopt standards to protect the privacy and security of certain health-related information.
The HIPAA privacy regulations contain detailed requirements concerning the use and disclosure of individually identifiable health
information and the grant of certain rights to patients with respect to such information by &#8220;covered entities.&#8221; As
a provider of healthcare who conducts certain electronic transactions, each of our facilities is considered a covered entity under
HIPAA. We have taken actions to comply with the HIPAA privacy regulations and believe that we are in substantial compliance with
those regulations. These actions include the creation and implementation of policies and procedures, staff training, execution
of HIPAA-compliant contractual arrangements with certain service providers and various other measures. Ongoing implementation and
oversight of these measures involves significant time, effort and expense.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition to the privacy requirements, HIPAA
covered entities must implement certain administrative, physical and technical security standards to protect the integrity, confidentiality
and availability of certain electronic health-related information received, maintained or transmitted by covered entities or their
business associates. We have taken actions in an effort to be in compliance with these security regulations and believe that we
are in substantial compliance, however, a security incident that bypasses our information security systems causing an information
security breach, loss of protected health information or other data subject to privacy laws or a material disruption of our operational
systems could result in a material adverse impact on our business, along with fines. Ongoing implementation and oversight of these
security measures involves significant time, effort and expense.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The Health Information Technology for Economic
and Clinical Health Act, or HITECH, as implemented in part by an omnibus final rule published in the Federal Register on January
25, 2013, further requires that patients be notified of any unauthorized acquisition, access, use, or disclosure of their unsecured
protected health information, or PHI, that compromises the privacy or security of such information. HHS has established the presumption
that all unauthorized uses or disclosures of unsecured protected health information constitute breaches unless the covered entity
or business associate establishes that there is a low probability the information has been compromised. HITECH and implementing
regulations specify that such notifications must be made without unreasonable delay and in no case later than 60 calendar days
after discovery of the breach. If a breach affects 500 patients or more, it must be reported immediately to HHS, which will post
the name of the breaching entity on its public website. Breaches affecting 500 patients or more in the same state or jurisdiction
must also be reported to the local media. If a breach involves fewer than 500 people, the covered entity must record it in a log
and notify HHS of such breaches at least annually. These breach notification requirements apply not only to unauthorized disclosures
of unsecured PHI to outside third parties, but also to unauthorized internal access to or use of such PHI.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">HITECH significantly expanded the scope of the
privacy and security requirements under HIPAA and increased penalties for violations. The amount of penalty that may be assessed
depends, in part, upon the culpability of the applicable covered entity or business associate in committing the violation. Some
penalties for certain violations that were not due to &#8220;willful neglect&#8221; may be waived by the Secretary of HHS in whole
or in part, to the extent that the payment of the penalty would be excessive relative to the violation. HITECH also authorized
state attorneys general to file suit on behalf of residents of their states. Applicable courts may award damages, costs and attorneys&#8217;
fees related to violations of HIPAA in such cases. HITECH also mandates that the Secretary of HHS conduct periodic compliance audits
of a cross-section of HIPAA covered entities and business associates. Every covered entity and business associate is subject to
being audited, regardless of the entity&#8217;s compliance record.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">States may impose more protective privacy restrictions
in laws related to health information and may afford individuals a private right of action with respect to the violation of such
laws. Both state and federal laws are subject to modification or enhancement of privacy protection at any time. We are subject
to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These statutes
vary and could impose additional requirements on us and more severe penalties for disclosures of health information. If we fail
to comply with HIPAA or similar state laws, including laws addressing data confidentiality, security or breach notification, we
could incur substantial monetary penalties and our reputation could be damaged.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition, states may also impose restrictions
related to the confidentiality of personal information that is not considered &#8220;protected health information&#8221; under
HIPAA. Such information may include certain identifying information and financial information of our patients. Theses state laws
may impose additional notification requirements in the event of a breach of such personal information. Failure to comply with such
data confidentiality, security and breach notification laws may result in substantial monetary penalties.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our business model depends on proprietary and third-party management
information systems that we use to, among other things, track financial and operating performance of our clinics, and any failure
to successfully design and maintain these systems or implement new systems could materially harm our operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We depend on integrated management information
systems, some of which are provided by third parties, and standardized procedures for operational and financial information, as
well as for patient records and our billing operations. We are currently replacing and upgrading our management information systems.
We may experience unanticipated delays, complications, data breaches or expenses in replacing, upgrading, implementing, integrating,
and operating our systems. Our management information systems regularly require modifications, improvements or replacements that
may require both substantial expenditures as well as interruptions in operations. Our ability to implement these systems is subject
to the availability of skilled information technology specialists to assist us in creating, implementing and supporting these systems.
Our failure to successfully design, implement and maintain all of our systems could have a material adverse effect on our business,
financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>If we fail to properly maintain the integrity of our data or
to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially
adversely affected.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We increasingly use electronic means to interact
with our customers and collect, maintain and store individually identifiable information, including, but not limited to, personal
financial information and health-related information. Despite the security measures we have in place to ensure compliance with
applicable laws and rules, our facilities and systems, and those of our third-party service providers, may be vulnerable to security
breaches, acts of cyber terrorism, vandalism or theft, computer viruses, misplaced or lost data, programming and/or human errors
or other similar events. Additionally, the collection, maintenance, use, disclosure and disposal of individually identifiable data
by our businesses are regulated at the federal and state levels as well as by certain financial industry groups, such as the Payment
Card Industry organization. Federal, state and financial industry groups may also consider from time to time new privacy and security
requirements that may apply to our businesses. Compliance with evolving privacy and security laws, requirements, and regulations
may result in cost increases due to necessary systems changes, new limitations or constraints on our business models and the development
of new administrative processes. They also may impose further restrictions on our collection, disclosure and use of individually
identifiable information that is housed in one or more of our databases. Noncompliance with privacy laws, financial industry group
requirements or a security breach involving the misappropriation, loss or other unauthorized disclosure of personal, sensitive
and/or confidential information, whether by us or by one of our vendors, could have material adverse effects on our business, operations,
reputation and financial condition, including decreased revenue; material fines and penalties; increased financial processing fees;
compensatory, statutory, punitive or other damages; adverse actions against our licenses to do business; and injunctive relief
whether by court or consent order.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>If our security systems are breached, we may face civil liability
and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract
and retain patients.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Techniques used to gain unauthorized access to
corporate data systems are constantly evolving, and we may be unable to anticipate or prevent unauthorized access to data pertaining
to our patients, including credit card and debit card information and other personally identifiable information. Our systems, which
are supported by our own systems and those of third-party vendors, are vulnerable to computer malware, Trojans, viruses, worms,
break-ins, phishing attacks, denial-of-service attacks, attempts to access our servers in an unauthorized manner, or other attacks
on and disruptions of our and third-party vendor computer systems, any of which could lead to system interruptions, delays, or
shutdowns, causing loss of critical data or the unauthorized access to personally identifiable information. If an actual or perceived
breach of security occurs on our systems or a vendor&#8217;s systems, we may face civil liability and reputational damage, either
of which would negatively affect our ability to attract and retain patients. We also would be required to expend significant resources
to mitigate the breach of security and to address related matters.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We may not be able to effectively control the
unauthorized actions of third parties who may have access to the patient data we collect. Any failure, or perceived failure, by
us to maintain the security of data relating to our patients and employees, and to comply with our posted privacy policy, laws
and regulations, rules of self-regulatory organizations, industry standards and contractual provisions to which we may be bound,
could result in the loss of confidence in us, or result in actions against us by governmental entities or others, all of which
could result in litigation and financial losses, and could potentially cause us to lose patients, revenue and employees.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are subject to a number of risks related to credit card and
debit card payments we accept.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We accept payments through credit and debit card
transactions. For credit and debit card payments, we pay interchange and other fees, which may increase over time. An increase
in those fees would require us to either increase the prices we charge for our services, which could cause us to lose patients
and revenue, or absorb an increase in our operating expenses, either of which could harm our operating results.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">If we or any of our processing vendors have problems
with our billing software, or the billing software malfunctions, it could have an adverse effect on patient satisfaction and could
cause one or more of the major credit card companies to disallow our continued use of their payment products. In addition, if our
billing software fails to work properly, and as a result, we do not automatically process monthly membership fees to our patients&#8217;
credit cards on a timely basis or at all, or there are issues with financial insolvency of our third-party vendors or other unanticipated
problems or events, we could lose revenue, which would harm our operating results.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are also subject to payment card association
operating rules, certification requirements and rules governing electronic funds transfers, which could change or be reinterpreted
to make it more difficult for us to comply. We are not currently accredited against, and in compliance with, the Payment Card Industry
Data Security Standard, or PCI DSS, the payment card industry&#8217;s security standard for companies that collect, store or transmit
certain data regarding credit and debit cards, credit and debit card holders and credit and debit card transactions. Once compliant,
there is no guarantee that we will maintain PCI DSS compliance. Our failure to comply fully with PCI DSS in the future could violate
payment card association operating rules, federal and state laws and regulations and the terms of our contracts with payment processors
and merchant banks. Such failure to comply fully also could subject us to fines, penalties, damages and civil liability and could
result in the suspension or loss of our ability to accept credit and debit card payments. Further, there is no guarantee that PCI
DSS compliance will prevent illegal or improper use of our payment systems or the theft, loss, or misuse of data pertaining to
credit and debit cards, credit and debit card holders and credit and debit card transactions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">If we fail to adequately control fraudulent credit
card transactions, we may face civil liability, diminished public perception of our security measures and significantly higher
credit card-related costs, each of which could adversely affect our business, financial condition and results of operations. If
we are unable to maintain our chargeback or refund rates at acceptable levels, credit and debit card companies may increase our
transaction fees, impose monthly fines until resolved or terminate their relationships with us. Any increases in our credit and
debit card fees could adversely affect our results of operations, particularly if we elect not to raise our rates for our service
to offset the increase. The termination of our ability to process payments on any major credit or debit card would significantly
impair our ability to operate our business.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We, along with our affiliated PCs and their chiropractors, may
be subject to malpractice and other similar claims and may be unable to obtain or maintain adequate insurance against these claims.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The provision of chiropractic services by chiropractors
entails an inherent risk of potential malpractice and other similar claims. While we do not have responsibility for compliance
by affiliated PCs and their chiropractors with regulatory and other requirements directly applicable to chiropractors, claims,
suits or complaints relating to services provided at the offices of our franchisees or affiliated PCs may be asserted against us.
As we develop company-owned or managed clinics, our exposure to malpractice claims will increase. We have experienced several malpractice
claims since our founding in April, 2010, which we have defended or are vigorously defending and do not expect their outcome to
have a material adverse effect on our business, financial condition or results of operations. The assertion or outcome of these
claims could result in higher administrative and legal expenses, including settlement costs or litigation damages. Our current
minimum professional liability insurance coverage required for our franchisees, affiliated PCs and company-owned clinics is $1.0
million per occurrence and $3.0 million in annual aggregate, with a self-insured retention of $0 per claim and $0 annual aggregate.
In addition, we have a corporate business owner&#8217;s policy with coverage of $2.0 million per occurrence and $4.0 million in
annual aggregate. If we are unable to obtain adequate insurance or if there is an increase in the future cost of insurance to us
and the chiropractors who provide chiropractic services or an increase in the amount we have to self-insure, there may be a material
adverse effect on our business and financial results.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We could be party to litigation that could adversely affect us
by distracting management, increasing our expenses or subjecting us to material monetary damages and other remedies.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition to malpractice claims, we are also
subject to a variety of other claims arising in the ordinary course of our business, including personal injury claims, contract
claims and claims alleging violations of federal and state law regarding workplace and employment matters, equal opportunity, harassment,
discrimination and similar matters, and we could become subject to class action or other lawsuits related to these or different
matters in the future. Regardless of whether any claims against us are valid, or whether we are ultimately held liable, claims
may be expensive to defend and may divert time and money away from our operations and hurt our performance. A judgment in excess
of our insurance coverage for any claims could materially and adversely affect our financial condition and results of operations.
Any adverse publicity resulting from these allegations may also materially and adversely affect our reputation or prospects, which
in turn could materially adversely affect our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are subject to the risk that our current insurance may not
provide adequate levels of coverage against claims.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our current insurance policies may not be adequate
to protect us from liabilities that we incur in our business. Additionally, in the future, our insurance premiums may increase,
and we may not be able to obtain similar levels of insurance on reasonable terms, or at all. Any substantial inadequacy of, or
inability to obtain insurance coverage could materially adversely affect our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Furthermore, there are types of losses we may
incur that cannot be insured against or that we believe are not economically reasonable to insure. Such losses could have a material
adverse effect on our business and results of operations. Failure to obtain and maintain adequate directors&#8217; and officers&#8217;
insurance would likely adversely affect our ability to attract and retain qualified officers and directors.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Events or rumors relating to our brand names or our ability to
defend successfully against intellectual property infringement claims by third parties could significantly impact our business.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Recognition of our brand names, including &#8220;THE
JOINT CHIROPRACTIC&#8221;, and the association of those brands with quality, convenient and inexpensive chiropractic maintenance
care are an integral part of our business. The occurrence of any events or rumors that cause patients to no longer associate the
brands with quality, convenient and inexpensive chiropractic maintenance care may materially adversely affect the value of the
brand names and demand for chiropractic services at our franchisees or their affiliated PCs.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our ability to compete effectively depends in
part upon our intellectual property rights, including but not limited to our trademarks. Our use of contractual provisions, confidentiality
procedures and agreements, and trademark, copyright, unfair competition, trade secret and other laws to protect our intellectual
property rights may not be adequate. Litigation may be necessary to enforce our intellectual property rights, or to defend against
claims by third parties that the conduct of our businesses or our use of intellectual property infringes upon such third party&#8217;s
intellectual property rights. Any intellectual property litigation or claims brought against us, whether or not meritorious, could
result in substantial costs and diversion of our resources, and there can be no assurances that favorable final outcomes will be
obtained in all cases. Our business, financial condition or results of operations could be adversely affected as a result.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We present Adjusted EBITDA as a supplemental measure to help
us describe our operating performance. Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should
not be construed as an alternative to net income (loss) or as a better indicator of operating performance.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Adjusted EBITDA consists of net income (loss),
before interest, income taxes, depreciation and amortization, acquisition related and stock compensation expense, bargain purchase
gain, and loss on disposition or impairment. We present Adjusted EBITDA as a supplemental measure to help us describe our operating
performance. Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should not be construed as an alternative
to net income (loss) (as determined in accordance with generally accepted accounting principles in the United States, or GAAP)
or as a better indicator of operating performance. You should not consider Adjusted EBITDA as a substitute for operating profit,
as an indicator of our operating performance or as an alternative to cash flows from operating activities as a measure of liquidity.
We may calculate Adjusted EBITDA differently from other companies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition, in the future we may incur expenses
similar to those excluded when calculating Adjusted EBITDA. Our presentation of these measures should not be construed as an inference
that our future results will be unaffected by unusual or non-recurring items. Our computation of Adjusted EBITDA may not be comparable
to other similarly titled measures computed by other companies, because all companies do not calculate Adjusted EBITDA in the same
fashion.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our management does not consider Adjusted EBITDA
in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of Adjusted
EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements.
Some of these limitations are: (i) Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital
expenditures or contractual commitments; (ii) Adjusted EBITDA does not reflect changes in, or cash requirements for, our working
capital needs; (iii) Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest
or principal payments, on our debts, and although depreciation and amortization are non-cash charges, the assets being depreciated
and amortized will often have to be replaced in the future; (iv) Adjusted EBITDA does not reflect any cash requirements for such
replacements; (v) Adjusted EBITDA does not reflect the bargain purchase gain, which represents the excess of the fair value of
net assets acquired over the purchase consideration; and (vi) Adjusted EBITDA does not reflect the loss on disposition or impairment,
which represents the impairment of assets from Company managed clinics held for sale as of the reporting date. We do not consider
these to be indicative of our ongoing operations.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Changes to financial accounting standards will require our operating
leases to be recognized on the balance sheet.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">All of our existing clinics are subject to leases.
As we increase the number of our company-owned or managed clinics we will have increased our obligations under our operating leases.
Changes to financial accounting standards will require such leases to be recognized on our balance sheet in the future. The lease
terms of our clinics vary, but typically have initial terms of between five and ten years with five year renewal options. The accounting
treatment of these leases is described in Note 1 to our consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In February, 2016, the Financial Accounting Standards
Board, or FASB, released the new Accounting Standards Update related to leases. The changes require that substantially all operating
leases be recognized as assets and liabilities on our balance sheet, which is a significant departure from the current standard,
which classifies operating leases as off balance sheet transactions and accounts for only the current year operating lease expense
in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments
over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after December
15, 2018. While we have not quantified the impact this standard will have on our financial statements, when our current operating
leases are instead recognized on the balance sheet, it will result in a significant increase in the liabilities reflected on our
balance sheet and in the interest expense and depreciation and amortization expense reflected in our statement of operations, while
reducing the amount of rent expense.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Changes in U.S. tax laws could have a material adverse effect
on our business, cash flow, results of operations or financial conditions.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The Tax Cuts and Jobs Act (the &#8220;Act&#8221;)
was enacted on December 22, 2017 and contains many significant changes to U.S. Federal tax laws. The Act requires complex computations
that were not previously provided for under U.S. tax law. The Company has provided for an estimated effect of the Act in its financial
statements. The Act requires significant judgments to be made in interpretation of the law and significant estimates in the calculation
of the provision for income taxes. However, additional guidance may be issued by the IRS, Department of the Treasury, or other
governing body that may significantly differ from the Company&#8217;s interpretation of the law, which may result in a material
adverse effect on our business, cash flow, results of operations or financial conditions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are an &#8220;emerging growth company&#8221; as defined in
the Securities Act and the reduced disclosure requirements applicable to emerging growth companies may make our common stock less
attractive to investors.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are an &#8220;emerging growth company&#8221;
as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies&#8221;
including, among other things, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002, as amended, reduced financial disclosure requirements, which include being permitted to provide only two years of
audited financial statements, with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations&#8221; disclosure, reduced disclosure obligations regarding executive compensation and exemptions from
the requirements of holding a non-binding stockholder advisory vote on executive compensation and stockholder approval of any golden
parachute payments not previously approved. As a result, our stockholders may not have access to certain information that they
may deem important. In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of
the extended transition period provided in Section 7(a)(2) of the Securities Act for complying with new or revised accounting standards.
We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will
be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We could be an emerging growth company until
as late as December 31, 2019 (the last day of the fiscal year following the fifth anniversary of the date of our initial public
offering, which occurred on November 14, 2014), although circumstances could cause us to lose that status earlier, including (i)
if our total annual gross revenue exceeds $1.0 billion, if we issue more than $1.0 billion in non-convertible debt securities during
any three-year period, or (ii) if the market value of our common stock held by non-affiliates exceeds $700.0 million as of any
June 30 before that time. Investors may find our common stock less attractive because we may rely on these exemptions. If some
investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and
our stock price may be more volatile.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Pursuant to the JOBS Act, our independent registered public accounting
firm will not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404
for so long as we are an &#8220;emerging growth company.&#8221;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Section 404 of the Sarbanes-Oxley Act of 2002,
as amended, or the Sarbanes-Oxley Act, requires annual management assessments of the effectiveness of our internal control over
financial reporting, starting with the second annual report that we file with the SEC as a public company, including disclosure
of any material weaknesses identified by our management in our internal control over financial reporting. The Sarbanes-Oxley Act
generally requires in the same report a report by our independent registered public accounting firm on the effectiveness of our
internal control over financial reporting. However, under the JOBS Act, our independent registered public accounting firm will
not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404 until we
are no longer an &#8220;emerging growth company.&#8221; We could be an &#8220;emerging growth company&#8221; as late as December
31, 2019 (the last day of the fiscal year following the fifth anniversary of the date of our initial public offering, which occurred
on November 14, 2014).</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We may identify material weaknesses that we may
not be able to remediate in time to meet the applicable deadline imposed upon us for compliance with the requirements of Section
404 of the Sarbanes-Oxley Act. In addition, if we fail to achieve and maintain the adequacy of our internal controls, as such standards
are modified, supplemented or amended from time to time, we may not be able to conclude that we have effective internal controls
over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act. If we are not able to implement the requirements
of Section 404 of the Sarbanes-Oxley Act in a timely manner or with adequate compliance, our independent registered public accounting
firm may issue an adverse opinion due to ineffective internal controls over financial reporting and we may be subject to sanctions
or investigation by regulatory authorities, such as the SEC. As a result, there could be a negative reaction in the financial markets
due to a loss of confidence in the reliability of our financial statements. In addition, we may be required to incur costs in improving
our internal control system and the hiring of additional personnel. Any such action could have a material adverse effect on our
business, prospects, results of operations and financial condition.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our management, with the participation of our
Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period ended December 31, 2017. Based
on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure
controls and procedures were effective.</p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>The requirements of being a public company, including compliance
with the reporting requirements of the Exchange Act and the requirements of the Sarbanes-Oxley Act, may strain our resources, increase
our costs and distract management, and we may be unable to comply with these requirements in a timely or cost-effective manner.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our initial public offering had a significant,
transformative effect on us. Prior to our initial public offering, our business operated as a privately-owned company, and we now
incur significant additional legal, accounting, reporting and other expenses as a result of having publicly-traded common stock.
As a public company with listed equity securities, we need to comply with certain laws, regulations and requirements, including
corporate governance provisions of the Sarbanes-Oxley Act, related regulations of the SEC, and the requirements of The NASDAQ Capital
Market with which we had not been required to comply as a private company. Complying with these statutes, regulations and requirements
occupies a significant amount of time of our Board of Directors and management and has significantly increased our costs and expenses.
We will continue to:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">institute more comprehensive corporate governance and compliance functions; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">design, establish, evaluate and maintain a system of internal control over financial reporting in compliance with the requirements of Section 404(a) of the Sarbanes-Oxley Act and the related rules and regulations of the SEC and the Public Company Accounting Oversight Board; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">comply with rules promulgated by The NASDAQ Capital Market; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">prepare and distribute periodic public reports in compliance with our obligations under the federal securities laws; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">establish new internal policies, such as those relating to disclosure controls and procedures and insider trading; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">to a greater degree than previously, involve and retain outside counsel and accountants in the above activities. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Risks Related to Our Public Offerings and Listing of Our Common
Stock on the NASDAQ Capital Market</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our stock price could be volatile and could decline.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The price at which our common stock will trade
could be extremely volatile and may fluctuate substantially due to the following factors, some of which are beyond our control:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">variations in our operating results;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">variations between our actual operating results and the expectations of securities analysts, investors and the financial community;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">announcements of developments affecting our business or expansion plans by us or others; and</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">conditions and trends in the chiropractic industry.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As a result of these and other factors, investors
in our common stock may not be able to resell their shares at or above their purchase price.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the past, securities class action litigation
often has been instituted against companies following periods of volatility in the market price of their securities. This type
of litigation, if directed at us, could result in substantial costs and a diversion of management&#8217;s attention and resources.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Provisions of Delaware law could discourage a takeover that stockholders
may consider favorable.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As a Delaware corporation, we have elected
to be subject to the Delaware anti-takeover provisions contained in Section 203 of the Delaware General Corporation Law. Under
Delaware law, a corporation may not engage in a business combination with any holder of 15% or more of its capital stock unless
the holder has held the stock for three years or, among other things, the Board of Directors has approved the transaction. Our
Board of Directors could rely on this provision to prevent or delay an acquisition of us. For a description of our capital stock,
see &#8220;Description of Capital Stock.&#8221;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Future sales of our common stock may depress our stock price
and our share price may decline due to the large number of shares eligible for future sale or exchange.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Sales of substantial amounts of our common
stock in the public market by our officers, directors or significant shareholders may adversely affect the market price of our
common stock. Shares issued upon the exercise of outstanding options and shares issuable upon the exercise of the warrants we issued
to the underwriters in our initial public offering also may be sold in the public market. Such sales could create the perception
to the public of difficulties or problems with our business. As a result, these sales might make it more difficult for us to sell
securities in the future at a time and price that we deem necessary or appropriate.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The market price of our common stock could decline
as a result of sales of a large number of shares of common stock in the market or the perception that such sales could occur. These
sales, or the possibility that these sales may occur, might also make it more difficult for us to sell equity securities in the
future at a time and at a price that we deem appropriate. As of December 31, 2017, we have 13,586,254 outstanding shares of common
stock, and are authorized to sell up to 20,000,000 shares of common stock. The trading volume of shares of our common stock has
averaged 31,452 shares per day during the year ended December 31, 2017. Accordingly, sales of even small amounts of shares of our
common stock by existing stockholders may drive down the trading price of our common stock.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>If securities analysts do not publish research or reports about
our business or if they downgrade our company or our sector, the price of our common stock could decline.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The trading market for our common stock depends
in part on the research and reports that industry or financial analysts publish about us or our business. We do not influence or
control the reporting of these analysts. If one or more of the analysts who do cover us downgrade or provide a negative outlook
on our company or our industry, or the stock of any of our competitors, the price of our common stock could decline. If one or
more of these analysts ceases coverage of our company, we could lose visibility in the market, which in turn could cause the price
of our common stock to decline.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our actual results may differ from forecasts.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">It is difficult to accurately forecast our
revenues, operating expenses and results, and operating data. The inability by us or the financial community to accurately forecast
our operating results could cause our net losses in a given quarter to be greater than expected, which could cause a decline in
the trading price of our common stock. We base our current and forecasted expense&nbsp;and cash expenditure levels on our operating
plans and estimates of future revenues, which are dependent on the growth of the number of patients and the demand for our services.
As a result, we may be unable to make accurate financial forecasts or to adjust our spending in a timely manner to compensate for
any unexpected shortfalls in revenues. We believe that these difficulties in forecasting are even greater for financial analysts
that may publish their own estimates of our financial results.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We do not intend to pay dividends. You will not receive funds
without selling shares, and you may lose the entire amount of your investment.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We have never declared or paid any cash dividends
on our capital stock and do not intend to pay dividends in the foreseeable future. We intend to invest our future earnings, if
any, to fund our growth. We cannot assure you that you will receive a positive return on your investment when you subsequently
sell your shares or that you will not lose the entire amount of your investment.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Claims for indemnification by our directors and officers may
reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to
us.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our amended and restated certificate of incorporation
and bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware
law. In addition, we have entered and expect to continue to enter into agreements to indemnify our directors, executive officers
and other employees as determined by our Board of Directors. Under the terms of such indemnification agreements, we are required
to indemnify each of our directors and officers, to the fullest extent permitted by the laws of the state of Delaware, if the basis
of the indemnitee&#8217;s involvement was by reason of the fact that the indemnitee is or was a director or officer of the Company
or any of its subsidiaries or was serving at the Company&#8217;s request in an official capacity for another entity. We must indemnify
our officers and directors against all reasonable fees, expenses, charges and other costs of any type or nature whatsoever, including
any and all expenses and obligations paid or incurred in connection with investigating, defending, being a witness in, participating
in (including on appeal), or preparing to defend, be a witness or participate in any completed, actual, pending or threatened action,
suit, claim or proceeding, whether civil, criminal, administrative or investigative, or establishing or enforcing a right to indemnification
under the indemnification agreement. The indemnification agreements also require us, if so requested, to advance within 30 days
of such request all reasonable fees, expenses, charges and other costs that such director or officer incurred, provided that such
person will return any such advance if it is ultimately determined that such person is not entitled to indemnification by us. Any
claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims
and may reduce the amount of money available to us.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_004"></a>ITEM 1B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UNRESOLVED STAFF COMMENTS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Not applicable.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_005"></a><b>ITEM 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
PROPERTIES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We lease the property for our corporate headquarters
and all of the properties on which we own or manage clinics. As of March 2, 2018, we leased 47 facilities in which we operate or
intend to operate clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our corporate headquarters are located at 16767
North Perimeter Drive, Suite 240, Scottsdale, Arizona 85260. The term of our lease for this location expires on July 31, 2019.
The primary functions performed at our corporate headquarters are financial, accounting, treasury, marketing, operations, human
resources, information systems support and legal.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are also obligated under non-cancellable leases
for the clinics which we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial
term of five years, include one to two options to renew for terms of five years, and require us to pay a proportionate share of
real estate taxes, insurance, common area maintenance charges and other operating costs.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_006"></a>ITEM 3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
LEGAL PROCEEDINGS &nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the normal course of business, we are party
to litigation from time to time. We maintain insurance to cover certain actions and believe that resolution of such litigation
will not have a material adverse effect on the Company.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_007"></a><b>ITEM 4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
MINE SAFETY DISCLOSURES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Not applicable.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><a name="a_008"></a><b>PART II</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_009"></a>ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
MARKET&nbsp;FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Beginning November 11, 2014, our common stock
is traded on the NASDAQ Capital Market under the symbol &#8220;JYNT.&#8221; The following table sets forth the high and low sales
prices for our common stock for the calendar quarters or other periods indicated as reported by the NASDAQ Capital Market.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;<b>Company Stock Performance</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td nowrap style="border-bottom: black 1pt solid"><font style="font-size: 10pt">Fiscal Year 2016</font></td>
    <td>&nbsp;</td>
    <td nowrap colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">High</font></td>
    <td>&nbsp;</td>
    <td nowrap colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Low</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">First Quarter</font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">5.89</font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">2.65</font></td>
    <td style="width: 1%">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Second Quarter</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">3.90</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.03</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Third Quarter</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">3.20</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.85</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Fourth Quarter</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.80</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.96</font></td>
    <td>&nbsp;</td></tr>
</table>
<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td nowrap style="border-bottom: black 1pt solid"><font style="font-size: 10pt">Fiscal Year 2017</font></td>
    <td>&nbsp;</td>
    <td nowrap colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">High</font></td>
    <td>&nbsp;</td>
    <td nowrap colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Low</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 72%"><font style="font-size: 10pt">First Quarter</font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">4.74</font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">2.48</font></td>
    <td style="width: 1%">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Second Quarter</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">4.35</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">3.41</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Third Quarter</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">5.07</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">3.46</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Fourth Quarter</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">6.00</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">4.10</font></td>
    <td>&nbsp;</td></tr>
</table>
<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Holders</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2017, there were approximately&nbsp;11
holders of record of our common stock and&nbsp;13,586,254 shares of our common stock outstanding.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Dividends</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Since our initial public offering, we have
not declared nor paid dividends on our common stock and we do not expect to pay cash dividends on our common stock in the foreseeable
future.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_010"></a>ITEM 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp; SELECTED FINANCIAL DATA</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year Ended December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; text-align: center">(in thousands, except per share data)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0pt">Consolidated Statement of Operations Data:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: 10pt">Total revenues</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">25,164</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">20,524</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Cost of revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,312</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,940</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Selling, general and administrative expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">24,609</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">29,072</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Loss from operations</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(3,175</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,008</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Net loss</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(3,275</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,174</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Basic and diluted loss per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(0.25</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1.20</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Weighted average shares outstanding used in computing basic and diluted loss
    per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,245,119</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,696,649</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: 10pt">Non-GAAP Financial Data:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Net loss</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(3,275</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,174</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Interest expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">105</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">15</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Depreciation and amoritzation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,017</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,566</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Tax expense</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">36</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">164</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 20pt">EBITDA</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(1,117</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(12,429</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Stock compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">594</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Acquisition related expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">14</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">76</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Loss on disposition or impairment</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">418</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,520</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 20pt">Adjusted EBITDA</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(91</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(7,710</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td></tr>
</table>




<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<p style="margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold; text-align: left">Consolidated Balance Sheet Data:</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center">(in thousands)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 12%; font-size: 10pt; text-align: right">4,216</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 12%; font-size: 10pt; text-align: right">3,010</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,725</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Deferred franchise costs</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,297</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,585</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Goodwill and intangible assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,676</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,089</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Other assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,920</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,646</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Total assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">16,910</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">17,055</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Deferred revenue</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,247</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,309</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Other liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,764</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,820</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Total liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,011</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">10,129</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Stockholders' equity</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,899</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,925</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 3px">&nbsp;</td>
    <td style="width: 20px">
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">(1)</p></td>
    <td>
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Adjusted EBITDA consists of net loss, before interest, income taxes,
        depreciation and amortization, acquisition related and stock compensation expense, bargain purchase gain, and loss on disposition
        or impairment. We have provided Adjusted EBITDA because it is a measure of financial performance commonly used for comparing companies
        in our industry. Adjusted EBITDA provides an alternative measure of cash flow from operations. You should not consider Adjusted
        EBITDA as a substitute for operating profit as an indicator of our operating performance or as an alternative to cash flows from
        operating activities as a measure of liquidity. We may calculate Adjusted EBITDA differently from other companies.</p></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe that the use of Adjusted EBITDA provides
an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures
with other outpatient medical clinics, which may present similar non-GAAP financial measures to investors. In addition, you should
be aware when evaluating Adjusted EBITDA that in the future we may incur expenses similar to those excluded when calculating these
measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected
by unusual or non-recurring items. Our computation of Adjusted EBITDA may not be comparable to other similarly titled measures
computed by other companies, because all companies do not calculate Adjusted EBITDA in the same fashion.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our management does not consider Adjusted EBITDA
in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of Adjusted
EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements.
Some of these limitations are:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">a.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">b.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">c.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debts;  </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px; text-align: justify">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">d.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">e.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect the bargain purchase gain,
    which represents the excess of the fair value of net assets acquired over the purchase consideration. We do not consider this
    to be indicative of our ongoing operations; and</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">f.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect the loss on disposition or impairment, which represents the impairment of assets from Company managed clinics held for sale as of the reporting date. We do not consider this to be indicative of our ongoing operations. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Because of these limitations, Adjusted EBITDA
should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. We compensate
for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only supplementally. You should review
the reconciliation of net income (loss) to Adjusted EBITDA above and not rely on any single financial measure to evaluate our business.
The table above reconciles net loss to adjusted EBITDA for the years ended December 31, 2017 and 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_011"></a>ITEM 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following discussion and analysis of the
results of operations and financial condition of The Joint Corp. for the years ended December 31, 2017 and 2016 should be read
in conjunction with the consolidated financial statements and the notes thereto, and other financial information contained elsewhere
in this Form 10-K.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Overview</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our principal business is to develop, own,
operate, support and manage chiropractic clinics through franchising and the sale of regional developer rights, and through direct
ownership and management arrangements throughout the United States.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;We seek to be the leading provider
of chiropractic care in the markets we serve and to become the most recognized brand in our industry through the rapid and focused
expansion of chiropractic clinics in key markets throughout North America and abroad.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Key Performance Measures.</i>&nbsp;&nbsp;We
receive both weekly and monthly performance reports from our clinics which include key performance indicators including gross clinic
sales, total royalty income, and patient office visits. We believe these indicators provide us with useful data with which to measure
our performance and to measure our franchisees&#8217; and clinics&#8217; performance.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Key Clinic Development Trends</i>. &nbsp;&nbsp;As
of December 31, 2017, we and our franchisees operated 399 clinics. Of the 47 company-owned or managed clinics, 16 were constructed
and developed by us, and 31 were acquired from franchisees.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our current strategy is to grow through the
sale and development of additional franchises, and to foster the growth of acquired and developed clinics that are owned and managed
by us. In addition, we believe that we can accelerate the development of, and revenue generation from, company-owned or managed
clinics through the further selective acquisition of existing franchised clinics. We will seek out the opportunistic acquisition
of existing franchised clinics that meet our criteria for demographics, site attractiveness, proximity to other clinics and additional
suitability factors.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We believe that The Joint has a remarkably
sound concept, benefiting from the fundamental changes taking place in the manner in which Americans access chiropractic care and
their growing interest in seeking effective, affordable natural solutions for general wellness. These trends join with the strong
preference we have seen among chiropractic doctors to reject the insurance-based model, to produce a dynamic combination that benefits
the consumer and the service provider alike. We believe that these forces create an important opportunity to accelerate the growth
of our network.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Significant Events and/or Recent Developments</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January 2017, we entered into a Credit and
Security Agreement (the &#8220;Credit Agreement&#8221;), and signed a revolving credit note payable to the lender. Under the Credit
Agreement, we are able to borrow up to an aggregate of $5,000,000 under revolving loans. Interest on the unpaid outstanding principal
amount of any revolving loans is at a rate equal to 10% per annum, provided, however, that the minimum amount of interest paid
in the aggregate on all revolving loans granted over the term of the Credit Agreement is $200,000. Interest is due and payable
on the last day of each fiscal quarter in an amount determined by us, but not less than $25,000. The lender&#8217;s lending commitments
under the Credit Agreement terminate in December 2019, unless sooner terminated in accordance with the provisions of the Credit
Agreement. We intend to use the credit facility for general working capital needs. We have drawn $1,000,000 of the $5,000,000 available
under the Credit Agreement.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January 2017, we sold the assets of six
of our 11 clinics in the Chicago area for a nominal amount to a limited liability company that includes existing franchisees. The
purchaser will continue to operate the clinics as franchised locations pursuant to a franchise agreement. Concurrently, we sold
regional developer rights to the Chicago area to the purchaser of our six Chicago clinics for $300,000. Pursuant to the regional
developer agreement, the limited liability company has agreed to open a minimum of 30 Chicago area clinics over the next 10 years.
We have closed the remaining five Chicago-area clinics, as well as three Company-managed clinics in upstate New York. We recognized
an additional lease exit liability in the first quarter of 2017 related to these closures. These assets were designated as held
for sale as of December 31, 2016, and we recognized a loss on disposition or impairment of approximately $3.5 million. We made
these tactical decisions in the 4<sup>th</sup> quarter of 2016 to reduce our current cash usage, allowing us to focus on accelerating
the point at which we believe we will achieve cash-flow breakeven.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the first quarter of 2017, we sold regional
developer territories for Chicago, Philadelphia and Washington State for a total of approximately $650,000. Their combined development
schedule requires the opening and operating of a minimum of 70 clinics over a ten-year period. The revenues related to these sales
will be recognized over the estimated number of franchised clinics to be opened in the respective territories.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the second quarter of 2017, we sold
two regional developer territories for Central Florida and Ohio for a total of $620,000.&nbsp; Their combined development schedule
requires the opening and operating of a minimum of 79 franchised clinics over a ten-year period.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the third quarter of 2017, we sold three
regional developer territories for New Jersey, Maryland/Washington DC and Minnesota for a total of approximately $440,000. Their
combined development schedule requires the opening and operating of a minimum of 62 franchised clinics over a ten-year period,
with respect to New Jersey and Maryland/Washington DC and a five-year period for the Minnesota territory.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the fourth quarter of 2017, we sold
two regional developer territories for certain areas of Texas, Oklahoma and Arkansas as well as Tennessee for a total of approximately
$642,000. Their combined development schedule requires the opening and operating of a minimum of 48 franchised clinics over a ten-year
period, with respect to Texas, Oklahoma and Arkansas and an eight-year period for the Tennessee territory.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the twelve months ended December 31,
2017, we terminated three franchise licenses that were in default. In conjunction with these terminations, during the twelve months
ended December 31, 2017, we recognized $92,915 of revenue and $18,250 of costs, which were previously deferred.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Factors Affecting Our Performance</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our operating results may fluctuate significantly
as a result of a variety of factors, including the timing of new clinic openings, markets in which they are contained and related
expenses, general economic conditions, consumer confidence in the economy, consumer preferences, and competitive factors.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &ldquo;<I>Revenue from Contracts with Customers,</I>&rdquo;
which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods
or services to customers. The standard also calls for additional disclosures around the nature, amount, timing and uncertainty
of revenue and cash flows arising from contracts with customers. The ASU will replace most existing revenue recognition guidance
in U.S. GAAP when it becomes effective. The new standard becomes effective for the Company on January 1, 2018. The Company expects
the adoption of this standard to negatively impact 2018 consolidated franchise fee revenues by approximately $0.2 million, favorably
impact regional developer fees revenue by approximately $0.2 million, and favorably decrease franchise cost of revenue by approximately
$0.1 million as compared to forecasted amounts under previous GAAP.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Significant Accounting Polices and Estimates</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of consolidated financial statements
requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts
of revenues and expenses during the reporting period. We base our accounting estimates on historical experience and other factors
that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.&nbsp; We have discussed
the development and selection of significant accounting policies and estimates with our Audit Committee.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Intangible Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired
franchise and regional developer rights and customer relationships.&nbsp;&nbsp;We amortize the fair value of re-acquired franchise
rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from
six to eight years. In the case of regional developer rights, we amortize the acquired regional developer rights over seven years.
The fair value of customer relationships is amortized over their estimated useful life of&nbsp;two&nbsp;years.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Goodwill</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of the purchase
price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note 2 to the
consolidated financial statements. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject
to annual impairment tests. As required, we perform an annual impairment test of goodwill as of the first day of the fourth quarter
or more frequently if events or circumstances change that would more likely than not reduce the fair value of a reporting unit
below its carrying value. The Company recorded an impairment charge of $54,994 during the year ended December 31, 2016 which represents
the write-off of the goodwill associated with an acquired clinic in New York. No impairment was recorded for the year ended December
31, 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Long-Lived Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We review our long-lived assets for impairment
whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily
to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have been impaired. Impairments
of $0 and approximately $2.4 million were recorded for the years ended December 31, 2017 and 2016, respectively.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Stock-Based Compensation</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We account for share-based payments by recognizing
compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date
fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes
option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components
of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend
yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation
costs ratably over the period of service using the straight-line method.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company generates revenue through initial
franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and
from its company-owned and managed clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Franchise Fees.</i>&nbsp;The Company requires
the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial
term of ten years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services
under the franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;The Company&#8217;s services under
the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing
operations support. The Company provides no financing to franchisees and offers no guarantees on their behalf.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Regional Developer Fees</i>. During 2011,
the Company established a regional developer program to engage independent contractors to assist in developing specified geographical
regions. Under the historical program, regional developers paid a license fee ranging from $7,250 to 25% of the then current franchise
fee for each franchise they received the right to develop within the region. In 2017, the program was revised to grant exclusive
geographical territory and establish a minimum development obligation within that defined territory. Regional developers receive
fees ranging from $14,500 to $19,950, which are collected from franchisees upon the sale of franchises within their region and
a royalty of 3% of sales generated by franchised clinics in their region. Regional developer fees paid to the Company are nonrefundable
and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer
agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on
a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement.
Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which
is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the
regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent,
the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among,
and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. The franchisor&#8217;s
services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification
of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of
the regional developer agreements grant the Company the option to repurchase the regional developer&#8217;s license.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended December 31, 2017, the Company
entered into ten regional developer agreements for which it received approximately $2.1 million, which was deferred as of the respective
transaction dates and will be recognized on a pro-rata basis over the estimated number of franchised clinics to be opened in the
respective regions. Certain of these regional developer agreements resulted in the regional developer acquiring the rights to existing
royalty streams from clinics already open in the respective territory. In those instances, the revenue associated with the sale
of the royalty stream is being recognized over the remaining life of the respective franchise agreements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Revenues and Management Fees from Company
Clinics.&nbsp;&nbsp;</i>The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&nbsp;
In those states where the Company owns and operates the clinics, revenues are recognized when services are performed. The Company
offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&nbsp;
Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service
is performed.&nbsp;&nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor,
the Company enters into a management agreement with the doctor&#8217;s PC.&nbsp; Under the management agreement, the Company provides
administrative and business management services to the doctor&#8217;s PC in return for a monthly management fee.&nbsp; When the
collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees
expected to be collected from the PCs.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i></i></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Royalties.</i>&nbsp;The Company collects
royalties, as stipulated in its franchise agreements, equal to 7% of gross sales, and a marketing and advertising fee currently
equal to 2% of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly
flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly two working days after each sales
period has ended.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>IT Related Income and Software Fees.</i>&nbsp;&nbsp;The
Company collects a monthly fee for use of its proprietary chiropractic software, computer support, and internet services support.
These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&#8217;s
computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card),
credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon receipt of equipment by the
franchisee.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Results of Operations</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Total Revenues</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Components of revenues for the year ended December
31, 2017 as compared to the year ended December 31, 2016, are as follows:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Change from<br> Prior Year</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent Change <br> from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 0pt">Revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; font-size: 10pt; text-align: left; padding-left: 10pt">Revenues and management fees from company clinics</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">11,125,115</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">8,550,980</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">2,574,135</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 9%; font-size: 10pt; text-align: right">30.1</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Royalty fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,722,856</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,973,079</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,749,777</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">29.3</td><td style="font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Franchise fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,442,415</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,286,809</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(844,394</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(36.9</td><td style="font-size: 10pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Advertising fund revenue</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,753,776</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,866,406</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">887,370</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">47.5</td><td style="font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">IT related income and software fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,137,363</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">932,709</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">204,654</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">21.9</td><td style="font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Regional developer fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">583,550</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">617,573</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(34,023</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(5.5</td><td style="font-size: 10pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other revenues</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">398,929</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">296,084</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">102,845</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">34.7</td><td style="font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total revenues</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">25,164,004</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">20,523,640</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,640,364</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">22.6</td><td style="font-size: 10pt; text-align: left">%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The reasons for the significant changes in our components of total
revenues are as follows:&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Consolidated Results</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">Total revenues increased by $4.6 million primarily due to the continued revenue growth of our company-owned&nbsp;or managed clinics, and continued expansion and revenue growth of our franchise base.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Corporate Clinics</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>&nbsp;</i></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">Revenues and management fees from company-owned or managed clinics increased primarily due to improved same-store sales growth, offset by fewer company-owned or managed clinics in operation during 2017 compared to 2016.&nbsp;&nbsp;As of December 31, 2017 and 2016, there were 47 and 61 company-owned or managed clinics in operation, respectively. </font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i></i></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Franchise Operations</i></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">Royalty fees have increased due to an increase in the number of franchised clinics in operation along with continued sales growth in existing franchised clinics.&nbsp;&nbsp;As of December 31, 2017 and 2016, there were 352 and 309 franchised clinics in operation, respectively.&nbsp;&nbsp;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">Franchise fees decreased due to the timing of franchise license terminations and fewer clinic openings. In the year ended December 31, 2017 and 2016, we recognized revenue from terminations of $0.1 million and $0.5 million, respectively. In the year ended December 31, 2017 and 2016, we had 41 and 56 franchised clinic openings, respectively.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">Regional developer fees decreased due to the timing of regional developer terminations. We recognized revenue in relation to regional developer terminations of $0 and $0.1 million during the years ended December 31, 2017 and 2016, respectively.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">IT related income and software fee, advertising fund revenue and other revenues increased due to an increase in our franchise clinic base as described above.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Cost of Revenues</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Cost of Revenues</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">3,312,194</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">2,939,609</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">372,585</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">12.7</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
</table>




<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended December 31, 2017, as compared
with the year ended December 31, 2016, the total cost of revenues increased due to an increase in regional developer royalties
of $0.6 million triggered by an increase of royalty revenues of approximately 29%, offset by a reduction of $0.2 million in regional
developer commissions recognized in conjunction with franchise openings.&nbsp;</p>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Selling and Marketing Expenses</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Selling and Marketing Expenses</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">4,473,881</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">4,419,180</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">54,701</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">1.2</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Selling and marketing expenses increased slightly
for the year ended December 31, 2017, as compared to the year ended December 31, 2016, driven by an increase in the overall size
of the national marketing fund due to a larger franchise clinic base, offset by lower spending on company-owned or managed clinics
advertising and promotion due to the sale or closure of 14 clinics.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Depreciation and Amortization Expenses</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Depreciation and Amortization Expenses</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">2,017,323</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">2,566,136</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(548,813</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(21.4</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Depreciation and amortization expenses decreased
for the year ended December 31, 2017, as compared to the year ended December 31, 2016, primarily due to the sale or closure of
14 company-owned or managed clinics.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>General and Administrative Expenses</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">General and Administrative Expenses</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">18,117,533</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">22,086,321</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(3,968,788</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(18.0</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">General and administrative expenses decreased
during the year ended December 31, 2017, compared to the year ended December 31, 2016, primarily due to the following:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 58px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">A decrease of approximately $1.2 million in payroll related expenses and approximately $0.8 million in utilities and facilities related expenses primarily due to the sale or closure of 14 company-owned or managed clinics; and</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 58px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">A decrease of approximately $0.6 million in legal and accounting related expenses and approximately $1.0 million of other miscellaneous expenses as a result of certain legal settlements and real estate development expenses recognized in the year ended December 31, 2016.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Loss from Operations</i></b>&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>&nbsp;</i></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Loss from Operations</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(3,174,898</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(15,007,976</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">11,833,078</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(78.8</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td></tr>
</table>



<p style="font-size: 10pt; margin: 0pt 0"><i></i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Consolidated Results </i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Consolidated loss from operations decreased
by $11.8 million for the year ended December 31, 2017 compared to the year ended December 31, 2016, primarily driven by the $8.0
million decrease in operating loss in the corporate clinic segment, discussed below, a decrease in corporate general and administrative
expenses of $2.1 million, and increased net income from franchise operations of $1.7 million discussed below.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Franchise Operations</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our franchise operations segment had net income
from operations of $6.2 million for the year ended December 31, 2017, an increase of $1.7 million, compared to net income from
operations of $4.5 million for the year ended December 31, 2016. This increase was primarily driven by:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 58px; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">An increase of approximately $1.2 million in total revenues (net of national marketing fund contributions), due primarily to an approximately 29% increase in franchise royalty revenues; and</font></td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">A decrease of approximately $0.8 million in general and administrative expenses, primarily related to
decreases of $0.6 million in payroll related expenses and $0.2 million in legal, accounting and professional services; offset by,</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">An increase of approximately $0.4 million in royalties and commissions, paid to regional developers.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Corporate Clinics</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our corporate clinics segment (i.e., company-owned
or managed clinics) had a loss from operations of $1.7 million for the year ended December 31, 2017, a decrease of $8.0 million
compared to a loss from operations of $9.7 million for the same period ended December 31, 2016. This decrease was primarily driven
by:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 58px">&nbsp;</td>
    <td style="vertical-align: top; width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td><font style="font-size: 10pt">a $3.5 million loss recorded during the year ended December 31, 2016, on disposition or impairment of the portfolio of clinics in Illinois and New York deemed to be held for sale as of December 31, 2016. The loss on disposition or impairment consisted of a $2.4 million impairment charge to lower the carrying costs of property and equipment to its estimated fair value less cost to sell, a $0.7 million write-off of accounts receivable deemed to be uncollectible for certain working capital advances made to PC entities in Illinois and New York, a $0.1 million impairment charge related to goodwill and intangible assets associated with an acquired clinic in New York, and a $0.3 million lease exit liability recorded for certain abandoned leases during the fourth quarter. During the year ended December 31, 2017, we recorded a $0.4 million loss on disposition or impairment primarily related to additional lease exit liabilities recorded to exit the remaining clinics in the Illinois and New York markets. Overall this represented a $3.1 million decrease in loss from operations;</font></td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="text-align: justify; width: 58px">&nbsp;</td>
    <td style="vertical-align: top; width: 24px"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">An increase in revenues of approximately $2.6 million from company-owned or managed clinics; and</font></td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td><font style="font-size: 10pt">A decrease of approximately $0.8 million in occupancy costs, $0.6 million of selling and marketing expenses, $0.6 million in depreciation and amortization, and $0.3 million of other general and administrative costs primarily due to the sale or closure of 14 company-owned or managed clinics.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Income Tax (Expense) Benefit</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Income Tax Expense</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(35,880</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(164,429</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">128,549</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(78.2</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Changes in our income tax expense related primarily
to changes in the valuation allowance on our deferred tax assets and the impact of certain permanent differences on taxable income.
For the years ended December 31, 2017 and 2016, the effective rates were -1.1% and -2.6%, respectively. The difference is due to
an increased valuation allowance against our net deferred tax assets, in addition to state income taxes relating to Voluntary Disclosure
Agreements (&#8220;VDAs&#8221;) with various taxing jurisdictions and an adjustment to expected federal income tax refunds.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>U.S. Tax Reform</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In December 2017, the Tax Cuts and Jobs Act
(the &#8220;Act&#8221;) was enacted. The Act represents major tax reform legislation that, among other provisions, reduces the
U.S. corporate tax rate. Certain income tax effects of the Act, including $3.9 million of tax expense recorded principally due
to the write-down of our net deferred tax assets, are reflected in our financial results in accordance with Staff Accounting Bulletin
No. 118 (SAB 118), which provides SEC staff guidance regarding the application of Accounting Standards Codification (ASC) Topic
740, Income Taxes, in the reporting period in which the Act became law. See Note 9 to the consolidated financial statements for
further information on the financial statement impact of the Act.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Sources of Liquidity</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From 2012 until November 2014, when we completed
an initial public offering (&#8220;IPO&#8221;), we financed our business primarily through existing cash on hand and cash flows
from operations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 14, 2014, we completed our IPO
of 3,000,000 shares of common stock at a price to the public of $6.50 per share. As a result of the IPO, we received aggregate
net proceeds, after deducting underwriting discounts, commissions and other offering expenses, of approximately $17.1 million.&nbsp;&nbsp;On
November 18, 2014, our underwriters exercised their option to purchase 450,000 additional shares of common stock to cover over-allotments,
pursuant to which we received aggregate net proceeds of approximately $2.7 million.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 25, 2015 we completed our follow-on
public offering of 2,272,727 shares of our common stock at a price to the public of $5.50 per share. On December 30, 2015 our underwriters
exercised their over-allotment option to purchase an additional 340,909 shares of common stock to cover over-allotments pursuant
to which we received aggregate net proceeds of approximately $13.0 million.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We have used a significant amount of the net
proceeds from our public offerings for the development of company-owned or managed clinics.&nbsp; We accomplished this by developing
new clinics, and by repurchasing existing franchises. In addition, we have used proceeds from our offerings to repurchase existing
regional developer licenses and to continue to expand our franchised clinic business.&nbsp; We are holding the net proceeds in
cash or short-term bank deposits.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2017, we had cash and short-term
bank deposits of approximately $4.2 million. We generated approximately $0.2 million of cash flow from operating activities in
the year ended December 31, 2017. We will continue to preserve cash, and while we plan to resume the acquisition and development
of company-owned or managed clinics we intend to progress at a measured pace and target geographic clusters where we are able to
increase efficiencies through a consolidated real estate penetration strategy, leverage cooperative advertisement and marketing
and attain general corporate and administrative operating efficiencies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January 2017, we executed a Credit and Security
Agreement which provided a credit facility up to $5.0 million. We have drawn $1.0 million under the credit facility. See Note 7
to our consolidated financial statements included in this report for additional discussion of the credit facility.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Analysis of Cash Flows</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Net cash provided by operating activities was
$0.2 million for the year ended December 31, 2017, compared to net cash used in operating activities of $10.8 million for the year
ended December 31, 2016.&nbsp;&nbsp;This change was attributable primarily to a decrease in net loss.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Net cash used in investing activities was approximately
$0.4 million and $2.7 million during the years ended December 31, 2017 and 2016, respectively.&nbsp;&nbsp;For the year ended December
31, 2017, this includes purchases of property and equipment of approximately $0.4 million. For the year ended December 31, 2016,
this includes cash paid for acquisitions of approximately $0.8 million, cash paid for reacquisition and termination of regional
developer rights of approximately $0.3 million and purchases of property of equipment of approximately $1.6 million.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Net cash provided by (used in) financing activities
was approximately $1.4 million and ($0.2) million during the years ended December 31, 2017 and 2016, respectively.&nbsp;&nbsp;For
the year ended December 31, 2017, this includes borrowings on revolving credit note payable of $1 million, proceeds from sale of
treasury stock of approximately $0.3 million, proceeds from exercise of stock options of approximately $0.4 million partially offset
by repayments on notes payable of approximately $0.2 million. For the year ended December 31, 2016, this includes repayments on
notes payable of approximately $0.4 million partially offset by treasury stock sales of approximately $0.2 million.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Recent Accounting Pronouncements</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">See Note 1, <i>Nature of Operations and Summary
of Significant Accounting Policies</i>, for information regarding recently issued accounting pronouncements that may impact our
financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Contractual Obligations and Risk</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table summarizes our contractual
obligations at December 31, 2017 and the effect that such obligations are expected to have on our liquidity and cash flows in future
periods:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="27" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Payments Due by Fiscal Year</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Total</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2019</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2020</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2021</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2022</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Thereafter</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; font-size: 10pt; text-align: left">Operating leases</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">11,228,713</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">2,119,305</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">1,808,476</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">1,544,978</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">1,411,126</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">1,283,865</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">3,060,963</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Notes payable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,100,000</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">100,000</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,000,000</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">12,328,713</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,219,305</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,808,476</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,544,978</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,411,126</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,283,865</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,060,963</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Off-Balance Sheet Arrangements</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2017, we
did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special
purpose entities that were established for the purpose of facilitating off-balance sheet arrangements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_012"></a>ITEM 7A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Not required for smaller reporting companies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_013"></a>ITEM 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b><u>Page</u></b></font></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt"><b>The Joint Corp.</b></font></td>
    <td style="vertical-align: bottom; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_015"><font style="font-size: 10pt">Report of Independent Registered Public Accounting Firm</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_015"><font style="font-size: 10pt">43</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_016"><font style="font-size: 10pt">Consolidated Balance Sheets as of December&nbsp;31, 2017 and 2016</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_016"><font style="font-size: 10pt">44</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_017"><font style="font-size: 10pt">Consolidated Statements of Operations for the Years Ended December&nbsp;31, 2017 and 2016</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_017"><font style="font-size: 10pt">45</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_018"><font style="font-size: 10pt">Consolidated Statements of Stockholders&#8217; Equity for the Years Ended December&nbsp;31, 2017 and 2016</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_018"><font style="font-size: 10pt">46</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_019"><font style="font-size: 10pt">Consolidated Statements of Cash Flows for the Years Ended December&nbsp;31, 2017 and 2016</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_019"><font style="font-size: 10pt">47</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_014"><font style="font-size: 10pt">Notes to Consolidated Financial Statements</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_014"><font style="font-size: 10pt">49</font></a></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_015"></a>Report of Independent Registered Public Accounting
Firm</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&nbsp;</b></p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">To the Shareholders and Board of Directors of</p>

<p style="margin: 0pt 0; font-size: 10pt">The Joint Corp. and Subsidiary</p>

<p style="margin: 0pt 0; font-size: 10pt">Scottsdale, Arizona</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; font-weight: bold">OPINION ON THE CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="margin: 0pt 0; font-size: 10pt; font-weight: bold">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">We have audited the accompanying consolidated balance sheets of
The Joint Corp. and Subsidiary (the &quot;Company&quot;) as of December 31, 2017 and 2016, and the related consolidated statements
of operations, stockholders' equity, and cash flows, for each year in the two-year period ended December 31, 2017, and the related
notes (collectively referred to as the &quot;financial statements&quot;). In our opinion, the financial statements present fairly,
in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of its operations
and its cash flows for each year in the two-year period ended December 31, 2017, in conformity with accounting principles generally
accepted in the United States of America.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; font-weight: bold">BASIS FOR OPINION</p>

<p style="margin: 0pt 0; font-size: 10pt; font-weight: bold">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) (&quot;PCAOB&quot;) and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of
internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's
internal control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">Our audits included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: right">EKS&amp;H LLLP</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">March 9, 2018</p>

<p style="margin: 0pt 0; font-size: 10pt">Denver, Colorado</p>

<p style="margin: 0pt 0; font-size: 10pt">&nbsp;</p>

<p style="margin: 0pt 0; font-size: 10pt">We have served as the Company's auditor since 2013.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_016"></a>CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<div data-td-taggable-table="" data-td-statement-type="balance-sheet"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2017</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: center; text-indent: -10pt; padding-left: 10pt">ASSETS</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current assets:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash and cash equivalents</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">4,216,221</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">3,009,864</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Restricted cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">103,819</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">334,394</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable, net</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,138,380</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,021,733</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Income taxes receivable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">42,014</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Notes receivable - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">171,928</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">40,826</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred franchise costs - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">484,081</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">748,300</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Prepaid expenses and other current assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">542,342</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">499,525</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Total current assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,656,771</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,696,656</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Property and equipment, net</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,800,466</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,724,706</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Notes receivable, net of current portion and reserve</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">351,857</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Deferred franchise costs, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">812,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">836,350</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Intangible assets, net</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,760,042</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,338,922</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Goodwill</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,916,426</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,750,338</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Deposits and other assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">611,808</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">707,889</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Total assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">16,909,970</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,054,861</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: center; text-indent: -10pt; padding-left: 10pt">LIABILITIES AND STOCKHOLDERS' EQUITY</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Current liabilities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,068,669</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,054,946</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Accrued expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">86,959</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">299,997</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Co-op funds liability</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">89,681</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">73,246</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Payroll liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">867,430</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">750,421</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Notes payable - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">100,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">331,500</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred rent - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">152,198</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">215,450</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred revenue - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,553,818</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,077,430</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Other current liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">48,534</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">60,894</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Total current liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,967,289</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,863,884</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Notes payable, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,000,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Deferred rent, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">802,492</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,400,790</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Deferred revenue, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,693,441</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,231,712</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Deferred tax liability</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">136,434</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">120,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Other liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">411,497</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">512,362</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 30pt">Total liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">12,011,153</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">10,129,448</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Commitments and contingencies</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Stockholders' equity:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2017, and December 31, 2016</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Common stock, $0.001 par value; 20,000,000 shares authorized, 13,600,338 shares issued and 13,586,254 shares outstanding as of December 31, 2017 and 13,317,393 shares issued and 13,020,889 outstanding as of December 31, 2016</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,317</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Additional paid-in capital</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">37,229,869</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">36,398,588</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Treasury stock 14,084 shares as of December 31, 2017 and 296,504 shares as of December 31, 2016, at cost</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(86,045</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(503,118</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Accumulated deficit</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(32,258,607</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(28,983,374</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Total stockholders' equity</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4,898,817</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">6,925,413</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total liabilities and stockholders' equity</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">16,909,970</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,054,861</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>The accompanying notes are an integral part of these consolidated
financial statements.</i></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><a name="a_017"></a><b>CONSOLIDATED STATEMENTS OF OPERATIONS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<div data-td-taggable-table="" data-td-statement-type="income"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Revenues and management fees from company clinics</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">11,125,115</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">8,550,980</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Royalty fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,722,856</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,973,079</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Franchise fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,442,415</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,286,809</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Advertising fund revenue</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,753,776</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,866,406</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">IT related income and software fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,137,363</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">932,709</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Regional developer fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">583,550</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">617,573</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Other revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">398,929</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">296,084</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 30pt">Total revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">25,164,004</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20,523,640</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Cost of revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Franchise cost of revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,996,797</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,717,691</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">IT cost of revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">315,397</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">221,918</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 30pt">Total cost of revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3,312,194</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2,939,609</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Selling and marketing expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,473,881</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,419,180</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Depreciation and amortization</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,017,323</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,566,136</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">General and administrative expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">18,117,533</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">22,086,321</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 30pt">Total selling, general and administrative expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">24,608,737</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">29,071,637</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Loss on disposition or impairment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">417,971</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3,520,370</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Loss from operations</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(3,174,898</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,007,976</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Other expense, net</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(64,455</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(1,467</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Loss before income tax expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(3,239,353</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,009,443</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: right; text-indent: -10pt; padding-left: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Income tax expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(35,880</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(164,429</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: right; text-indent: -10pt; padding-left: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Net loss and comprehensive loss</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(3,275,233</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(15,173,872</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Loss per share:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Basic and diluted loss per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(0.25</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1.20</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Basic and diluted weighted average shares outstanding</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,245,119</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,696,649</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>The accompanying notes are an integral part of these consolidated
financial statements.</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_018"></a>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<div data-td-taggable-table="" data-td-statement-type="stockholders-equity"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Common Stock</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Additional<br> Paid In</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Treasury Stock</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Accumulated</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Shares</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Amount</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Capital</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Shares</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Amount</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Deficit</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Total</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; font-size: 10pt; padding-bottom: 1.1pt">Balances, December 31, 2015</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">13,070,180</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">13,070</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">35,267,376</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">534,000</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(791,638</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(13,809,502</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20,679,306</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock-based compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123,481</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123,481</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Issuance of vested restricted stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">162,441</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">162</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(162</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Exercise of stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">37,824</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">38</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">70,893</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">70,931</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Issuance of common stock, offering costs adjustment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,042</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,042</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Purchases of treasury stock under employee stock plans</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,376</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(83,391</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(83,391</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Sale of treasury stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(161,911</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(250,872</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">371,911</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">210,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Issuance of common stock for legal settlement</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">46,948</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">47</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">99,953</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">100,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net loss</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(15,173,872</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(15,173,872</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Balances, December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,317,393</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,317</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">36,398,588</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">296,504</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(503,118</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(28,983,374</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,925,413</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Stock-based compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">594,371</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">594,371</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Issuance of vested restricted stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">76,070</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">76</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(76</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Purchases of treasury stock under employee stock plans</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">708</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(2,655</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(2,655</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Sale of treasury stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(127,057</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(283,128</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">419,728</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">292,671</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Exercise of stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">206,875</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">207</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">364,043</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">364,250</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net loss</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(3,275,233</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(3,275,233</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Balances, December 31, 2017</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,600,338</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,600</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">37,229,869</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">14,084</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(86,045</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(32,258,607</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,898,817</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_019"></a>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<div data-td-taggable-table="" data-td-statement-type="cash-flows"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center">Year Ended</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Cash flows from operating activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt; width: 68%">Net loss</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">(3,275,233</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">(15,173,872</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Adjustments to reconcile net loss to net cash used in operating activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">(Recovery) provision for bad debts</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(40,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(10,830</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Regional developer fees recognized upon acquisition of development rights</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(138,500</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Adjustment to deferred revenue from previous acquisitions</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">133,943</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Net franchise fees recognized upon termination of franchise agreements</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(73,665</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(342,259</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Depreciation and amortization</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,017,323</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,566,136</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Gain on sale of fixed assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(14,525</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(2,191</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Loss on disposition or impairment of assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">417,971</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,520,370</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Deferred income taxes</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">15,734</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">120,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Stock based compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">594,371</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123,481</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Cash paid for legal settlement</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">100,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Changes in operating assets and liabilities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Restricted cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">230,575</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">50,888</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Accounts receivable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(124,108</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(999,522</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Income taxes receivable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">42,014</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">28,967</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Prepaid expenses and other current assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(42,817</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(133,492</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Deferred franchise costs</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">269,719</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">361,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Deposits and other assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">96,081</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">71,549</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Accounts payable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(36,751</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(953,084</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Accrued expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(213,038</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(75,532</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Co-op funds liability</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">16,435</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(127,832</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Payroll liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">117,009</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(742,954</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Other liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(734,321</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(19,130</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Deferred rent</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(410,964</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">824,390</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Deferred revenue</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,170,691</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(896,195</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Net cash provided by (used in) operating activities</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">156,444</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(10,847,312</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Cash flows from investing activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Cash paid for acquisitions</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(839,000</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Reacquisition and termination of regional developer rights</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(325,000</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Purchase of property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(449,204</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,567,727</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Payments received on notes receivable</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">76,351</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">35,905</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Net cash used in investing activities</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(372,853</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,695,822</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Cash flows from financing activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Borrowings on revolving credit note payable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,000,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Issuance of common stock, offering costs adjustment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,042</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Purchases of treasury stock under employee stock plans</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(2,655</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(83,391</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Proceeds from sale of treasury stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">292,671</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">210,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Proceeds from exercise of stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">364,250</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">70,931</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Repayments on notes payable</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(231,500</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(436,350</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 0pt">Net cash provided by (used in) financing activities</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,422,766</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(239,852</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt">Net increase (decrease) in cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,206,357</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(13,782,986</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt">Cash at beginning of year</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,009,864</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">16,792,850</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; text-indent: 10pt">Cash at end of year</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">4,216,221</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">3,009,864</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>


<p style="margin: 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p><div data-td-statement-type="note"><p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">During the years ended December 31, 2017 and 2016, cash paid for income taxes was $29,315 and $11,250, respectively. During the years ended December 31, 2017 and 2016, cash paid for interest was $108,016 and $15,262, respectively.</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">Supplemental disclosure of non-cash activity:</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">As of December 31, 2017, the Company had property and equipment purchases of $50,474 which were included in accounts payable. As of December 31, 2016, the Company had property and equipment purchases of $11,059 which were included in accounts payable.</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">In connection with the acquisitions of franchises during the year ended December 31, 2016, the Company acquired $293,014 of property and equipment, intangible assets of $339,000, goodwill of $269,780 and assumed deferred revenue associated with membership packages paid in advance of $45,072 in exchange for $839,000 in cash and notes payable issued to the sellers for an aggregate amount of $186,000. Additionally, at the time of these transactions, the Company carried deferred revenue of $29,000, representing franchise fees collected upon the execution of franchise agreements, and deferred costs of $1,450, related to its acquisition of undeveloped franchises. The Company netted these amounts against the aggregate purchase price of the acquisitions (Note 2).</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">In connection with the reacquisition and termination of regional developer rights during the year ended December 31, 2016, the Company had deferred revenue of $224,750 representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;In accordance with ASC-952-605, the Company netted these amounts against the aggregate purchase price of the acquisitions.</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">In connection with the sale of the regional
developer territories in Central Florida, Maryland/Washington DC, Minnesota, Texas, Oklahoma and Arkansas, the Company issued
notes receivable in the amount of $559,310 with revenue to be recognized over the anticipated number of clinics to be opened in
the respective territories. The Company has recognized $14,967 of revenue related to these notes in the year ended December 31,
2017.</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">During December of 2016, the Company entered into a settlement agreement, whereby it resolved a pending litigation matter. Under the terms of the settlement agreement, the Company agreed to a one-time settlement amount comprised of cash and 46,948 shares of common stock. The fair value of the total consideration related to common stock was $100,000. The fair value of the common stock was measured using the closing price of the Company's common stock on the settlement date.</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">During December of 2017 the Company recorded an adjustment to goodwill related to deferred revenue from previous acquisitions of $166,088.</p></div><p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="margin: 0">&nbsp;</p>

<p style="text-align: center; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these consolidated financial statements.</p>


<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><a name="a_014"></a><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 1:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Nature of Operations and Summary of Significant Accounting Policies</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Principles of Consolidation</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The accompanying consolidated financial statements
include the accounts of The Joint Corp. and its wholly-owned subsidiary, The Joint Corporate Unit No. 1, LLC (collectively, the
&#8220;Company&#8221;), which was dormant for all periods presented.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">All significant intercompany accounts and transactions
between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from general
and administrative expenses to other expense, net, as well as certain balances from other revenues to revenues and management fees
from company clinics for the year ended December 31, 2016 to conform to the current year presentation and align with the segment
footnote presentation.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Comprehensive Loss</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;Net loss and comprehensive loss are the
same for the years ended December 31, 2017 and 2016.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Nature of Operations</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Joint Corp., a Delaware corporation, was
formed on March 10, 2010. Its principal business purposes are owning, operating, managing and franchising chiropractic clinics,
selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations
throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and
various state authorities.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">The following table summarizes the number of clinics in operation under franchise agreements
and as company-owned or managed for the years ended December 31, 2017 and 2016:</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 85%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> &nbsp;December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold">Franchised clinics:</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">309</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">265</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened or purchased during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">41</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">56</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired or sold during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(6</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(4</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(6</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">352</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">309</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>


<p style="margin: 0">&nbsp;</p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 85%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> &nbsp;December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold">Company-owned or managed clinics:</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">61</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">47</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(14</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">47</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">61</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">399</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">370</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Clinics licenses sold but not yet developed</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">104</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">115</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Executed letters of intent for future clinic licenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Variable Interest Entities</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An entity deemed to hold the controlling interest
in a voting interest entity or deemed to be the primary beneficiary of a&nbsp;variable interest entity&nbsp;(&#8220;VIE&#8221;)
is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it
has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's
economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of
benefits from the VIE. Investments where the Company does not hold the controlling interest and are not the primary beneficiary
are accounted for under the equity method.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Certain states, in which the Company manages
clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized
under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management
services agreements with PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic
practice.&nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power
to direct the activities of the PCs. As such, the activity of the PCs is not included in the Company&#8217;s consolidated financial
statements</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company considers all highly liquid instruments
purchased with an original maturity of three months or less to be cash equivalents. The Company continually monitors its positions
with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout
the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company
had no cash equivalents as of December 31, 2017 and 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Restricted Cash</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Restricted cash relates to cash franchisees
and corporate clinics contribute to the Company&#8217;s National Marketing Fund and cash franchisees provide to various voluntary
regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with
the Franchise Disclosure Document with a focus on regional and national marketing and advertising.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Concentrations of Credit Risk</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From time to time, the Company grants credit
in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The
Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit
risk. As of December 31, 2017 and 2016, one PC entity and six franchisees represented 13% and 24%, respectively, of outstanding
accounts receivable. The Company did not have any customers that represented greater than 10% of its revenues during the years
ended December 31, 2017 and 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Accounts Receivable</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Accounts receivable represent amounts due from
franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which the
Company performs management services for the repayment of working capital advances. The Company considers an allowance for doubtful
accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually
reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&#8217;s
best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company
tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining
the allowance. As of December 31, 2017 and 2016, the Company had an allowance for doubtful accounts of $0 and $131,830, respectively.&nbsp;During
the year ended December 31, 2017 the Company recovered $40,000 of accounts receivable that had previously been deemed uncollectible.</p>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company writes off accounts receivable
when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In
the year ended December 31, 2017, the Company determined that certain working capital advances from its PC entities in Illinois
and New York were no longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off
approximately $47,000 of accounts receivable to loss on disposition or impairment related to these entities during the year ended
December 31, 2017. The Company wrote-off $731,857 of accounts receivable to loss on disposition or impairment related to these
entities during the year ended December 31, 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Deferred Franchise Costs</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred franchise costs represent commissions
that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is
generally upon the opening of a clinic.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Property and Equipment</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment are stated at cost.
Depreciation is computed using the straight-line method over the estimated useful lives of three to seven years. Leasehold improvements
are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maintenance and repairs are charged to expense
as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related
cost and accumulated depreciation are removed from the accounts and any gain or loss is included in the consolidated statement
of operations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Software Developed</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company capitalizes certain software development
costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company
for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application
has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software
is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The
Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in
additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are
expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally 5 years.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Intangible Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired
franchise and regional developer rights and customer relationships.&nbsp;&nbsp;The Company amortizes the fair value of re-acquired
franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which
range from six to eight years. The Company amortizes the acquired regional developer rights over seven years. The fair value of
customer relationships is amortized over their estimated useful life of&nbsp;two&nbsp;years.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of
$38,185 during the year ended December 31, 2016 related to closure of an acquired clinic in New York. No impairment was recorded
for the year ended December 31, 2017.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Goodwill</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of the purchase
price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note 2.&nbsp;&nbsp;Goodwill
and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required,
the Company performs an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if events
or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of
$54,994 during the year ended December 31, 2016 which represents the write-off of the goodwill associated with the closure of an
acquired clinic in New York. No impairment was recorded for the year ended December 31, 2017.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Long-Lived Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company reviews its long-lived assets for
impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. The
Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have
been impaired. No impairments were recorded for the year ended December 31, 2017. The Company recorded an impairment charge of
$2.3 million during the year ended December 31, 2016 due to the sale or closure of clinics in Illinois and New York (Note 4).</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Advertising Fund</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has established an advertising
fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2% of clinic
sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets.
As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected
in excess of marketing expenditures are included in restricted cash on the Company&#8217;s consolidated balance sheets.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Co-Op Marketing Funds</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Some franchises have established regional Co-Ops
for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing
funds collected are segregated and used for the purposes specified by the Co-Ops&#8217; officers. The marketing funds are included
in restricted cash on the Company&#8217;s consolidated balance sheets.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Accounting for Costs Associated with Exit or Disposal Activities
</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recognizes a liability for the
cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability
is incurred.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Costs to terminate an operating lease or other
contracts are (a)&nbsp;costs to terminate the contract before the end of its term or (b)&nbsp;costs that will continue to be incurred
under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be
incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date.
In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that
was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or
the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.</p>

<p style="font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: left">Lease exit liability at December 31, 2016</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">338,151</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-left: 10pt">Additions</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">883,146</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-left: 10pt">Settlements</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(891,991</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net accretion</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(29,906</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Lease exit liability at December 31, 2017</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">299,400</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016, the Company recognized
a liability of approximately $0.3 million related to operating leases that will no longer provide economic benefit to the entity,
net of estimated sublease income.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the year ended December 31, 2017, the Company
ceased use of eight clinic locations from its corporate clinics segment and recognized a liability of approximately $0.9 million
for lease exit costs incurred based on the remaining lease rental due, reduced by estimated sublease rental income that could be
reasonably obtained for the properties. The Company recognized the resulting expense of approximately $0.4 million in loss on disposition
or impairment in the accompanying consolidated statement of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Deferred Rent</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases office space for its corporate
offices and company-owned and managed clinics under operating leases, which may include rent holidays and rent escalation clauses.&nbsp;
It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&nbsp; The
Company records tenant improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction
to rent expense.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company generates revenue through initial
franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and
from its company-owned and managed clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Franchise Fees.</i>&nbsp;The Company requires
the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial
term of ten years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services
under the franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;The Company&#8217;s services under
the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing
operations support. The Company provides no financing to franchisees and offers no guarantees on their behalf.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Regional Developer Fees</i>. During 2011,
the Company established a regional developer program to engage independent contractors to assist in developing specified geographical
regions. Under the historical program, regional developers paid a license fee ranging from $7,250 to 25% of the then current franchise
fee for each franchise they received the right to develop within the region. In 2017, the program was revised to grant exclusive
geographical territory and establish a minimum development obligation within that defined territory. Regional developers receive
fees ranging from $14,500 to $19,950 which are collected from franchisees upon the sale of franchises within their region and a
royalty of 3% of sales generated by franchised clinics in their region. Regional developer fees paid to the Company are nonrefundable
and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer
agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on
a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement.
Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which
is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the
regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent,
the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among,
and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. The franchisor&#8217;s
services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification
of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of
the regional developer agreements grant the Company the option to repurchase the regional developer&#8217;s license.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended December 31, 2017, the Company
entered into ten regional developer agreements for which it received approximately $2.1 million, which was deferred as of the respective
transaction dates and will be recognized on a pro-rata basis over the estimated number of franchised clinics to be opened in the
respective regions. Certain of these regional developer agreements resulted in the regional developer acquiring the rights to existing
royalty streams from clinics already open in the respective territory. In those instances, the revenue associated from the sale
of the royalty stream is being recognized over the remaining life of the respective franchise agreements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Revenues and Management Fees from Company
Clinics.&nbsp;&nbsp;</i>The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&nbsp;
In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company
offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&nbsp;
Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service
is performed.&nbsp;&nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor,
the Company enters into a management agreement with the doctor&#8217;s PC.&nbsp; Under the management agreement, the Company provides
administrative and business management services to the doctor&#8217;s PC in return for a monthly management fee.&nbsp; When the
collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees
expected to be collected from the PCs.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i></i></p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Royalties.</i>&nbsp;The Company collects
royalties, as stipulated in the franchise agreement, equal to 7% of gross sales, and a marketing and advertising fee currently
equal to 2% of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly
flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly two working days after each sales
period has ended.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>IT Related Income and Software Fees.</i>&nbsp;&nbsp;The
Company collects a monthly fee for use of its proprietary chiropractic software, computer support, and internet services support.
These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&#8217;s
computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card),
credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon receipt of equipment by the
franchisee.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Advertising Costs</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Advertising costs are expensed as incurred.
Advertising expenses for years ended December 31, 2017 and 2016 were $1,397,076 and $2,279,572, respectively.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Income Taxes</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred income taxes are recognized for differences
between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally
to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred
tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible
when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available
to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount
expected to be realized.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for uncertainty in income
taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax
position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company
measures the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest
benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Loss per Common Share</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Basic loss per common share is computed by
dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share
is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock
options.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-align: left">Net loss</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">(3,275,233</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">(15,173,872</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,245,119</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,696,649</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,245,119</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">12,696,649</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(0.25</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1.20</td><td style="font-size: 10pt; text-align: left">)</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table summarizes the potential shares of common stock
that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">63,700</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">92,415</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,003,916</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">953,075</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Warrants</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">90,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">90,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Stock-Based Compensation</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for share-based payments
by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines
the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options
using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made
regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate,
volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to
the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Use of Estimates</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of the consolidated financial
statements in conformity with accounting principles generally accepted in the United States of America requires management to make
estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual
results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful
accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets,
classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets,
impairment of goodwill and intangible assets, and purchase price allocations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"><b><i>Recent Accounting Pronouncements</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &#8220;<i>Revenue from Contracts with Customers,</i>&#8221;
which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods
or services to customers. The standard also calls for additional disclosures around the nature, amount, timing and uncertainty
of revenue and cash flows arising from contracts with customers. The ASU will replace most existing revenue recognition guidance
in U.S. GAAP when it becomes effective. The new standard becomes effective for the Company on January 1, 2018.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In April 2016, the FASB issued ASU No. 2016-10,
&#8220;<i>Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,</i>&#8221; to clarify
the following two aspects of Topic 606: 1) identifying performance obligations, and 2) the licensing implementation guidance. The
effective date and transition requirements for these amendments are the same as the effective date and transition requirements
of ASU 2014-09.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In May 2016, the FASB issued ASU No. 2016-12,
&#8220;<i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients,</i>&#8221; to
clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications
and completed contracts at transition and disclosures no longer required if the full retrospective transition method is adopted.
The effective date and transition requirements for these amendments are the same as the effective date and transition requirements
of ASU 2014-09.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has performed a review of the
above revenue standards updates and does not expect the adoption of the updates to have a material impact on its revenues and
management fees from company clinics, advertising fund revenue, or IT related income and software fees. In addition, the Company
does not expect the adoption to have a material impact on its franchise royalty revenues, as they are based on a percent of sales.
The Company expects the adoption of Topic 606 to impact its accounting for initial franchise fees and regional developer fees.
Currently, the Company recognizes revenue from initial franchise fees and regional developer fees upon the opening of a franchised
clinic when the Company has performed all of its material obligations and initial services under the respective agreements. Upon
the adoption of Topic 606, the Company expects to recognize the revenue related to initial franchise fees and regional developer
fees over the term of the related franchise agreement or regional developer agreement. The Company has finalized its accounting
policies, and has selected the full retrospective method as its transition method.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company quantified the impact
of adopting this standard, and designed internal controls during the year ended December 31, 2017 to be implemented on
January 1, 2018. The Company estimates the cumulative catch-up adjustment to be recorded to retained earnings as of December
31, 2015 to be an approximately $3.3 million increase to the accumulated deficit as the Company has adopted the full
retrospective approach. This is made up of a decrease to franchise fee revenue of approximately $4.5 million, a decrease to regional
developer revenue of approximately $0.4 million, and a decrease to franchise cost of revenue of approximately $1.6 million.
The Company estimates the adjustment to be recorded to retained earnings as of December 31, 2016 to be an approximately $0.6
million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately $0.8
million, with a decrease to franchise cost of revenue of approximately $0.2 million. The Company estimates the adjustment to
be recorded to retained earnings as of December 31, 2017 to be an approximately $0.2 million increase to accumulated
deficit. This is made up of a decrease to franchise fee revenue of approximately $0.3 million, with an offsetting increase
to franchise cost of revenue of approximately $0.1 million. The impact to regional developer revenue for the years
ended December 31, 2016 and 2017 was not material. No impact to the Company's consolidated statement of cash flows is
expected as the initial fees will continue to be collected upon execution of the franchise agreement. The Company will comply
with the increased financial statement disclosure requirements during the first quarter of 2018.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In February 2016, the FASB issued ASU No. 2016-02,
&#8220;<i>Leases (Topic 842).</i>&#8221; The ASU requires that substantially all operating leases be recognized as assets and liabilities
on the Company&#8217;s balance sheet, which is a significant departure from the current standard, which classifies operating leases
as off-balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations.
The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease
will be accounted for as a liability. The effective date is for fiscal years beginning after December 31, 2018. While the Company
has not yet quantified the impact that this standard will have on its financial statements, it will result in a significant increase
in the assets and liabilities reflected on the Company&#8217;s balance sheet and in the interest expense and depreciation and amortization
expense reflected in its statement of operations, while reducing the amount of rent expense.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In August 2016, the FASB issued ASU No. 2016-15,&nbsp;<i>&#8220;Statement
of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.&#8221;&nbsp;</i>This update addresses how
certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This
update is effective for annual and interim reporting periods beginning after December 15, 2017. Early adoption is permitted. The
Company adopted the standard on January 1, 2018 and does not anticipate this amendment will have a material impact on its consolidated
financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In November 2016, the FASB issued ASU No. 2016-18,
&#8220;<i>Statement of Cash Flows (Topic 230): Restricted Cash&#8221;</i>&nbsp;(a consensus of the FASB Emerging Issues Task Force),
to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. The amendments
should be applied using a retrospective transition method, and are effective for fiscal years beginning after December 15, 2017,
including interim periods within those fiscal years. The Company adopted the standard on January 1, 2018 and does not anticipate
this amendment will have a material impact on its consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January 2017, the FASB issued ASU No. 2017-01,
&#8220;<i>Business Combinations (Topic 805): Clarifying the Definition of a Business,&#8221;&nbsp;</i>to clarify the definition
of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted
for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for
fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company adopted the standard
on January 1, 2018 and does not anticipate this amendment will have a material impact on its consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January 2017, the FASB issued ASU&nbsp;2017-04,&nbsp;&#8220;<i>Intangibles
- Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</i>.&#8221; This update simplifies the subsequent
measurement of goodwill by eliminating &#8220;Step 2&#8221; from the goodwill impairment test. This update is effective for annual
and interim reporting periods beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating
the impact this standard will have on the Company's consolidated financial statements and related disclosures.</p>

<p style="font-size: 10pt; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In May 2017, the FASB issued ASU No. 2017-09,&nbsp;<i>&#8220;Compensation&#8212;Stock
Compensation (Topic 718): Scope of Modification Accounting,&#8221;&nbsp;</i>to provide clarity and reduce both (1) diversity in
practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation&#8212;Stock Compensation, to a change
to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions
of a share-based payment award require an entity to apply modification accounting in ASC 718.The amendments are effective for fiscal
years beginning after December 15, 2017 and should be applied prospectively to an award modified on or after the adoption date.
Early adoption is permitted, including adoption in an interim period. The Company adopted the standard on January 1, 2018 and does
not anticipate this amendment will have a material impact on its consolidated financial statements.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b>Note 2:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Acquisitions</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Franchises acquired during 2016</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company continued to execute its growth strategy and entered into a series of unrelated transactions with existing franchisees
to re-acquire an aggregate of six developed franchises and one undeveloped franchise throughout California and New Mexico for an
aggregate purchase price of $1,025,000, subject to certain adjustments, consisting of cash of $839,000 and notes payable of $186,000.
The Company is operating the six developed franchises as company-owned or managed clinics and has terminated the undeveloped clinic
license. At the time these transactions were consummated, the Company carried <font style="background-color: white">a deferred
revenue balance of $29,000, representing franchise fees collected upon the execution of the franchise agreements, and deferred
franchise costs of $1,450, related to an undeveloped franchise.&nbsp;&nbsp;The Company accounted for the franchise rights associated
with the undeveloped franchise as a cancellation, and the respective deferred revenue and deferred franchise costs were netted
against the aggregate purchase price.&nbsp;&nbsp;The remaining $997,450 was accounted for as consideration paid for the acquired
franchises.</font></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company incurred approximately $75,000
of transaction costs related to these acquisitions for the year ended December 31, 2016, which are included in general and administrative
expenses in the accompanying consolidated statements of operations.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Purchase Price Allocation</i></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following summarizes the aggregate estimated
fair values of the assets acquired and liabilities assumed during 2016 as of the acquisition date:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">293,014</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Intangible assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">339,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Favorable leases</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">140,728</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">269,780</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Total assets acquired</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,042,522</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(45,072</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">997,450</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets in the table above consist
of reacquired franchise rights of $181,000 and customer relationships of $158,000 and will be amortized over their estimated useful
lives ranging from six to eight years and two years, respectively.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill recorded in connection with these
acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities.
All of the recorded goodwill is tax-deductible.&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Pro Forma Results of Operations (Unaudited)</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table summarizes selected unaudited
pro forma condensed consolidated statements of operations data for the year ended December 31, 2017 and 2016 as if the acquisitions
in 2016 had been completed on January 1, 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Pro Forma for the Year Ended</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31, 2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Revenues, net</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">20,985,277</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Net loss</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(15,483,492</td><td style="font-size: 10pt; text-align: left">)</td></tr>
</table></div>




<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">This selected unaudited pro forma consolidated
financial data is included only for the purpose of illustration and does not necessarily indicate what the operating results would
have been if the acquisitions had been completed on that date. Moreover, this information is not indicative of what the Company&#8217;s
future operating results will be. The information for 2016 prior to the acquisitions is included based on prior accounting records
maintained by the acquired companies. In some cases, accounting policies differed materially from accounting policies adopted by
the Company following the acquisitions. For 2016, this information includes actual data recorded in the Company&#8217;s consolidated
financial statements for the period subsequent to the date of the acquisitions. The Company&#8217;s consolidated statements of
operations for the year ended December 31, 2016 includes net revenue and net income of approximately $7.5 million and $0.7 million,
respectively, attributable to the acquisitions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The pro forma amounts included in the table
above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation
and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets
had been applied from January 1, 2015, together with the consequential tax impacts.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 3:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Notes Receivable</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective July 2012, the Company sold a company-owned
clinic, including the license agreement, equipment, and customer base, in exchange for a $90,000 unsecured promissory note. The
note bore interest at 6% per annum for fifty-four months and required monthly principal and interest payments over forty-two months,
beginning on August 2013. The note matured in January 2017 and was paid in full upon maturity.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective July 2015, the Company entered into
two license transfer agreements, in exchange for $10,000 and $29,925 in separate unsecured promissory notes.&nbsp; The non-interest-bearing
notes require monthly principal payments over 24 months, beginning on September 1, 2015. The note was settled in full in 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Effective May 2016, the Company entered into three license transfer
agreements, in exchange for three separate $7,500 unsecured promissory notes.&nbsp; The non-interest-bearing notes require monthly
principal payments over six months, beginning on May 1, 2017. The note matured in October 2017 and was paid in full upon maturity.&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective April 29, 2017, the Company entered
into a regional developer agreement for certain territories in the state of Florida in exchange for $320,000, of which $187,000
was funded through a promissory note. The note bears interest at 10% per annum for 42 months and requires monthly principal and
interest payments over 36 months, beginning November 1, 2017 and maturing on October 1, 2020.&nbsp;The note is secured by the regional
developer rights in the respective territory.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective August 31, 2017, the Company entered
into a regional developer agreement for certain territories in Maryland/Washington DC in exchange for $220,000, of which $117,475
was funded through a promissory note. The note bears interest at 10% per annum for 36 months and requires monthly principal and
interest payments over 36 months, beginning September 1, 2017 and maturing on August 1, 2020. The note is secured by the regional
developer rights in the respective territory.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective September 22, 2017, the Company entered
into a regional developer and asset purchase agreement for certain territories in Minnesota in exchange for $228,293, of which
$119,147 was funded through a promissory note. The note bears interest at 10% per annum for 36 months and requires monthly principal
and interest payments over 36 months, beginning October 1, 2017 and maturing on September 1, 2020. The note is secured by the regional
developer rights in the respective territory.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective October 10, 2017, the Company entered
into a regional developer agreement for certain territories in Texas, Oklahoma and Arkansas in exchange for $170,000, of which
$135,688 was funded through a promissory note. The note bears interest at 10% per annum for 36 months and requires monthly principal
and interest payments over 36 months, beginning September 24, 2017 and maturing on October 24, 2020. The note is secured by the
regional developer rights in the respective territory.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The outstanding balance of the notes as of
December 31, 2017 and 2016 were $523,785 and $40,826, respectively.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 4:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Property and Equipment</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment consist of the following:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2016</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Office and computer equipment</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">1,137,970</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">1,083,039</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Leasehold improvements</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,117,379</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,085,366</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Software developed</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,066,454</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">891,192</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,321,803</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,059,597</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Accumulated depreciation</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(3,928,349</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(2,566,172</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,393,454</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,493,425</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Construction in progress</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">407,012</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">231,281</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,800,466</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,724,706</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Depreciation expense was $1,438,443 and $1,818,403
for the years ended December 31, 2017 and 2016, respectively.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In December 2016, the Company determined that
14 clinics from its Corporate Clinics segment met the criteria for classification as held for sale. Accordingly, in December 2016,
the Company recognized a $2.4 million impairment charge to lower the carrying costs of the property and equipment to its estimated
fair value less cost to sell which was recorded in the loss on disposition or impairment line of the 2016 consolidated statement
of operations. The Company completed the sale of the property in the first quarter of 2017 for nominal consideration.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 5:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Fair Value Consideration</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#8217;s financial instruments include
cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying
amounts of its financial instruments approximate their fair value due to their short maturities.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company does not use derivative financial
instruments to hedge exposures to cash-flow, market or foreign-currency risks.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Authoritative guidance defines fair value as
the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that
maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs
be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed
based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s
assumptions of what market participants would use in pricing the asset or liability developed based on the best information available
in the circumstances. The hierarchy is broken down into three levels based on reliability of the inputs as follows:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 1%; text-align: justify">&nbsp;</td>
    <td style="width: 6%; text-align: justify"><font style="font-size: 10pt">Level 1:</font></td>
    <td style="width: 93%; text-align: justify"><font style="font-size: 10pt">Observable inputs such as quoted prices in active markets;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 1%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 6%; text-align: justify"><font style="font-size: 10pt">Level 2:</font></td>
    <td style="vertical-align: bottom; width: 93%; text-align: justify"><font style="font-size: 10pt">Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&nbsp;and</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 1%; text-align: justify">&nbsp;</td>
    <td style="width: 6%; text-align: justify"><font style="font-size: 10pt">Level 3:</font></td>
    <td style="width: 93%; text-align: justify"><font style="font-size: 10pt">Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2017 and 2016, the Company
does not have any financial instruments that are measured on a recurring basis as Level 1, 2 or 3.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016, the Company had non-recurring
fair value measurements. As a result of the sale of certain clinics subsequent to year end, the Company recorded the assets at
the lesser of their carrying values and their fair value less costs to sell, which resulted in a write-down of approximately $3.5
million. The inputs used to determine such fair values were based on the offer price provided by a third-party in connection with
the sale, and are classified within Level 3 in the hierarchy.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 6:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Intangible Assets</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On January 1, 2016, the Company entered into
an agreement under which it repurchased the regional development rights to develop franchises in San Bernardino and Riverside Counties
in California. The total consideration for the transaction was $275,000, paid in cash.<b>&nbsp;</b><font style="background-color: white">The
Company carried a deferred revenue balance associated with these transactions of $36,250, representing license fees collected upon
the execution of the regional developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with
the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase
price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp; </font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On June 1, 2016, the Company entered into an
agreement under which it repurchased the regional development rights to develop franchises in Virginia. The total consideration
for the transaction was $50,000, paid in cash.<b>&nbsp;</b><font style="background-color: white">The Company carried a deferred
revenue balance associated with these transactions of $188,500, representing license fees collected upon the execution of the regional
developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises
as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue
to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp;</font></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consisted of the following:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31, 2017</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Carrying<br> Amount</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Accumulated<br> Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Net Carrying<br> Value</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,673,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">657,943</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,015,057</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Customer relationships</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">701,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">674,667</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">26,333</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,162,000</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">443,348</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">718,652</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,536,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,775,958</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,760,042</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>


<p style="margin: 0">&nbsp;</p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31, 2016</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Carrying<br> Amount</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Accumulated<br> Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Net Carrying<br> Value</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,673,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">410,688</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,262,312</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Customer relationships</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">701,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">509,042</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">191,958</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,162,000</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">277,348</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">884,652</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,536,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,197,078</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,338,922</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Amortization expense was $578,880 and $747,733
for the year ended December 31, 2017 and 2016, respectively.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company evaluates the recoverability of
finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such
assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent
of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts
to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of
intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. The Company recorded an impairment
charge as a result of the closure of a clinic acquired in 2015 of $38,185 related to certain reacquired franchise rights and customer
relationships during the year ended December 31, 2016 which is included on the loss on disposition or impairment line of the statement
of consolidated operations.&nbsp;No impairment was recorded for the year ended December 31, 2017.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Estimated amortization expense for 2018 and subsequent years is
as follows:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: left">2018</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">439,590</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2019</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">413,256</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2020</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">413,256</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">348,034</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">133,693</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">12,213</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,760,042</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p></div><p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 7:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Debt</b></font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Notes Payable</i></b>&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2015, the Company issued 12 notes payable
totaling $800,350 as a portion of the consideration paid in connection with the Company&#8217;s various acquisitions. Interest
rates range from 1.5% to 5.25% with maturities through February of 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2016, the Company issued two notes
payable totaling $186,000 as a portion of the consideration paid in connection with the Company&#8217;s various acquisitions.
Interest rates for both notes are 4.25% with maturities through May of 2017. The outstanding note will be paid upon execution
of a final settlement and release agreement between the parties.</p>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maturities of notes payable are as follows
as of December 31, 2017:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: left">2018</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">100,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">100,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Credit and Security Agreement</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On January 3, 2017, the Company entered into
a Credit and Security Agreement (the &#8220;Credit Agreement&#8221;) and signed a revolving credit note payable to the lender.
Under the Credit Agreement, the Company is able to borrow up to an aggregate of $5,000,000 under revolving loans. Interest on the
unpaid outstanding principal amount of any revolving loans is at a rate equal to 10% per annum, provided that the minimum amount
of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is $200,000. Interest is
due and payable on the last day of each fiscal quarter in an amount determined by the Company, but not less than $25,000. The lender&#8217;s
lending commitments under the Credit Agreement terminate in December 2019, unless sooner terminated in accordance with the provisions
of the Credit Agreement. The Credit Agreement is collateralized by the assets in the Company&#8217;s company-owned or managed clinics.
The Company is using the credit facility for general working capital needs. As of December 31, 2017, the Company had drawn $1,000,000
of the $5,000,000 available under the Credit Agreement.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 8:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Equity</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;<i>Stock Options</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On May 15, 2014, the Company adopted the 2014
Stock Plan (&#8220;2014 Plan&#8221;). The 2014 Plan is designed to supersede and replace the 2012 Plan, effective as of the adoption
date and set aside 1,513,000 shares of the Company&#8217;s common stock that may be granted under the 2014 Plan.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company granted 660,000 stock options to employees with exercise prices ranging from $2.23 - $4.11.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2017, the
Company granted 295,286 stock options to employees with exercise prices ranging from $2.65 - $5.51.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#8217;s stock trading price is
the basis of fair value of its common stock used in determining the value of share-based awards. To the extent the value of the
Company&#8217;s share-based awards involves a measure of volatility, it will rely upon the volatilities from publicly traded companies
with similar business models until its common stock has accumulated enough trading history for it to utilize its own historical
volatility. We use the simplified method as to calculate the expected term of stock option grants to employees as we do not have
sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term of stock options granted
to employees. Accordingly, the expected life of the options granted is based on the average of the vesting term and the contractual
term of the option. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury 10-year
yield curve in effect at the date of the grant.&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has computed the fair value of
all options granted during the years ended December 31, 2017 and 2016, using the following assumptions:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Expected volatility</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 5%; font-size: 10pt; text-align: right">&nbsp;</td><td style="width: 6%; font-size: 10pt; text-align: center">42%</td><td style="width: 5%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 5%; font-size: 10pt; text-align: right">42%</td><td style="width: 6%; font-size: 10pt; text-align: center"> - </td><td style="width: 5%; font-size: 10pt; text-align: left">45%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Expected dividends</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">None</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">None</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Expected term (years)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">5.5</td><td style="font-size: 10pt; text-align: center">- </td><td style="font-size: 10pt; text-align: left">7</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">7</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Risk-free rate</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">1.98%</td><td style="font-size: 10pt; text-align: center"> to </td><td style="font-size: 10pt; text-align: left">2.20%</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">1.19%</td><td style="font-size: 10pt; text-align: center"> - </td><td style="font-size: 10pt; text-align: left">1.68%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Forfeiture rate</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">20%</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">20%</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summarizes the stock
options:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number of<br> Shares</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br> Average<br> Exercise<br> Price</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br> Average<br> Fair<br> Value</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br> Average<br> Remaining<br> Contractual Life</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">477,459</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4.30</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2.01</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">8.7</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Granted at market price</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">660,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3.22</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Exercised</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(37,824</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1.88</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(146,560</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4.34</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">953,075</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3.66</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1.86</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">6.9</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Granted at market price</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">295,286</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4.31</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Exercised</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(206,875</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1.76</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(37,570</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">5.11</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2017</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,003,916</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4.18</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1.87</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.1</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2017</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">287,230</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5.37</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2.38</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7.4</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The intrinsic value of the Company&#8217;s
stock options outstanding was $1,306,260 at December 31, 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended December 31, 2017 and 2016,
stock-based compensation expense for stock options was $380,067 and $561,559, respectively.&nbsp;&nbsp;Unrecognized stock-based
compensation expense for stock options for the year ended December 31, 2017 was $840,826, which is expected to be recognized ratably
over the next 2.7 years.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Restricted Stock</I></B></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B><I>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2016, the Company granted restricted
stock awards to seven members of the Board of Directors. The awards have been granted under The Joint Corp. 2014 Incentive Stock
Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) one year from the
Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for
each to earn 12,345 shares of common stock. The estimated fair market value of these shares was valued at $3.10 per share, based
on the Company&#8217;s stock trading price, totaling approximately $268,000 to be recognized ratably as the stock is vested.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2017, the Company granted restricted
stock awards to six members of the Board of Directors. The awards have been granted under The Joint Corp. 2014 Incentive Stock
Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) one year from the
Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for
each to earn 9,950 shares of common stock. The estimated fair market value of these shares was valued at $4.02 per share, based
on the Company&#8217;s stock trading price, totaling approximately $240,000 to be recognized ratably as the stock is vested.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summaries the restricted
stock activity:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Restricted Stock Awards</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Shares</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 16%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">339,288</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Awards granted</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">86,415</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Awards vested</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(162,440</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(170,848</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">92,415</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Awards granted</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">59,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Awards vested</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(76,070</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(12,345</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2017</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">63,700</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended December 31, 2017 and 2016,
stock-based compensation expense for restricted stock awards was $214,304 and $561,922, respectively.&nbsp;&nbsp;Unrecognized stock-based
compensation expense for restricted stock awards as of December 31, 2017 was $143,240 to be recognized ratably over 0.7 years.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Modifications</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company accelerated the vesting of all unvested stock options and restricted stock awards granted to the Company&#8217;s former
chief development officer in connection with his separation from the Company. In addition, the Company modified the post-employment
exercise period of the stock options previously granted, extending the exercise period to December 31, 2017.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company modified the post-employment exercise period of stock options previously granted to the Company&#8217;s former chief executive
officer in connection with his separation from the Company. The modification extended the exercise period to May 13, 2020. In addition,
the Company accelerated the vesting of 9,733 shares of the previously granted restricted stock awards that were scheduled to vest
in July 2016. The remaining unvested restricted stock awards were forfeited upon separation.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">These modifications resulted in an approximately
$412,000 increase in stock-based compensation for the year ended December 31, 2016.</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Treasury Stock</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In December 2013, the Company exercised its
right of first refusal under the terms of a Stockholders Agreement dated March 10, 2010 to repurchase 534,000 shares of the Company&#8217;s
common stock. The shares were purchased for $0.45 per share or $240,000 in cash along with the issuance of an option to repurchase
the 534,000 shares. The repurchased shares were recorded as treasury stock, at cost in the amount of $791,638. The option is classified
in equity as it is considered indexed to the Company&#8217;s stock and meets the criteria for classification in equity.&nbsp;&nbsp;The
option was granted to the seller for a term of 8 years.&nbsp;&nbsp;The option contained the following exercise prices:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<div data-td-taggable-table=""><table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 86%"><font style="font-size: 10pt">Year 1</font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.56</font></td>
    <td style="width: 1%">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Year 2</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.68</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Year 3</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.84</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Year 4</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.03</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Year 5</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.28</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Year 6</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.59</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Year 7</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.97</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Year 8</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.45</font></td>
    <td>&nbsp;</td></tr>
</table></div>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Consideration given in the form of the option
was valued using a Binomial Lattice-Based model resulting in a fair value of $1.03 per share option for a total fair value of $551,638.
The option was valued using the Binomial Lattice-Based valuation methodology because that model embodies all of the relevant assumptions
that address the features underlying the instrument.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During December 2016, the option holder partially
exercised the call option and purchased 250,872 shares at a total repurchase price of $210,000. The Company reduced the cost of
treasury shares by approximately $113,000 related to the transaction, reduced the value of the option by approximately $259,000,
and reduced additional paid-in-capital by approximately $162,000.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During September 2017, the option holder exercised
the remainder of the call option and purchased 283,128 shares at a total repurchase price of $292,671. The Company reduced the
cost of treasury shares by approximately $127,000 related to the transaction, reduced the value of the option by approximately
$292,000, and reduced additional paid-in-capital by approximately $127,000.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Warrants</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In conjunction with the IPO, the Company issued
warrants to the underwriters for the purchase of 90,000 shares of common stock, which can be exercised between November 10, 2015
and November 10, 2018 at an exercise price of $8.125 per share.&nbsp; The fair value of the warrants was determined using the Black-Scholes
option valuation model. The warrants expire on November 10, 2018 and have a remaining contractual life of .9 years as of December
31, 2017.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">The information below summarizes the warrants:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td nowrap style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" nowrap style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Number of <br>
Units</td><td nowrap style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" nowrap style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Weighted <br>
Average <br>
Exercise Price</td><td nowrap style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" nowrap style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Weighted <br>
Average <br>
Remaining <br>
Contractual Term (in years)</td><td nowrap style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" nowrap style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Intrinsic <br>
Value</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2015</td><td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">90,000</td><td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">8.13</td><td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">2.9</td><td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td><td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt">Granted</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">90,000</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">8.13</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">1.9</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt">Granted</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2017</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">90,000</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">8.13</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">0.9</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.25pt">Exercisable at December 31, 2017</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">90,000</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">8.13</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">0.9</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>





<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Issuance of Common Stock for Legal Settlement</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During December 2016, the Company entered
into a settlement agreement, whereby it resolved a pending litigation matter. Under the terms of the settlement agreement,
the Company agreed to a one-time settlement amount comprised of cash and newly issued shares of its common stock. The amounts
paid by the Company in this settlement was determined by the Company not to be material. The fair value of the total
consideration related to common stock was valued using the closing price of our common stock on the settlement date.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 9:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Income Taxes</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Income tax provision reported in the consolidated
statements of operations is comprised of the following (in hundreds):</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current provision:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; font-size: 10pt">Federal</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">22,800</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">State, net of state tax credits</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,100</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,900</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total current provision</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">20,100</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">43,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Deferred provision:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Federal</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">97,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt">State</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,000</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">23,300</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Total deferred provision</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">15,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">120,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total income tax provision</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">35,900</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">164,400</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following are the components of the Company&#8217;s
net deferred taxes for federal and state income taxes (in hundreds):</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Deferred revenue</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">756,900</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">1,509,400</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Deferred franchise costs</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(281,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(553,900</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Allowance for doubtful accounts</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">51,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Accrued expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">45,300</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">57,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Goodwill - component 1</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(136,500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(120,700</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Goodwill - component 2</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">55,500</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">86,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Restricted stock compensation</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(17,900</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(30,800</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Nonqualified stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">152,900</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">182,100</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred rent</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">257,100</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">629,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Lease abandonment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">80,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">108,900</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net operating loss carryforwards</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,061,300</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8,924,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Tax credits</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">14,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">14,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Charitable contribution carryover</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,200</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,500</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Asset basis difference related to property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">377,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">201,300</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1pt">Intangibles</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">368,100</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">429,600</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8,739,300</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">11,496,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Less valuation allowance</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(8,875,800</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(11,617,100</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Net non-current deferred tax liability</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(136,500</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(120,700</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The 2017 Tax Act was signed into law on December
22, 2017. The 2017 Tax Act significantly revises the U.S. corporate income tax by, among other things, lowering the statutory corporate
tax rate from 34% to 21%, eliminating certain deductions, imposing a mandatory one-time tax on accumulated earnings of foreign
subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax. The Company has not completed
its determination of the accounting implications of the 2017 Tax Act on its accruals. However, it has reasonably estimated the
effects of the 2017 Tax Act and recorded a provisional tax expense in its financial statements as of December 31, 2017 of approximately
$3.9 million. This amount is a remeasurement of federal net deferred tax assets resulting from the permanent reduction in the U.S.
statutory corporate tax rate to 21% from 34%. As the Company completes its analysis of the 2017 Tax Act, collects and prepares
necessary data, and interprets any additional guidance issued by the U.S. Treasury Department, the IRS, and other standard-setting
bodies, it may make adjustments to the provisional amounts.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">At December 31, 2017, the Company has federal
and state net operating losses of approximately $26,527,000 and $32,030,000 respectively. These net operating losses are available
to offset future taxable income and will begin to expire in 2035 for federal purposes and 2025 for state purposes.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following is a reconciliation of the statutory
federal income tax rate applied to pre-tax accounting net loss, compared to the income tax provision in the consolidated statement
of operations (in hundreds):</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For the Years Ended December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percent</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percent</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Expected federal tax benefit</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(1,100,000</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(34.00</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(5,106,100</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(34.00</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">State tax provision, net of federal benefit</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(140,200</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4.33</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(735,500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4.90</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Effect of (decrease) increase in valuation allowance</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(2,741,300</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(84.73</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,042,900</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">40.24</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Other permanent differences</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">16,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">0.52</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">108,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">0.72</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Stock Compensation</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(131,900</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4.08</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Impact of enacted tax reform</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,946,100</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">121.97</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">State deferred tax true up</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">185,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5.72</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other, net</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,500</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.05</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(145,700</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.97</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.25pt">Provision</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">35,900</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">1.11</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">164,400</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">1.09</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The state tax benefit stems from the resolution
of various voluntary disclosure agreements with multiple states where the Company had not yet been in compliance. In addition,
the Company is responsible to pay certain minimum and franchise taxes to jurisdictions in which it does business.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Changes in income tax expense related primarily
to changes in pretax losses during the year ended December 31, 2017, as compared to year ended December 31, 2016, and the effective
rate was 1.1% and 1.1%, respectively. The difference is primarily due to state taxes, stock compensation and the impact of enacted
tax reform which is mostly offset by the valuation allowance.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended December 31, 2017 and, 2016,
the Company recorded a liability for income taxes for operations and uncertain tax positions of $0 and approximately $40,000, respectively,
of which $0 and approximately $27,000 respectively, represent penalties and interest and are recorded in the &#8220;other liabilities&#8221;
section of the accompanying consolidated balance sheets. Interest and penalties associated with tax positions are recorded in the
period assessed as general and administrative expenses. Management made a determination that the Company was not in compliance
with several state and local tax jurisdictions in which the Company was doing business. Accordingly, management undertook to analyze
its tax exposures, both income and otherwise, with respect to jurisdictions in which compliance was deemed to be inadequate and
has entered into Voluntary Disclosure Agreements (VDAs) with the taxing authorities.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table sets forth a
reconciliation of the beginning and ending amount of uncertain tax positions during the tax years ended December 31, 2017 and
2016 (in hundreds):</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Tax</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Interest/<br> penalties</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Tax</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Interest/<br> penalties</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Uncertain tax positions - January 1</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">13,200</td><td style="width: 1%; font-size: 10pt; text-align: left"></td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">26,800</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">32,600</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">33,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross increases - tax positions in prior period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Gross decreases - tax positions in prior period</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(13,200</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(26,800</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(19,400</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(6,200</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Uncertain tax positions - December 31</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">13,200</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">26,800</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#8217;s tax returns for tax years
subject to examination by tax authorities include 2013 through the current period for state and 2014 through the current period
for federal purposes.&nbsp;</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 10:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Related Party Transactions</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company entered into consulting and legal
arrangements with certain stockholders related to services performed for the operations and transaction related activities of the
Company.&nbsp;&nbsp;Amounts paid to or for the benefit of these stockholders was approximately $205,000 and $461,000 for the years
ended December 31, 2017 and 2016, respectively.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 11:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Commitments and Contingencies</b></font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Operating Leases</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases its corporate office space
and the space for each of the company-owned or managed clinics in the portfolio.</p>

<p style="font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Total rent expense for the years ended December
31, 2017 and 2016 was $2,808,837 and $3,389,971, respectively.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Future minimum annual lease payments are as follows:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; font-size: 10pt; text-align: left">2018</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">2,119,305</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2019</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,808,476</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2020</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,544,978</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,411,126</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,283,865</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,060,963</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.25pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">11,228,713</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27.8pt; margin: 0pt 0">In December 2016, the Company ceased use of
five undeveloped clinic locations from its corporate clinics segment and recognized a liability for lease exit costs based on the
remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The
Company classified all of the approximately $338,000 lease exit liability in other liabilities, and related expense in loss on
disposition or impairment.</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Litigation</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the normal course of business, the Company
is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution
of such litigation will not have a material adverse effect on the Company.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b></b></font></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top"><td style="width: 73px"><font style="font-size: 10pt"><b>Note 12:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Segment Reporting</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An operating segment is defined as a component
of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision
Maker (&#8220;CODM&#8221;), to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief
Executive Officer.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has two operating business segments.
The Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics. As of December
31, 2017, the Company operated or managed 47 clinics under this segment. The Franchise Operations segment is comprised of the operating
activities of the franchise business unit. As of December 31, 2017, the franchise system consisted of 352 clinics in operation.
Corporate is a non-operating segment that develops and implements strategic initiatives and supports the Company&#8217;s two operating
business segments by centralizing key administrative functions such as finance and treasury, information technology, insurance
and risk management, litigation and human resources. Corporate also provides the necessary administrative functions to support
the Company as a publicly-traded company. A portion of the expenses incurred by Corporate are allocated to the operating segments.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The tables below present financial information
for the Company&#8217;s two operating business segments (in thousands):</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center">Year Ended</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; font-size: 10pt; text-align: left">Corporate clinics</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">11,125</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">8,550</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Franchise operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14,039</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,974</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total revenues</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">25,164</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">20,524</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Segment operating (loss) income:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Corporate clinics</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1,704</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(9,730</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Franchise operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6,243</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,561</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total segment operating (loss) income</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">4,539</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(5,169</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Depreciation and amortization:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Corporate clinics</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,608</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2,186</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Franchise operations</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Corporate administration</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">409</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">380</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total depreciation and amortization</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">2,017</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">2,566</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Reconciliation of total segment operating income (loss) to consolidated loss before income tax expense:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total segment operating income (loss)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">4,539</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(5,169</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Unallocated corporate overhead</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(7,714</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(9,839</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Consolidated loss from operations</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(3,175</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,008</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other (expense) income, net</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(64</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Loss before income tax expense</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(3,239</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">(15,009</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td></tr>
</table></div>




<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Segment assets:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">8,998</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">9,936</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Franchise operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,362</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,003</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total segment assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,360</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,939</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Unallocated cash and cash equivalents and restricted cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">4,320</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">3,344</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Unallocated property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">765</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">781</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other unallocated assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">465</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">991</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; padding-left: 20pt">Total assets</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">16,910</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td>
    <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right">17,055</td><td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&#8220;Unallocated cash and cash equivalents
and restricted cash&#8221; relates primarily to corporate cash and cash equivalents and restricted cash (see Note 1), &#8220;unallocated
property and equipment&#8221; relates primarily to corporate fixed assets, and &#8220;other unallocated assets&#8221; relates primarily
to deposits, prepaid and other assets.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_020"></a><b>ITEM 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">None.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_021"></a>ITEM 9A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CONTROLS AND PROCEDURES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Conclusion Regarding the Effectiveness of Disclosure Controls
and Procedures</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We conducted an evaluation, under the supervision
and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness
of the design and operation of our disclosure controls and procedures as of December&nbsp;31, 2017. Disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to provide reasonable assurance that information
required to be disclosed in our reports filed under the Exchange Act, such as this Annual Report on Form 10-K, is recorded, processed,
summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures
also include, without limitation, controls and procedures that are designed to provide reasonable assurance that such information
is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate,
to allow timely decisions regarding required disclosure.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The evaluation of our disclosure controls and
procedures included a review of the control objectives and design, our implementation of the controls and the effect of the controls
on the information generated for use in this Annual Report on Form 10-K. After conducting this evaluation, our Chief Executive
Officer and Chief Financial Officer concluded that our disclosure controls and procedures, as defined by Rule 13a-15(e) under the
Exchange Act, were effective as of December 31, 2017 to provide reasonable assurance that information required to be disclosed
in this Annual Report on Form 10-K was recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s
rules and forms and was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial
Officer, as appropriate, to allow timely decisions regarding required disclosure.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Management's Report on Internal Control Over Financial Reporting
</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Management is responsible for establishing
and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act). Internal
control over financial reporting is the process designed under the Chief Executive Officer&#8217;s and the Chief Financial Officer&#8217;s
supervision, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles in the United States.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">There are inherent limitations in the effectiveness
of internal control over financial reporting, including the possibility that misstatements may not be prevented or detected. Accordingly,
an effective control system, no matter how well designed and operated, can provide only reasonable assurance of achieving the designed
control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls
and procedures. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance
that all control issues and instances of fraud, if any, within the Company have been detected. The design of any system of controls
is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design
will succeed in achieving its stated goals under all potential future conditions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Under the supervision and with the participation
of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness
of our internal control over financial reporting as of December&nbsp;31, 2017, as required by Exchange Act Rule 13a-15(c). In making
this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;)
in the 2013 Internal Control - Integrated Framework. Based on our assessment under the framework in Internal Control - Integrated
Framework (2013 framework), management concluded that our internal control over financial reporting was effective as of December
31, 2017.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Changes in Internal Controls over Financial Reporting</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Management, including our Chief Executive Officer
and Chief Financial Officer, confirm there were no changes in our internal control over financial reporting during the year ended
December 31, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial
reporting.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We believe that a control system, no matter
how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation
of controls can provide absolute assurance that all control issues and instances of fraud, if any, within any company have been
detected.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_022"></a><b>ITEM 9B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
OTHER INFORMATION</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">None.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><a name="a_031"></a><b>PART III</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_023"></a><b>ITEM 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in our Proxy Statement to be filed pursuant to Regulation 14A within 120 days after our year ended December 31, 2017
in connection with our 2018 Annual Meeting of Stockholders, or the 2018 Proxy Statement, and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><b><i>Code of Business Conduct and Ethics</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We have adopted a Code of Business Conduct
and Ethics that applies to employees, officers and directors, including our executive management team, such as our Chief Executive
Officer and Chief Financial Officer. This Code of Business Conduct and Ethics is posted on our website at www.thejoint.com. We
intend to satisfy the requirements under Item 5.05 of Form 8-K regarding disclosure of amendments to, or waivers from, provisions
of the Code of Business Conduct and Ethics by posting such information on our website.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_024"></a>ITEM 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
EXECUTIVE COMPENSATION</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in the 2018 Proxy Statement and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_025"></a><b>ITEM 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this Item will
be included in the 2018 Proxy Statement and is incorporated herein by reference.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_026"></a><b>ITEM 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in the 2018 Proxy Statement and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_027"></a><b>ITEM 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in the 2018 Proxy Statement and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><a name="a_032"></a>PART IV</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_028"></a>ITEM 15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
EXHIBITS, FINANCIAL STATEMENT SCHEDULES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 2%; text-align: justify"><font style="font-size: 10pt">(a)</font></td>
    <td style="vertical-align: top; width: 96%; text-align: justify"><font style="font-size: 10pt">Documents filed as part of this report.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 2%; text-align: justify"><font style="font-size: 10pt">(1)</font></td>
    <td style="vertical-align: top; width: 96%; text-align: justify"><font style="font-size: 10pt"><i>Financial Statements</i>. The consolidated financial statements listed on the index to Item 8 of this Annual Report on Form 10-K are filed as a part of this Annual Report.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 2%; text-align: justify"><font style="font-size: 10pt">(2)</font></td>
    <td style="vertical-align: top; width: 96%; text-align: justify"><font style="font-size: 10pt"><i>Financial Statement Schedules. </i>All financial statement schedules have been omitted since the information is either not applicable or required or is included in the financial statements or notes thereof.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 2%; text-align: justify"><font style="font-size: 10pt">(3)</font></td>
    <td style="vertical-align: top; width: 96%; text-align: justify"><font style="font-size: 10pt"><i>Exhibits. </i>Those exhibits marked with a (*) refer to exhibits filed or furnished&nbsp;herewith. The other exhibits are incorporated herein by reference, as indicated in the following list. Those exhibits marked with a (+) refer to management contracts or compensatory plans or arrangements. Portions of the exhibits marked with a (&#937;) are the subject of a Confidential Treatment Request under 17 C.F.R. &#167;&#167; 200.80(b)(4), 200.83 and 240.24b-2.&nbsp;&nbsp;Omitted material for which confidential treatment has been requested has been filed separately with the SEC.</font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_029"></a><b>SIGNATURES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">Pursuant to the requirements of Section 13 or
15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized on March 9, 2018.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2" style="text-align: justify"><font style="font-size: 10pt"><b>The Joint Corp.</b></font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 55%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-size: 10pt">&nbsp;By:&nbsp;&nbsp;</font></td>
    <td style="width: 28%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Peter D.&nbsp;&nbsp;Holt</font></td>
    <td style="width: 15%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Peter D. Holt</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2">
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">President and Chief Executive Officer</p>
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">(Principal Executive Officer)</p>
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2" style="text-align: justify"><font style="font-size: 10pt"><b>The Joint Corp.</b></font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 55%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-size: 10pt">&nbsp;By:&nbsp;&nbsp;</font></td>
    <td style="width: 28%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ John P. Meloun</font></td>
    <td style="width: 15%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">John P. Meloun</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2">
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Chief Financial Officer</p>
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">(Principal Financial Officer)</p>
        <p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">&nbsp;KNOW ALL PERSONS BY THESE PRESENTS, that
each person whose signature appears below constitutes and appoints Peter D. Holt and John P. Meloun, jointly and severally, his
or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments
to this Report on Form&nbsp;10-K, and to file the same, with exhibits thereto and other documents in connection therewith with
the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her
substitute or substitutes may do or cause to be done by virtue hereof.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 30%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt"><b>Signature</b></font></td>
    <td style="width: 5%; text-align: justify">&nbsp;</td>
    <td style="width: 40%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt"><b>Title</b></font></td>
    <td style="width: 5%; text-align: justify">&nbsp;</td>
    <td style="width: 20%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt"><b>Date</b></font></td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Peter D. Holt</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">President, Chief Executive Officer and Director&nbsp;</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Peter D. Holt</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">(Principal Executive Officer) and Director</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ John P. Meloun</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">Chief Financial Officer </font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">John P. Meloun</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">(Principal Financial Officer)</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Matthew E. Rubel</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Lead Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Matthew E. Rubel</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ James H. Amos, Jr.</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">James H. Amos, Jr.</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Ronald V. DaVella</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Ronald V. DaVella</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Suzanne M. Decker</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Suzanne M. Decker</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Richard A. Kerley</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Richard A. Kerley</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Bret Sanders</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 9, 2018</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Bret Sanders</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>EXHIBIT INDEX</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top"><font style="font-size: 10pt"><b>Exhibit</b></font></td>
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="5" style="vertical-align: top; text-align: center"><font style="font-size: 10pt"><u>Incorporated by Reference</u></font></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Provided</font></td></tr>
<tr>
    <td style="vertical-align: top; width: 6%"><font style="font-size: 10pt"><b><u>Number</u></b></font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 58%; text-align: center"><font style="font-size: 10pt"><b><u>Description</u></b></font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%; text-align: center"><font style="font-size: 10pt"><u>Form</u></font></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; width: 11%; text-align: center"><font style="font-size: 10pt"><u>File No.</u></font></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td nowrap style="vertical-align: top; width: 5%; text-align: center"><font style="font-size: 10pt"><u>Exhibit(s)</u></font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%; text-align: center"><font style="font-size: 10pt"><u>Filing Date</u></font></td>
    <td style="vertical-align: top; width: 5%; text-align: center"><font style="font-size: 10pt"><u>Herewith</u></font></td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex3-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;3.1</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex3-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Amended and Restated Certificate of Incorporation of Registrant.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex3-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex3-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex3-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">3.2</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex3-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316008413/exh_3ii1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;3.2</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316008413/exh_3ii1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Amended and Restated Bylaws of Registrant, plus amendments.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316008413/exh_3ii1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316008413/exh_3ii1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316008413/exh_3ii1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">3(ii).1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316008413/exh_3ii1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;3/07/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;4.1</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Warrant to Purchase Common Stock issued to Feltl and Company, Inc. on November 14, 2014.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-207632</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">4.2</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;4.2</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Warrant to Purchase Common Stock issued to Roth Capital Partners, LLC on November 14, 2014.&nbsp;</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-207632</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">4.3</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex4-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Form of Indemnification Agreement between Registrant and each of its directors and officers and related schedule.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.2#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2012 Stock Plan.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.2</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.3#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Amended and Restated 2014 Incentive Stock Plan.&nbsp;</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.3</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-3.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-4.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.4#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-4.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Form of Incentive Stock Option Agreement under 2014 Stock Plan.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-4.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-4.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-207632</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-4.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.4</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-4.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.5#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Form of Nonstatutory Stock Option Agreement under 2014 Stock Plan.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-207632</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.5</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-6.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.6#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-6.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Form of Nonstatutory Stock Option Agreement under 2014 Stock Plan for Article 7, Annual Option Grants.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-6.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-6.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-207632</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-6.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.6</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-6.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.7#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-7.htm" style="-sec-extract: exhibit">Employment Agreement between Registrant and John B. Richards dated October 23, 2015</a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-207632</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.7</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.8</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Lease Agreement dated between Registrant and DTR 14, LLC, for Registrant&#8217;s office located at 16767 North Perimeter Drive, Suite 240, Scottsdale, Arizona 85260.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.5&nbsp;&nbsp;</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-5.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014&nbsp;</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-6.htm" style="-sec-extract: exhibit">10.9#</a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-6.htm" style="-sec-extract: exhibit">Employment Agreement between Registrant and David Orwasher dated January 1, 2014.</a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-6.htm" style="-sec-extract: exhibit">S-1</a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-6.htm" style="-sec-extract: exhibit">333-198860</a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-6.htm" style="-sec-extract: exhibit">10.6</a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-6.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"></td></tr></table>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->


<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 6%">&nbsp;</td>
    <td style="text-align: center; width: 1%">&nbsp;</td>
    <td style="width: 58%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 11%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; width: 5%">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; width: 5%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.10#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Employment Term Sheet between Registrant and John B. Richards, Chief Executive Officer of Registrant.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.7</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-7.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-8.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.11#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-8.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Employment Term Sheet between Registrant and Catherine Hall, Chief Marketing Officer of Registrant.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-8.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-8.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-8.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.8</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-8.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414075219/v397068_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.12#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414075219/v397068_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Employment Agreement between The Joint Corp. and Francis T. Joyce dated December 12, 2014</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414075219/v397068_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414075219/v397068_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724&nbsp;</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414075219/v397068_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414075219/v397068_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">12/22/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-9.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.13#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-9.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Stock Option Agreement between Registrant and David Orwasher dated January 1, 2014.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-9.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-9.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-9.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.9</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-9.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-10.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.14#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-10.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Stock Option Agreement between Registrant and Catherine Hall dated May 15, 2014.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-10.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-10.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-10.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-10.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.15#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Restricted Stock Award Agreement between Registrant and John B. Richards dated January 1, 2014.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.11</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-12.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.16#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-12.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Restricted Stock Award Agreement between Registrant and David Orwasher dated January 1, 2014.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-12.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-12.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-12.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.12</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-12.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.17#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Restricted Stock Award Agreement between Registrant and Francis T. Joyce dated December 16, 2014</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-207632</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.14</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10/27/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-13.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.18</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-13.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Form of Registrant&#8217;s Franchise Disclosure Document.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-13.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-13.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-13.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.13</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-13.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.19</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Form of Registrant&#8217;s Regional Developer License Agreement.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.14</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-14.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-15.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.20</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-15.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Form of Registrant&#8217;s Franchise Agreement.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-15.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-15.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-15.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.15</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-15.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-16.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.21#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-16.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Written Description of Management Services Arrangement between Registrant and Business Ventures Corp.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-16.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-16.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-16.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.16</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-16.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-17.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.22#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-17.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Written Description of Consulting Arrangement between Registrant and John Leonesio.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-17.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-17.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-17.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.17</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-17.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-18.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.23</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-18.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Indemnification Agreement between Registrant and former director Fred Gerretzen.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-18.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-18.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-18.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.18</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-18.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-19.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.24</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-19.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Indemnification Agreement between Registrant and former officer Ronald Record.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-19.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-19.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-19.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.19</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-19.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 6%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.25</font></a></td>
    <td style="width: 1%; text-align: center">&nbsp;</td>
    <td style="width: 58%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Termination Agreement dated as of December 31, 2014 by The Joint Corp., Kairos Marketing, LLC and Chad Meisinger.</font></a></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 11%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.2</font></a></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;1/07/2015</font></a></td>
    <td style="vertical-align: top; width: 5%; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.26</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of December 31, 2014 between The Joint Corp., The Joint RRC Corp., Raymond G. Espinoza, Chad Meisinger and Rob Morris.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415001069/v398280_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;1/07/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415006321/v400456_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.27</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415006321/v400456_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of January 30, 2015 between The Joint Corp., TJSC, LLC, Theodore Amendola and Scott Lewandowski.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415006321/v400456_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415006321/v400456_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415006321/v400456_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415006321/v400456_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;2/05/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415010883/v402271_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.28</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415010883/v402271_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated February 17, 2015 by and among The Joint Corp., Roth &amp; Pelan Enterprises, LLC, Timothy Roth, Blue Sky &amp; Sunny Days, Inc., and Thomas Pelan.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415010883/v402271_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415010883/v402271_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415010883/v402271_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415010883/v402271_ex10-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;2/19/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"></td></tr></table>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->


<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 6%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 58%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 11%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; width: 5%">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; width: 5%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415014880/v403926_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.29</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415014880/v403926_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of February 27, 2015 between The Joint Corp., The Joint San Gabriel Valley, Inc. and Vincent Huan.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415014880/v403926_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415014880/v403926_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415014880/v403926_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415014880/v403926_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;3/09/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415024147/v407662_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.30</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415024147/v407662_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of March 31, 2015 between The Joint Corp., The Joint Chiropractic Bell Towne, LLC, Marla R. Allan and Marc W. Payson.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415024147/v407662_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415024147/v407662_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415024147/v407662_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415024147/v407662_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;4/22/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.31</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Franchise Agreement Termination and Reinstatement Agreement dated as of as of April 30, 2015, by The Joint Corp., Stephanie McRae and South Bay Joint Development, Inc.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.2</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;5/05/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.32</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of April 30, 2015, between The Joint Corp., San Diego Joint Development, Inc., Stephanie McRae, and Elizabeth McRae.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415027527/v409457_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;5/05/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.33</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Regional Developer Termination Agreement dated as of as of May 18, 2015, among The Joint
    Corp., Dennis Conklin, Eric Hua and Orange County Wellness, Inc.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.2</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-2.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;5/21/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.34</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of May 18, 2015, among First Light Junction, Inc., a California corporation, Eric Hua and Tracy Hua.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415032900/v411414_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;5/21/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415035731/v412594_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.35</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415035731/v412594_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of June&nbsp;&nbsp;3, 2015, by and between The Joint Corp., a Delaware corporation, WHB Franchise Inc., a California corporation and William Bargfrede.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415035731/v412594_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415035731/v412594_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415035731/v412594_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415035731/v412594_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;6/05/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415036468/v412887_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.36</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415036468/v412887_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of June 5, 2015, by and among The Joint
    Corp., a Delaware corporation, Clear Path Ventures, Inc., a California corporation, Carol Warren, and Jodi Wolf.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415036468/v412887_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415036468/v412887_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415036468/v412887_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415036468/v412887_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;6/10/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415041287/v414968_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.37</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415041287/v414968_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of July 1, 2015, by and among The Joint Corp., a Delaware corporation, Chiro-Novo, LLC, an Arizona limited liability company, Kent L. Cooper, as trustee of The Kent L. Cooper Trust, Benjamin Cooper, as trustee of The Benjamin and Milena Cooper Family Trust dated May 2, 2006, Robert A. Cooper and Andrew C. Cooper.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415041287/v414968_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415041287/v414968_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724&nbsp;</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415041287/v414968_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420415041287/v414968_ex2-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;7/07/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_22.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.38</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_22.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Termination Agreement dated as of as of August 10, 2015, among The Joint Corp., a Delaware corporation and Align Group, LLC a New York limited liability company, and Marc Ressler.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_22.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_22.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_22.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.2</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_22.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;8/14/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_21.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.39</font></a></td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_21.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of August 10, 2015, by and between The Joint Corp., a Delaware corporation, Chiro Group, LLC, a New York limited liability company, Marc Ressler, Angelo Marracino, Jesse Curry and Cleon Easton.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_21.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_21.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_21.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">2.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184315004712/exh_21.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;8/14/2015</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007009/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.40</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007009/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of December 29, 2015, by and among The Joint Corp., a Delaware corporation, Forte Vita Ventures, Inc., a California corporation, Neil Sinay and Jennifer M. Sinay.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007009/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007009/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007009/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">1.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007009/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;1/05/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007092/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.41</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007092/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Regional Developer License Purchase Agreement, dated January 1, 2016, among the Company, Christina Ybanez and Mark Elias.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007092/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007092/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007092/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">1.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316007092/exh_11.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;1/07/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 6%"></td></tr></table>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->


<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.42#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Employment Agreement dated April 27, 2016, between The Joint Corp. and Peter Holt</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">5/3/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.43#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Separation Agreement dated April 29, 2016, between The Joint Corp. and David Orwasher</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.2</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009601/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">5/3/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009730/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.44</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009730/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of April 29, 2016, by and among The Joint Corp., a Delaware corporation, Guthrie Joint Venture NM, LLC, a New Mexico limited liability company and Ronald Guthrie</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009730/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009730/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009730/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009730/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">5/5/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009987/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.45</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009987/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Asset and Franchise Purchase Agreement dated as of May 6, 2016 by and among The Joint Corp., a Delaware corporation, T&amp;J Chiropractic Management, Inc., a California corporation, Vortex Financial Management, Inc., a California corporation, Anita Davis, Johnny Linderman and Ped Abghari aka Ted Abghari.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009987/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009987/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009987/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316009987/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">5/12/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>

<tr>
    <td style="vertical-align: top; width: 6%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316010920/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.46#</font></a></td>
    <td style="width: 1%; text-align: center">&nbsp;</td>
    <td style="width: 58%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316010920/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Separation Agreement dated June 29, 2015, between The Joint Corp. and John Richards</font></a></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316010920/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 11%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316010920/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316010920/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td style="width: 1%; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; width: 5%; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316010920/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">6/30/2016</font></a></td>
    <td style="vertical-align: top; width: 5%; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316013131/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.47#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316013131/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Employment Agreement dated November 8, 2016, between The Joint Corp. and John Meloun</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316013131/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316013131/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316013131/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184316013131/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">11/10/2016</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.48</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Credit and Security Agreement dated as of January 3, 2017, by and between The Joint Corp/, a Delaware corporation, and Tower 7 Partnership LLC, and Ohio limited liability company</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36724</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.1</font></a></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_101.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">1/9/2017</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.49</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Revolving Credit Note, dated January 3, 2017, by The Joint Corp., a Delaware corporation in favor of Tower 7 Partnership LLC</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36274</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.2</font></a></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">1/9/2017</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.49</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Revolving Credit Note, dated January 3, 2017, by The Joint Corp., a Delaware corporation in favor of Tower 7 Partnership LLC</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36274</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.2</font></a></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_102.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">1/9/2017</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_103.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.50#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_103.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">Amended and Restated Employment Agreement dated January 3, 2017, between The Joint Corp., a Delaware corporation, and Peter Holt</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_103.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">8-K</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_103.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">001-36274</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_103.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">10.3</font></a></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000117184317000140/exh_103.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">1/9/2017</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_991.htm">10.51</A></td>
    <td style="text-align: center">&nbsp;</td>
    <td><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_991.htm">Asset Purchase Agreement dated January 6<sup>th</sup>, 2017, by and between The Joint Corp., a Delaware
corporation, Don Daniels, Larry Maddalena and Jody O&rsquo;Donnell.</A></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_991.htm">10-K</A></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_991.htm">&nbsp;001-36724</A></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_991.htm">99.1</A></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_991.htm">3/10/2017</A></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_992.htm">10.52</A></td>
    <td style="text-align: center">&nbsp;</td>
    <td><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_992.htm">Assignment and Assumption Agreement dated February 24, 2017, by and between The Joint Corp., a Delaware
corporation, Don Daniels, Larry Maddalena and Jody O&rsquo;Donnell and Porter Partners, LLC.</A></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_992.htm">10-K</A></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_992.htm">&nbsp;001-36724</A></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_992.htm">99.2</A></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><A HREF="http://www.sec.gov/Archives/edgar/data/1612630/000117184317001428/exh_992.htm">3/10/2017</A></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_1053.htm"><font style="font-size: 10pt">10.53#</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="exh_1053.htm"><font style="font-size: 10pt">2017 Executive Short-Term Incentive Plan</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><a href="exh_1053.htm"><font style="font-size: 10pt">X</font></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_1054.htm">10.54#</a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="exh_1054.htm">Form of Restricted Stock Award.</a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><a href="exh_1054.htm">X</a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex21-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">21.1</font></a></td>
    <td style="text-align: center">&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex21-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">List of subsidiaries of The Joint Corp.</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex21-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">S-1</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex21-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">333-198860</font></a></td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex21-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">21.1</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex21-1.htm" style="-sec-extract: exhibit"><font style="font-size: 10pt">&nbsp;&nbsp;9/19/2014</font></a></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_23.htm"><font style="font-size: 10pt">23</font></a></td>
    <td>&nbsp;</td>
    <td><a href="exh_23.htm"><font style="font-size: 10pt">Consent of EKS&amp;H LLLP</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><a href="exh_23.htm"><font style="font-size: 10pt">X</font></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_311.htm"><font style="font-size: 10pt">31.1</font></a></td>
    <td>&nbsp;</td>
    <td><a href="exh_311.htm"><font style="font-size: 10pt">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><a href="exh_311.htm"><font style="font-size: 10pt">X</font></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_312.htm"><font style="font-size: 10pt">31.2</font></a></td>
    <td>&nbsp;</td>
    <td><a href="exh_312.htm"><font style="font-size: 10pt">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><a href="exh_312.htm"><font style="font-size: 10pt">X</font></a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_32.htm"><font style="font-size: 10pt">32</font></a></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><a href="exh_32.htm"><font style="font-size: 10pt">Certification by Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002&nbsp;</font></a></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><a href="exh_32.htm"><font style="font-size: 10pt">X</font></a></td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 6%"></td></tr></table>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->


<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 6%">&nbsp;</td>
    <td style="text-align: justify; width: 1%">&nbsp;</td>
    <td style="width: 58%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 11%">&nbsp;</td>
    <td style="vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 5%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; width: 5%">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; width: 5%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top"><font style="font-size: 10pt">101.INS</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">XBRL Instance Document</font></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">X</font></td></tr>
<tr>
    <td style="vertical-align: top"><font style="font-size: 10pt">101.SCH</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">XBRL Taxonomy Extension Schema Document (4)</font></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">X</font></td></tr>
<tr>
    <td style="vertical-align: top"><font style="font-size: 10pt">101.CAL</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">XBRL Taxonomy Extension Calculation Linkbase Document (4)</font></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">X</font></td></tr>
<tr>
    <td style="vertical-align: top"><font style="font-size: 10pt">101.DEF</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">XBRL Taxonomy Extension Definition Linkbase Document (4)</font></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">X</font></td></tr>
<tr>
    <td style="vertical-align: top"><font style="font-size: 10pt">101.LAB</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">XBRL Taxonomy Extension Label Linkbase Document (4)</font></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">X</font></td></tr>
<tr>
    <td style="vertical-align: top"><font style="font-size: 10pt">101.PRE</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">XBRL Taxonomy Extension Presentation Linkbase Document (4)</font></td>
    <td>&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">X</font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">___________________</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><font style="font-size: 10pt">#</font></td>
    <td style="width: 98%"><font style="font-size: 10pt">Management contract or compensatory plan or arrangement.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin-top: 0pt; text-align: center; margin-bottom: 0pt">77</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div align="CENTER" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font-size: 10pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"></p>


</body></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.53
<SEQUENCE>2
<FILENAME>exh_1053.htm
<DESCRIPTION>EXHIBIT 10.53
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="margin: 0; text-align: right"><b>Exhibit 10.53</b></p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>The Joint Corp.</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>2017 Executive Short-Term Incentive Plan (STIP)</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><u>Plan Overview</u></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">The Joint Corp. (&ldquo;the Company&rdquo;) 2017 Executive Short-Term
Incentive Plan (&ldquo;Executive STIP&rdquo;) is an annual bonus plan. The STIP pool earned for 2017 will be determined based upon
the achievement of the Company&rsquo;s target Adjusted EBITDA for 2017.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><u>Eligibility</u>: The CEO and CFO of the Company are eligible
to participate in the Executive STIP. Participants must be actively employed by the Company on the date of payout in order to receive
an award under the Executive STIP. While bonus opportunities are not strictly tied to management level, current practices are consistent
by level with the following ranges of percentage of base salary:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 40%">
<tr style="vertical-align: bottom">
    <td style="width: 50%; font-size: 10pt; padding-left: 0.5in">CEO</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 49%; font-size: 10pt; text-align: right">50%</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; padding-left: 0.5in">CFO</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">40%</td></tr>
</table>


<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><u>Proration</u>: For those participants whose employment with the
Company starts during 2017, their participation in the plan shall be prorated based on the number of days employed during 2017
divided by 365 days.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><u>Award</u>: 100% of each individual Executive STIP award is a function of achieving
the Target Adjusted EBITDA (defined below). The percentage of achievement of that metric will be the same as the percentage of
funding (between zero and 100%) of the maximum bonus pool.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">STIP awards are expected to be made in Q1 2018 following approval
by the Compensation Committee of the Board of Directors (the &ldquo;Compensation Committee&rdquo;) and completion of the Company&rsquo;s
audited 2017 financial results.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">The awards under the Executive STIP will be 50% in cash and 50%
in restricted stock awards which will vest on the date of grant. However, the Board of Directors reserves the right to reconsider
the 50/50 allocation of cash to restricted stock awards based upon the facts and circumstances at the time of approval.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><u>2017 Executive STIP Corporate Targets</u>: The target Adjusted
EBITDA (herein defined as &ldquo;Target Adjusted EBITDA&rdquo;) will be established by the Compensation Committee. Upon achievement
of the Target Adjusted EBITDA for 2017, for each dollar of Adjusted EBITDA in excess of Target Adjusted EBITDA, 70% of such amount
will be credited to a STIP pool, which will be combined with the 2017 Non-Executive STIP Pool (the &ldquo;Combined Pool&rdquo;)
until a maximum of the Combined Pool an amount established by the Compensation Committee (the &ldquo;Combined Pool Maximum&rdquo;)
is reached. In no event will the amount in the Combined Pool exceed the Combined Pool Maximum.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">The Combined Pool will not be funded if the Company draws on its
line of credit in excess of the initial $1 million required draw except in the circumstances where the Board of Directors have
approved the strategic use of the line of credit.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><u>Plan Description</u></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><u>Target Adjusted EBITDA</u>: In connection with the annual budgeting
process, the Company will establish an annual budget with corresponding Adjusted EBITDA and the annual Target Adjusted EBITDA,
if different, must be approved by the Board of Directors of the Company.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><u>Adjusted EBITDA Definition</u>: The Company shall prepare a budget
on a consistent basis from year to year and apply a consistent definition of Adjusted EBITDA. The Company calculates Adjusted EBITDA
as follows:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><img src="exh1053.jpg" alt=""></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0; text-align: right">2</p>

<!-- Field: Rule-Page --><div align="center" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font-size: 10pt; margin: 0pt 0; text-align: right"></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>



<p style="margin: 0">&#160;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.54
<SEQUENCE>3
<FILENAME>exh_1054.htm
<DESCRIPTION>EXHIBIT 10.54
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="margin: 0; text-align: right"><b>Exhibit 10.54</b></p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&#160;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">[[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]]</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Restricted Stock Award</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(The Joint Corp. Amended and Restated 2014 Incentive Stock Plan)
</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Subject to the following terms, The Joint Corp., a Delaware corporation
(the <b>Company</b>), grants to the following employee of the Company (<b>Grantee</b>), as of the following grant date (the <b>Grant
Date</b>), the following number of restricted shares (the <b>Restricted Shares</b>), which will become vested in accordance with
the following vesting schedule, subject to expiration prior to vesting in accordance with the terms of this Award:</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 50%; font-size: 10pt; padding-bottom: 1pt; text-indent: 1in">Grantee:</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <td style="width: 49%; font-size: 10pt; text-align: left; padding-bottom: 1pt">[[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]]</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left; text-indent: 1in">Grant Date:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt">[[GRANTDATE]]</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 1in">Number of</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 1in">Restricted Shares:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt">[[SHARESGRANTED]]</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left; text-indent: -2in; padding-left: 3in">Vesting Schedule:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt">[[VESTINGTEMPLATEDESC]]</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold">Terms of Award</td></tr>
</table>


<p style="font-size: 10pt; text-align: left; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Plan</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">This Award has been granted under <font style="font-size: 10pt">The
Joint Corp. Amended and Restated 2014 Incentive Stock Plan</font> (the <b>Plan</b>), which is incorporated in this Award by reference.
Capitalized terms used in this Award without being defined (for example, the term &ldquo;Plan Administrator&rdquo;) have the same
meanings that they have in the Plan.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Vesting</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Any unvested portion of the Restricted Shares shall lapse and be
cancelled on Grantee&rsquo;s Termination Date unless Grantee&rsquo;s Termination occurs by reason of his or her death, in which
case the Restricted Shares shall become fully vested as of Grantee&rsquo;s Termination Date.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Restricted Shares shall become fully vested upon a Change in
Control, as provided in Article 8 of the Plan, prior to Grantee&rsquo;s Termination Date.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Stock Certificates</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company shall be the custodian for all shares of Restricted Stock.
Reasonably promptly following the Executive&rsquo;s written request after any unvested Restricted Shares have become vested, the
Company shall issue and deliver to the Executive a stock certificate in the Executive&rsquo;s name representing those vested Restricted
Shares on the Company&rsquo;s stock records.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Voting and Distributions</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Grantee shall not have the right to vote Restricted Shares and shall
not be entitled to dividends and distributions in respect of Restricted Shares until the Restricted Shares are vested.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Tax Liability</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Unless Grantee has made a timely election under section 83(b) of
the Code to be taxed as of the Grant Date rather than as the Restricted Shares become vested, the Company shall have the right,
upon the vesting of any Restricted Shares, to deduct or withhold, or require Grantee to remit to the Company, an amount sufficient
to satisfy the federal, state, local and other taxes (including Grantee&rsquo;s FICA obligation) that the Company is required to
withhold by reason of such vesting.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Confidentiality and
Nonsolicitation Agreement</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">This Award and the grant of the Restricted Shares are subject to
Grantee&rsquo;s (i) entering into the confidentiality and nonsolicitation agreement which has been provided to Grantee if Grantee
has not previously entered into such agreement in connection with Grantee&rsquo;s receipt of an Award under the Plan (the <b>Nonsolicitation
Agreement</b>) or (ii) Grantee&rsquo;s reaffirmation of the Nonsolicitation Agreement that Grantee previously entered into in connection
with Grantee&rsquo;s receipt of an Award under the Plan.&nbsp; The Company would not have granted the Award to Grantee without
Grantee&rsquo;s entering into or reaffirming the Nonsolicitation Agreement.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Transferability</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Any unvested portion of the Restricted Shares may not be sold, transferred,
assigned or pledged (whether by operation of law or otherwise), except as provided by will or the applicable intestacy laws, and
shall not be subject to execution, attachment or similar process. Once vested, any sale, transfer, assignment or pledge of the
Restricted Shares is subject to the restrictions on transfer imposed by any applicable state and federal securities laws.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Interpretation</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">This Award is subject to the terms of the Plan, as the Plan may be
amended (but except as required by applicable law, no amendment of the Plan after the Grant Date shall adversely affect Grantee&rsquo;s
rights in respect of the Award without Grantee&rsquo;s consent). If there is a conflict or inconsistency between this Award and
the Plan, the terms of the Plan shall control. The Plan Administrator&rsquo;s interpretation of this Award and the Plan shall be
final and binding.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>No
Right to Continued Employment</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Nothing in this Award shall be considered to confer on Grantee any
right to continue in the employ of the Company or a Subsidiary or to limit the right of the Company or a Subsidiary to terminate
Grantee&rsquo;s employment.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Governing
Law</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">This Award shall be governed in accordance with the laws of the State
of Arizona.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Binding
Effect</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">This Award shall be binding on the Company and Grantee and on Grantee&rsquo;s
heirs, legatees and legal representatives.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0"><font style="font-weight: normal">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Effective
Date</p>

<p style="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">This Award shall not become effective until Grantee&rsquo;s acceptance
of this Award and the acceptance or reaffirmation of the Nonsolicitation Agreement. Upon Grantee&rsquo;s acceptance of this Award
and the acceptance or reaffirmation of the Nonsolicitation Agreement, this Award shall become effective, retroactive to the Grant
Date, without the necessity of further action by either the Company or Grantee.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 50%; font-size: 10pt; text-indent: 0.5in">&nbsp;</td><td style="width: 1%; font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="width: 49%; font-size: 10pt; font-weight: bold; text-align: left">The Joint Corp.</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; padding-left: 3in">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; padding-left: 3in">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt">By &nbsp;&nbsp;&nbsp;_____________________________</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 3.25in; padding-left: 3in">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Peter D. Holt</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-indent: 3.25in; padding-left: 3in">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">President &amp; Chief Executive Officer</td></tr>
</table>


<p style="font-size: 10pt; margin: 0pt 0 0pt 3in"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Acceptance by Grantee</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">I accept this Restricted Stock Award and agree to be bound by all
of its terms. I acknowledge receipt of a copy of the Plan, and I (i) agree to enter into the Nonsolicitation Agreement, a copy
of which I acknowledge receipt, if I have not previously entered into such agreement in connection with the receipt of an Award
under the Plan or (ii) reaffirm the Nonsolicitation Agreement that I have previously entered into in connection with the receipt
of an Award under the Plan.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">__________________________________________</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">[[FIRSTNAME]] [[MIDDLENAME]] [[LASTNAME]]</p>

<p style="font-size: 10pt; margin: 0pt 0 0pt 3in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0 0pt 3in">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">Grantee&rsquo;s address:</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">[[RESADDR1]] [[RESADDR2]] [[RESADDR3]]</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">__________________________________________</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">[[RESCITY]], [[RESSTATEORPROV]] [[RESPOSTALCODE]]</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">__________________________________________</p>

<p style="font-size: 10pt; margin: 0pt 0; text-indent: 2.25in">[[RESCOUNTRY]]</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</p>



<p style="margin: 0"></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>exh_23.htm
<DESCRIPTION>EXHIBIT 23
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="margin: 0; text-align: right"><b>Exhibit 23</b></p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&#160;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">We consent to the incorporation by reference in the registration
statement (No. 333-208262) on Form S-8 of our report dated March 9, 2018 with respect to the consolidated balance sheets of The
Joint Corp. and Subsidiary as of December 31, 2017 and 2016, and the related consolidated statements of operations, stockholders'
equity, and cash flows, for each year in the two-year period ended December 31, 2017, which report appears in the December 31,
2017 annual report on Form 10-K of The Joint Corp. and Subsidiary. We also consent to the reference to our firm under the heading
&quot;Experts&quot; in such registration statements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">EKS&amp;H LLLP</p>

<p style="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">March 9, 2018</p>

<p style="font-size: 10pt; margin: 0pt 0">Denver, Colorado</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exh_311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><B>Exhibit 31.1</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">I, Peter D. Holt, certify that:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 7%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 90%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form 10-K of The Joint Corp.;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 7%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 90%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 7%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 90%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 7%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 90%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 14%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">a.</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">b.</P></TD>
    <TD STYLE="vertical-align: top; width: 83%">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Designed such disclosure controls and procedures, or caused such
        disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
        including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
        which this report is being prepared;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Designed such internal control over financial reporting, or caused
        such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
        the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
        accepted accounting principles;</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 14%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">c.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 83%; text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 14%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">d.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 83%; text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 7%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 90%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 14%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 83%; text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 14%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 83%; text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 51%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 48%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Date: March 9, 2018</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ Peter D. Holt</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Peter D. Holt</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">President and Chief Executive Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Executive Officer)</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exh_312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><B>Exhibit 31.2</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">I, John P. Meloun, certify that:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 11%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 86%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form 10-K of The Joint Corp.;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 11%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 86%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 11%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 86%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 11%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 86%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 15%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">a.</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; margin: 0pt 0">b.</P></TD>
    <TD STYLE="vertical-align: top; width: 82%">
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Designed such disclosure controls and procedures, or caused such
        disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
        including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
        which this report is being prepared;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Designed such internal control over financial reporting, or caused
        such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
        the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
        accepted accounting principles;</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 15%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">c.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 82%; text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 15%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">d.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 82%; text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 11%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 86%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 15%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 82%; text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 15%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 82%; text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 48%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Date: March 9,&nbsp;2018</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ John P. Meloun</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">John P. Meloun</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Chief Financial Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Financial Officer)</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>exh_32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><B>Exhibit 32</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&nbsp;1350,</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>AS ADOPTED PURSUANT TO SECTION&nbsp;906 OF
THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">For purposes of Section&nbsp;1350 of Chapter
63 of Title 18 of the United States Code, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, each of the
undersigned officers of The Joint Corp., a Delaware corporation (&ldquo;Company&rdquo;), does hereby certify, to such officer&rsquo;s
knowledge, that:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">The Annual Report on Form 10-K for the fiscal
year ended December&nbsp;31, 2017 (&ldquo;Form 10-K&rdquo;) of the Company fully complies with the requirements of Section&nbsp;13(a)
or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-K fairly presents, in all material
respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 52%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Dated: March 9, 2018</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ Peter D. Holt</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Peter D. Holt</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">President and Chief Executive Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Executive Officer)</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 52%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Dated: March 9, 2018</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ John P. Meloun</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">John P. Meloun</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Chief Financial Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Financial Officer)</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>jynt-20171231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:32PM UTC 2018-03-09--><xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:jynt="http://www.thejoint.com/20171231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:href="jynt-20171231.xsd" xlink:type="simple"/>
  <dei:AmendmentFlag contextRef="d_2017-01-01_2017-12-31" id="c-15">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="d_2017-01-01_2017-12-31" id="c-4">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="d_2017-01-01_2017-12-31" id="c-14">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="d_2017-01-01_2017-12-31" id="c-13">2017</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate contextRef="d_2017-01-01_2017-12-31" id="c-12">2017-12-31</dei:DocumentPeriodEndDate>
  <dei:DocumentType contextRef="d_2017-01-01_2017-12-31" id="c-11">10-K</dei:DocumentType>
  <dei:EntityCentralIndexKey contextRef="d_2017-01-01_2017-12-31" id="c-2">0001612630</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding contextRef="i_2018-03-02" decimals="INF" id="c-9" unitRef="xbrli-shares">13586254</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus contextRef="d_2017-01-01_2017-12-31" id="c-6">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="d_2017-01-01_2017-12-31" id="c-5">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityPublicFloat contextRef="i_2017-06-30" decimals="-5" id="c-10" unitRef="iso4217-usd">46500000</dei:EntityPublicFloat>
  <dei:EntityRegistrantName contextRef="d_2017-01-01_2017-12-31" id="c-1">JOINT Corp</dei:EntityRegistrantName>
  <dei:EntityVoluntaryFilers contextRef="d_2017-01-01_2017-12-31" id="c-7">No</dei:EntityVoluntaryFilers>
  <dei:EntityWellKnownSeasonedIssuer contextRef="d_2017-01-01_2017-12-31" id="c-8">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:TradingSymbol contextRef="d_2017-01-01_2017-12-31" id="c-3">jynt</dei:TradingSymbol>
  <jynt:AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions contextRef="d_2017-12-01_2017-12-31" decimals="INF" id="c27579037" unitRef="iso4217-usd">166088</jynt:AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions>
  <jynt:AdvertisingFundPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581239">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Fund&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:AdvertisingFundPolicyTextBlock>
  <jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment contextRef="i_2017-12-31" decimals="INF" id="c27579789" unitRef="iso4217-usd">377800</jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment>
  <jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment contextRef="i_2016-12-31" decimals="INF" id="c27579790" unitRef="iso4217-usd">201300</jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment>
  <jynt:BinomialLatticeBasedModelFairValueSharePrice contextRef="i_2013-12-31" decimals="INF" id="c27579581" unitRef="iso4217-usd-per-xbrli-shares">1.03</jynt:BinomialLatticeBasedModelFairValueSharePrice>
  <jynt:BinomialLatticeBasedModelFairValueTotal contextRef="i_2013-12-31" decimals="INF" id="c27579582" unitRef="iso4217-usd">551638</jynt:BinomialLatticeBasedModelFairValueTotal>
  <jynt:BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579346" unitRef="iso4217-usd">997450</jynt:BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579365" unitRef="iso4217-usd">140728</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases>
  <jynt:ClassOfWarrantOrRightIssuedDuringPeriod contextRef="d_2014-11-14_2014-11-14" decimals="INF" id="c27579593" unitRef="xbrli-shares">90000</jynt:ClassOfWarrantOrRightIssuedDuringPeriod>
  <jynt:ClassOfWarrantsOrRightsOutstandingRemainingContractualLife contextRef="d_2017-01-01_2017-12-31" id="c27579595">P328D</jynt:ClassOfWarrantsOrRightsOutstandingRemainingContractualLife>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579292" unitRef="xbrli-pure">-6</jynt:ClinicsAcquiredDuringThePeriod>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579293" unitRef="xbrli-pure">6</jynt:ClinicsAcquiredDuringThePeriod>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" id="c27579302" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c27579303" unitRef="xbrli-pure">6</jynt:ClinicsAcquiredDuringThePeriod>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579294" unitRef="xbrli-pure">4</jynt:ClinicsClosedDuringThePeriod>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579295" unitRef="xbrli-pure">6</jynt:ClinicsClosedDuringThePeriod>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c27579304" unitRef="xbrli-pure">14</jynt:ClinicsClosedDuringThePeriod>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" id="c27579305" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579290" unitRef="xbrli-pure">41</jynt:ClinicsOpenedDuringThePeriod>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579291" unitRef="xbrli-pure">56</jynt:ClinicsOpenedDuringThePeriod>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" id="c27579300" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c27579301" unitRef="xbrli-pure">8</jynt:ClinicsOpenedDuringThePeriod>
  <jynt:ClinicsSoldButNotYetOperational contextRef="i_2017-12-31" decimals="INF" id="c27579310" unitRef="xbrli-pure">104</jynt:ClinicsSoldButNotYetOperational>
  <jynt:ClinicsSoldButNotYetOperational contextRef="i_2016-12-31" decimals="INF" id="c27579311" unitRef="xbrli-pure">115</jynt:ClinicsSoldButNotYetOperational>
  <jynt:CoOpFundsLiabilityCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578695" unitRef="iso4217-usd">89681</jynt:CoOpFundsLiabilityCurrent>
  <jynt:CoOpFundsLiabilityCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578696" unitRef="iso4217-usd">73246</jynt:CoOpFundsLiabilityCurrent>
  <jynt:DeferredFranchiseCosts contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579345" unitRef="iso4217-usd">1450</jynt:DeferredFranchiseCosts>
  <jynt:DeferredFranchiseCostsCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578669" unitRef="iso4217-usd">484081</jynt:DeferredFranchiseCostsCurrent>
  <jynt:DeferredFranchiseCostsCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578670" unitRef="iso4217-usd">748300</jynt:DeferredFranchiseCostsCurrent>
  <jynt:DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c27579025" unitRef="iso4217-usd">1450</jynt:DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice>
  <jynt:DeferredFranchiseCostsNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27578679" unitRef="iso4217-usd">812600</jynt:DeferredFranchiseCostsNoncurrent>
  <jynt:DeferredFranchiseCostsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27578680" unitRef="iso4217-usd">836350</jynt:DeferredFranchiseCostsNoncurrent>
  <jynt:DeferredTaxAssetDeferredRentCurrent contextRef="i_2017-12-31" decimals="INF" id="c27579779" unitRef="iso4217-usd">257100</jynt:DeferredTaxAssetDeferredRentCurrent>
  <jynt:DeferredTaxAssetDeferredRentCurrent contextRef="i_2016-12-31" decimals="INF" id="c27579780" unitRef="iso4217-usd">629600</jynt:DeferredTaxAssetDeferredRentCurrent>
  <jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27579783" unitRef="iso4217-usd">7061300</jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent>
  <jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27579784" unitRef="iso4217-usd">8924800</jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent>
  <jynt:DeferredTaxAssetRestrictedStockCompensationCurrent contextRef="i_2017-12-31" decimals="INF" id="c27579775" unitRef="iso4217-usd">-17900</jynt:DeferredTaxAssetRestrictedStockCompensationCurrent>
  <jynt:DeferredTaxAssetRestrictedStockCompensationCurrent contextRef="i_2016-12-31" decimals="INF" id="c27579776" unitRef="iso4217-usd">-30800</jynt:DeferredTaxAssetRestrictedStockCompensationCurrent>
  <jynt:DeferredTaxAssetsAccruedExpensesCurrent contextRef="i_2017-12-31" decimals="INF" id="c27579769" unitRef="iso4217-usd">45300</jynt:DeferredTaxAssetsAccruedExpensesCurrent>
  <jynt:DeferredTaxAssetsAccruedExpensesCurrent contextRef="i_2016-12-31" decimals="INF" id="c27579770" unitRef="iso4217-usd">57400</jynt:DeferredTaxAssetsAccruedExpensesCurrent>
  <jynt:DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent contextRef="i_2017-12-31" id="c27579767" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent contextRef="i_2016-12-31" decimals="INF" id="c27579768" unitRef="iso4217-usd">51400</jynt:DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent>
  <jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent contextRef="i_2017-12-31" decimals="INF" id="c27579787" unitRef="iso4217-usd">5200</jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent>
  <jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent contextRef="i_2016-12-31" decimals="INF" id="c27579788" unitRef="iso4217-usd">6500</jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent>
  <jynt:DeferredTaxAssetsFranchiseCosts contextRef="i_2017-12-31" decimals="INF" id="c27579765" unitRef="iso4217-usd">-281000</jynt:DeferredTaxAssetsFranchiseCosts>
  <jynt:DeferredTaxAssetsFranchiseCosts contextRef="i_2016-12-31" decimals="INF" id="c27579766" unitRef="iso4217-usd">-553900</jynt:DeferredTaxAssetsFranchiseCosts>
  <jynt:DeferredTaxAssetsGoodwillComponent1 contextRef="i_2017-12-31" decimals="INF" id="c27579771" unitRef="iso4217-usd">-136500</jynt:DeferredTaxAssetsGoodwillComponent1>
  <jynt:DeferredTaxAssetsGoodwillComponent1 contextRef="i_2016-12-31" decimals="INF" id="c27579772" unitRef="iso4217-usd">-120700</jynt:DeferredTaxAssetsGoodwillComponent1>
  <jynt:DeferredTaxAssetsGoodwillComponent2 contextRef="i_2017-12-31" decimals="INF" id="c27579773" unitRef="iso4217-usd">55500</jynt:DeferredTaxAssetsGoodwillComponent2>
  <jynt:DeferredTaxAssetsGoodwillComponent2 contextRef="i_2016-12-31" decimals="INF" id="c27579774" unitRef="iso4217-usd">86800</jynt:DeferredTaxAssetsGoodwillComponent2>
  <jynt:DeferredTaxAssetsIntangibleAssets contextRef="i_2017-12-31" decimals="INF" id="c27579791" unitRef="iso4217-usd">368100</jynt:DeferredTaxAssetsIntangibleAssets>
  <jynt:DeferredTaxAssetsIntangibleAssets contextRef="i_2016-12-31" decimals="INF" id="c27579792" unitRef="iso4217-usd">429600</jynt:DeferredTaxAssetsIntangibleAssets>
  <jynt:DeferredTaxAssetsLeaseAbandonment contextRef="i_2017-12-31" decimals="INF" id="c27579781" unitRef="iso4217-usd">80600</jynt:DeferredTaxAssetsLeaseAbandonment>
  <jynt:DeferredTaxAssetsLeaseAbandonment contextRef="i_2016-12-31" decimals="INF" id="c27579782" unitRef="iso4217-usd">108900</jynt:DeferredTaxAssetsLeaseAbandonment>
  <jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27579777" unitRef="iso4217-usd">152900</jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent>
  <jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27579778" unitRef="iso4217-usd">182100</jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent>
  <jynt:DeferredTaxAssetsRevenueCurrent contextRef="i_2017-12-31" decimals="INF" id="c27579763" unitRef="iso4217-usd">756900</jynt:DeferredTaxAssetsRevenueCurrent>
  <jynt:DeferredTaxAssetsRevenueCurrent contextRef="i_2016-12-31" decimals="INF" id="c27579764" unitRef="iso4217-usd">1509400</jynt:DeferredTaxAssetsRevenueCurrent>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579823" unitRef="iso4217-usd">185000</jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount contextRef="d_2016-01-01_2016-12-31" id="c27579825" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579824" unitRef="xbrli-pure">0.0572</jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent contextRef="d_2016-01-01_2016-12-31" id="c27579826" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579815" unitRef="iso4217-usd">-131900</jynt:EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount>
  <jynt:EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount contextRef="d_2016-01-01_2016-12-31" id="c27579817" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579816" unitRef="xbrli-pure">-0.0408</jynt:EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent>
  <jynt:EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent contextRef="d_2016-01-01_2016-12-31" id="c27579818" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579811" unitRef="iso4217-usd">16700</jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount>
  <jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579813" unitRef="iso4217-usd">108800</jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount>
  <jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579133" unitRef="xbrli-pure">0.02</jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage>
  <jynt:FranchiseRoyaltyGrossSalesPercentage contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579153" unitRef="xbrli-pure">0.07</jynt:FranchiseRoyaltyGrossSalesPercentage>
  <jynt:FutureClinicsLicensesWithAnExecutedLetterOfIntent contextRef="i_2017-12-31" decimals="INF" id="c27579312" unitRef="xbrli-pure">8</jynt:FutureClinicsLicensesWithAnExecutedLetterOfIntent>
  <jynt:FutureClinicsLicensesWithAnExecutedLetterOfIntent contextRef="i_2016-12-31" id="c27579313" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581249">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;IT Related Income and Software Fees.&lt;/div&gt;&amp;nbsp;&amp;nbsp;The Company collects a monthly fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&amp;#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&amp;nbsp;upon receipt of equipment by the franchisee.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock>
  <jynt:IncreaseDecreaseInCoOpFundsLiability contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578966" unitRef="iso4217-usd">16435</jynt:IncreaseDecreaseInCoOpFundsLiability>
  <jynt:IncreaseDecreaseInCoOpFundsLiability contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578967" unitRef="iso4217-usd">-127832</jynt:IncreaseDecreaseInCoOpFundsLiability>
  <jynt:IncreaseDecreaseInDeferredFranchiseCosts contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578958" unitRef="iso4217-usd">-269719</jynt:IncreaseDecreaseInDeferredFranchiseCosts>
  <jynt:IncreaseDecreaseInDeferredFranchiseCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578959" unitRef="iso4217-usd">-361600</jynt:IncreaseDecreaseInDeferredFranchiseCosts>
  <jynt:LeaseExitLiability contextRef="i_2016-12-31" decimals="INF" id="c27579134" unitRef="iso4217-usd">338151</jynt:LeaseExitLiability>
  <jynt:LeaseExitLiability contextRef="i_2016-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember" decimals="INF" id="c27579862" unitRef="iso4217-usd">338000</jynt:LeaseExitLiability>
  <jynt:LeaseExitLiability contextRef="i_2017-12-31" decimals="INF" id="c27579318" unitRef="iso4217-usd">299400</jynt:LeaseExitLiability>
  <jynt:LeaseExitLiabilityAdditions contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579137" unitRef="iso4217-usd">883146</jynt:LeaseExitLiabilityAdditions>
  <jynt:LeaseExitLiabilityNetAccretion contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579317" unitRef="iso4217-usd">29906</jynt:LeaseExitLiabilityNetAccretion>
  <jynt:LeaseExitLiabilitySettlement contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579316" unitRef="iso4217-usd">891991</jynt:LeaseExitLiabilitySettlement>
  <jynt:LeaseExitLiabilityTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-18">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Lease exit liability at December 31, 2016&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;338,151&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Additions&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;883,146&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Settlements&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(891,991&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Net accretion&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(29,906&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Lease exit liability at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;299,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</jynt:LeaseExitLiabilityTableTextBlock>
  <jynt:LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement contextRef="d_2017-01-03_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember" decimals="INF" id="c27579520" unitRef="iso4217-usd">200000</jynt:LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement>
  <jynt:NatureOfOperationsPolicyPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581227">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Nature of Operations&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Joint Corp., a Delaware corporation, was formed on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March 10, 2010. &lt;/div&gt;Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016:&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: right" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold" nowrap="nowrap"&gt;Franchised clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics open at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened or purchased during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;41&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;56&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;352&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" margin: 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: right" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold" nowrap="nowrap"&gt;Company-owned or managed clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics open at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(14&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;399&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;370&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Clinics licenses sold but not yet developed&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;104&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;115&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Executed letters of intent for future clinic licenses&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:NatureOfOperationsPolicyPolicyTextBlock>
  <jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578935" unitRef="iso4217-usd">73665</jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements>
  <jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578936" unitRef="iso4217-usd">342259</jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements>
  <jynt:NotesReceivableContractualTerm contextRef="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" id="c27579377">P4Y180D</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2015-07-01_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member" id="c27579382">P2Y</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" id="c27579387">P180D</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2017-04-29_2017-04-29_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember" id="c27579391">P3Y180D</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2017-08-01_2017-08-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember" id="c27579396">P3Y</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2017-09-01_2017-09-22_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember" id="c27579401">P3Y</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2017-10-10_2017-10-10_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingPromissoryNoteMaturingOctober242020Member_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" id="c27579406">P3Y</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableInterestRate contextRef="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c27579376" unitRef="xbrli-pure">0.06</jynt:NotesReceivableInterestRate>
  <jynt:NotesReceivableInterestRate contextRef="d_2017-04-29_2017-04-29_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember" decimals="INF" id="c27579390" unitRef="xbrli-pure">0.1</jynt:NotesReceivableInterestRate>
  <jynt:NotesReceivableInterestRate contextRef="d_2017-08-01_2017-08-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember" decimals="INF" id="c27579395" unitRef="xbrli-pure">0.1</jynt:NotesReceivableInterestRate>
  <jynt:NotesReceivableInterestRate contextRef="d_2017-09-01_2017-09-22_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember" decimals="INF" id="c27579400" unitRef="xbrli-pure">0.1</jynt:NotesReceivableInterestRate>
  <jynt:NotesReceivableInterestRate contextRef="d_2017-10-10_2017-10-10_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingPromissoryNoteMaturingOctober242020Member_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" decimals="INF" id="c27579405" unitRef="xbrli-pure">0.1</jynt:NotesReceivableInterestRate>
  <jynt:NotesReceivablePrincipalAndInterestTerm contextRef="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" id="c27579378">P3Y180D</jynt:NotesReceivablePrincipalAndInterestTerm>
  <jynt:NotesReceivablePrincipalAndInterestTerm contextRef="d_2017-04-29_2017-04-29_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember" id="c27579392">P3Y</jynt:NotesReceivablePrincipalAndInterestTerm>
  <jynt:NotesReceivablePrincipalAndInterestTerm contextRef="d_2017-08-01_2017-08-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember" id="c27579397">P3Y</jynt:NotesReceivablePrincipalAndInterestTerm>
  <jynt:NotesReceivablePrincipalAndInterestTerm contextRef="d_2017-09-01_2017-09-22_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember" id="c27579402">P3Y</jynt:NotesReceivablePrincipalAndInterestTerm>
  <jynt:NotesReceivablePrincipalAndInterestTerm contextRef="d_2017-10-10_2017-10-10_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingPromissoryNoteMaturingOctober242020Member_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" id="c27579407">P3Y</jynt:NotesReceivablePrincipalAndInterestTerm>
  <jynt:NumberOfClinicsClassifiedAsHeldForSale contextRef="d_2016-12-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="INF" id="c27579418" unitRef="xbrli-pure">14</jynt:NumberOfClinicsClassifiedAsHeldForSale>
  <jynt:NumberOfFranchises contextRef="i_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember" decimals="INF" id="c27579075" unitRef="xbrli-pure">6</jynt:NumberOfFranchises>
  <jynt:NumberOfLicenseTransferAgreements contextRef="d_2015-07-01_2015-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c27579379" unitRef="xbrli-pure">2</jynt:NumberOfLicenseTransferAgreements>
  <jynt:NumberOfLicenseTransferAgreements contextRef="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" decimals="INF" id="c27579384" unitRef="xbrli-pure">3</jynt:NumberOfLicenseTransferAgreements>
  <jynt:NumberOfMajorCustomers contextRef="d_2017-01-01_2017-12-31_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember" decimals="INF" id="c27579087" unitRef="xbrli-pure">0</jynt:NumberOfMajorCustomers>
  <jynt:NumberOfMajorCustomers contextRef="d_2016-01-01_2016-12-31_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember" decimals="INF" id="c27579090" unitRef="xbrli-pure">0</jynt:NumberOfMajorCustomers>
  <jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c27579508" unitRef="xbrli-pure">12</jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions>
  <jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579514" unitRef="xbrli-pure">2</jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions>
  <jynt:NumberOfPCEntities contextRef="i_2017-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember" decimals="INF" id="c27579071" unitRef="xbrli-pure">1</jynt:NumberOfPCEntities>
  <jynt:NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579343" unitRef="xbrli-pure">6</jynt:NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics>
  <jynt:NumberOfUndevelopedFranchiseAgreementsTerminated contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="INF" id="c27579861" unitRef="xbrli-pure">5</jynt:NumberOfUndevelopedFranchiseAgreementsTerminated>
  <jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579339" unitRef="xbrli-pure">1</jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod>
  <jynt:NumberOfUnsecuredPromissoryNotes contextRef="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" decimals="INF" id="c27579385" unitRef="xbrli-pure">3</jynt:NumberOfUnsecuredPromissoryNotes>
  <jynt:OptionExcercisePriceYearOne contextRef="i_2013-12-31" decimals="INF" id="c27579680" unitRef="iso4217-usd-per-xbrli-shares">0.56</jynt:OptionExcercisePriceYearOne>
  <jynt:OptionExercisePriceYearEight contextRef="i_2013-12-31" decimals="INF" id="c27579687" unitRef="iso4217-usd-per-xbrli-shares">2.45</jynt:OptionExercisePriceYearEight>
  <jynt:OptionExercisePriceYearFive contextRef="i_2013-12-31" decimals="INF" id="c27579684" unitRef="iso4217-usd-per-xbrli-shares">1.28</jynt:OptionExercisePriceYearFive>
  <jynt:OptionExercisePriceYearFour contextRef="i_2013-12-31" decimals="INF" id="c27579683" unitRef="iso4217-usd-per-xbrli-shares">1.03</jynt:OptionExercisePriceYearFour>
  <jynt:OptionExercisePriceYearSeven contextRef="i_2013-12-31" decimals="INF" id="c27579686" unitRef="iso4217-usd-per-xbrli-shares">1.97</jynt:OptionExercisePriceYearSeven>
  <jynt:OptionExercisePriceYearSix contextRef="i_2013-12-31" decimals="INF" id="c27579685" unitRef="iso4217-usd-per-xbrli-shares">1.59</jynt:OptionExercisePriceYearSix>
  <jynt:OptionExercisePriceYearThree contextRef="i_2013-12-31" decimals="INF" id="c27579682" unitRef="iso4217-usd-per-xbrli-shares">0.84</jynt:OptionExercisePriceYearThree>
  <jynt:OptionExercisePriceYearTwo contextRef="i_2013-12-31" decimals="INF" id="c27579681" unitRef="iso4217-usd-per-xbrli-shares">0.68</jynt:OptionExercisePriceYearTwo>
  <jynt:OptionToRepurchaseSharesChangeInFairValue contextRef="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27579586" unitRef="iso4217-usd">-259000</jynt:OptionToRepurchaseSharesChangeInFairValue>
  <jynt:OptionToRepurchaseSharesChangeInFairValue contextRef="d_2017-09-01_2017-09-30_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27579591" unitRef="iso4217-usd">-292000</jynt:OptionToRepurchaseSharesChangeInFairValue>
  <jynt:ReacquisitionAndTerminationOfRegionalDeveloperRights contextRef="d_2017-01-01_2017-12-31" id="c27578981" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:ReacquisitionAndTerminationOfRegionalDeveloperRights contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578982" unitRef="iso4217-usd">325000</jynt:ReacquisitionAndTerminationOfRegionalDeveloperRights>
  <jynt:RegionalDeveloperFeesPolicyPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581246">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Regional Developer Fees&lt;/div&gt;. During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2011,&lt;/div&gt; the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under the historical program, regional developers paid a license fee ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7,250&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;25%&lt;/div&gt; of the then current franchise fee for each franchise they received the right to develop within the region. In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the program was revised to grant exclusive geographical territory and establish a minimum development obligation within that defined territory. Regional developers receive fees ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$14,500&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$19,950&lt;/div&gt; which are collected from franchisees upon the sale of franchises within their region and a royalty of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3%&lt;/div&gt; of sales generated by franchised clinics in their region. Regional developer fees paid to the Company are nonrefundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. The franchisor&amp;#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&amp;#x2019;s license.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company entered into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;ten&lt;/div&gt; regional developer agreements for which it received approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.1&lt;/div&gt; million, which was deferred as of the respective transaction dates and will be recognized on a pro-rata basis over the estimated number of franchised clinics to be opened in the respective regions. Certain of these regional developer agreements resulted in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, the revenue associated from the sale of the royalty stream is being recognized over the remaining life of the respective franchise agreements.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:RegionalDeveloperFeesPolicyPolicyTextBlock>
  <jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights contextRef="d_2017-01-01_2017-12-31" id="c27578931" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578932" unitRef="iso4217-usd">138500</jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights>
  <jynt:RegionalDeveloperFeesRevenue contextRef="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312015Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579189" unitRef="iso4217-usd">-400000</jynt:RegionalDeveloperFeesRevenue>
  <jynt:RegionalDeveloperFeesRevenue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578768" unitRef="iso4217-usd">583550</jynt:RegionalDeveloperFeesRevenue>
  <jynt:RegionalDeveloperFeesRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578769" unitRef="iso4217-usd">617573</jynt:RegionalDeveloperFeesRevenue>
  <jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise contextRef="i_2017-12-31_RangeAxis-MinimumMember" decimals="INF" id="c27579147" unitRef="iso4217-usd">14500</jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise>
  <jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise contextRef="i_2017-12-31_RangeAxis-MaximumMember" decimals="INF" id="c27579148" unitRef="iso4217-usd">19950</jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise>
  <jynt:RegionalDevelopersLicenseFee contextRef="i_2017-12-31" decimals="INF" id="c27579144" unitRef="iso4217-usd">7250</jynt:RegionalDevelopersLicenseFee>
  <jynt:RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579145" unitRef="xbrli-pure">0.25</jynt:RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage>
  <jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579149" unitRef="xbrli-pure">0.03</jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage>
  <jynt:RegionalDevelopmentAgreement contextRef="i_2017-04-29_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember" decimals="INF" id="c27579388" unitRef="iso4217-usd">320000</jynt:RegionalDevelopmentAgreement>
  <jynt:RegionalDevelopmentAgreement contextRef="i_2017-08-31_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember" decimals="INF" id="c27579393" unitRef="iso4217-usd">220000</jynt:RegionalDevelopmentAgreement>
  <jynt:RegionalDevelopmentAgreement contextRef="i_2017-09-22_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember" decimals="INF" id="c27579398" unitRef="iso4217-usd">228293</jynt:RegionalDevelopmentAgreement>
  <jynt:RegionalDevelopmentAgreement contextRef="i_2017-10-10_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" decimals="INF" id="c27579403" unitRef="iso4217-usd">170000</jynt:RegionalDevelopmentAgreement>
  <jynt:RepurchaseRightToDevelopFranchisesConsideration contextRef="d_2016-01-02_2016-01-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" decimals="INF" id="c27579459" unitRef="iso4217-usd">275000</jynt:RepurchaseRightToDevelopFranchisesConsideration>
  <jynt:RepurchaseRightToDevelopFranchisesConsideration contextRef="d_2016-06-01_2016-06-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember" decimals="INF" id="c27579461" unitRef="iso4217-usd">50000</jynt:RepurchaseRightToDevelopFranchisesConsideration>
  <jynt:RevenueDeferredAdjustment contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578933" unitRef="iso4217-usd">133943</jynt:RevenueDeferredAdjustment>
  <jynt:RevenueDeferredAdjustment contextRef="d_2016-01-01_2016-12-31" id="c27578934" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:RevenuesAndManagementFeesPolicyPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581247">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Revenues and Management Fees from Company Clinics.&amp;nbsp;&amp;nbsp;&lt;/div&gt;The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&amp;nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&amp;nbsp; Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&amp;nbsp;&amp;nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&amp;#x2019;s PC.&amp;nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&amp;#x2019;s PC in return for a monthly management fee.&amp;nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:RevenuesAndManagementFeesPolicyPolicyTextBlock>
  <jynt:RoyaltiesPolicyPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581248">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Royalties.&lt;/div&gt;&amp;nbsp;The Company collects royalties, as stipulated in the franchise agreement, equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7%&lt;/div&gt; of gross sales, and a marketing and advertising fee currently equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; working days after each sales period has ended.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:RoyaltiesPolicyPolicyTextBlock>
  <jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c27579626" unitRef="xbrli-pure">0.2</jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate>
  <jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c27579629" unitRef="xbrli-pure">0.2</jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2016-01-01_2016-12-31_RangeAxis-MinimumMember" decimals="INF" id="c27579537" unitRef="iso4217-usd-per-xbrli-shares">2.23</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2016-01-01_2016-12-31_RangeAxis-MaximumMember" decimals="INF" id="c27579538" unitRef="iso4217-usd-per-xbrli-shares">4.11</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2017-01-01_2017-12-31_RangeAxis-MinimumMember" decimals="INF" id="c27579540" unitRef="iso4217-usd-per-xbrli-shares">2.65</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2017-01-01_2017-12-31_RangeAxis-MaximumMember" decimals="INF" id="c27579541" unitRef="iso4217-usd-per-xbrli-shares">5.51</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579669" unitRef="iso4217-usd-per-xbrli-shares">2.38</jynt:ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue>
  <jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber contextRef="i_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579708" unitRef="xbrli-shares">90000</jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber>
  <jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms contextRef="d_2017-01-01_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579710">0.9</jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms>
  <jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice contextRef="i_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579709" unitRef="iso4217-usd-per-xbrli-shares">8.13</jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice>
  <jynt:UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579844" unitRef="iso4217-usd">26800</jynt:UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties>
  <jynt:UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579846" unitRef="iso4217-usd">6200</jynt:UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties>
  <us-gaap:AccountsPayableCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578691" unitRef="iso4217-usd">1068669</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578692" unitRef="iso4217-usd">1054946</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578663" unitRef="iso4217-usd">1138380</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578664" unitRef="iso4217-usd">1021733</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578693" unitRef="iso4217-usd">86959</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578694" unitRef="iso4217-usd">299997</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="i_2017-12-31" decimals="INF" id="c27579431" unitRef="iso4217-usd">3928349</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="i_2016-12-31" decimals="INF" id="c27579432" unitRef="iso4217-usd">2566172</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AdditionalPaidInCapital contextRef="i_2017-12-31" decimals="INF" id="c27578745" unitRef="iso4217-usd">37229869</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital contextRef="i_2016-12-31" decimals="INF" id="c27578746" unitRef="iso4217-usd">36398588</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578814" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578815" unitRef="iso4217-usd">1123481</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578817" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578818" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578819" unitRef="iso4217-usd">1123481</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578877" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578878" unitRef="iso4217-usd">594371</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578880" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578881" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578882" unitRef="iso4217-usd">594371</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578835" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578836" unitRef="iso4217-usd">1042</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578838" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578839" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578840" unitRef="iso4217-usd">1042</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581250">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Advertising costs are expensed as incurred. Advertising expenses for years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,397,076&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2,279,572,&lt;/div&gt; respectively.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
  <us-gaap:AdvertisingExpense contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579157" unitRef="iso4217-usd">1397076</us-gaap:AdvertisingExpense>
  <us-gaap:AdvertisingExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579158" unitRef="iso4217-usd">2279572</us-gaap:AdvertisingExpense>
  <us-gaap:AdvertisingRevenue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578764" unitRef="iso4217-usd">2753776</us-gaap:AdvertisingRevenue>
  <us-gaap:AdvertisingRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578765" unitRef="iso4217-usd">1866406</us-gaap:AdvertisingRevenue>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579548" unitRef="iso4217-usd">380067</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579549" unitRef="iso4217-usd">561559</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579567" unitRef="iso4217-usd">214304</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579568" unitRef="iso4217-usd">561922</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i_2017-12-31" decimals="INF" id="c27579100" unitRef="iso4217-usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i_2016-12-31" decimals="INF" id="c27579102" unitRef="iso4217-usd">131830</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579104" unitRef="iso4217-usd">40000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579109" unitRef="iso4217-usd">47000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579110" unitRef="iso4217-usd">731857</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579463" unitRef="iso4217-usd">578880</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579464" unitRef="iso4217-usd">747733</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2017-01-01_2017-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember" decimals="INF" id="c27579330" unitRef="xbrli-shares">63700</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember" decimals="INF" id="c27579331" unitRef="xbrli-shares">92415</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2017-01-01_2017-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember" decimals="INF" id="c27579332" unitRef="xbrli-shares">1003916</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember" decimals="INF" id="c27579333" unitRef="xbrli-shares">953075</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2017-01-01_2017-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember" decimals="INF" id="c27579334" unitRef="xbrli-shares">90000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember" decimals="INF" id="c27579335" unitRef="xbrli-shares">90000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:Assets contextRef="i_2017-12-31" decimals="INF" id="c27578687" unitRef="iso4217-usd">16909970</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2016-12-31" decimals="INF" id="c27578688" unitRef="iso4217-usd">17054861</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2017-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579917" unitRef="iso4217-usd">8998000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579918" unitRef="iso4217-usd">9936000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2017-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c27579919" unitRef="iso4217-usd">2362000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c27579920" unitRef="iso4217-usd">2003000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2017-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579921" unitRef="iso4217-usd">11360000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579922" unitRef="iso4217-usd">11939000</us-gaap:Assets>
  <us-gaap:AssetsCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578673" unitRef="iso4217-usd">6656771</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578674" unitRef="iso4217-usd">5696656</us-gaap:AssetsCurrent>
  <us-gaap:AssetsFairValueAdjustment contextRef="d_2016-01-01_2016-12-31" decimals="-3" id="c27579452" unitRef="iso4217-usd">3500000</us-gaap:AssetsFairValueAdjustment>
  <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-22">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Pro Forma for the Year Ended&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31, 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Revenues, net&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,985,277&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,483,492&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="d_2017-01-01_2017-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" id="c27579372" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" decimals="INF" id="c27579373" unitRef="iso4217-usd">-15483492</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="d_2017-01-01_2017-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" id="c27579370" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" decimals="INF" id="c27579371" unitRef="iso4217-usd">20985277</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579347" unitRef="iso4217-usd">75000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579340" unitRef="iso4217-usd">1025000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="d_2016-01-01_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c27579023" unitRef="iso4217-usd">186000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
  <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579342" unitRef="iso4217-usd">186000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801804">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Acquisitions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Franchises acquired during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company continued to execute its growth strategy and entered into a series of unrelated transactions with existing franchisees to re-acquire an aggregate of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; developed franchises and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; undeveloped franchise throughout California and New Mexico for an aggregate purchase price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,025,000,&lt;/div&gt; subject to certain adjustments, consisting of cash of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$839,000&lt;/div&gt; and notes payable of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$186,000.&lt;/div&gt; The Company is operating the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; developed franchises as company-owned or managed clinics and has terminated the undeveloped clinic license. At the time these transactions were consummated, the Company carried &lt;div style="display: inline; background-color: white"&gt;a deferred revenue balance of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,000,&lt;/div&gt; representing franchise fees collected upon the execution of the franchise agreements, and deferred franchise costs of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,450,&lt;/div&gt; related to an undeveloped franchise.&amp;nbsp;&amp;nbsp;The Company accounted for the franchise rights associated with the undeveloped franchise as a cancellation, and the respective deferred revenue and deferred franchise costs were netted against the aggregate purchase price.&amp;nbsp;&amp;nbsp;The remaining &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$997,450&lt;/div&gt; was accounted for as consideration paid for the acquired franchises.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company incurred approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$75,000&lt;/div&gt; of transaction costs related to these acquisitions for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;which are included in general and administrative expenses in the accompanying consolidated statements of operations.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Purchase Price Allocation&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following summarizes the aggregate estimated fair values of the assets acquired and liabilities assumed during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; as of the acquisition date:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Property and equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;293,014&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Intangible assets&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Favorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;140,728&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Goodwill&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;269,780&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,042,522&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Deferred membership revenue&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(45,072&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Net purchase price&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;997,450&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets in the table above consist of reacquired franchise rights of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$181,000&lt;/div&gt; and customer relationships of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$158,000&lt;/div&gt; and will be amortized over their estimated useful lives ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; years and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; years, respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Goodwill recorded in connection with these acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities. All of the recorded goodwill is tax-deductible.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Pro Forma Results of Operations (Unaudited)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following table summarizes selected unaudited pro forma condensed consolidated statements of operations data for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; as if the acquisitions in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; had been completed on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Pro Forma for the Year Ended&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;December 31, 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Revenues, net&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,985,277&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,483,492&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 61; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;This selected unaudited pro forma consolidated financial data is included only for the purpose of illustration and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; necessarily indicate what the operating results would have been if the acquisitions had been completed on that date. Moreover, this information is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; indicative of what the Company&amp;#x2019;s future operating results will be. The information for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; prior to the acquisitions is included based on prior accounting records maintained by the acquired companies. In some cases, accounting policies differed materially from accounting policies adopted by the Company following the acquisitions. For &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; this information includes actual data recorded in the Company&amp;#x2019;s consolidated financial statements for the period subsequent to the date of the acquisitions. The Company&amp;#x2019;s consolidated statements of operations for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;includes net revenue and net income of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7.5&lt;/div&gt; million and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.7&lt;/div&gt; million, respectively, attributable to the acquisitions.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The pro forma amounts included in the table above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2015, &lt;/div&gt;together with the consequential tax impacts.&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579362" unitRef="iso4217-usd">700000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
  <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579361" unitRef="iso4217-usd">7500000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579367" unitRef="iso4217-usd">1042522</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="i_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member" decimals="INF" id="c27579021" unitRef="iso4217-usd">45072</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579368" unitRef="iso4217-usd">45072</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="i_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member" decimals="INF" id="c27579019" unitRef="iso4217-usd">339000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579364" unitRef="iso4217-usd">339000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="i_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member" decimals="INF" id="c27579018" unitRef="iso4217-usd">293014</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579363" unitRef="iso4217-usd">293014</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579016" unitRef="iso4217-usd">50474</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579017" unitRef="iso4217-usd">11059</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2017-12-31" decimals="INF" id="c27578659" unitRef="iso4217-usd">4216221</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2016-12-31" decimals="INF" id="c27578660" unitRef="iso4217-usd">3009864</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2015-12-31" decimals="INF" id="c27579007" unitRef="iso4217-usd">16792850</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2017-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579923" unitRef="iso4217-usd">4320000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579924" unitRef="iso4217-usd">3344000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579004" unitRef="iso4217-usd">1206357</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579005" unitRef="iso4217-usd">-13782986</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581229">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Cash and Cash Equivalents&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company considers all highly liquid instruments purchased with an original maturity of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company had &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; cash equivalents as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="d_2017-01-01_2017-12-31" id="c27581230">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Restricted Cash&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&amp;#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:CashEquivalentsAtCarryingValue contextRef="i_2017-12-31" decimals="INF" id="c27579063" unitRef="iso4217-usd">0</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:CashEquivalentsAtCarryingValue contextRef="i_2016-12-31" decimals="INF" id="c27579065" unitRef="iso4217-usd">0</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801797">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;During the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; cash paid for income taxes was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,315&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$11,250,&lt;/div&gt; respectively. During the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; cash paid for interest was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$108,016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$15,262,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;Supplemental disclosure of non-cash activity:&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company had property and equipment purchases of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$50,474&lt;/div&gt; which were included in accounts payable. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company had property and equipment purchases of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$11,059&lt;/div&gt; which were included in accounts payable.&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;In connection with the acquisitions of franchises during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company acquired &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$293,014&lt;/div&gt; of property and equipment, intangible assets of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$339,000,&lt;/div&gt; goodwill of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$269,780&lt;/div&gt; and assumed deferred revenue associated with membership packages paid in advance of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$45,072&lt;/div&gt; in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$839,000&lt;/div&gt; in cash and notes payable issued to the sellers for an aggregate amount of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$186,000.&lt;/div&gt; Additionally, at the time of these transactions, the Company carried deferred revenue of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,000,&lt;/div&gt; representing franchise fees collected upon the execution of franchise agreements, and deferred costs of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,450,&lt;/div&gt; related to its acquisition of undeveloped franchises. The Company netted these amounts against the aggregate purchase price of the acquisitions (Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&lt;/div&gt;).&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;In connection with the reacquisition and termination of regional developer rights during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company had deferred revenue of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$224,750&lt;/div&gt; representing license fees collected upon the execution of the regional developer agreements.&amp;nbsp;&amp;nbsp;In accordance with ASC-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;952&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;605,&lt;/div&gt; the Company netted these amounts against the aggregate purchase price of the acquisitions.&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;In connection with the sale of the regional developer territories in Central Florida, Maryland/Washington DC, Minnesota, Texas, Oklahoma and Arkansas, the Company issued notes receivable in the amount of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$559,310&lt;/div&gt; with revenue to be recognized over the anticipated number of clinics to be opened in the respective territories. The Company has recognized &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$14,967&lt;/div&gt; of revenue related to these notes in the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December &lt;/div&gt;of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company entered into a settlement agreement, whereby it resolved a pending litigation matter. Under the terms of the settlement agreement, the Company agreed to a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt;-time settlement amount comprised of cash and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;46,948&lt;/div&gt; shares of common stock. The fair value of the total consideration related to common stock was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$100,000.&lt;/div&gt; The fair value of the common stock was measured using the closing price of the Company's common stock on the settlement date.&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December &lt;/div&gt;of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; the Company recorded an adjustment to goodwill related to deferred revenue from previous acquisitions of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$166,088.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="i_2014-11-14" decimals="INF" id="c27579594" unitRef="iso4217-usd-per-xbrli-shares">8.125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:CommitmentsAndContingencies contextRef="i_2017-12-31" id="c27578722" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies contextRef="i_2016-12-31" id="c27578723" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801829">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt; min-width: 700px;"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Commitments and Contingencies&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Operating Leases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company leases its corporate office space and the space for each of the company-owned or managed clinics in the portfolio.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Total rent expense for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2,808,837&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3,389,971,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;Future minimum annual lease payments are as follows:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,119,305&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,808,476&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,544,978&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,411,126&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,283,865&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,060,963&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,228,713&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 27.8pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 2016, &lt;/div&gt;the Company ceased use of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;five&lt;/div&gt; undeveloped clinic locations from its corporate clinics segment and recognized a liability for lease exit costs based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company classified all of the approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$338,000&lt;/div&gt; lease exit liability in other liabilities, and related expense in loss on disposition or impairment.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Litigation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; have a material adverse effect on the Company.&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="i_2017-12-31" decimals="INF" id="c27578737" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="i_2016-12-31" decimals="INF" id="c27578738" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="i_2017-12-31" decimals="INF" id="c27578739" unitRef="xbrli-shares">20000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized contextRef="i_2016-12-31" decimals="INF" id="c27578740" unitRef="xbrli-shares">20000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="i_2017-12-31" decimals="INF" id="c27578741" unitRef="xbrli-shares">13600338</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="i_2016-12-31" decimals="INF" id="c27578742" unitRef="xbrli-shares">13317393</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="i_2017-12-31" decimals="INF" id="c27578743" unitRef="xbrli-shares">13586254</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding contextRef="i_2016-12-31" decimals="INF" id="c27578744" unitRef="xbrli-shares">13020889</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue contextRef="i_2017-12-31" decimals="INF" id="c27578735" unitRef="iso4217-usd">13600</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="i_2016-12-31" decimals="INF" id="c27578736" unitRef="iso4217-usd">13317</us-gaap:CommonStockValue>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581226">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Comprehensive Loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;Net loss and comprehensive loss are the same for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="d_2017-01-01_2017-12-31" id="c27581231">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Concentrations of Credit Risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; PC entity and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; franchisees represented &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13%&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24%,&lt;/div&gt; respectively, of outstanding accounts receivable. The Company did &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; have any customers that represented greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; of its revenues during the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="d_2017-01-01_2017-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember" decimals="INF" id="c27579081" unitRef="xbrli-pure">0.13</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="d_2016-01-01_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember" decimals="INF" id="c27579084" unitRef="xbrli-pure">0.24</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581225">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Principles of Consolidation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly-owned subsidiary, The Joint Corporate Unit &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; LLC (collectively, the &amp;#x201c;Company&amp;#x201d;), which was dormant for all periods presented.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from general and administrative expenses to other expense, net, as well as certain balances from other revenues to revenues and management fees from company clinics for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;to conform to the current year presentation and align with the segment footnote presentation.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="d_2017-01-01_2017-12-31" id="c27581228">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Variable Interest Entities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&amp;nbsp;variable interest entity&amp;nbsp;(&amp;#x201c;VIE&amp;#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; hold the controlling interest and are &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; the primary beneficiary are accounted for under the equity method.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Certain states, in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice.&amp;nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; have the power to direct the activities of the PCs. As such, the activity of the PCs is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; included in the Company&amp;#x2019;s consolidated financial statements&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
  <us-gaap:ConstructionInProgressGross contextRef="i_2017-12-31" decimals="INF" id="c27579435" unitRef="iso4217-usd">407012</us-gaap:ConstructionInProgressGross>
  <us-gaap:ConstructionInProgressGross contextRef="i_2016-12-31" decimals="INF" id="c27579436" unitRef="iso4217-usd">231281</us-gaap:ConstructionInProgressGross>
  <us-gaap:CooperativeAdvertisingPolicy contextRef="d_2017-01-01_2017-12-31" id="c27581240">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Co-Op Marketing Funds&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&amp;#x2019; officers. The marketing funds are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CooperativeAdvertisingPolicy>
  <us-gaap:CostOfRevenue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578779" unitRef="iso4217-usd">3312194</us-gaap:CostOfRevenue>
  <us-gaap:CostOfRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578780" unitRef="iso4217-usd">2939609</us-gaap:CostOfRevenue>
  <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581241">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounting for Costs Associated with Exit or Disposal Activities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Costs to terminate an operating lease or other contracts are (a)&amp;nbsp;costs to terminate the contract before the end of its term or (b)&amp;nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Lease exit liability at December 31, 2016&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;338,151&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Additions&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;883,146&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Settlements&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(891,991&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Net accretion&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(29,906&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Lease exit liability at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;299,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company recognized a liability of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.3&lt;/div&gt; million related to operating leases that will &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; longer provide economic benefit to the entity, net of estimated sublease income.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company ceased use of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; clinic locations from its corporate clinics segment and recognized a liability of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.9&lt;/div&gt; million for lease exit costs incurred based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company recognized the resulting expense of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.4&lt;/div&gt; million in loss on disposition or impairment in the accompanying consolidated statement of operations.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="d_2017-01-01_2017-12-31" id="c27579748" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579749" unitRef="iso4217-usd">22800</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579752" unitRef="iso4217-usd">20100</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579753" unitRef="iso4217-usd">43700</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579750" unitRef="iso4217-usd">20100</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579751" unitRef="iso4217-usd">20900</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:DebtDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801815">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Debt&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Notes Payable&lt;/div&gt;&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company issued &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12&lt;/div&gt; notes payable totaling &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$800,350&lt;/div&gt; as a portion of the consideration paid in connection with the Company&amp;#x2019;s various acquisitions. Interest rates range from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.5%&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.25%&lt;/div&gt; with maturities through &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; February &lt;/div&gt;of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company issued &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; notes payable totaling &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$186,000&lt;/div&gt; as a portion of the consideration paid in connection with the Company&amp;#x2019;s various acquisitions. Interest rates for both notes are &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.25%&lt;/div&gt; with maturities through &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May &lt;/div&gt;of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt; The outstanding note will be paid upon execution of a final settlement and release agreement between the parties.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Maturities of notes payable are as follows as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017:&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;100,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;100,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Credit and Security Agreement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 3, 2017, &lt;/div&gt;the Company entered into a Credit and Security Agreement (the &amp;#x201c;Credit Agreement&amp;#x201d;) and signed a revolving credit note payable to the lender. Under the Credit Agreement, the Company is able to borrow up to an aggregate of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5,000,000&lt;/div&gt; under revolving loans. Interest on the unpaid outstanding principal amount of any revolving loans is at a rate equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; per annum, provided that the minimum amount of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$200,000.&lt;/div&gt; Interest is due and payable on the last day of each fiscal quarter in an amount determined by the Company, but &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; less than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$25,000.&lt;/div&gt; The lender&amp;#x2019;s lending commitments under the Credit Agreement terminate in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 2019, &lt;/div&gt;unless sooner terminated in accordance with the provisions of the Credit Agreement. The Credit Agreement is collateralized by the assets in the Company&amp;#x2019;s company-owned or managed clinics. The Company is using the credit facility for general working capital needs. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company had drawn &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,000,000&lt;/div&gt; of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5,000,000&lt;/div&gt; available under the Credit Agreement.&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:DebtInstrumentFaceAmount contextRef="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" decimals="INF" id="c27579509" unitRef="iso4217-usd">800350</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentFaceAmount contextRef="i_2016-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" decimals="INF" id="c27579515" unitRef="iso4217-usd">186000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MinimumMember" decimals="INF" id="c27579510" unitRef="xbrli-pure">0.015</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MaximumMember" decimals="INF" id="c27579511" unitRef="xbrli-pure">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2016-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" decimals="INF" id="c27579516" unitRef="xbrli-pure">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember" decimals="INF" id="c27579519" unitRef="xbrli-pure">0.1</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579755" unitRef="iso4217-usd">13800</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579756" unitRef="iso4217-usd">97400</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578943" unitRef="iso4217-usd">15734</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578944" unitRef="iso4217-usd">120700</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredRentCreditCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578701" unitRef="iso4217-usd">152198</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578702" unitRef="iso4217-usd">215450</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27578711" unitRef="iso4217-usd">802492</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredRentCreditNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27578712" unitRef="iso4217-usd">1400790</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredRevenue contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c27579024" unitRef="iso4217-usd">29000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-12-31" decimals="INF" id="c27579027" unitRef="iso4217-usd">224750</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2017-12-31_DeferredRevenueArrangementTypeAxis-RegionalDevelopmentAgreementMember" decimals="INF" id="c27579151" unitRef="iso4217-usd">2100000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579344" unitRef="iso4217-usd">29000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-01-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" decimals="INF" id="c27579460" unitRef="iso4217-usd">36250</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-06-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember" decimals="INF" id="c27579462" unitRef="iso4217-usd">188500</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenueCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578703" unitRef="iso4217-usd">2553818</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578704" unitRef="iso4217-usd">3077430</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27578713" unitRef="iso4217-usd">4693441</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27578714" unitRef="iso4217-usd">2231712</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueRevenueRecognized1 contextRef="d_2017-01-01_2017-12-31_NoncashOrPartNoncashDivestituresByUniqueNameAxis-RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" decimals="INF" id="c27579031" unitRef="iso4217-usd">14967</us-gaap:DeferredRevenueRevenueRecognized1>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579757" unitRef="iso4217-usd">2000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579758" unitRef="iso4217-usd">23300</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredTaxAssetsGrossNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27579793" unitRef="iso4217-usd">8739300</us-gaap:DeferredTaxAssetsGrossNoncurrent>
  <us-gaap:DeferredTaxAssetsGrossNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27579794" unitRef="iso4217-usd">11496400</us-gaap:DeferredTaxAssetsGrossNoncurrent>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="i_2017-12-31" decimals="INF" id="c27579785" unitRef="iso4217-usd">14000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="i_2016-12-31" decimals="INF" id="c27579786" unitRef="iso4217-usd">14000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27579795" unitRef="iso4217-usd">8875800</us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent>
  <us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27579796" unitRef="iso4217-usd">11617100</us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27578715" unitRef="iso4217-usd">136434</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27578716" unitRef="iso4217-usd">120700</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:DepositsAssetsNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27578685" unitRef="iso4217-usd">611808</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:DepositsAssetsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27578686" unitRef="iso4217-usd">707889</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:Depreciation contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579415" unitRef="iso4217-usd">1438443</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c27579416" unitRef="iso4217-usd">1818403</us-gaap:Depreciation>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578783" unitRef="iso4217-usd">2017323</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578784" unitRef="iso4217-usd">2566136</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579897" unitRef="iso4217-usd">1608000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579898" unitRef="iso4217-usd">2186000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" id="c27579899" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" id="c27579900" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-CorporateMember" decimals="-3" id="c27579901" unitRef="iso4217-usd">409000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateMember" decimals="-3" id="c27579902" unitRef="iso4217-usd">380000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578802" unitRef="iso4217-usd-per-xbrli-shares">-0.25</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578803" unitRef="iso4217-usd-per-xbrli-shares">-1.20</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581441">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Loss per Common Share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 68%; font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,275,233&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,173,872&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Weighted average common shares outstanding - basic&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,245,119&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of dilutive securities:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding - diluted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,245,119&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.25&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 58; Value: 1 --&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Unvested restricted stock&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;63,700&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,003,916&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="d_2017-01-01_2017-12-31" decimals="3" id="c27579732" unitRef="xbrli-pure">0.011</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="d_2016-01-01_2016-12-31" decimals="3" id="c27579733" unitRef="xbrli-pure">0.011</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="d_2018-01-01_2018-12-31_StatementScenarioAxis-ScenarioForecastMember" decimals="3" id="c27579717" unitRef="xbrli-pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579800" unitRef="xbrli-pure">0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c27579802" unitRef="xbrli-pure">0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579808" unitRef="xbrli-pure">-0.8473</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c27579810" unitRef="xbrli-pure">0.4024</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579820" unitRef="xbrli-pure">1.2197</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="d_2016-01-01_2016-12-31" id="c27579822" unitRef="xbrli-pure" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579828" unitRef="xbrli-pure">0.0005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c27579830" unitRef="xbrli-pure">-0.0097</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579832" unitRef="xbrli-pure">0.0111</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c27579834" unitRef="xbrli-pure">0.0109</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579804" unitRef="xbrli-pure">-0.0433</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c27579806" unitRef="xbrli-pure">-0.049</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="d_2017-01-01_2017-12-31" decimals="4" id="c27579812" unitRef="xbrli-pure">0.0052</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c27579814" unitRef="xbrli-pure">0.0072</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578697" unitRef="iso4217-usd">867430</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578698" unitRef="iso4217-usd">750421</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c27579551">P2Y255D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember" id="c27579570">P255D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="i_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579550" unitRef="iso4217-usd">840826</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="i_2017-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579569" unitRef="iso4217-usd">143240</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801810">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Fair Value Consideration&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company&amp;#x2019;s financial instruments include cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying amounts of its financial instruments approximate their fair value due to their short maturities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&amp;#x2019;s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; levels based on reliability of the inputs as follows:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1%; text-align: justify"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 6%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 93%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Observable inputs such as quoted prices in active markets;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr&gt; &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="vertical-align: top; width: 6%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom; width: 93%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&amp;nbsp;and&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 63; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1%; text-align: justify"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 6%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 93%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Unobservable inputs in which there is little or &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; market data, which require the reporting entity to develop its own assumptions.&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; &lt;/div&gt;have any financial instruments that are measured on a recurring basis as Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&lt;/div&gt; or &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company had non-recurring fair value measurements. As a result of the sale of certain clinics subsequent to year end, the Company recorded the assets at the lesser of their carrying values and their fair value less costs to sell, which resulted in a write-down of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.5&lt;/div&gt; million. The inputs used to determine such fair values were based on the offer price provided by a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;third&lt;/div&gt;-party in connection with the sale, and are classified within Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3&lt;/div&gt; in the hierarchy.&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="i_2016-12-31" decimals="-3" id="c27579448" unitRef="iso4217-usd">0</us-gaap:FinancialInstrumentsOwnedAtFairValue>
  <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="i_2017-12-31" decimals="-3" id="c27579455" unitRef="iso4217-usd">0</us-gaap:FinancialInstrumentsOwnedAtFairValue>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-ComputerSoftwareIntangibleAssetMember" id="c27579113">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember" id="c27579114">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember" id="c27579115">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" id="c27579116">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" id="c27579117">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember" id="c27579351">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember" id="c27579352">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" id="c27579353">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c27579475" unitRef="iso4217-usd">657943</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c27579478" unitRef="iso4217-usd">674667</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c27579481" unitRef="iso4217-usd">443348</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2017-12-31" decimals="INF" id="c27579484" unitRef="iso4217-usd">1775958</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c27579488" unitRef="iso4217-usd">410688</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c27579491" unitRef="iso4217-usd">509042</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c27579494" unitRef="iso4217-usd">277348</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31" decimals="INF" id="c27579497" unitRef="iso4217-usd">1197078</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="i_2017-12-31" decimals="INF" id="c27579504" unitRef="iso4217-usd">12213</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="i_2017-12-31" decimals="INF" id="c27579499" unitRef="iso4217-usd">439590</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="i_2017-12-31" decimals="INF" id="c27579503" unitRef="iso4217-usd">133693</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="i_2017-12-31" decimals="INF" id="c27579502" unitRef="iso4217-usd">348034</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="i_2017-12-31" decimals="INF" id="c27579501" unitRef="iso4217-usd">413256</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="i_2017-12-31" decimals="INF" id="c27579500" unitRef="iso4217-usd">413256</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c27579474" unitRef="iso4217-usd">1673000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c27579477" unitRef="iso4217-usd">701000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c27579480" unitRef="iso4217-usd">1162000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2017-12-31" decimals="INF" id="c27579483" unitRef="iso4217-usd">3536000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c27579487" unitRef="iso4217-usd">1673000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c27579490" unitRef="iso4217-usd">701000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c27579493" unitRef="iso4217-usd">1162000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31" decimals="INF" id="c27579496" unitRef="iso4217-usd">3536000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2017-12-31" decimals="INF" id="c27579505" unitRef="iso4217-usd">1760042</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c27579476" unitRef="iso4217-usd">1015057</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c27579479" unitRef="iso4217-usd">26333</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c27579482" unitRef="iso4217-usd">718652</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c27579489" unitRef="iso4217-usd">1262312</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c27579492" unitRef="iso4217-usd">191958</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c27579495" unitRef="iso4217-usd">884652</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31" decimals="INF" id="c27579498" unitRef="iso4217-usd">2338922</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c27579349" unitRef="iso4217-usd">181000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c27579350" unitRef="iso4217-usd">158000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FranchiseCosts contextRef="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312015Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579190" unitRef="iso4217-usd">-1600000</us-gaap:FranchiseCosts>
  <us-gaap:FranchiseCosts contextRef="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-The12MonthsEndedDecember312016Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579193" unitRef="iso4217-usd">-200000</us-gaap:FranchiseCosts>
  <us-gaap:FranchiseCosts contextRef="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312017Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579196" unitRef="iso4217-usd">100000</us-gaap:FranchiseCosts>
  <us-gaap:FranchiseCosts contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578775" unitRef="iso4217-usd">2996797</us-gaap:FranchiseCosts>
  <us-gaap:FranchiseCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578776" unitRef="iso4217-usd">2717691</us-gaap:FranchiseCosts>
  <us-gaap:FranchiseRevenue contextRef="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312015Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579188" unitRef="iso4217-usd">-4500000</us-gaap:FranchiseRevenue>
  <us-gaap:FranchiseRevenue contextRef="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-The12MonthsEndedDecember312016Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579192" unitRef="iso4217-usd">-800000</us-gaap:FranchiseRevenue>
  <us-gaap:FranchiseRevenue contextRef="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312017Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579195" unitRef="iso4217-usd">-300000</us-gaap:FranchiseRevenue>
  <us-gaap:FranchiseRevenue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578762" unitRef="iso4217-usd">1442415</us-gaap:FranchiseRevenue>
  <us-gaap:FranchiseRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578763" unitRef="iso4217-usd">2286809</us-gaap:FranchiseRevenue>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578939" unitRef="iso4217-usd">14525</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578940" unitRef="iso4217-usd">2191</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579138" unitRef="iso4217-usd">-417971</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
  <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578790" unitRef="iso4217-usd">-3520370</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
  <us-gaap:GainLossRelatedToLitigationSettlement contextRef="d_2017-01-01_2017-12-31" id="c27578947" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:GainLossRelatedToLitigationSettlement contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578948" unitRef="iso4217-usd">-100000</us-gaap:GainLossRelatedToLitigationSettlement>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578785" unitRef="iso4217-usd">18117533</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578786" unitRef="iso4217-usd">22086321</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:Goodwill contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579366" unitRef="iso4217-usd">269780</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="i_2017-12-31" decimals="INF" id="c27578683" unitRef="iso4217-usd">2916426</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="i_2016-12-31" decimals="INF" id="c27578684" unitRef="iso4217-usd">2750338</us-gaap:Goodwill>
  <us-gaap:GoodwillAcquiredDuringPeriod contextRef="d_2016-01-01_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member" decimals="INF" id="c27579020" unitRef="iso4217-usd">269780</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="d_2017-01-01_2017-12-31" id="c27581237">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.&lt;/div&gt;&amp;nbsp;&amp;nbsp;Goodwill and intangible assets deemed to have indefinite lives are &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; day of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;fourth&lt;/div&gt; quarter or more frequently if events or circumstances change that would more likely than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; reduce the fair value of a reporting unit below its carrying value.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 55; Value: 1 --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$54,994&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impairment was recorded for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
  <us-gaap:GoodwillImpairmentLoss contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579126" unitRef="iso4217-usd">54994</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:GoodwillImpairmentLoss contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579127" unitRef="iso4217-usd">0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember" decimals="INF" id="c27579118" unitRef="iso4217-usd">38185</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579119" unitRef="iso4217-usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="d_2015-01-01_2015-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember" decimals="INF" id="c27579469" unitRef="iso4217-usd">38185</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579130" unitRef="iso4217-usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579131" unitRef="iso4217-usd">2300000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf contextRef="d_2016-12-01_2016-12-31_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember" decimals="INF" id="c27579419" unitRef="iso4217-usd">2400000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581238">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Long-Lived Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may &lt;/div&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; long-lived assets have been impaired. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impairments were recorded for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017. &lt;/div&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.3&lt;/div&gt; million during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;due to the sale or closure of clinics in Illinois and New York (Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4&lt;/div&gt;).&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578795" unitRef="iso4217-usd">-3239353</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578796" unitRef="iso4217-usd">-15009443</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801823">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Income tax provision reported in the consolidated statements of operations is comprised of the following (in hundreds):&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Current provision:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;22,800&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;State, net of state tax credits&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total current provision&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;43,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred provision:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;97,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;State&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;23,300&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total deferred provision&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total income tax provision&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;35,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 69; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following are the components of the Company&amp;#x2019;s net deferred taxes for federal and state income taxes (in hundreds):&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Deferred revenue&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;756,900&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,509,400&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred franchise costs&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(281,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(553,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;51,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Accrued expenses&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;45,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;57,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - component 1&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(136,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - component 2&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;55,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Restricted stock compensation&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(17,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(30,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Nonqualified stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;152,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;182,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred rent&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;257,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;629,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Lease abandonment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;80,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,061,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,924,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Tax credits&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Charitable contribution carryover&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,200&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Asset basis difference related to property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;377,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;201,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Intangibles&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;368,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;429,600&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,739,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,496,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(8,875,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(11,617,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Net non-current deferred tax liability&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(136,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; Tax Act was signed into law on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 22, 2017. &lt;/div&gt;The &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; Tax Act significantly revises the U.S. corporate income tax by, among other things, lowering the statutory corporate tax rate from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;34%&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;21%,&lt;/div&gt; eliminating certain deductions, imposing a mandatory &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt;-time tax on accumulated earnings of foreign subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax. The Company has &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; completed its determination of the accounting implications of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; Tax Act on its accruals. However, it has reasonably estimated the effects of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; Tax Act and recorded a provisional tax expense in its financial statements as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.9&lt;/div&gt; million. This amount is a remeasurement of federal net deferred tax assets resulting from the permanent reduction in the U.S. statutory corporate tax rate to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;21%&lt;/div&gt; from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;34%.&lt;/div&gt; As the Company completes its analysis of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; Tax Act, collects and prepares necessary data, and interprets any additional guidance issued by the U.S. Treasury Department, the IRS, and other standard-setting bodies, it &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may &lt;/div&gt;make adjustments to the provisional amounts.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;At &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company has federal and state net operating losses of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$26,527,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$32,030,000&lt;/div&gt; respectively. These net operating losses are available to offset future taxable income and will begin to expire in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2035&lt;/div&gt; for federal purposes and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2025&lt;/div&gt; for state purposes.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 70; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following is a reconciliation of the statutory federal income tax rate applied to pre-tax accounting net loss, compared to the income tax provision in the consolidated statement of operations (in hundreds):&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;For the Years Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Percent&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Percent&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Expected federal tax benefit&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1,100,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,106,100&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;State tax provision, net of federal benefit&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(140,200&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.33&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(735,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.90&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of (decrease) increase in valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2,741,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(84.73&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,042,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40.24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Other permanent differences&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.52&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.72&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock Compensation&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(131,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.08&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Impact of enacted tax reform&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,946,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;121.97&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;State deferred tax true up&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;185,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.72&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.05&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(145,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.97&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Provision&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;35,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.11&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.09&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The state tax benefit stems from the resolution of various voluntary disclosure agreements with multiple states where the Company had &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; yet been in compliance. In addition, the Company is responsible to pay certain minimum and franchise taxes to jurisdictions in which it does business.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Changes in income tax expense related primarily to changes in pretax losses during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;as compared to year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;and the effective rate was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.1%&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.1%,&lt;/div&gt; respectively. The difference is primarily due to state taxes, stock compensation and the impact of enacted tax reform which is mostly offset by the valuation allowance.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and, &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company recorded a liability for income taxes for operations and uncertain tax positions of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0&lt;/div&gt; and approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$40,000,&lt;/div&gt; respectively, of which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0&lt;/div&gt; and approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$27,000&lt;/div&gt; respectively, represent penalties and interest and are recorded in the &amp;#x201c;other liabilities&amp;#x201d; section of the accompanying consolidated balance sheets. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Management made a determination that the Company was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; in compliance with several state and local tax jurisdictions in which the Company was doing business. Accordingly, management undertook to analyze its tax exposures, both income and otherwise, with respect to jurisdictions in which compliance was deemed to be inadequate and has entered into Voluntary Disclosure Agreements (VDAs) with the taxing authorities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following table sets forth a reconciliation of the beginning and ending amount of uncertain tax positions during the tax years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; (in hundreds):&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Uncertain tax positions - January 1&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;32,600&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Gross increases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross decreases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(19,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Uncertain tax positions - December 31&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company&amp;#x2019;s tax returns for tax years subject to examination by tax authorities include &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2013&lt;/div&gt; through the current period for state and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; through the current period for federal purposes.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="i_2016-12-31" decimals="INF" id="c27579836" unitRef="iso4217-usd">26800</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="i_2017-12-31" id="c27579848" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="i_2015-12-31" decimals="INF" id="c27579838" unitRef="iso4217-usd">33000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="d_2017-01-01_2017-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember" decimals="INF" id="c27579737" unitRef="iso4217-usd">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="d_2016-01-01_2016-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember" decimals="INF" id="c27579738" unitRef="iso4217-usd">27000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578797" unitRef="iso4217-usd">35880</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578798" unitRef="iso4217-usd">164429</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579722" unitRef="iso4217-usd">3900000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581251">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;50%&lt;/div&gt; likelihood of being realized upon ultimate resolution.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579807" unitRef="iso4217-usd">-2741300</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579809" unitRef="iso4217-usd">6042900</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579819" unitRef="iso4217-usd">3946100</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
  <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="d_2016-01-01_2016-12-31" id="c27579821" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579799" unitRef="iso4217-usd">-1100000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579801" unitRef="iso4217-usd">-5106100</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579827" unitRef="iso4217-usd">1500</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
  <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579829" unitRef="iso4217-usd">-145700</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579803" unitRef="iso4217-usd">-140200</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579805" unitRef="iso4217-usd">-735500</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxesPaid contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579011" unitRef="iso4217-usd">29315</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesPaid contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579012" unitRef="iso4217-usd">11250</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesReceivable contextRef="i_2017-12-31" id="c27578665" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:IncomeTaxesReceivable contextRef="i_2016-12-31" decimals="INF" id="c27578666" unitRef="iso4217-usd">42014</us-gaap:IncomeTaxesReceivable>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578962" unitRef="iso4217-usd">-36751</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578963" unitRef="iso4217-usd">-953084</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578952" unitRef="iso4217-usd">124108</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578953" unitRef="iso4217-usd">999522</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578964" unitRef="iso4217-usd">-213038</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578965" unitRef="iso4217-usd">-75532</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578974" unitRef="iso4217-usd">1170691</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578975" unitRef="iso4217-usd">-896195</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578960" unitRef="iso4217-usd">-96081</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578961" unitRef="iso4217-usd">-71549</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578968" unitRef="iso4217-usd">117009</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578969" unitRef="iso4217-usd">-742954</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578954" unitRef="iso4217-usd">-42014</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
  <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578955" unitRef="iso4217-usd">-28967</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
  <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578972" unitRef="iso4217-usd">-410964</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
  <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578973" unitRef="iso4217-usd">824390</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578970" unitRef="iso4217-usd">-734321</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578971" unitRef="iso4217-usd">-19130</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578956" unitRef="iso4217-usd">42817</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578957" unitRef="iso4217-usd">133492</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578950" unitRef="iso4217-usd">-230575</us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities>
  <us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578951" unitRef="iso4217-usd">-50888</us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities>
  <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="d_2017-01-01_2017-12-31" id="c27579324" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="d_2016-01-01_2016-12-31" id="c27579325" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801811">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Intangible Assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2016, &lt;/div&gt;the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in San Bernardino and Riverside Counties in California. The total consideration for the transaction was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$275,000,&lt;/div&gt; paid in cash.&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="display: inline; background-color: white"&gt;The Company carried a deferred revenue balance associated with these transactions of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$36,250,&lt;/div&gt; representing license fees collected upon the execution of the regional developer agreements.&amp;nbsp;&amp;nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&amp;nbsp;&amp;nbsp; &lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; June 1, 2016, &lt;/div&gt;the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in Virginia. The total consideration for the transaction was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$50,000,&lt;/div&gt; paid in cash.&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="display: inline; background-color: white"&gt;The Company carried a deferred revenue balance associated with these transactions of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$188,500,&lt;/div&gt; representing license fees collected upon the execution of the regional developer agreements.&amp;nbsp;&amp;nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&amp;nbsp;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets consisted of the following:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;As of December 31, 2017&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Gross Carrying&lt;br /&gt; Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Accumulated&lt;br /&gt; Amortization&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Net Carrying&lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Amortized intangible assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Reacquired franchise rights&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,673,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;657,943&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,015,057&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Customer relationships&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;701,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;674,667&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,333&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Reacquired development rights&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,162,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;443,348&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718,652&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,536,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,775,958&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,760,042&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" margin: 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;As of December 31, 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Gross Carrying&lt;br /&gt; Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Accumulated&lt;br /&gt; Amortization&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Net Carrying&lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Amortized intangible assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Reacquired franchise rights&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,673,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;410,688&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,262,312&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Customer relationships&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;701,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;509,042&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;191,958&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Reacquired development rights&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,162,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;277,348&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;884,652&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,536,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,197,078&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,338,922&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Amortization expense was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$578,880&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$747,733&lt;/div&gt; for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company evaluates the recoverability of finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may &lt;/div&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of intangible assets is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; recoverable, the carrying amount of such assets is reduced to fair value. The Company recorded an impairment charge as a result of the closure of a clinic acquired in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$38,185&lt;/div&gt; related to certain reacquired franchise rights and customer relationships during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;which is included on the loss on disposition or impairment line of the statement of consolidated operations.&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impairment was recorded for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 64; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;Estimated amortization expense for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018&lt;/div&gt; and subsequent years is as follows:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;439,590&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;348,034&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;133,693&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,213&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,760,042&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="d_2017-01-01_2017-12-31" id="c27581236">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Intangible Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&amp;nbsp;&amp;nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; years. The Company amortizes the acquired regional developer rights over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. The fair value of customer relationships is amortized over their estimated useful life of&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt;&amp;nbsp;years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$38,185&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;related to closure of an acquired clinic in New York. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impairment was recorded for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="i_2017-12-31" decimals="INF" id="c27578681" unitRef="iso4217-usd">1760042</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="i_2016-12-31" decimals="INF" id="c27578682" unitRef="iso4217-usd">2338922</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:InterestPaid contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579014" unitRef="iso4217-usd">108016</us-gaap:InterestPaid>
  <us-gaap:InterestPaid contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579015" unitRef="iso4217-usd">15262</us-gaap:InterestPaid>
  <us-gaap:InternalUseSoftwarePolicy contextRef="d_2017-01-01_2017-12-31" id="c27581235">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Software Developed&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5&lt;/div&gt; years.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InternalUseSoftwarePolicy>
  <us-gaap:LesseeLeasesPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581242">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Rent&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may &lt;/div&gt;include rent holidays and rent escalation clauses.&amp;nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&amp;nbsp; The Company records tenant improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
  <us-gaap:Liabilities contextRef="i_2017-12-31" decimals="INF" id="c27578719" unitRef="iso4217-usd">12011153</us-gaap:Liabilities>
  <us-gaap:Liabilities contextRef="i_2016-12-31" decimals="INF" id="c27578720" unitRef="iso4217-usd">10129448</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="i_2017-12-31" decimals="INF" id="c27578755" unitRef="iso4217-usd">16909970</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="i_2016-12-31" decimals="INF" id="c27578756" unitRef="iso4217-usd">17054861</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578707" unitRef="iso4217-usd">4967289</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578708" unitRef="iso4217-usd">5863884</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="i_2017-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember" decimals="INF" id="c27579735" unitRef="iso4217-usd">0</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="i_2016-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember" decimals="INF" id="c27579736" unitRef="iso4217-usd">40000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <us-gaap:LineOfCredit contextRef="i_2017-12-31_CreditFacilityAxis-RevolvingCreditFacilityMember" decimals="INF" id="c27579523" unitRef="iso4217-usd">1000000</us-gaap:LineOfCredit>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember" decimals="INF" id="c27579518" unitRef="iso4217-usd">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest contextRef="d_2017-01-03_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember" decimals="INF" id="c27579522" unitRef="iso4217-usd">25000</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
  <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801807">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Notes Receivable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July 2012, &lt;/div&gt;the Company sold a company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$90,000&lt;/div&gt; unsecured promissory note. The note bore interest at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6%&lt;/div&gt; per annum for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;fifty-four&lt;/div&gt; months and required monthly principal and interest payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;forty-two&lt;/div&gt; months, beginning on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August 2013. &lt;/div&gt;The note matured in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 2017 &lt;/div&gt;and was paid in full upon maturity.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July 2015, &lt;/div&gt;the Company entered into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; license transfer agreements, in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$10,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,925&lt;/div&gt; in separate unsecured promissory notes.&amp;nbsp; The non-interest-bearing notes require monthly principal payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24&lt;/div&gt; months, beginning on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September 1, 2015. &lt;/div&gt;The note was settled in full in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 2016, &lt;/div&gt;the Company entered into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; license transfer agreements, in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; separate &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7,500&lt;/div&gt; unsecured promissory notes.&amp;nbsp; The non-interest-bearing notes require monthly principal payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; months, beginning on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 1, 2017. &lt;/div&gt;The note matured in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; October 2017 &lt;/div&gt;and was paid in full upon maturity.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; April 29, 2017, &lt;/div&gt;the Company entered into a regional developer agreement for certain territories in the state of Florida in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$320,000,&lt;/div&gt; of which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$187,000&lt;/div&gt; was funded through a promissory note. The note bears interest at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; per annum for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;42&lt;/div&gt; months and requires monthly principal and interest payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;36&lt;/div&gt; months, beginning &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November 1, 2017 &lt;/div&gt;and maturing on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; October 1, 2020.&amp;nbsp;&lt;/div&gt;The note is secured by the regional developer rights in the respective territory.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August 31, 2017, &lt;/div&gt;the Company entered into a regional developer agreement for certain territories in Maryland/Washington DC in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$220,000,&lt;/div&gt; of which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$117,475&lt;/div&gt; was funded through a promissory note. The note bears interest at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; per annum for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;36&lt;/div&gt; months and requires monthly principal and interest payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;36&lt;/div&gt; months, beginning &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September 1, 2017 &lt;/div&gt;and maturing on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August 1, 2020. &lt;/div&gt;The note is secured by the regional developer rights in the respective territory.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September 22, 2017, &lt;/div&gt;the Company entered into a regional developer and asset purchase agreement for certain territories in Minnesota in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$228,293,&lt;/div&gt; of which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$119,147&lt;/div&gt; was funded through a promissory note. The note bears interest at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; per annum for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;36&lt;/div&gt; months and requires monthly principal and interest payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;36&lt;/div&gt; months, beginning &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; October 1, 2017 &lt;/div&gt;and maturing on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September 1, 2020. &lt;/div&gt;The note is secured by the regional developer rights in the respective territory.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; October 10, 2017, &lt;/div&gt;the Company entered into a regional developer agreement for certain territories in Texas, Oklahoma and Arkansas in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$170,000,&lt;/div&gt; of which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$135,688&lt;/div&gt; was funded through a promissory note. The note bears interest at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; per annum for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;36&lt;/div&gt; months and requires monthly principal and interest payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;36&lt;/div&gt; months, beginning &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September 24, 2017 &lt;/div&gt;and maturing on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; October 24, 2020. &lt;/div&gt;The note is secured by the regional developer rights in the respective territory.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 62; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The outstanding balance of the notes as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$523,785&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$40,826,&lt;/div&gt; respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
  <us-gaap:LongTermDebt contextRef="i_2017-12-31" decimals="INF" id="c27579528" unitRef="iso4217-usd">100000</us-gaap:LongTermDebt>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="i_2017-12-31" decimals="INF" id="c27579526" unitRef="iso4217-usd">100000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:LongTermNotesPayable contextRef="i_2017-12-31" decimals="INF" id="c27578709" unitRef="iso4217-usd">1000000</us-gaap:LongTermNotesPayable>
  <us-gaap:LongTermNotesPayable contextRef="i_2016-12-31" id="c27578710" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579002" unitRef="iso4217-usd">1422766</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579003" unitRef="iso4217-usd">-239852</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578987" unitRef="iso4217-usd">-372853</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578988" unitRef="iso4217-usd">-2695822</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578976" unitRef="iso4217-usd">156444</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578977" unitRef="iso4217-usd">-10847312</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578799" unitRef="iso4217-usd">-3275233</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578800" unitRef="iso4217-usd">-15173872</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578863" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" id="c27578864" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578866" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c27578867" unitRef="iso4217-usd">-15173872</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578912" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" id="c27578913" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578915" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c27578916" unitRef="iso4217-usd">-3275233</us-gaap:NetIncomeLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581507">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Recent Accounting Pronouncements&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 2014, &lt;/div&gt;the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers,&lt;/div&gt;&amp;#x201d; which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The standard also calls for additional disclosures around the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for the Company on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; April 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606&lt;/div&gt;): Identifying Performance Obligations and Licensing,&lt;/div&gt;&amp;#x201d; to clarify the following &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; aspects of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606:&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1&lt;/div&gt;) identifying performance obligations, and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&lt;/div&gt;) the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606&lt;/div&gt;): Narrow-Scope Improvements and Practical Expedients,&lt;/div&gt;&amp;#x201d; to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has performed a review of the above revenue standards updates and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; expect the adoption of the updates to have a material impact on its revenues and management fees from company clinics, advertising fund revenue, or IT related income and software fees. In addition, the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; expect the adoption to have a material impact on its franchise royalty revenues, as they are based on a percent of sales. The Company expects the adoption of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606&lt;/div&gt; to impact its accounting for initial franchise fees and regional developer fees. Currently, the Company recognizes revenue from initial franchise fees and regional developer fees upon the opening of a franchised clinic when the Company has performed all of its material obligations and initial services under the respective agreements. Upon the adoption of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606,&lt;/div&gt; the Company expects to recognize the revenue related to initial franchise fees and regional developer fees over the term of the related franchise agreement or regional developer agreement. The Company has finalized its accounting policies, and has selected the full retrospective method as its transition method.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 59; Value: 1 --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company quantified the impact of adopting this standard, and designed internal controls during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;to be implemented on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018. &lt;/div&gt;The Company estimates the cumulative catch-up adjustment to be recorded to retained earnings as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2015 &lt;/div&gt;to be an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.3&lt;/div&gt; million increase to the accumulated deficit as the Company has adopted the full retrospective approach. This is made up of a decrease to franchise fee revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$4.5&lt;/div&gt; million, a decrease to regional developer revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.4&lt;/div&gt; million, and a decrease to franchise cost of revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1.6&lt;/div&gt; million. The Company estimates the adjustment to be recorded to retained earnings as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;to be an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.6&lt;/div&gt; million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.8&lt;/div&gt; million, with a decrease to franchise cost of revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.2&lt;/div&gt; million. The Company estimates the adjustment to be recorded to retained earnings as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;to be an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.2&lt;/div&gt; million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.3&lt;/div&gt; million, with an offsetting increase to franchise cost of revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.1&lt;/div&gt; million. The impact to regional developer revenue for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; material. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impact to the Company's consolidated statement of cash flows is expected as the initial fees will continue to be collected upon execution of the franchise agreement. The Company will comply with the increased financial statement disclosure requirements during the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; quarter of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; February 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;02,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Leases (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;842&lt;/div&gt;).&lt;/div&gt;&amp;#x201d; The ASU requires that substantially all operating leases be recognized as assets and liabilities on the Company&amp;#x2019;s balance sheet, which is a significant departure from the current standard, which classifies operating leases as off-balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2018. &lt;/div&gt;While the Company has &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; yet quantified the impact that this standard will have on its financial statements, it will result in a significant increase in the assets and liabilities reflected on the Company&amp;#x2019;s balance sheet and in the interest expense and depreciation and amortization expense reflected in its statement of operations, while reducing the amount of rent expense.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic;"&gt;&amp;#x201c;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230&lt;/div&gt;): Classification of Certain Cash Receipts and Cash Payments.&amp;#x201d;&amp;nbsp;&lt;/div&gt;This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017. &lt;/div&gt;Early adoption is permitted. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;18,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230&lt;/div&gt;): Restricted Cash&amp;#x201d;&lt;/div&gt;&amp;nbsp;(a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017, &lt;/div&gt;including interim periods within those fiscal years. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 2017, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Business Combinations (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;805&lt;/div&gt;): Clarifying the Definition of a Business,&amp;#x201d;&amp;nbsp;&lt;/div&gt;to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017, &lt;/div&gt;including interim periods within those fiscal years. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 2017, &lt;/div&gt;the FASB issued ASU&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;04,&lt;/div&gt;&amp;nbsp;&amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Intangibles - Goodwill and Other (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;350&lt;/div&gt;): Simplifying the Test for Goodwill Impairment&lt;/div&gt;.&amp;#x201d; This update simplifies the subsequent measurement of goodwill by eliminating &amp;#x201c;Step &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&amp;#x201d;&lt;/div&gt; from the goodwill impairment test. This update is effective for annual and interim reporting periods beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2019. &lt;/div&gt;Early adoption is permitted. The Company is currently evaluating the impact this standard will have on the Company's consolidated financial statements and related disclosures.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0; background-color: white"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 2017, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic;"&gt;&amp;#x201c;Compensation&amp;#x2014;Stock Compensation (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718&lt;/div&gt;): Scope of Modification Accounting,&amp;#x201d;&amp;nbsp;&lt;/div&gt;to provide clarity and reduce both (&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1&lt;/div&gt;) diversity in practice and (&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&lt;/div&gt;) cost and complexity when applying the guidance in Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718,&lt;/div&gt; Compensation&amp;#x2014;Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718.The&lt;/div&gt; amendments are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017 &lt;/div&gt;and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 contextRef="d_2017-01-01_2017-12-31_NoncashOrPartNoncashDivestituresByUniqueNameAxis-RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" decimals="INF" id="c27579030" unitRef="iso4217-usd">559310</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
  <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578667" unitRef="iso4217-usd">171928</us-gaap:NotesAndLoansReceivableNetCurrent>
  <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578668" unitRef="iso4217-usd">40826</us-gaap:NotesAndLoansReceivableNetCurrent>
  <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27578677" unitRef="iso4217-usd">351857</us-gaap:NotesAndLoansReceivableNetNoncurrent>
  <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="i_2016-12-31" id="c27578678" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NotesPayableCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578699" unitRef="iso4217-usd">100000</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578700" unitRef="iso4217-usd">331500</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesReceivableNet contextRef="i_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c27579375" unitRef="iso4217-usd">90000</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote1Member" decimals="INF" id="c27579380" unitRef="iso4217-usd">10000</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member" decimals="INF" id="c27579381" unitRef="iso4217-usd">29925</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" decimals="INF" id="c27579386" unitRef="iso4217-usd">7500</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2017-04-29_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember" decimals="INF" id="c27579389" unitRef="iso4217-usd">187000</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2017-08-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember" decimals="INF" id="c27579394" unitRef="iso4217-usd">117475</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2017-09-22_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember" decimals="INF" id="c27579399" unitRef="iso4217-usd">119147</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2017-10-10_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingPromissoryNoteMaturingOctober242020Member_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" decimals="INF" id="c27579404" unitRef="iso4217-usd">135688</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2017-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c27579410" unitRef="iso4217-usd">523785</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2016-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c27579411" unitRef="iso4217-usd">40826</us-gaap:NotesReceivableNet>
  <us-gaap:NumberOfOperatingSegments contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579875" unitRef="xbrli-pure">2</us-gaap:NumberOfOperatingSegments>
  <us-gaap:NumberOfStores contextRef="i_2017-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="INF" id="c27579876" unitRef="xbrli-pure">47</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2017-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="INF" id="c27579877" unitRef="xbrli-pure">352</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579288" unitRef="xbrli-pure">309</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579289" unitRef="xbrli-pure">265</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2017-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c27579296" unitRef="xbrli-pure">352</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c27579298" unitRef="xbrli-pure">61</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c27579299" unitRef="xbrli-pure">47</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2017-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c27579306" unitRef="xbrli-pure">47</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2017-12-31" decimals="INF" id="c27579308" unitRef="xbrli-pure">399</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31" decimals="INF" id="c27579309" unitRef="xbrli-pure">370</us-gaap:NumberOfStores>
  <us-gaap:OpenTaxYear contextRef="d_2017-01-01_2017-12-31_IncomeTaxAuthorityAxis-StateAndLocalJurisdictionMember_TaxPeriodAxis-EarliestTaxYearMember" id="c27579742">2013</us-gaap:OpenTaxYear>
  <us-gaap:OpenTaxYear contextRef="d_2017-01-01_2017-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember_TaxPeriodAxis-LatestTaxYearMember" id="c27579744">2014</us-gaap:OpenTaxYear>
  <us-gaap:OperatingIncomeLoss contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578791" unitRef="iso4217-usd">-3174898</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578792" unitRef="iso4217-usd">-15007976</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579890" unitRef="iso4217-usd">-1704000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579891" unitRef="iso4217-usd">-9730000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c27579892" unitRef="iso4217-usd">6243000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c27579893" unitRef="iso4217-usd">4561000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2017-01-01_2017-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579894" unitRef="iso4217-usd">4539000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579895" unitRef="iso4217-usd">-5169000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2017-01-01_2017-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember" decimals="-3" id="c27579908" unitRef="iso4217-usd">-7714000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember" decimals="-3" id="c27579909" unitRef="iso4217-usd">-9839000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="i_2017-12-31" decimals="INF" id="c27579873" unitRef="iso4217-usd">11228713</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="i_2017-12-31" decimals="INF" id="c27579867" unitRef="iso4217-usd">2119305</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="i_2017-12-31" decimals="INF" id="c27579871" unitRef="iso4217-usd">1283865</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="i_2017-12-31" decimals="INF" id="c27579870" unitRef="iso4217-usd">1411126</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="i_2017-12-31" decimals="INF" id="c27579869" unitRef="iso4217-usd">1544978</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="i_2017-12-31" decimals="INF" id="c27579868" unitRef="iso4217-usd">1808476</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="i_2017-12-31" decimals="INF" id="c27579872" unitRef="iso4217-usd">3060963</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579859" unitRef="iso4217-usd">2808837</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579860" unitRef="iso4217-usd">3389971</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLossCarryforwards contextRef="i_2017-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember" decimals="INF" id="c27579726" unitRef="iso4217-usd">26527000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards contextRef="i_2017-12-31_IncomeTaxAuthorityAxis-ForeignCountryMember" decimals="INF" id="c27579727" unitRef="iso4217-usd">32030000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801798">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Nature of Operations and Summary of Significant Accounting Policies&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Principles of Consolidation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly-owned subsidiary, The Joint Corporate Unit &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; LLC (collectively, the &amp;#x201c;Company&amp;#x201d;), which was dormant for all periods presented.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from general and administrative expenses to other expense, net, as well as certain balances from other revenues to revenues and management fees from company clinics for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;to conform to the current year presentation and align with the segment footnote presentation.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Comprehensive Loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;Net loss and comprehensive loss are the same for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Nature of Operations&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Joint Corp., a Delaware corporation, was formed on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March 10, 2010. &lt;/div&gt;Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016:&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: right" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold" nowrap="nowrap"&gt;Franchised clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics open at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened or purchased during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;41&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;56&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;352&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" margin: 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: right" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold" nowrap="nowrap"&gt;Company-owned or managed clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics open at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(14&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;399&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;370&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Clinics licenses sold but not yet developed&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;104&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;115&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Executed letters of intent for future clinic licenses&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 53; Value: 1 --&gt;   &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Variable Interest Entities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&amp;nbsp;variable interest entity&amp;nbsp;(&amp;#x201c;VIE&amp;#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; hold the controlling interest and are &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; the primary beneficiary are accounted for under the equity method.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Certain states, in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice.&amp;nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; have the power to direct the activities of the PCs. As such, the activity of the PCs is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; included in the Company&amp;#x2019;s consolidated financial statements&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Cash and Cash Equivalents&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company considers all highly liquid instruments purchased with an original maturity of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company had &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; cash equivalents as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Restricted Cash&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&amp;#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Concentrations of Credit Risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; PC entity and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; franchisees represented &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13%&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24%,&lt;/div&gt; respectively, of outstanding accounts receivable. The Company did &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; have any customers that represented greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; of its revenues during the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounts Receivable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which the Company performs management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&amp;#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company had an allowance for doubtful accounts of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$131,830,&lt;/div&gt; respectively.&amp;nbsp;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;the Company recovered &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$40,000&lt;/div&gt; of accounts receivable that had previously been deemed uncollectible.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 54; Value: 1 --&gt;    &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company determined that certain working capital advances from its PC entities in Illinois and New York were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$47,000&lt;/div&gt; of accounts receivable to loss on disposition or impairment related to these entities during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017. &lt;/div&gt;The Company wrote-off &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$731,857&lt;/div&gt; of accounts receivable to loss on disposition or impairment related to these entities during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Franchise Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Property and Equipment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in the consolidated statement of operations.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Software Developed&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5&lt;/div&gt; years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Intangible Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&amp;nbsp;&amp;nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; years. The Company amortizes the acquired regional developer rights over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. The fair value of customer relationships is amortized over their estimated useful life of&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt;&amp;nbsp;years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$38,185&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;related to closure of an acquired clinic in New York. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impairment was recorded for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.&lt;/div&gt;&amp;nbsp;&amp;nbsp;Goodwill and intangible assets deemed to have indefinite lives are &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; day of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;fourth&lt;/div&gt; quarter or more frequently if events or circumstances change that would more likely than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; reduce the fair value of a reporting unit below its carrying value.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 55; Value: 1 --&gt;    &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$54,994&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impairment was recorded for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Long-Lived Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may &lt;/div&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; long-lived assets have been impaired. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impairments were recorded for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017. &lt;/div&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.3&lt;/div&gt; million during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;due to the sale or closure of clinics in Illinois and New York (Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4&lt;/div&gt;).&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Fund&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Co-Op Marketing Funds&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&amp;#x2019; officers. The marketing funds are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounting for Costs Associated with Exit or Disposal Activities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Costs to terminate an operating lease or other contracts are (a)&amp;nbsp;costs to terminate the contract before the end of its term or (b)&amp;nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Lease exit liability at December 31, 2016&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;338,151&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Additions&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;883,146&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-left: 10pt"&gt;Settlements&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(891,991&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Net accretion&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(29,906&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Lease exit liability at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;299,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company recognized a liability of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.3&lt;/div&gt; million related to operating leases that will &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; longer provide economic benefit to the entity, net of estimated sublease income.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company ceased use of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; clinic locations from its corporate clinics segment and recognized a liability of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.9&lt;/div&gt; million for lease exit costs incurred based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company recognized the resulting expense of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.4&lt;/div&gt; million in loss on disposition or impairment in the accompanying consolidated statement of operations.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 56; Value: 1 --&gt;      &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Rent&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may &lt;/div&gt;include rent holidays and rent escalation clauses.&amp;nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&amp;nbsp; The Company records tenant improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Revenue Recognition&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Franchise Fees.&lt;/div&gt;&amp;nbsp;The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;ten&lt;/div&gt; years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&amp;nbsp;&amp;nbsp;The Company&amp;#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; financing to franchisees and offers &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; guarantees on their behalf.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Regional Developer Fees&lt;/div&gt;. During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2011,&lt;/div&gt; the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under the historical program, regional developers paid a license fee ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7,250&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;25%&lt;/div&gt; of the then current franchise fee for each franchise they received the right to develop within the region. In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the program was revised to grant exclusive geographical territory and establish a minimum development obligation within that defined territory. Regional developers receive fees ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$14,500&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$19,950&lt;/div&gt; which are collected from franchisees upon the sale of franchises within their region and a royalty of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3%&lt;/div&gt; of sales generated by franchised clinics in their region. Regional developer fees paid to the Company are nonrefundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. The franchisor&amp;#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&amp;#x2019;s license.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company entered into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;ten&lt;/div&gt; regional developer agreements for which it received approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.1&lt;/div&gt; million, which was deferred as of the respective transaction dates and will be recognized on a pro-rata basis over the estimated number of franchised clinics to be opened in the respective regions. Certain of these regional developer agreements resulted in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, the revenue associated from the sale of the royalty stream is being recognized over the remaining life of the respective franchise agreements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Revenues and Management Fees from Company Clinics.&amp;nbsp;&amp;nbsp;&lt;/div&gt;The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&amp;nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&amp;nbsp; Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&amp;nbsp;&amp;nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&amp;#x2019;s PC.&amp;nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&amp;#x2019;s PC in return for a monthly management fee.&amp;nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 57; Value: 1 --&gt;    &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Royalties.&lt;/div&gt;&amp;nbsp;The Company collects royalties, as stipulated in the franchise agreement, equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7%&lt;/div&gt; of gross sales, and a marketing and advertising fee currently equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; working days after each sales period has ended.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;IT Related Income and Software Fees.&lt;/div&gt;&amp;nbsp;&amp;nbsp;The Company collects a monthly fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&amp;#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&amp;nbsp;upon receipt of equipment by the franchisee.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Advertising costs are expensed as incurred. Advertising expenses for years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,397,076&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2,279,572,&lt;/div&gt; respectively.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;50%&lt;/div&gt; likelihood of being realized upon ultimate resolution.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Loss per Common Share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 68%; font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,275,233&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,173,872&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Weighted average common shares outstanding - basic&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,245,119&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of dilutive securities:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding - diluted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,245,119&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.25&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 58; Value: 1 --&gt;    &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Unvested restricted stock&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;63,700&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,003,916&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Stock-Based Compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Recent Accounting Pronouncements&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 2014, &lt;/div&gt;the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers,&lt;/div&gt;&amp;#x201d; which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The standard also calls for additional disclosures around the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for the Company on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; April 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606&lt;/div&gt;): Identifying Performance Obligations and Licensing,&lt;/div&gt;&amp;#x201d; to clarify the following &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; aspects of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606:&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1&lt;/div&gt;) identifying performance obligations, and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&lt;/div&gt;) the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606&lt;/div&gt;): Narrow-Scope Improvements and Practical Expedients,&lt;/div&gt;&amp;#x201d; to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has performed a review of the above revenue standards updates and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; expect the adoption of the updates to have a material impact on its revenues and management fees from company clinics, advertising fund revenue, or IT related income and software fees. In addition, the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; expect the adoption to have a material impact on its franchise royalty revenues, as they are based on a percent of sales. The Company expects the adoption of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606&lt;/div&gt; to impact its accounting for initial franchise fees and regional developer fees. Currently, the Company recognizes revenue from initial franchise fees and regional developer fees upon the opening of a franchised clinic when the Company has performed all of its material obligations and initial services under the respective agreements. Upon the adoption of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606,&lt;/div&gt; the Company expects to recognize the revenue related to initial franchise fees and regional developer fees over the term of the related franchise agreement or regional developer agreement. The Company has finalized its accounting policies, and has selected the full retrospective method as its transition method.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 59; Value: 1 --&gt;    &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company quantified the impact of adopting this standard, and designed internal controls during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;to be implemented on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018. &lt;/div&gt;The Company estimates the cumulative catch-up adjustment to be recorded to retained earnings as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2015 &lt;/div&gt;to be an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.3&lt;/div&gt; million increase to the accumulated deficit as the Company has adopted the full retrospective approach. This is made up of a decrease to franchise fee revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$4.5&lt;/div&gt; million, a decrease to regional developer revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.4&lt;/div&gt; million, and a decrease to franchise cost of revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1.6&lt;/div&gt; million. The Company estimates the adjustment to be recorded to retained earnings as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;to be an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.6&lt;/div&gt; million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.8&lt;/div&gt; million, with a decrease to franchise cost of revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.2&lt;/div&gt; million. The Company estimates the adjustment to be recorded to retained earnings as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;to be an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.2&lt;/div&gt; million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.3&lt;/div&gt; million, with an offsetting increase to franchise cost of revenue of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.1&lt;/div&gt; million. The impact to regional developer revenue for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; material. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No&lt;/div&gt; impact to the Company's consolidated statement of cash flows is expected as the initial fees will continue to be collected upon execution of the franchise agreement. The Company will comply with the increased financial statement disclosure requirements during the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; quarter of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; February 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;02,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Leases (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;842&lt;/div&gt;).&lt;/div&gt;&amp;#x201d; The ASU requires that substantially all operating leases be recognized as assets and liabilities on the Company&amp;#x2019;s balance sheet, which is a significant departure from the current standard, which classifies operating leases as off-balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2018. &lt;/div&gt;While the Company has &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; yet quantified the impact that this standard will have on its financial statements, it will result in a significant increase in the assets and liabilities reflected on the Company&amp;#x2019;s balance sheet and in the interest expense and depreciation and amortization expense reflected in its statement of operations, while reducing the amount of rent expense.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic;"&gt;&amp;#x201c;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230&lt;/div&gt;): Classification of Certain Cash Receipts and Cash Payments.&amp;#x201d;&amp;nbsp;&lt;/div&gt;This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017. &lt;/div&gt;Early adoption is permitted. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November 2016, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;18,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230&lt;/div&gt;): Restricted Cash&amp;#x201d;&lt;/div&gt;&amp;nbsp;(a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017, &lt;/div&gt;including interim periods within those fiscal years. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 2017, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Business Combinations (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;805&lt;/div&gt;): Clarifying the Definition of a Business,&amp;#x201d;&amp;nbsp;&lt;/div&gt;to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017, &lt;/div&gt;including interim periods within those fiscal years. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 2017, &lt;/div&gt;the FASB issued ASU&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;04,&lt;/div&gt;&amp;nbsp;&amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Intangibles - Goodwill and Other (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;350&lt;/div&gt;): Simplifying the Test for Goodwill Impairment&lt;/div&gt;.&amp;#x201d; This update simplifies the subsequent measurement of goodwill by eliminating &amp;#x201c;Step &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&amp;#x201d;&lt;/div&gt; from the goodwill impairment test. This update is effective for annual and interim reporting periods beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2019. &lt;/div&gt;Early adoption is permitted. The Company is currently evaluating the impact this standard will have on the Company's consolidated financial statements and related disclosures.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0; background-color: white"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 2017, &lt;/div&gt;the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;No.&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic;"&gt;&amp;#x201c;Compensation&amp;#x2014;Stock Compensation (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718&lt;/div&gt;): Scope of Modification Accounting,&amp;#x201d;&amp;nbsp;&lt;/div&gt;to provide clarity and reduce both (&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1&lt;/div&gt;) diversity in practice and (&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&lt;/div&gt;) cost and complexity when applying the guidance in Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718,&lt;/div&gt; Compensation&amp;#x2014;Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718.The&lt;/div&gt; amendments are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 15, 2017 &lt;/div&gt;and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted the standard on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January 1, 2018 &lt;/div&gt;and does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; anticipate this amendment will have a material impact on its consolidated financial statements.&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:OtherAssets contextRef="i_2017-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579927" unitRef="iso4217-usd">465000</us-gaap:OtherAssets>
  <us-gaap:OtherAssets contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579928" unitRef="iso4217-usd">991000</us-gaap:OtherAssets>
  <us-gaap:OtherIncome contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578770" unitRef="iso4217-usd">398929</us-gaap:OtherIncome>
  <us-gaap:OtherIncome contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578771" unitRef="iso4217-usd">296084</us-gaap:OtherIncome>
  <us-gaap:OtherLiabilitiesCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578705" unitRef="iso4217-usd">48534</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578706" unitRef="iso4217-usd">60894</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="i_2017-12-31" decimals="INF" id="c27578717" unitRef="iso4217-usd">411497</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c27578718" unitRef="iso4217-usd">512362</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578793" unitRef="iso4217-usd">-64455</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578794" unitRef="iso4217-usd">-1467</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherSalesRevenueNet contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578758" unitRef="iso4217-usd">11125115</us-gaap:OtherSalesRevenueNet>
  <us-gaap:OtherSalesRevenueNet contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578759" unitRef="iso4217-usd">8550980</us-gaap:OtherSalesRevenueNet>
  <us-gaap:PaymentsForProceedsFromLoansReceivable contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578985" unitRef="iso4217-usd">-76351</us-gaap:PaymentsForProceedsFromLoansReceivable>
  <us-gaap:PaymentsForProceedsFromLoansReceivable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578986" unitRef="iso4217-usd">-35905</us-gaap:PaymentsForProceedsFromLoansReceivable>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578994" unitRef="iso4217-usd">2655</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578995" unitRef="iso4217-usd">83391</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="d_2017-01-01_2017-12-31" id="c27578992" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578993" unitRef="iso4217-usd">1042</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c27579341" unitRef="iso4217-usd">839000</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="d_2016-01-01_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c27579022" unitRef="iso4217-usd">839000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="d_2017-01-01_2017-12-31" id="c27578979" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578980" unitRef="iso4217-usd">839000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578983" unitRef="iso4217-usd">449204</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578984" unitRef="iso4217-usd">1567727</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="i_2017-12-31" decimals="INF" id="c27578727" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="i_2016-12-31" decimals="INF" id="c27578728" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="i_2017-12-31" decimals="INF" id="c27578729" unitRef="xbrli-shares">50000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized contextRef="i_2016-12-31" decimals="INF" id="c27578730" unitRef="xbrli-shares">50000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="i_2017-12-31" decimals="INF" id="c27578731" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued contextRef="i_2016-12-31" decimals="INF" id="c27578732" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="i_2017-12-31" decimals="INF" id="c27578733" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding contextRef="i_2016-12-31" decimals="INF" id="c27578734" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue contextRef="i_2017-12-31" id="c27578725" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PreferredStockValue contextRef="i_2016-12-31" id="c27578726" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i_2017-12-31" decimals="INF" id="c27578671" unitRef="iso4217-usd">542342</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i_2016-12-31" decimals="INF" id="c27578672" unitRef="iso4217-usd">499525</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:ProceedsFromLinesOfCredit contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578990" unitRef="iso4217-usd">1000000</us-gaap:ProceedsFromLinesOfCredit>
  <us-gaap:ProceedsFromLinesOfCredit contextRef="d_2016-01-01_2016-12-31" id="c27578991" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:ProceedsFromSaleOfTreasuryStock contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578996" unitRef="iso4217-usd">292671</us-gaap:ProceedsFromSaleOfTreasuryStock>
  <us-gaap:ProceedsFromSaleOfTreasuryStock contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578997" unitRef="iso4217-usd">210000</us-gaap:ProceedsFromSaleOfTreasuryStock>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578998" unitRef="iso4217-usd">364250</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578999" unitRef="iso4217-usd">70931</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801808">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt; min-width: 700px;"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Property and Equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Property and equipment consist of the following:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Office and computer equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,137,970&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,083,039&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Leasehold improvements&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,117,379&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,085,366&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Software developed&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,066,454&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;891,192&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,321,803&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,059,597&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Accumulated depreciation&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,928,349&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2,566,172&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,393,454&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,493,425&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Construction in progress&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;407,012&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;231,281&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,800,466&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,724,706&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Depreciation expense was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,438,443&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,818,403&lt;/div&gt; for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 2016, &lt;/div&gt;the Company determined that &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; clinics from its Corporate Clinics segment met the criteria for classification as held for sale. Accordingly, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 2016, &lt;/div&gt;the Company recognized a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.4&lt;/div&gt; million impairment charge to lower the carrying costs of the property and equipment to its estimated fair value less cost to sell which was recorded in the loss on disposition or impairment line of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; consolidated statement of operations. The Company completed the sale of the property in the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; quarter of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; for nominal consideration.&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember" decimals="INF" id="c27579423" unitRef="iso4217-usd">1137970</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember" decimals="INF" id="c27579424" unitRef="iso4217-usd">1083039</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember" decimals="INF" id="c27579425" unitRef="iso4217-usd">5117379</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember" decimals="INF" id="c27579426" unitRef="iso4217-usd">5085366</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember" decimals="INF" id="c27579427" unitRef="iso4217-usd">1066454</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember" decimals="INF" id="c27579428" unitRef="iso4217-usd">891192</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2017-12-31" decimals="INF" id="c27579429" unitRef="iso4217-usd">7321803</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31" decimals="INF" id="c27579430" unitRef="iso4217-usd">7059597</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2017-12-31" decimals="INF" id="c27578675" unitRef="iso4217-usd">3800466</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2016-12-31" decimals="INF" id="c27578676" unitRef="iso4217-usd">4724706</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember" decimals="INF" id="c27579433" unitRef="iso4217-usd">3393454</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember" decimals="INF" id="c27579434" unitRef="iso4217-usd">4493425</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2017-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579925" unitRef="iso4217-usd">765000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c27579926" unitRef="iso4217-usd">781000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581234">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Property and Equipment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in the consolidated statement of operations.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-23">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Office and computer equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,137,970&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,083,039&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Leasehold improvements&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,117,379&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,085,366&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Software developed&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,066,454&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;891,192&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,321,803&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,059,597&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Accumulated depreciation&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,928,349&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2,566,172&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,393,454&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,493,425&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Construction in progress&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;407,012&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;231,281&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,800,466&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,724,706&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="d_2017-01-01_2017-12-31_RangeAxis-MinimumMember" id="c27579111">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="d_2017-01-01_2017-12-31_RangeAxis-MaximumMember" id="c27579112">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578929" unitRef="iso4217-usd">-40000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578930" unitRef="iso4217-usd">-10830</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-38">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,998&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9,936&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,362&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,003&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;Total segment assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,360&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,939&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Unallocated cash and cash equivalents and restricted cash&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,320&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,344&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Unallocated property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;765&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;781&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Other unallocated assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;465&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;991&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; padding-left: 20pt"&gt;Total assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,910&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,055&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
  <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="d_2017-01-01_2017-12-31_RelatedPartyTransactionsByRelatedPartyAxis-ShareholderMember" decimals="INF" id="c27579852" unitRef="iso4217-usd">205000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
  <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="d_2016-01-01_2016-12-31_RelatedPartyTransactionsByRelatedPartyAxis-ShareholderMember" decimals="INF" id="c27579853" unitRef="iso4217-usd">461000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801828">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt; min-width: 700px;"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Related Party Transactions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company entered into consulting and legal arrangements with certain stockholders related to services performed for the operations and transaction related activities of the Company.&amp;nbsp;&amp;nbsp;Amounts paid to or for the benefit of these stockholders was approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$205,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$461,000&lt;/div&gt; for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:RepaymentsOfNotesPayable contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579000" unitRef="iso4217-usd">231500</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RepaymentsOfNotesPayable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579001" unitRef="iso4217-usd">436350</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="i_2017-12-31" decimals="INF" id="c27578661" unitRef="iso4217-usd">103819</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="i_2016-12-31" decimals="INF" id="c27578662" unitRef="iso4217-usd">334394</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312015Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579187" unitRef="iso4217-usd">-3300000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-The12MonthsEndedDecember312016Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579191" unitRef="iso4217-usd">-600000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312017Member_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c27579194" unitRef="iso4217-usd">-200000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i_2017-12-31" decimals="INF" id="c27578751" unitRef="iso4217-usd">-32258607</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i_2016-12-31" decimals="INF" id="c27578752" unitRef="iso4217-usd">-28983374</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="d_2017-01-01_2017-12-31" id="c27581244">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Revenue Recognition&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:RevenueRecognitionServicesCommissions contextRef="d_2017-01-01_2017-12-31" id="c27581233">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Franchise Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionServicesCommissions>
  <us-gaap:RevenueRecognitionServicesFranchiseFees contextRef="d_2017-01-01_2017-12-31" id="c27581245">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Franchise Fees.&lt;/div&gt;&amp;nbsp;The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;ten&lt;/div&gt; years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&amp;nbsp;&amp;nbsp;The Company&amp;#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; financing to franchisees and offers &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; guarantees on their behalf.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionServicesFranchiseFees>
  <us-gaap:Revenues contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578772" unitRef="iso4217-usd">25164004</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578773" unitRef="iso4217-usd">20523640</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579883" unitRef="iso4217-usd">11125000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c27579884" unitRef="iso4217-usd">8550000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c27579885" unitRef="iso4217-usd">14039000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c27579886" unitRef="iso4217-usd">11974000</us-gaap:Revenues>
  <us-gaap:RoyaltyRevenue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578760" unitRef="iso4217-usd">7722856</us-gaap:RoyaltyRevenue>
  <us-gaap:RoyaltyRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578761" unitRef="iso4217-usd">5973079</us-gaap:RoyaltyRevenue>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-20">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Unvested restricted stock&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;63,700&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,003,916&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-32">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Current provision:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;22,800&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;State, net of state tax credits&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total current provision&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;43,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred provision:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;97,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;State&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;23,300&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total deferred provision&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total income tax provision&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;35,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-33">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Deferred revenue&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;756,900&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,509,400&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred franchise costs&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(281,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(553,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;51,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Accrued expenses&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;45,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;57,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - component 1&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(136,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - component 2&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;55,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Restricted stock compensation&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(17,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(30,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Nonqualified stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;152,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;182,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred rent&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;257,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;629,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Lease abandonment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;80,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,061,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,924,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Tax credits&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Charitable contribution carryover&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,200&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Asset basis difference related to property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;377,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;201,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Intangibles&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;368,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;429,600&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,739,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,496,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(8,875,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(11,617,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Net non-current deferred tax liability&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(136,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-19">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 68%; font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,275,233&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,173,872&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Weighted average common shares outstanding - basic&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,245,119&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of dilutive securities:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding - diluted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,245,119&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.25&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-34">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;For the Years Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Percent&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Percent&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Expected federal tax benefit&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1,100,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,106,100&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;State tax provision, net of federal benefit&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(140,200&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.33&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(735,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.90&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of (decrease) increase in valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2,741,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(84.73&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,042,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40.24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Other permanent differences&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.52&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.72&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock Compensation&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(131,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.08&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Impact of enacted tax reform&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,946,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;121.97&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;State deferred tax true up&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;185,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.72&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.05&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(145,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.97&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Provision&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;35,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.11&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.09&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-17">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Franchised clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics open at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened or purchased during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;41&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;56&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;352&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Company-owned or managed clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics open at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed or sold during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(14&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;399&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;370&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Clinics licenses sold but not yet developed&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;104&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;115&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Executed letters of intent for future clinic licenses&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-36">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,119,305&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,808,476&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,544,978&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,411,126&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,283,865&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,060,963&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,228,713&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-24">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;As of December 31, 2017&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Gross Carrying&lt;br /&gt; Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Accumulated&lt;br /&gt; Amortization&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Net Carrying&lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Amortized intangible assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Reacquired franchise rights&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,673,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;657,943&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,015,057&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Customer relationships&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;701,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;674,667&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,333&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Reacquired development rights&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,162,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;443,348&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718,652&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,536,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,775,958&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,760,042&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;As of December 31, 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Gross Carrying&lt;br /&gt; Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Accumulated&lt;br /&gt; Amortization&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Net Carrying&lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Amortized intangible assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Reacquired franchise rights&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,673,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;410,688&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,262,312&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Customer relationships&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;701,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;509,042&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;191,958&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Reacquired development rights&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,162,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;277,348&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;884,652&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,536,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,197,078&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,338,922&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-26">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;100,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;100,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-21">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Property and equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;293,014&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Intangible assets&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Favorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;140,728&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Goodwill&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;269,780&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,042,522&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Deferred membership revenue&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(45,072&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Net purchase price&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;997,450&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-37">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Revenues:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,125&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,550&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,039&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,974&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total revenues&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;25,164&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,524&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment operating (loss) income:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1,704&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,730&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,243&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,561&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total segment operating (loss) income&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,539&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,169&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Depreciation and amortization:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,608&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,186&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Corporate administration&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;409&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;380&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total depreciation and amortization&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,017&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,566&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Reconciliation of total segment operating income (loss) to consolidated loss before income tax expense:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total segment operating income (loss)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,539&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,169&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unallocated corporate overhead&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(7,714&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,839&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Consolidated loss from operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,175&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,008&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other (expense) income, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(64&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Loss before income tax expense&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,239&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,009&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-28">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Number of&lt;br /&gt; Shares&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Exercise&lt;br /&gt; Price&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Fair&lt;br /&gt; Value&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Remaining&lt;br /&gt; Contractual Life&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;477,459&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.30&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.01&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.7&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;660,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.22&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(37,824&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.88&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(146,560&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.34&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.66&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.86&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;295,286&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.31&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(206,875&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.76&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(37,570&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.11&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,003,916&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.18&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.87&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.1&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;287,230&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.37&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.38&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7.4&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-27">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Expected volatility&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;42%&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;42%&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; - &lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;45%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected dividends&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected term (years)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.5&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;- &lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Risk-free rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.98%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; to &lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.19%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; - &lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.68%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Forfeiture rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-29">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid"&gt;Restricted Stock Awards&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Shares&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,288&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,415&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(162,440&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(170,848&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;59,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(76,070&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(12,345&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;63,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-31">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: center"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"&gt;Number of &lt;br /&gt; Units&lt;/td&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"&gt;Weighted &lt;br /&gt; Average &lt;br /&gt; Exercise Price&lt;/td&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"&gt;Weighted &lt;br /&gt; Average &lt;br /&gt; Remaining &lt;br /&gt; Contractual Term (in years)&lt;/td&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"&gt;Intrinsic &lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; padding-bottom: 2.25pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.9&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Outstanding at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Exercisable at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ScheduleOfTreasuryStockByClassTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-30">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="width: 86%"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 1&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 11%; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;0.56&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 2&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;0.68&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 3&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;0.84&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 4&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.03&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 5&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.28&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 6&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.59&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 7&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.97&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 8&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;2.45&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
  <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-35">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Uncertain tax positions - January 1&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;32,600&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Gross increases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross decreases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(19,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Uncertain tax positions - December 31&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
  <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="d_2017-01-01_2017-12-31" id="c-25">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;439,590&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;348,034&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;133,693&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,213&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,760,042&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801831">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&amp;#x201c;CODM&amp;#x201d;), to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; operating business segments. The Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company operated or managed &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt; clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the franchise system consisted of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;352&lt;/div&gt; clinics in operation. Corporate is a non-operating segment that develops and implements strategic initiatives and supports the Company&amp;#x2019;s &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; operating business segments by centralizing key administrative functions such as finance and treasury, information technology, insurance and risk management, litigation and human resources. Corporate also provides the necessary administrative functions to support the Company as a publicly-traded company. A portion of the expenses incurred by Corporate are allocated to the operating segments.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 72; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The tables below present financial information for the Company&amp;#x2019;s &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; operating business segments (in thousands):&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Revenues:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,125&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,550&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,039&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,974&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total revenues&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;25,164&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,524&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment operating (loss) income:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1,704&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,730&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,243&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,561&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total segment operating (loss) income&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,539&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,169&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Depreciation and amortization:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,608&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,186&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Corporate administration&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;409&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;380&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Total depreciation and amortization&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,017&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,566&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Reconciliation of total segment operating income (loss) to consolidated loss before income tax expense:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total segment operating income (loss)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,539&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,169&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unallocated corporate overhead&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(7,714&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,839&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Consolidated loss from operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,175&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,008&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other (expense) income, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(64&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt"&gt;Loss before income tax expense&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,239&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,009&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,998&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9,936&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,362&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,003&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;Total segment assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,360&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,939&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Unallocated cash and cash equivalents and restricted cash&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,320&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,344&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Unallocated property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;765&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;781&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Other unallocated assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;465&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;991&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; padding-left: 20pt"&gt;Total assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,910&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,055&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: center; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;#x201c;Unallocated cash and cash equivalents and restricted cash&amp;#x201d; relates primarily to corporate cash and cash equivalents and restricted cash (see Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1&lt;/div&gt;), &amp;#x201c;unallocated property and equipment&amp;#x201d; relates primarily to corporate fixed assets, and &amp;#x201c;other unallocated assets&amp;#x201d; relates primarily to deposits, prepaid and other assets.&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:SellingAndMarketingExpense contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578781" unitRef="iso4217-usd">4473881</us-gaap:SellingAndMarketingExpense>
  <us-gaap:SellingAndMarketingExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578782" unitRef="iso4217-usd">4419180</us-gaap:SellingAndMarketingExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578787" unitRef="iso4217-usd">24608737</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578788" unitRef="iso4217-usd">29071637</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ShareBasedCompensation contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578945" unitRef="iso4217-usd">594371</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578946" unitRef="iso4217-usd">1123481</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579573" unitRef="iso4217-usd">412000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" id="c27579555">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" id="c27579562">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579674" unitRef="xbrli-shares">170848</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579678" unitRef="xbrli-shares">12345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579672" unitRef="xbrli-shares">86415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579676" unitRef="xbrli-shares">59700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579692" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2017-01-01_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579700" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579693" unitRef="iso4217-usd-per-xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="d_2017-01-01_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579701" unitRef="iso4217-usd-per-xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2015-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579671" unitRef="xbrli-shares">339288</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579675" unitRef="xbrli-shares">92415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2017-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579679" unitRef="xbrli-shares">63700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579688" unitRef="xbrli-shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579696" unitRef="xbrli-shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579704" unitRef="xbrli-shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="i_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579689" unitRef="iso4217-usd-per-xbrli-shares">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579697" unitRef="iso4217-usd-per-xbrli-shares">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="i_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c27579705" unitRef="iso4217-usd-per-xbrli-shares">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="d_2015-01-01_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579690">P2Y328D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579698">P1Y328D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="d_2017-01-01_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c27579706">P328D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579673" unitRef="xbrli-shares">162440</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c27579677" unitRef="xbrli-shares">76070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c27579608" unitRef="xbrli-pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c27579611" unitRef="xbrli-pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c27579602" unitRef="xbrli-pure">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" decimals="4" id="c27579604" unitRef="xbrli-pure">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" decimals="4" id="c27579606" unitRef="xbrli-pure">0.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" decimals="4" id="c27579619" unitRef="xbrli-pure">0.0198</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" decimals="4" id="c27579621" unitRef="xbrli-pure">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" decimals="4" id="c27579622" unitRef="xbrli-pure">0.0119</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" decimals="4" id="c27579624" unitRef="xbrli-pure">0.0168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" decimals="INF" id="c27579556" unitRef="xbrli-shares">12345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" decimals="INF" id="c27579563" unitRef="xbrli-shares">9950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="i_2014-05-15_PlanNameAxis-The2014PlanMember" decimals="INF" id="c27579534" unitRef="xbrli-shares">1513000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="i_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579667" unitRef="xbrli-shares">287230</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="i_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579668" unitRef="iso4217-usd-per-xbrli-shares">5.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579643" unitRef="xbrli-shares">146560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579659" unitRef="xbrli-shares">37570</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579644" unitRef="iso4217-usd-per-xbrli-shares">4.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579660" unitRef="iso4217-usd-per-xbrli-shares">5.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579536" unitRef="xbrli-shares">660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579539" unitRef="xbrli-shares">295286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579635" unitRef="xbrli-shares">660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579651" unitRef="xbrli-shares">295286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="i_2017-12-31" decimals="INF" id="c27579546" unitRef="iso4217-usd">1306260</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="i_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579631" unitRef="xbrli-shares">477459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579647" unitRef="xbrli-shares">953075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="i_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579663" unitRef="xbrli-shares">1003916</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="i_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579632" unitRef="iso4217-usd-per-xbrli-shares">4.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579648" unitRef="iso4217-usd-per-xbrli-shares">3.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="i_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579664" unitRef="iso4217-usd-per-xbrli-shares">4.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579640" unitRef="iso4217-usd-per-xbrli-shares">1.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579656" unitRef="iso4217-usd-per-xbrli-shares">1.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579636" unitRef="iso4217-usd-per-xbrli-shares">3.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579652" unitRef="iso4217-usd-per-xbrli-shares">4.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="d_2017-01-01_2017-12-31" id="c27581442">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Stock-Based Compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:SharePrice contextRef="i_2016-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" decimals="INF" id="c27579557" unitRef="iso4217-usd-per-xbrli-shares">3.10</us-gaap:SharePrice>
  <us-gaap:SharePrice contextRef="i_2017-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" decimals="INF" id="c27579564" unitRef="iso4217-usd-per-xbrli-shares">4.02</us-gaap:SharePrice>
  <us-gaap:SharePrice contextRef="i_2013-12-31" decimals="INF" id="c27579576" unitRef="iso4217-usd-per-xbrli-shares">0.45</us-gaap:SharePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-FormerChiefExecutiveOfficerMember" decimals="INF" id="c27579571" unitRef="xbrli-shares">9733</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" decimals="INF" id="c27579558" unitRef="iso4217-usd">268000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember" decimals="INF" id="c27579565" unitRef="iso4217-usd">240000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="d_2013-12-01_2013-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c27579580">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" id="c27579613">P5Y182D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" id="c27579615">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c27579617">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c27579670">P7Y146D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c27579634">P8Y255D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c27579650">P6Y328D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c27579666">P8Y36D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579633" unitRef="iso4217-usd-per-xbrli-shares">2.01</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579649" unitRef="iso4217-usd-per-xbrli-shares">1.86</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579665" unitRef="iso4217-usd-per-xbrli-shares">1.87</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
  <us-gaap:SharesOutstanding contextRef="i_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578806" unitRef="xbrli-shares">13070180</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578809" unitRef="xbrli-shares">534000</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578869" unitRef="xbrli-shares">13317393</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578872" unitRef="xbrli-shares">296504</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578918" unitRef="xbrli-shares">13600338</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578921" unitRef="xbrli-shares">14084</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c27579034" unitRef="xbrli-shares">46948</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578855" unitRef="xbrli-shares">46948</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578820" unitRef="xbrli-shares">162441</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578823" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578883" unitRef="xbrli-shares">76070</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579639" unitRef="xbrli-shares">37824</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c27579655" unitRef="xbrli-shares">206875</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578827" unitRef="xbrli-shares">37824</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578830" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578904" unitRef="xbrli-shares">206875</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c27579583" unitRef="xbrli-shares">250872</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued contextRef="d_2017-09-01_2017-09-30" decimals="INF" id="c27579588" unitRef="xbrli-shares">283128</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578851" unitRef="xbrli-shares">250872</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578897" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578900" unitRef="xbrli-shares">283128</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c27579035" unitRef="iso4217-usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578856" unitRef="iso4217-usd">47</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578857" unitRef="iso4217-usd">99953</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578859" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578860" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578861" unitRef="iso4217-usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578821" unitRef="iso4217-usd">162</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578822" unitRef="iso4217-usd">-162</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578824" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578825" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31" id="c27578826" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578884" unitRef="iso4217-usd">76</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578885" unitRef="iso4217-usd">-76</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578887" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578888" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2017-01-01_2017-12-31" id="c27578889" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578828" unitRef="iso4217-usd">38</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578829" unitRef="iso4217-usd">70893</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578831" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578832" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578833" unitRef="iso4217-usd">70931</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578905" unitRef="iso4217-usd">207</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578906" unitRef="iso4217-usd">364043</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c27578908" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578909" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578910" unitRef="iso4217-usd">364250</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c27579584" unitRef="iso4217-usd">210000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27579585" unitRef="iso4217-usd">113000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27579587" unitRef="iso4217-usd">162000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-09-01_2017-09-30" decimals="INF" id="c27579589" unitRef="iso4217-usd">292671</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-09-01_2017-09-30_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27579590" unitRef="iso4217-usd">127000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-09-01_2017-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27579592" unitRef="iso4217-usd">127000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578849" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578850" unitRef="iso4217-usd">-161911</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578852" unitRef="iso4217-usd">371911</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578853" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578854" unitRef="iso4217-usd">210000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578898" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578899" unitRef="iso4217-usd">-127057</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578901" unitRef="iso4217-usd">419728</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578902" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578903" unitRef="iso4217-usd">292671</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockRepurchasedDuringPeriodShares contextRef="d_2013-12-01_2013-12-31" decimals="INF" id="c27579575" unitRef="xbrli-shares">534000</us-gaap:StockRepurchasedDuringPeriodShares>
  <us-gaap:StockRepurchasedDuringPeriodShares contextRef="d_2013-01-01_2013-12-31" decimals="INF" id="c27579578" unitRef="xbrli-shares">534000</us-gaap:StockRepurchasedDuringPeriodShares>
  <us-gaap:StockRepurchasedDuringPeriodValue contextRef="d_2013-12-01_2013-12-31" decimals="INF" id="c27579577" unitRef="iso4217-usd">240000</us-gaap:StockRepurchasedDuringPeriodValue>
  <us-gaap:StockholdersEquity contextRef="i_2017-12-31" decimals="INF" id="c27578753" unitRef="iso4217-usd">4898817</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31" decimals="INF" id="c27578754" unitRef="iso4217-usd">6925413</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578807" unitRef="iso4217-usd">13070</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578808" unitRef="iso4217-usd">35267376</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578810" unitRef="iso4217-usd">-791638</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c27578811" unitRef="iso4217-usd">-13809502</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31" decimals="INF" id="c27578812" unitRef="iso4217-usd">20679306</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578870" unitRef="iso4217-usd">13317</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578871" unitRef="iso4217-usd">36398588</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578873" unitRef="iso4217-usd">-503118</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c27578874" unitRef="iso4217-usd">-28983374</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c27578919" unitRef="iso4217-usd">13600</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c27578920" unitRef="iso4217-usd">37229869</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578922" unitRef="iso4217-usd">-86045</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c27578923" unitRef="iso4217-usd">-32258607</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="d_2017-01-01_2017-12-31" id="s801817">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic;"&gt;Stock Options&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 15, 2014, &lt;/div&gt;the Company adopted the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Stock Plan (&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;#x201c;2014&lt;/div&gt; Plan&amp;#x201d;). The &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Plan is designed to supersede and replace the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2012&lt;/div&gt; Plan, effective as of the adoption date and set aside &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,513,000&lt;/div&gt; shares of the Company&amp;#x2019;s common stock that &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may &lt;/div&gt;be granted under the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Plan.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company granted &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;660,000&lt;/div&gt; stock options to employees with exercise prices ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.23&lt;/div&gt; - &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$4.11.&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company granted &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;295,286&lt;/div&gt; stock options to employees with exercise prices ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.65&lt;/div&gt; - &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5.51.&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company&amp;#x2019;s stock trading price is the basis of fair value of its common stock used in determining the value of share-based awards. To the extent the value of the Company&amp;#x2019;s share-based awards involves a measure of volatility, it will rely upon the volatilities from publicly traded companies with similar business models until its common stock has accumulated enough trading history for it to utilize its own historical volatility. We use the simplified method as to calculate the expected term of stock option grants to employees as we do &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term of stock options granted to employees. Accordingly, the expected life of the options granted is based on the average of the vesting term and the contractual term of the option. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10&lt;/div&gt;-year yield curve in effect at the date of the grant.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has computed the fair value of all options granted during the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; using the following assumptions:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Year Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: right" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2017&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Expected volatility&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;42%&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;42%&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; - &lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;45%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected dividends&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected term (years)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.5&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;- &lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Risk-free rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.98%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; to &lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.19%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; - &lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.68%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Forfeiture rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The information below summarizes the stock options:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Number of&lt;br /&gt; Shares&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Exercise&lt;br /&gt; Price&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Fair&lt;br /&gt; Value&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Remaining&lt;br /&gt; Contractual Life&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;477,459&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.30&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.01&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.7&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;660,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.22&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(37,824&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.88&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(146,560&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.34&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.66&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.86&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;295,286&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.31&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(206,875&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.76&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(37,570&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.11&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,003,916&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.18&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.87&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.1&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;287,230&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.37&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.38&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7.4&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 66; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The intrinsic value of the Company&amp;#x2019;s stock options outstanding was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,306,260&lt;/div&gt; at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; stock-based compensation expense for stock options was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$380,067&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$561,559,&lt;/div&gt; respectively.&amp;nbsp;&amp;nbsp;Unrecognized stock-based compensation expense for stock options for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$840,826,&lt;/div&gt; which is expected to be recognized ratably over the next &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.7&lt;/div&gt; years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Restricted Stock&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company granted restricted stock awards to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; members of the Board of Directors. The awards have been granted under The Joint Corp. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Incentive Stock Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; year from the Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for each to earn &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,345&lt;/div&gt; shares of common stock. The estimated fair market value of these shares was valued at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.10&lt;/div&gt; per share, based on the Company&amp;#x2019;s stock trading price, totaling approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$268,000&lt;/div&gt; to be recognized ratably as the stock is vested.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the Company granted restricted stock awards to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; members of the Board of Directors. The awards have been granted under The Joint Corp. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Incentive Stock Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; year from the Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for each to earn &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9,950&lt;/div&gt; shares of common stock. The estimated fair market value of these shares was valued at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$4.02&lt;/div&gt; per share, based on the Company&amp;#x2019;s stock trading price, totaling approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$240,000&lt;/div&gt; to be recognized ratably as the stock is vested.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The information below summaries the restricted stock activity:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Restricted Stock Awards&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap"&gt;Shares&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,288&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,415&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(162,440&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(170,848&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;59,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(76,070&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(12,345&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;63,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; stock-based compensation expense for restricted stock awards was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$214,304&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$561,922,&lt;/div&gt; respectively.&amp;nbsp;&amp;nbsp;Unrecognized stock-based compensation expense for restricted stock awards as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$143,240&lt;/div&gt; to be recognized ratably over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.7&lt;/div&gt; years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Modifications&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company accelerated the vesting of all unvested stock options and restricted stock awards granted to the Company&amp;#x2019;s former chief development officer in connection with his separation from the Company. In addition, the Company modified the post-employment exercise period of the stock options previously granted, extending the exercise period to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016, &lt;/div&gt;the Company modified the post-employment exercise period of stock options previously granted to the Company&amp;#x2019;s former chief executive officer in connection with his separation from the Company. The modification extended the exercise period to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May 13, 2020. &lt;/div&gt;In addition, the Company accelerated the vesting of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9,733&lt;/div&gt; shares of the previously granted restricted stock awards that were scheduled to vest in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July 2016. &lt;/div&gt;The remaining unvested restricted stock awards were forfeited upon separation.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 67; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;These modifications resulted in an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$412,000&lt;/div&gt; increase in stock-based compensation for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Treasury Stock&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 2013, &lt;/div&gt;the Company exercised its right of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; refusal under the terms of a Stockholders Agreement dated &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March 10, 2010 &lt;/div&gt;to repurchase &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;534,000&lt;/div&gt; shares of the Company&amp;#x2019;s common stock. The shares were purchased for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.45&lt;/div&gt; per share or &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$240,000&lt;/div&gt; in cash along with the issuance of an option to repurchase the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;534,000&lt;/div&gt; shares. The repurchased shares were recorded as treasury stock, at cost in the amount of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$791,638.&lt;/div&gt; The option is classified in equity as it is considered indexed to the Company&amp;#x2019;s stock and meets the criteria for classification in equity.&amp;nbsp;&amp;nbsp;The option was granted to the seller for a term of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt; years.&amp;nbsp;&amp;nbsp;The option contained the following exercise prices:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="width: 86%"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 1&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 11%; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;0.56&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 2&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;0.68&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 3&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;0.84&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 4&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.03&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 5&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.28&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 6&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.59&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 7&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;1.97&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: white"&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Year 8&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&lt;div style="display: inline; font-size: 10pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;2.45&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Consideration given in the form of the option was valued using a Binomial Lattice-Based model resulting in a fair value of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1.03&lt;/div&gt; per share option for a total fair value of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$551,638.&lt;/div&gt; The option was valued using the Binomial Lattice-Based valuation methodology because that model embodies all of the relevant assumptions that address the features underlying the instrument.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 2016, &lt;/div&gt;the option holder partially exercised the call option and purchased &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;250,872&lt;/div&gt; shares at a total repurchase price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$210,000.&lt;/div&gt; The Company reduced the cost of treasury shares by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$113,000&lt;/div&gt; related to the transaction, reduced the value of the option by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$259,000,&lt;/div&gt; and reduced additional paid-in-capital by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$162,000.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September 2017, &lt;/div&gt;the option holder exercised the remainder of the call option and purchased &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;283,128&lt;/div&gt; shares at a total repurchase price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$292,671.&lt;/div&gt; The Company reduced the cost of treasury shares by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$127,000&lt;/div&gt; related to the transaction, reduced the value of the option by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$292,000,&lt;/div&gt; and reduced additional paid-in-capital by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$127,000.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In conjunction with the IPO, the Company issued warrants to the underwriters for the purchase of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt; shares of common stock, which can be exercised between &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November 10, 2015 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November 10, 2018 &lt;/div&gt;at an exercise price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$8.125&lt;/div&gt; per share.&amp;nbsp; The fair value of the warrants was determined using the Black-Scholes option valuation model. The warrants expire on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November 10, 2018 &lt;/div&gt;and have a remaining contractual life of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;.9&lt;/div&gt; years as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 68; Value: 1 --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;The information below summarizes the warrants:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap"&gt;Number of &lt;br /&gt; Units&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap"&gt;Weighted &lt;br /&gt; Average &lt;br /&gt; Exercise Price&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap"&gt;Weighted &lt;br /&gt; Average &lt;br /&gt; Remaining &lt;br /&gt; Contractual Term (in years)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap"&gt;Intrinsic &lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; padding-bottom: 2.25pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.9&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Outstanding at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;Exercisable at December 31, 2017&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.25pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Issuance of Common Stock for Legal Settlement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 2016, &lt;/div&gt;the Company entered into a settlement agreement, whereby it resolved a pending litigation matter. Under the terms of the settlement agreement, the Company agreed to a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt;-time settlement amount comprised of cash and newly issued shares of its common stock. The amounts paid by the Company in this settlement was determined by the Company &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;not&lt;/div&gt; to be material. The fair value of the total consideration related to common stock was valued using the closing price of our common stock on the settlement date.&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:TechnologyServicesCosts contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578777" unitRef="iso4217-usd">315397</us-gaap:TechnologyServicesCosts>
  <us-gaap:TechnologyServicesCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578778" unitRef="iso4217-usd">221918</us-gaap:TechnologyServicesCosts>
  <us-gaap:TechnologyServicesRevenue contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578766" unitRef="iso4217-usd">1137363</us-gaap:TechnologyServicesRevenue>
  <us-gaap:TechnologyServicesRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578767" unitRef="iso4217-usd">932709</us-gaap:TechnologyServicesRevenue>
  <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="d_2017-01-01_2017-12-31" id="c27581232">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounts Receivable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which the Company performs management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&amp;#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company had an allowance for doubtful accounts of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$131,830,&lt;/div&gt; respectively.&amp;nbsp;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017 &lt;/div&gt;the Company recovered &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$40,000&lt;/div&gt; of accounts receivable that had previously been deemed uncollectible.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 54; Value: 1 --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017, &lt;/div&gt;the Company determined that certain working capital advances from its PC entities in Illinois and New York were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt; longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$47,000&lt;/div&gt; of accounts receivable to loss on disposition or impairment related to these entities during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2017. &lt;/div&gt;The Company wrote-off &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$731,857&lt;/div&gt; of accounts receivable to loss on disposition or impairment related to these entities during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December 31, 2016.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
  <us-gaap:TreasuryStockRetiredCostMethodAmount contextRef="d_2013-12-01_2013-12-31" decimals="INF" id="c27579579" unitRef="iso4217-usd">791638</us-gaap:TreasuryStockRetiredCostMethodAmount>
  <us-gaap:TreasuryStockShares contextRef="i_2017-12-31" decimals="INF" id="c27578749" unitRef="xbrli-shares">14084</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockShares contextRef="i_2016-12-31" decimals="INF" id="c27578750" unitRef="xbrli-shares">296504</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockSharesAcquired contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578844" unitRef="xbrli-shares">13376</us-gaap:TreasuryStockSharesAcquired>
  <us-gaap:TreasuryStockSharesAcquired contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578890" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:TreasuryStockSharesAcquired contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578893" unitRef="xbrli-shares">708</us-gaap:TreasuryStockSharesAcquired>
  <us-gaap:TreasuryStockValue contextRef="i_2017-12-31" decimals="INF" id="c27578747" unitRef="iso4217-usd">86045</us-gaap:TreasuryStockValue>
  <us-gaap:TreasuryStockValue contextRef="i_2016-12-31" decimals="INF" id="c27578748" unitRef="iso4217-usd">503118</us-gaap:TreasuryStockValue>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578842" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" id="c27578843" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578845" unitRef="iso4217-usd">83391</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578846" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578847" unitRef="iso4217-usd">83391</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c27578891" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" id="c27578892" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c27578894" unitRef="iso4217-usd">2655</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c27578895" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578896" unitRef="iso4217-usd">2655</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:UnrecognizedTaxBenefits contextRef="i_2016-12-31" decimals="INF" id="c27579835" unitRef="iso4217-usd">13200</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefits contextRef="i_2017-12-31" id="c27579847" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefits contextRef="i_2015-12-31" decimals="INF" id="c27579837" unitRef="iso4217-usd">32600</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579843" unitRef="iso4217-usd">13200</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
  <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579845" unitRef="iso4217-usd">19400</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="d_2017-01-01_2017-12-31" id="c27579840" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="d_2016-01-01_2016-12-31" id="c27579842" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="d_2017-01-01_2017-12-31" id="c27579839" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="d_2016-01-01_2016-12-31" id="c27579841" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UseOfEstimates contextRef="d_2017-01-01_2017-12-31" id="c27581443">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579326" unitRef="xbrli-shares">13245119</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579327" unitRef="xbrli-shares">12696649</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27578804" unitRef="xbrli-shares">13245119</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27578805" unitRef="xbrli-shares">12696649</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="d_2017-01-01_2017-12-31" decimals="INF" id="c27579321" unitRef="xbrli-shares">13245119</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c27579322" unitRef="xbrli-shares">12696649</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended"/>
  <xbrli:unit id="xbrli-shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="xbrli-pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="iso4217-usd">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="iso4217-usd-per-xbrli-shares">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:context id="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2013-01-01_2013-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2013-12-01_2013-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-12-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2013-12-01_2013-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-12-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2014-11-14_2014-11-14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-11-14</xbrli:startDate>
      <xbrli:endDate>2014-11-14</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:FranchiseRightsAndCustomerRelationshipsReacquiredMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jynt:LossOnDispositionOrImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-07-01_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNote2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-07-01</xbrli:startDate>
      <xbrli:endDate>2015-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-07-01_2015-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-07-01</xbrli:startDate>
      <xbrli:endDate>2015-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">jynt:The2014PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-FormerChiefExecutiveOfficerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">jynt:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jynt:AccountsPayable1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:TheJointRRCCorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:FranchiseRightsAndCustomerRelationshipsReacquiredMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jynt:LossOnDispositionOrImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_RelatedPartyTransactionsByRelatedPartyAxis-ShareholderMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jynt:ShareholderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-02_2016-01-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-02</xbrli:startDate>
      <xbrli:endDate>2016-01-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-05-01</xbrli:startDate>
      <xbrli:endDate>2016-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-06-01_2016-06-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInVirginiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-06-01</xbrli:startDate>
      <xbrli:endDate>2016-06-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jynt:LossOnDispositionOrImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">jynt:The2014PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:TheJointRRCCorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-ComputerSoftwareIntangibleAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:DevelopmentRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember_TaxPeriodAxis-LatestTaxYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_IncomeTaxAuthorityAxis-StateAndLocalJurisdictionMember_TaxPeriodAxis-EarliestTaxYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_NoncashOrPartNoncashDivestituresByUniqueNameAxis-RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NoncashOrPartNoncashDivestituresByUniqueNameAxis">jynt:RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_RelatedPartyTransactionsByRelatedPartyAxis-ShareholderMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jynt:ShareholderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-03_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-03</xbrli:startDate>
      <xbrli:endDate>2017-01-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-04-29_2017-04-29_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInCentralFloridaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-04-29</xbrli:startDate>
      <xbrli:endDate>2017-04-29</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-08-01_2017-08-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInMarylandwashingtonDCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-08-01</xbrli:startDate>
      <xbrli:endDate>2017-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-09-01_2017-09-22_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInMinnesotaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-09-01</xbrli:startDate>
      <xbrli:endDate>2017-09-22</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-09-01_2017-09-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-09-01</xbrli:startDate>
      <xbrli:endDate>2017-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-09-01_2017-09-30_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-09-01</xbrli:startDate>
      <xbrli:endDate>2017-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-09-01_2017-09-30_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-09-01</xbrli:startDate>
      <xbrli:endDate>2017-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-09-01_2017-09-30_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-09-01</xbrli:startDate>
      <xbrli:endDate>2017-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-10-10_2017-10-10_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingPromissoryNoteMaturingOctober242020Member_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:InterestBearingPromissoryNoteMaturingOctober242020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-10-10</xbrli:startDate>
      <xbrli:endDate>2017-10-10</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-12-01_2017-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-12-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-The12MonthsEndedDecember312016Member_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">jynt:AccountingStandardsUpdate201409201610And201612Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">jynt:The12MonthsEndedDecember312016Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312015Member_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">jynt:AccountingStandardsUpdate201409201610And201612Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">jynt:TheYearEndedDecember312015Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2018-01-01_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312017Member_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">jynt:AccountingStandardsUpdate201409201610And201612Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">jynt:TheYearEndedDecember312017Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2018-01-01_2018-12-31_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2013-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-05-15_PlanNameAxis-The2014PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">jynt:The2014PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-05-15</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-11-14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-11-14</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNote1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNote2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-01-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchisesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-01-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-05-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-06-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchisesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInVirginiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-06-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">jynt:The2014PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jynt:AccountsPayable1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:DevelopmentRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-04-29_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInCentralFloridaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-04-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-04-29_StatementGeographicalAxis-RegionalDeveloperTerritoryInCentralFloridaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInCentralFloridaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-04-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-06-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-08-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInMarylandwashingtonDCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-08-31_StatementGeographicalAxis-RegionalDeveloperTerritoryInMarylandwashingtonDCMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInMarylandwashingtonDCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-09-22_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInMinnesotaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-09-22</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-09-22_StatementGeographicalAxis-RegionalDeveloperTerritoryInMinnesotaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoryInMinnesotaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-09-22</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-10-10_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingPromissoryNoteMaturingOctober242020Member_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:InterestBearingPromissoryNoteMaturingOctober242020Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-10-10</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-10-10_StatementGeographicalAxis-RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-10-10</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_AwardTypeAxis-RestrictedStockMember_PlanNameAxis-The2014PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">jynt:The2014PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_CreditFacilityAxis-RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_DeferredRevenueArrangementTypeAxis-RegionalDevelopmentAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:RegionalDevelopmentAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:DevelopmentRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_IncomeTaxAuthorityAxis-ForeignCountryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2018-03-02">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-The12MonthsEndedDecember312016Member_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">jynt:AccountingStandardsUpdate201409201610And201612Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">jynt:The12MonthsEndedDecember312016Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312015Member_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">jynt:AccountingStandardsUpdate201409201610And201612Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">jynt:TheYearEndedDecember312015Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2018-03-31_AdjustmentsForNewAccountingPronouncementsAxis-AccountingStandardsUpdate201409201610And201612Member_CreationDateAxis-TheYearEndedDecember312017Member_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">jynt:AccountingStandardsUpdate201409201610And201612Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">jynt:TheYearEndedDecember312017Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>jynt-20171231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:32PM UTC 2018-03-09--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:jynt="http://www.thejoint.com/20171231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.thejoint.com/20171231">
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20171231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20171231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20171231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20171231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="statement-document-and-entity-information" roleURI="http://www.thejoint.com/20171231/role/statement-document-and-entity-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets" roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets-parentheticals" roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-operations" roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-changes-in-stockholders-equity" roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-changes-in-stockholders-equity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">004 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-cash-flows" roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">005 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-supplemental-disclosure-of-noncash-activity" roleURI="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">006 - Disclosure - Supplemental Disclosure of Non-cash Activity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">007 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions" roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">008 - Disclosure - Note 2 - Acquisitions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-notes-receivable" roleURI="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">009 - Disclosure - Note 3 - Notes Receivable</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment" roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">010 - Disclosure - Note 4 - Property and Equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-fair-value-consideration" roleURI="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">011 - Disclosure - Note 5 - Fair Value Consideration</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets" roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">012 - Disclosure - Note 6 - Intangible Assets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-debt" roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">013 - Disclosure - Note 7 - Debt</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">014 - Disclosure - Note 8 - Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes" roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">015 - Disclosure - Note 9 - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-related-party-transactions" roleURI="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">016 - Disclosure - Note 10 - Related Party Transactions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies" roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">017 - Disclosure - Note 11 - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting" roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">018 - Disclosure - Note 12 - Segment Reporting</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-significant-accounting-policies-policies" roleURI="http://www.thejoint.com/20171231/role/statement-significant-accounting-policies-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">019 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">020 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">021 - Disclosure - Note 2 - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">022 - Disclosure - Note 4 - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">023 - Disclosure - Note 6 - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-debt-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">024 - Disclosure - Note 7 - Debt (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">025 - Disclosure - Note 8 - Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">026 - Disclosure - Note 9 - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">027 - Disclosure - Note 11 - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-tables" roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">028 - Disclosure - Note 12 - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-supplemental-disclosure-of-noncash-activity-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">029 - Disclosure - Supplemental Disclosure of Non-cash Activity (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">030 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">031 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">032 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Lease Exit Liability (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">033 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">034 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">035 - Disclosure - Note 2 - Acquisitions (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-purchase-price-allocation-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">036 - Disclosure - Note 2 - Acquisitions - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-supplemental-pro-forma-information-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">037 - Disclosure - Note 2 - Acquisitions - Supplemental Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-notes-receivable-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">038 - Disclosure - Note 3 - Notes Receivable (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">039 - Disclosure - Note 4 - Property and Equipment (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">040 - Disclosure - Note 4 - Property and Equipment - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-fair-value-consideration-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">041 - Disclosure - Note 5 - Fair Value Consideration (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">042 - Disclosure - Note 6 - Intangible Assets (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-intangible-assets-acquired-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">043 - Disclosure - Note 6 - Intangible Assets - Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-estimated-amortization-expense-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">044 - Disclosure - Note 6 - Intangible Assets - Estimated Amortization Expense (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-debt-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">045 - Disclosure - Note 7 - Debt (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-debt-maturities-of-notes-payable-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">046 - Disclosure - Note 7 - Debt - Maturities of Notes Payable (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">047 - Disclosure - Note 8 - Equity (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-fair-value-assumptions-of-options-granted-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">048 - Disclosure - Note 8 - Equity - Fair Value Assumptions of Options Granted (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-stock-options-activity-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-options-activity-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">049 - Disclosure - Note 8 - Equity - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-restricted-stock-activity-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-restricted-stock-activity-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">050 - Disclosure - Note 8 - Equity - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-stock-repurchase-option-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-repurchase-option-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">051 - Disclosure - Note 8 - Equity - Stock Repurchase Option (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-warrants-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-warrants-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">052 - Disclosure - Note 8 - Equity - Warrants (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">053 - Disclosure - Note 9 - Income Taxes (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-income-tax-provision-benefit-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">054 - Disclosure - Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-net-deferred-taxes-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">055 - Disclosure - Note 9 - Income Taxes - Net Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">056 - Disclosure - Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-uncertain-tax-benefits-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">057 - Disclosure - Note 9 - Income Taxes - Uncertain Tax Benefits (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-related-party-transactions-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">058 - Disclosure - Note 10 - Related Party Transactions (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">059 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">060 - Disclosure - Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-details-textual" roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">061 - Disclosure - Note 12 - Segment Reporting (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-segment-reporting-financial-information-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">062 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-segment-reporting-information-assets-details" roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">063 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="jynt_AccountingStandardsUpdate201409201610And201612Member" name="AccountingStandardsUpdate201409201610And201612Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_AccountsPayable1Member" name="AccountsPayable1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" name="AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_AdvertisingFundPolicyTextBlock" name="AdvertisingFundPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" name="AssetBasisDifferenceRelatedToPropertyAndEquipment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BinomialLatticeBasedModelFairValueSharePrice" name="BinomialLatticeBasedModelFairValueSharePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BinomialLatticeBasedModelFairValueTotal" name="BinomialLatticeBasedModelFairValueTotal" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" name="BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" name="ClassOfWarrantOrRightIssuedDuringPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" name="ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsAcquiredDuringThePeriod" name="ClinicsAcquiredDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsClosedDuringThePeriod" name="ClinicsClosedDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsOpenedDuringThePeriod" name="ClinicsOpenedDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsSoldButNotYetOperational" name="ClinicsSoldButNotYetOperational" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_CoOpFundsLiabilityCurrent" name="CoOpFundsLiabilityCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_CompanyOwnedClinicMember" name="CompanyOwnedClinicMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_CorporateClinicsMember" name="CorporateClinicsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_DeferredFranchiseCosts" name="DeferredFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredFranchiseCostsCurrent" name="DeferredFranchiseCostsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" name="DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredFranchiseCostsNoncurrent" name="DeferredFranchiseCostsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetDeferredRentCurrent" name="DeferredTaxAssetDeferredRentCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" name="DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" name="DeferredTaxAssetRestrictedStockCompensationCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsAccruedExpensesCurrent" name="DeferredTaxAssetsAccruedExpensesCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" name="DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" name="DeferredTaxAssetsCharitableContributionCarryoverCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsFranchiseCosts" name="DeferredTaxAssetsFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsGoodwillComponent1" name="DeferredTaxAssetsGoodwillComponent1" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsGoodwillComponent2" name="DeferredTaxAssetsGoodwillComponent2" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsIntangibleAssets" name="DeferredTaxAssetsIntangibleAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsLeaseAbandonment" name="DeferredTaxAssetsLeaseAbandonment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" name="DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsRevenueCurrent" name="DeferredTaxAssetsRevenueCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_DevelopmentRightsMember" name="DevelopmentRightsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" name="EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" name="EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" name="EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" name="EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" name="EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FormerChiefExecutiveOfficerMember" name="FormerChiefExecutiveOfficerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchiseFeesMember" name="FranchiseFeesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" name="FranchiseMonthlyMarketingFeeGrossSalesPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchiseOperationsMember" name="FranchiseOperationsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" name="FranchiseRightsAndCustomerRelationshipsReacquiredMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_FranchiseRoyaltyGrossSalesPercentage" name="FranchiseRoyaltyGrossSalesPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchisesMember" name="FranchisesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" name="FutureClinicsLicensesWithAnExecutedLetterOfIntent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" name="ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_IncreaseDecreaseInCoOpFundsLiability" name="IncreaseDecreaseInCoOpFundsLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_IncreaseDecreaseInDeferredFranchiseCosts" name="IncreaseDecreaseInDeferredFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" name="InterestBearingPromissoryNoteMaturingOctober242020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_LeaseExitLiability" name="LeaseExitLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_LeaseExitLiabilityAdditions" name="LeaseExitLiabilityAdditions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_LeaseExitLiabilityNetAccretion" name="LeaseExitLiabilityNetAccretion" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_LeaseExitLiabilitySettlement" name="LeaseExitLiabilitySettlement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_LeaseExitLiabilityTableTextBlock" name="LeaseExitLiabilityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" name="LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_LossOnDispositionOrImpairmentMember" name="LossOnDispositionOrImpairmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NatureOfOperationsPolicyPolicyTextBlock" name="NatureOfOperationsPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" name="NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" name="NoninterestBearingUnsecuredPromissoryNote1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" name="NoninterestBearingUnsecuredPromissoryNote2Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" name="NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" name="NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NotesReceivableContractualTerm" name="NotesReceivableContractualTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NotesReceivableInterestRate" name="NotesReceivableInterestRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NotesReceivablePrincipalAndInterestTerm" name="NotesReceivablePrincipalAndInterestTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfClinicsClassifiedAsHeldForSale" name="NumberOfClinicsClassifiedAsHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfFranchises" name="NumberOfFranchises" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfLicenseTransferAgreements" name="NumberOfLicenseTransferAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfMajorCustomers" name="NumberOfMajorCustomers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" name="NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfPCEntities" name="NumberOfPCEntities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" name="NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" name="NumberOfUndevelopedFranchiseAgreementsTerminated" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" name="NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfUnsecuredPromissoryNotes" name="NumberOfUnsecuredPromissoryNotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_OptionExcercisePriceYearOne" name="OptionExcercisePriceYearOne" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearEight" name="OptionExercisePriceYearEight" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearFive" name="OptionExercisePriceYearFive" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearFour" name="OptionExercisePriceYearFour" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearSeven" name="OptionExercisePriceYearSeven" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearSix" name="OptionExercisePriceYearSix" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearThree" name="OptionExercisePriceYearThree" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearTwo" name="OptionExercisePriceYearTwo" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionToRepurchaseSharesChangeInFairValue" name="OptionToRepurchaseSharesChangeInFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" name="PropertyPlantAndEquipmentExcludingConstructionInProgressMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" name="ReacquisitionAndTerminationOfRegionalDeveloperRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" name="ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" name="RegionalDeveloperFeesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" name="RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDeveloperFeesRevenue" name="RegionalDeveloperFeesRevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" name="RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperRightsInVirginiaMember" name="RegionalDeveloperRightsInVirginiaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" name="RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" name="RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" name="RegionalDeveloperTerritoryInCentralFloridaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" name="RegionalDeveloperTerritoryInMarylandwashingtonDCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperTerritoryInMinnesotaMember" name="RegionalDeveloperTerritoryInMinnesotaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" name="RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_RegionalDevelopersLicenseFee" name="RegionalDevelopersLicenseFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" name="RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" name="RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDevelopmentAgreement" name="RegionalDevelopmentAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_RegionalDevelopmentAgreementMember" name="RegionalDevelopmentAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RepurchaseRightToDevelopFranchisesConsideration" name="RepurchaseRightToDevelopFranchisesConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RevenueDeferredAdjustment" name="RevenueDeferredAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" name="RevenuesAndManagementFeesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RoyaltiesPolicyPolicyTextBlock" name="RoyaltiesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" name="ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" name="ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" nillable="true" substitutionGroup="xbrli:item" type="us-types:durationStringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_ShareholderMember" name="ShareholderMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" name="The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" name="The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" name="The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_The12MonthsEndedDecember312016Member" name="The12MonthsEndedDecember312016Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_The2014PlanMember" name="The2014PlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_TheJointRRCCorpMember" name="TheJointRRCCorpMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_TheYearEndedDecember312015Member" name="TheYearEndedDecember312015Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_TheYearEndedDecember312017Member" name="TheYearEndedDecember312017Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" name="UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" name="statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-11-commitments-and-contingencies-tables" name="statement-statement-note-11-commitments-and-contingencies-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" name="statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" name="statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-12-segment-reporting-tables" name="statement-statement-note-12-segment-reporting-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details" name="statement-statement-note-2-acquisitions-purchase-price-allocation-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" name="statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-2-acquisitions-tables" name="statement-statement-note-2-acquisitions-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" name="statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-4-property-and-equipment-tables" name="statement-statement-note-4-property-and-equipment-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" name="statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" name="statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-6-intangible-assets-tables" name="statement-statement-note-6-intangible-assets-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details" name="statement-statement-note-7-debt-maturities-of-notes-payable-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-7-debt-tables" name="statement-statement-note-7-debt-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" name="statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" name="statement-statement-note-8-equity-restricted-stock-activity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-stock-options-activity-details" name="statement-statement-note-8-equity-stock-options-activity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" name="statement-statement-note-8-equity-stock-repurchase-option-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-tables" name="statement-statement-note-8-equity-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-warrants-details" name="statement-statement-note-8-equity-warrants-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" name="statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" name="statement-statement-note-9-income-taxes-net-deferred-taxes-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" name="statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-tables" name="statement-statement-note-9-income-taxes-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" name="statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-significant-accounting-policies-policies" name="statement-statement-significant-accounting-policies-policies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>jynt-20171231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:32PM UTC 2018-03-09--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details" xlink:href="jynt-20171231.xsd#statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets" xlink:href="jynt-20171231.xsd#statement-consolidated-balance-sheets" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="jynt_DeferredFranchiseCostsCurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_IncomeTaxesReceivable" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="jynt_CoOpFundsLiabilityCurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermNotesPayable" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_TreasuryStockValue" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-operations" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_OtherSalesRevenueNet" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="jynt_RegionalDeveloperFeesRevenue" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_OtherIncome" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_AdvertisingRevenue" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_TechnologyServicesRevenue" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RoyaltyRevenue" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_FranchiseRevenue" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_FranchiseCosts" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_TechnologyServicesCosts" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingAndMarketingExpense" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostOfRevenue" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-cash-flows" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RevenueDeferredAdjustment" xlink:label="jynt_RevenueDeferredAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="arc"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="jynt_RevenueDeferredAdjustment" xlink:type="arc"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="arc"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="arc"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="arc"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="arc"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc"/>
    <link:calculationArc order="23" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsIntangibleAssets" xlink:label="jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="arc"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="arc"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="arc"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="arc"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="arc"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="arc"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="arc"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>jynt-20171231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:32PM UTC 2018-03-09--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-document-and-entity-information" xlink:href="jynt-20171231.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets-parentheticals" xlink:href="jynt-20171231.xsd#statement-consolidated-balance-sheets-parentheticals" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets-parentheticals" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockShares" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity" xlink:href="jynt-20171231.xsd#statement-supplemental-disclosure-of-noncash-activity" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:label="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:label="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:to="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:label="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreementMember" xlink:label="jynt_RegionalDevelopmentAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The12MonthsEndedDecember312016Member" xlink:label="jynt_The12MonthsEndedDecember312016Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312015Member" xlink:label="jynt_TheYearEndedDecember312015Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312017Member" xlink:label="jynt_TheYearEndedDecember312017Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="us-gaap_CreationDateAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="us-gaap_DefaultFinancialStatementsDateMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_RegionalDevelopmentAgreementMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember-default" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreationDateAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefaultFinancialStatementsDateMember" xlink:to="jynt_TheYearEndedDecember312015Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_DefaultFinancialStatementsDateMember-default" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefaultFinancialStatementsDateMember" xlink:to="jynt_The12MonthsEndedDecember312016Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefaultFinancialStatementsDateMember" xlink:to="jynt_TheYearEndedDecember312017Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable" xlink:href="jynt-20171231.xsd#statement-note-3-notes-receivable" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:label="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:label="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:label="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:label="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:label="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration" xlink:href="jynt-20171231.xsd#statement-note-5-fair-value-consideration" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt" xlink:href="jynt-20171231.xsd#statement-note-7-debt" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity" xlink:href="jynt-20171231.xsd#statement-note-8-equity" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The2014PlanMember" xlink:label="jynt_The2014PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="jynt_The2014PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions" xlink:href="jynt-20171231.xsd#statement-note-10-related-party-transactions" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareholderMember" xlink:label="jynt_ShareholderMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="jynt_ShareholderMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-significant-accounting-policies-policies" xlink:href="jynt-20171231.xsd#statement-significant-accounting-policies-policies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-significant-accounting-policies-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AdvertisingFundPolicyTextBlock" xlink:label="jynt_AdvertisingFundPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RoyaltiesPolicyPolicyTextBlock" xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CooperativeAdvertisingPolicy" xlink:label="us-gaap_CooperativeAdvertisingPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionServicesCommissions" xlink:label="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PolicyTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InternalUseSoftwarePolicy" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_AdvertisingFundPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CooperativeAdvertisingPolicy" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="25" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="26" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="27" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc"/>
    <link:definitionArc order="28" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:type="arc"/>
    <link:definitionArc order="29" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityTableTextBlock" xlink:label="jynt_LeaseExitLiabilityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="jynt_LeaseExitLiabilityTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-tables" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-tables" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-tables" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-tables" xlink:href="jynt-20171231.xsd#statement-note-7-debt-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-tables" xlink:href="jynt-20171231.xsd#statement-note-8-equity-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-tables" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-tables" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-tables" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity-details-textual" xlink:href="jynt-20171231.xsd#statement-supplemental-disclosure-of-noncash-activity-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" xlink:label="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:label="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:label="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:to="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxesPaid" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestPaid" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:label="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityAdditions" xlink:label="jynt_LeaseExitLiabilityAdditions" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfFranchises" xlink:label="jynt_NumberOfFranchises" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfMajorCustomers" xlink:label="jynt_NumberOfMajorCustomers" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfPCEntities" xlink:label="jynt_NumberOfPCEntities" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersLicenseFee" xlink:label="jynt_RegionalDevelopersLicenseFee" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreementMember" xlink:label="jynt_RegionalDevelopmentAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The12MonthsEndedDecember312016Member" xlink:label="jynt_The12MonthsEndedDecember312016Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312015Member" xlink:label="jynt_TheYearEndedDecember312015Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312017Member" xlink:label="jynt_TheYearEndedDecember312017Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="us-gaap_CreationDateAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="us-gaap_DefaultFinancialStatementsDateMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_RegionalDevelopmentAgreementMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember-default" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreationDateAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefaultFinancialStatementsDateMember" xlink:to="jynt_TheYearEndedDecember312015Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_DefaultFinancialStatementsDateMember-default" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefaultFinancialStatementsDateMember" xlink:to="jynt_The12MonthsEndedDecember312016Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefaultFinancialStatementsDateMember" xlink:to="jynt_TheYearEndedDecember312017Member" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfPCEntities" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfFranchises" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfMajorCustomers" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilityAdditions" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFee" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdvertisingExpense" xlink:type="arc"/>
    <link:definitionArc order="25" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:definitionArc order="26" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FranchiseRevenue" xlink:type="arc"/>
    <link:definitionArc order="27" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDeveloperFeesRevenue" xlink:type="arc"/>
    <link:definitionArc order="28" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FranchiseCosts" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-details-textual" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCosts" xlink:label="jynt_DeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable-details-textual" xlink:href="jynt-20171231.xsd#statement-note-3-notes-receivable-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:label="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivableContractualTerm" xlink:label="jynt_NotesReceivableContractualTerm" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivableInterestRate" xlink:label="jynt_NotesReceivableInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivablePrincipalAndInterestTerm" xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfLicenseTransferAgreements" xlink:label="jynt_NumberOfLicenseTransferAgreements" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUnsecuredPromissoryNotes" xlink:label="jynt_NumberOfUnsecuredPromissoryNotes" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:label="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:label="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:label="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:label="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreement" xlink:label="jynt_RegionalDevelopmentAgreement" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesReceivableNet" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableInterestRate" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableContractualTerm" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfLicenseTransferAgreements" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUnsecuredPromissoryNotes" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopmentAgreement" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-details-textual" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration-details-textual" xlink:href="jynt-20171231.xsd#statement-note-5-fair-value-consideration-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration-details-textual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsFairValueAdjustment" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-details-textual" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-details-textual" xlink:href="jynt-20171231.xsd#statement-note-7-debt-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCredit" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-details-textual" xlink:href="jynt-20171231.xsd#statement-note-8-equity-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BinomialLatticeBasedModelFairValueTotal" xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The2014PlanMember" xlink:label="jynt_The2014PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="jynt_The2014PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharePrice" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc"/>
    <link:definitionArc order="25" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-details-textual" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-details-textual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OpenTaxYear" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions-details-textual" xlink:href="jynt-20171231.xsd#statement-note-10-related-party-transactions-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareholderMember" xlink:label="jynt_ShareholderMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="jynt_ShareholderMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-details-textual" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityAdditions" xlink:label="jynt_LeaseExitLiabilityAdditions" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityNetAccretion" xlink:label="jynt_LeaseExitLiabilityNetAccretion" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilitySettlement" xlink:label="jynt_LeaseExitLiabilitySettlement" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilityAdditions" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilitySettlement" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilityNetAccretion" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details" xlink:href="jynt-20171231.xsd#statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebt" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-stock-repurchase-option-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExcercisePriceYearOne" xlink:label="jynt_OptionExcercisePriceYearOne" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearEight" xlink:label="jynt_OptionExercisePriceYearEight" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearFive" xlink:label="jynt_OptionExercisePriceYearFive" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearFour" xlink:label="jynt_OptionExercisePriceYearFour" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearSeven" xlink:label="jynt_OptionExercisePriceYearSeven" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearSix" xlink:label="jynt_OptionExercisePriceYearSix" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearThree" xlink:label="jynt_OptionExercisePriceYearThree" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearTwo" xlink:label="jynt_OptionExercisePriceYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExcercisePriceYearOne" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearTwo" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearThree" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFour" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFive" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSix" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSeven" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearEight" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-options-activity-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-stock-options-activity-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-options-activity-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-restricted-stock-activity-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-warrants-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-warrants-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-warrants-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets" xlink:href="jynt-20171231.xsd#statement-consolidated-balance-sheets" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsCurrent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="jynt_CoOpFundsLiabilityCurrent" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermNotesPayable" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_TreasuryStockValue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-operations" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherSalesRevenueNet" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RoyaltyRevenue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_FranchiseRevenue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_AdvertisingRevenue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_TechnologyServicesRevenue" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="jynt_RegionalDeveloperFeesRevenue" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherIncome" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfRevenueAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_FranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_TechnologyServicesCosts" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-changes-in-stockholders-equity" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-changes-in-stockholders-equity" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-changes-in-stockholders-equity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsClosedDuringThePeriod" xlink:label="jynt_ClinicsClosedDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsOpenedDuringThePeriod" xlink:label="jynt_ClinicsOpenedDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsSoldButNotYetOperational" xlink:label="jynt_ClinicsSoldButNotYetOperational" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:label="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EntityOperatedUnitsMember" xlink:label="us-gaap_EntityOperatedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisedUnitsMember" xlink:label="us-gaap_FranchisedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisorDisclosureAxis" xlink:label="us-gaap_FranchisorDisclosureAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FranchisorDisclosureAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FranchisorDisclosureDomain" xlink:to="us-gaap_FranchisedUnitsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FranchisorDisclosureDomain" xlink:to="us-gaap_EntityOperatedUnitsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsOpenedDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsAcquiredDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsClosedDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsSoldButNotYetOperational" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheJointRRCCorpMember" xlink:label="jynt_TheJointRRCCorpMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_TheJointRRCCorpMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConstructionInProgressGross" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-cash-flows" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RevenueDeferredAdjustment" xlink:label="jynt_RevenueDeferredAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RevenueDeferredAdjustment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsIntangibleAssets" xlink:label="jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract" xlink:label="us-gaap_DepreciationAndAmortizationAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_CorporateMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_CorporateNonSegmentMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DepreciationAndAmortizationAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>jynt-20171231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:32PM UTC 2018-03-09--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DocumentAndEntityInformation" xlink:label="jynt_DocumentAndEntityInformation" xlink:type="locator"/>
    <link:label xlink:label="jynt_DocumentAndEntityInformation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document And Entity Information</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DocumentAndEntityInformation" xlink:to="jynt_DocumentAndEntityInformation-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoteToFinancialStatementDetailsTextual-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note To Financial Statement Details Textual</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="jynt_NoteToFinancialStatementDetailsTextual-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-significant-accounting-policies-policies" xlink:label="jynt_statement-statement-significant-accounting-policies-policies" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-significant-accounting-policies-policies-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-significant-accounting-policies-policies" xlink:to="jynt_statement-statement-significant-accounting-policies-policies-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Nature of Operations and Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-2-acquisitions-tables" xlink:label="jynt_statement-statement-note-2-acquisitions-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-2-acquisitions-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 2 - Acquisitions</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-2-acquisitions-tables" xlink:to="jynt_statement-statement-note-2-acquisitions-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-4-property-and-equipment-tables" xlink:label="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-4-property-and-equipment-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 4 - Property and Equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:to="jynt_statement-statement-note-4-property-and-equipment-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-6-intangible-assets-tables" xlink:label="jynt_statement-statement-note-6-intangible-assets-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-6-intangible-assets-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 6 - Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-6-intangible-assets-tables" xlink:to="jynt_statement-statement-note-6-intangible-assets-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-7-debt-tables" xlink:label="jynt_statement-statement-note-7-debt-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-7-debt-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 7 - Debt</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-7-debt-tables" xlink:to="jynt_statement-statement-note-7-debt-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-tables" xlink:label="jynt_statement-statement-note-8-equity-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Equity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-tables" xlink:to="jynt_statement-statement-note-8-equity-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-tables" xlink:label="jynt_statement-statement-note-9-income-taxes-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 9 - Income Taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-tables" xlink:to="jynt_statement-statement-note-9-income-taxes-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 11 - Commitments and Contingencies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:to="jynt_statement-statement-note-11-commitments-and-contingencies-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-12-segment-reporting-tables" xlink:label="jynt_statement-statement-note-12-segment-reporting-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-12-segment-reporting-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 12 - Segment Reporting</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-12-segment-reporting-tables" xlink:to="jynt_statement-statement-note-12-segment-reporting-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Lease Exit Liability (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Revenues</link:label>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details" xlink:label="jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 2 - Acquisitions - Purchase Price Allocation (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details" xlink:to="jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:label="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 2 - Acquisitions - Supplemental Pro Forma Information (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:to="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:label="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 4 - Property and Equipment - Summary of Property and Equipment (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:to="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 6 - Intangible Assets - Intangible Assets Acquired (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:to="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 6 - Intangible Assets - Estimated Amortization Expense (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:to="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details" xlink:label="jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 7 - Debt - Maturities of Notes Payable (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details" xlink:to="jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:label="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Equity - Fair Value Assumptions of Options Granted (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:to="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:label="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-stock-options-activity-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Equity - Stock Options Activity (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:to="jynt_statement-statement-note-8-equity-stock-options-activity-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:label="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-restricted-stock-activity-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Equity - Restricted Stock Activity (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:to="jynt_statement-statement-note-8-equity-restricted-stock-activity-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:label="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-stock-repurchase-option-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Equity - Stock Repurchase Option (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:to="jynt_statement-statement-note-8-equity-stock-repurchase-option-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-warrants-details" xlink:label="jynt_statement-statement-note-8-equity-warrants-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-warrants-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 8 - Equity - Warrants (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-warrants-details" xlink:to="jynt_statement-statement-note-8-equity-warrants-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:label="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:to="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:label="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 9 - Income Taxes - Net Deferred Taxes (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:to="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:label="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:to="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:label="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 9 - Income Taxes - Uncertain Tax Benefits (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:to="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:to="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:to="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:to="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatements" xlink:label="jynt_NotesToFinancialStatements" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesToFinancialStatements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesToFinancialStatements" xlink:to="jynt_NotesToFinancialStatements-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesToFinancialStatementsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="jynt_NotesToFinancialStatementsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInDeferredRevenue</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LineOfCreditFacilityPeriodicPaymentInterest</link:label>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Interest</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInAccruedLiabilities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockSharesAcquired-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UseOfEstimates-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:label="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Territories with Texas, Arkansas, and Oklahoma [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related to a developer territories entered into with Texas, Arkansas, and Oklahoma.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:to="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</link:label>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Sale of treasury stock (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharesOutstanding</link:label>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInAccountsPayable</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unallocated cash and cash equivalents and restricted cash</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash at beginning of year</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash at end of year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CashEquivalentsAtCarryingValue</link:label>
    <link:label xlink:label="us-gaap_CashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchiseRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise fees</link:label>
    <link:label xlink:label="us-gaap_FranchiseRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchiseRevenue" xlink:to="us-gaap_FranchiseRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RoyaltyRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty fees</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyRevenue" xlink:to="us-gaap_RoyaltyRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TechnologyServicesRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IT related income and software fees</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TechnologyServicesRevenue" xlink:to="us-gaap_TechnologyServicesRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EntityOperatedUnitsMember" xlink:label="us-gaap_EntityOperatedUnitsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EntityOperatedUnitsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Operated Units [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityOperatedUnitsMember" xlink:to="us-gaap_EntityOperatedUnitsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NumberOfStores</link:label>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stores</link:label>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Clinics open at beginning of period</link:label>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Clinics in operation at the end of the period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfStores" xlink:to="us-gaap_NumberOfStores-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisorDisclosureAxis" xlink:label="us-gaap_FranchisorDisclosureAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchisorDisclosureAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisedUnitsMember" xlink:label="us-gaap_FranchisedUnitsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchisedUnitsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchised Units [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchisedUnitsMember" xlink:to="us-gaap_FranchisedUnitsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherSalesRevenueNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues and management fees from company clinics</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSalesRevenueNet" xlink:to="us-gaap_OtherSalesRevenueNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchisorDisclosureDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchisorDisclosureDomain" xlink:to="us-gaap_FranchisorDisclosureDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Franchisor Disclosure [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:to="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInOtherDeferredLiability</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred rent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FinancialInstrumentsOwnedAtFairValue</link:label>
    <link:label xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments, Owned, at Fair Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdvertisingRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising fund revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingRevenue" xlink:to="us-gaap_AdvertisingRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskPercentage1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ConcentrationRiskPercentage1</link:label>
    <link:label xlink:label="us-gaap_ConcentrationRiskPercentage1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</link:label>
    <link:label xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, offering costs adjustment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TreasuryStockValueAcquiredCostMethod</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TreasuryStockRetiredCostMethodAmount</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CustomerConcentrationRiskMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TreasuryStockValue</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockValue-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock 14,084 shares as of December 31, 2017 and 296,504 shares as of December 31, 2016, at cost</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesReceivableNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NotesReceivableNet</link:label>
    <link:label xlink:label="us-gaap_NotesReceivableNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Receivable, Net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableNet" xlink:to="us-gaap_NotesReceivableNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskByTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodShares-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockRepurchasedDuringPeriodShares</link:label>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodShares-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</link:label>
    <link:label xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Received</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TitleOfIndividualAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockRepurchasedDuringPeriodValue</link:label>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInDepositOtherAssets</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Divestiture, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of treasury stock</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Treasury Stock Reissued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:label="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unique Name [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCostsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred franchise costs - current portion</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred current net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCostsCurrent" xlink:to="jynt_DeferredFranchiseCostsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_CoOpFundsLiabilityCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Co-op funds liability</link:label>
    <link:label xlink:label="jynt_CoOpFundsLiabilityCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate carrying amount of Co-op funds liability (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_CoOpFundsLiabilityCurrent" xlink:to="jynt_CoOpFundsLiabilityCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred franchise costs, net of current portion</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred noncurrent net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCostsNoncurrent" xlink:to="jynt_DeferredFranchiseCostsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SalesRevenueNetMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Net [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsReceivableMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllocatedShareBasedCompensationExpense</link:label>
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise of stock options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of vested restricted stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of vested restricted stock (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income taxes receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInAccountsReceivable</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted at Market Price, Number of Shares (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional developer fees</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developer Fees Revenue</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRevenue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of regional development fees revenue recognized.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperFeesRevenue" xlink:to="jynt_RegionalDeveloperFeesRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllowanceForDoubtfulAccountsReceivable</link:label>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of common stock</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilitiesAndStockholdersEquity</link:label>
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsGrossNoncurrent</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less valuation allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NumberOfOperatingSegments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NumberOfOperatingSegments</link:label>
    <link:label xlink:label="us-gaap_NumberOfOperatingSegments-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherIncome-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Regional developer fees recognized upon acquisition of development rights</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of regional developer fees recognized upon acquisition of development rights.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="locator"/>
    <link:label xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_IncreaseDecreaseInCoOpFundsLiability</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-op funds liability</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the increase (decrease) in co-op funds liability during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_IncreaseDecreaseInDeferredFranchiseCosts</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise costs</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the increase (decrease) during the reporting period in deferred franchise costs.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Franchise Costs Netted Against Aggregate Purchase Price</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred franchise costs netted against the aggregate purchase price of acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:to="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseFeesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Fees [Member]</link:label>
    <link:label xlink:label="jynt_FranchiseFeesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to franchise fees collected upon the execution of franchise agreements.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseFeesMember" xlink:to="jynt_FranchiseFeesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfFranchises" xlink:label="jynt_NumberOfFranchises" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfFranchises-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfFranchises</link:label>
    <link:label xlink:label="jynt_NumberOfFranchises-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Franchises</link:label>
    <link:label xlink:label="jynt_NumberOfFranchises-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of franchises.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfFranchises" xlink:to="jynt_NumberOfFranchises-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SegmentReportingDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfPCEntities" xlink:label="jynt_NumberOfPCEntities" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfPCEntities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfPCEntities</link:label>
    <link:label xlink:label="jynt_NumberOfPCEntities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of PC Entities</link:label>
    <link:label xlink:label="jynt_NumberOfPCEntities-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of PC entities.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfPCEntities" xlink:to="jynt_NumberOfPCEntities-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfMajorCustomers" xlink:label="jynt_NumberOfMajorCustomers" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfMajorCustomers-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfMajorCustomers</link:label>
    <link:label xlink:label="jynt_NumberOfMajorCustomers-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Major Customers</link:label>
    <link:label xlink:label="jynt_NumberOfMajorCustomers-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfMajorCustomers" xlink:to="jynt_NumberOfMajorCustomers-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage</link:label>
    <link:label xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Monthly Marketing Fee Gross Sales Percentage</link:label>
    <link:label xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of gross sales a franchise pays for monthly marketing fees as stipulated in the typical franchise agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:to="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DisclosureTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes to Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers License Fee Current Franchise Fee Percentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The percentage of the then current franchise fee regional developers pay as a license fee.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:to="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers Royalty Sales Generated by Franchises Percentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of sales generated by franchised clinics in their region regional developers receive as royalties.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:to="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeLeasesPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_FranchiseRoyaltyGrossSalesPercentage</link:label>
    <link:label xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Royalty Gross Sales Percentage</link:label>
    <link:label xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of gross sales collected as royalties from franchises typically collected bi-monthly two working days after each sales period has ended as stipulated in the franchise agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:to="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AdvertisingFundPolicyTextBlock" xlink:label="jynt_AdvertisingFundPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_AdvertisingFundPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Fund, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_AdvertisingFundPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the advertising fund.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AdvertisingFundPolicyTextBlock" xlink:to="jynt_AdvertisingFundPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenuesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues and Management Fees, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the revenues and management fees from the Company clinics.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:to="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Fees, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for regional developer fees.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:to="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerSharePolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherNonoperatingIncomeExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OtherNonoperatingIncomeExpense</link:label>
    <link:label xlink:label="us-gaap_OtherNonoperatingIncomeExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IT Related Income And Software Fees, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for income and software fees related to information technology.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:to="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RoyaltiesPolicyPolicyTextBlock" xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the royalties from franchises.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:to="jynt_RoyaltiesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsClosedDuringThePeriod" xlink:label="jynt_ClinicsClosedDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsClosedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClinicsClosedDuringThePeriod</link:label>
    <link:label xlink:label="jynt_ClinicsClosedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Closed or sold during the period</link:label>
    <link:label xlink:label="jynt_ClinicsClosedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of clinics closed during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsClosedDuringThePeriod" xlink:to="jynt_ClinicsClosedDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsOpenedDuringThePeriod" xlink:label="jynt_ClinicsOpenedDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsOpenedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClinicsOpenedDuringThePeriod</link:label>
    <link:label xlink:label="jynt_ClinicsOpenedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opened or purchased during the period</link:label>
    <link:label xlink:label="jynt_ClinicsOpenedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of number of clinics opened during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsOpenedDuringThePeriod" xlink:to="jynt_ClinicsOpenedDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsSoldButNotYetOperational" xlink:label="jynt_ClinicsSoldButNotYetOperational" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsSoldButNotYetOperational-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinics licenses sold but not yet developed</link:label>
    <link:label xlink:label="jynt_ClinicsSoldButNotYetOperational-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of clinics that have been sold as franchises, but are not yet operational.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsSoldButNotYetOperational" xlink:to="jynt_ClinicsSoldButNotYetOperational-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InternalUseSoftwarePolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCosts" xlink:label="jynt_DeferredFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredFranchiseCosts</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Franchise Costs</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred costs incurred and are directly related to generating franchise revenues.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCosts" xlink:to="jynt_DeferredFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepositsAssetsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheJointRRCCorpMember" xlink:label="jynt_TheJointRRCCorpMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_TheJointRRCCorpMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Joint RRC Corp [Member]</link:label>
    <link:label xlink:label="jynt_TheJointRRCCorpMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Entity acquired by the company.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_TheJointRRCCorpMember" xlink:to="jynt_TheJointRRCCorpMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchisesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchises [Member]</link:label>
    <link:label xlink:label="jynt_FranchisesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information about the Company's franchises.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchisesMember" xlink:to="jynt_FranchisesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueRevenueRecognized1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredRevenueRevenueRecognized1</link:label>
    <link:label xlink:label="us-gaap_DeferredRevenueRevenueRecognized1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Revenue, Revenue Recognized</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueRevenueRecognized1" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingIncomeLoss</link:label>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating income (loss)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivableContractualTerm" xlink:label="jynt_NotesReceivableContractualTerm" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesReceivableContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NotesReceivableContractualTerm</link:label>
    <link:label xlink:label="jynt_NotesReceivableContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Receivable, Contractual Term</link:label>
    <link:label xlink:label="jynt_NotesReceivableContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The contractual term stated in note receivable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesReceivableContractualTerm" xlink:to="jynt_NotesReceivableContractualTerm-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivableInterestRate" xlink:label="jynt_NotesReceivableInterestRate" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesReceivableInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NotesReceivableInterestRate</link:label>
    <link:label xlink:label="jynt_NotesReceivableInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:label xlink:label="jynt_NotesReceivableInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the per annum interest rate stated in notes receivable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesReceivableInterestRate" xlink:to="jynt_NotesReceivableInterestRate-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_CompanyOwnedClinicMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company-owned Clinic [Member]</link:label>
    <link:label xlink:label="jynt_CompanyOwnedClinicMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the sale of the Company-owned clinic.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_CompanyOwnedClinicMember" xlink:to="jynt_CompanyOwnedClinicMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesRentExpenseNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesRentExpenseNet</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesRentExpenseNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostOfRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CostOfRevenue</link:label>
    <link:label xlink:label="us-gaap_CostOfRevenue-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cost of revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivablePrincipalAndInterestTerm" xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NotesReceivablePrincipalAndInterestTerm</link:label>
    <link:label xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Receivable, Principal and Interest, Term</link:label>
    <link:label xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the term over which principal and interest are to be paid.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:to="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred provision</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockShares-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value; 20,000,000 shares authorized, 13,600,338 shares issued and 13,586,254 shares outstanding as of December 31, 2017 and 13,317,393 shares issued and 13,020,889 outstanding as of December 31, 2016</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise cost of revenues</link:label>
    <link:label xlink:label="us-gaap_FranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Costs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchiseCosts" xlink:to="us-gaap_FranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CooperativeAdvertisingPolicy" xlink:label="us-gaap_CooperativeAdvertisingPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CooperativeAdvertisingPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cooperative Advertising Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CooperativeAdvertisingPolicy" xlink:to="us-gaap_CooperativeAdvertisingPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensation</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensation-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes receivable, net of current portion and reserve</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Costs, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_CurrentFiscalYearEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_DevelopmentRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Rights [Member]</link:label>
    <link:label xlink:label="jynt_DevelopmentRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rights, generally of limited duration, that the entity has obtained through an arrangement related to the regional developer.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DevelopmentRightsMember" xlink:to="jynt_DevelopmentRightsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:type="locator"/>
    <link:label xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RepurchaseRightToDevelopFranchisesConsideration</link:label>
    <link:label xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase Right to Develop Franchises, Consideration</link:label>
    <link:label xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consideration paid or payable for repurchasing development rights to develop franchises in certain areas.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:to="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalPeriodFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalYearFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TechnologyServicesCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IT cost of revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TechnologyServicesCosts" xlink:to="us-gaap_TechnologyServicesCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2017, and December 31, 2016</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetUsefulLife</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-interest Bearing Unsecured Promissory Note Maturing October 1, 2017 [Member]</link:label>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information relating to a non-interest bearing unsecured promissory note maturing October 1, 2017.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUnsecuredPromissoryNotes" xlink:label="jynt_NumberOfUnsecuredPromissoryNotes" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfUnsecuredPromissoryNotes</link:label>
    <link:label xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Unsecured Promissory Notes</link:label>
    <link:label xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of unsecured promissory notes received during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfUnsecuredPromissoryNotes" xlink:to="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Rights in Virginia [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information about regional developer rights in Virginia.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrants or Rights, Outstanding, Remaining Contractual Life</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the remaining contractual life for warrants outstanding.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:to="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClassOfWarrantOrRightIssuedDuringPeriod</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Issued During Period</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of warrants or rights issued during period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:to="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepreciationDepletionAndAmortization-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label xlink:label="us-gaap_DepreciationDepletionAndAmortization-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonqualified stock options</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from non-qualified stock options and carryforwards classified as non-current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BinomialLatticeBasedModelFairValueSharePrice</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Binomial Lattice-based Model, Fair Value, Share Price</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the fair value share price derived from the binomial lattice-based model.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:to="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Depreciation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Depreciation</link:label>
    <link:label xlink:label="us-gaap_Depreciation-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AssetsCurrent</link:label>
    <link:label xlink:label="us-gaap_AssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityPublicFloat-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityFilerCategory-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BinomialLatticeBasedModelFairValueTotal" xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:type="locator"/>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BinomialLatticeBasedModelFairValueTotal</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Binomial Lattice-based Model, Fair Value, Total</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the total value of the option determined by the binomial lattice-based model.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:to="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCurrentReportingStatus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract" xlink:label="us-gaap_DepreciationAndAmortizationAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepreciationAndAmortizationAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and amortization:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_DepreciationAndAmortizationAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityVoluntaryFilers-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityWellKnownSeasonedIssuer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</link:label>
    <link:label xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:label xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on disposition or impairment</link:label>
    <link:label xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposition or impairment of assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross increases - tax positions in prior period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The2014PlanMember" xlink:label="jynt_The2014PlanMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_The2014PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2014 Plan [Member]</link:label>
    <link:label xlink:label="jynt_The2014PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to the 2014 Plan.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_The2014PlanMember" xlink:to="jynt_The2014PlanMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxesReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionServicesCommissions" xlink:label="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRecognitionServicesCommissions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Services, Commissions [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionServicesCommissions" xlink:to="us-gaap_RevenueRecognitionServicesCommissions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:type="locator"/>
    <link:label xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue</link:label>
    <link:label xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Fair Value (in dollars per share)</link:label>
    <link:label xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The weighted-average fair value as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:to="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="locator"/>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the forfeiture rate in determine the fair value for the share-based compensation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:to="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State, net of state tax credits</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Services, Franchise Fees [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:to="us-gaap_RevenueRecognitionServicesFranchiseFees-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AssetsFairValueAdjustment</link:label>
    <link:label xlink:label="us-gaap_AssetsFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Adjustment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueAdjustment" xlink:to="us-gaap_AssetsFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExcercisePriceYearOne" xlink:label="jynt_OptionExcercisePriceYearOne" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExcercisePriceYearOne-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 1 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExcercisePriceYearOne-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in the first year.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExcercisePriceYearOne" xlink:to="jynt_OptionExcercisePriceYearOne-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearThree" xlink:label="jynt_OptionExercisePriceYearThree" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearThree-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 3 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearThree-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year three.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearThree" xlink:to="jynt_OptionExercisePriceYearThree-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentFederalTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearTwo" xlink:label="jynt_OptionExercisePriceYearTwo" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 2 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year two.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearTwo" xlink:to="jynt_OptionExercisePriceYearTwo-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearFive" xlink:label="jynt_OptionExercisePriceYearFive" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearFive-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 5 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearFive-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year five.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearFive" xlink:to="jynt_OptionExercisePriceYearFive-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentIncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current provision</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearFour" xlink:label="jynt_OptionExercisePriceYearFour" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearFour-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 4 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearFour-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year four.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearFour" xlink:to="jynt_OptionExercisePriceYearFour-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearSeven" xlink:label="jynt_OptionExercisePriceYearSeven" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearSeven-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 7 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearSeven-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year seven.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearSeven" xlink:to="jynt_OptionExercisePriceYearSeven-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</link:label>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearSix" xlink:label="jynt_OptionExercisePriceYearSix" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearSix-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 6 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearSix-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year six.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearSix" xlink:to="jynt_OptionExercisePriceYearSix-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearEight" xlink:label="jynt_OptionExercisePriceYearEight" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearEight-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 8 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearEight-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year eight.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearEight" xlink:to="jynt_OptionExercisePriceYearEight-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareholderMember" xlink:label="jynt_ShareholderMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_ShareholderMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholder [Member]</link:label>
    <link:label xlink:label="jynt_ShareholderMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information related to a shareholder in the company.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ShareholderMember" xlink:to="jynt_ShareholderMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCommonStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxesPaid-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxesPaid</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxesPaid-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InterestPaid-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_InterestPaid</link:label>
    <link:label xlink:label="us-gaap_InterestPaid-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Paid</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdditionalPaidInCapital-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="locator"/>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Number of Units (in shares)</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of shares into which fully or partially vested equity instruments other than option outstanding as of the balance sheet date can be currently converted under the option plan.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfLicenseTransferAgreements" xlink:label="jynt_NumberOfLicenseTransferAgreements" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfLicenseTransferAgreements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfLicenseTransferAgreements</link:label>
    <link:label xlink:label="jynt_NumberOfLicenseTransferAgreements-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of License Transfer Agreements</link:label>
    <link:label xlink:label="jynt_NumberOfLicenseTransferAgreements-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of license transfer agreements the Company entered into.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfLicenseTransferAgreements" xlink:to="jynt_NumberOfLicenseTransferAgreements-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The weighted average exercise price of exercisable awards on equity-based plans excluding option plans.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Plant and Equipment, Excluding Construction in Progress [Member]</link:label>
    <link:label xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale, not including construction in progress.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:to="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term for exercisable equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockholdersEquity</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommitmentsAndContingencies-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Liabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Liabilities</link:label>
    <link:label xlink:label="us-gaap_Liabilities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes receivable - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilitySettlement" xlink:label="jynt_LeaseExitLiabilitySettlement" xlink:type="locator"/>
    <link:label xlink:label="jynt_LeaseExitLiabilitySettlement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_LeaseExitLiabilitySettlement</link:label>
    <link:label xlink:label="jynt_LeaseExitLiabilitySettlement-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label xlink:label="jynt_LeaseExitLiabilitySettlement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of settlements associated with lease exit liability.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LeaseExitLiabilitySettlement" xlink:to="jynt_LeaseExitLiabilitySettlement-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:label="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoryInCentralFloridaMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Territory in Central Florida [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoryInCentralFloridaMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to regional developer territory in Central Florida.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:to="jynt_RegionalDeveloperTerritoryInCentralFloridaMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityNetAccretion" xlink:label="jynt_LeaseExitLiabilityNetAccretion" xlink:type="locator"/>
    <link:label xlink:label="jynt_LeaseExitLiabilityNetAccretion-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_LeaseExitLiabilityNetAccretion</link:label>
    <link:label xlink:label="jynt_LeaseExitLiabilityNetAccretion-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net accretion</link:label>
    <link:label xlink:label="jynt_LeaseExitLiabilityNetAccretion-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of net accretion associated with lease exit liability.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LeaseExitLiabilityNetAccretion" xlink:to="jynt_LeaseExitLiabilityNetAccretion-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostOfRevenueAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of revenues:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenueAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityTableTextBlock" xlink:label="jynt_LeaseExitLiabilityTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_LeaseExitLiabilityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Exit Liability [Table Text Block]</link:label>
    <link:label xlink:label="jynt_LeaseExitLiabilityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of lease exit liabilities.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LeaseExitLiabilityTableTextBlock" xlink:to="jynt_LeaseExitLiabilityTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityAdditions" xlink:label="jynt_LeaseExitLiabilityAdditions" xlink:type="locator"/>
    <link:label xlink:label="jynt_LeaseExitLiabilityAdditions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label xlink:label="jynt_LeaseExitLiabilityAdditions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Exit Liability, Additions</link:label>
    <link:label xlink:label="jynt_LeaseExitLiabilityAdditions-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of additions associated with lease exit liability.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LeaseExitLiabilityAdditions" xlink:to="jynt_LeaseExitLiabilityAdditions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsReceivableNetCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PropertyPlantAndEquipmentUsefulLife</link:label>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueDisclosuresTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="locator"/>
    <link:label xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights</link:label>
    <link:label xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reacquisition and termination of regional developer rights</link:label>
    <link:label xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow for the reacquisition and termination of regional developer rights.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsCurrentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInFinancingActivities</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInInvestingActivities</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInOperatingActivities</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LeaseholdImprovementsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</link:label>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax expense</link:label>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsOfStockIssuanceCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsOfStockIssuanceCosts</link:label>
    <link:label xlink:label="us-gaap_PaymentsOfStockIssuanceCosts-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, offering costs adjustment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TypeOfAdoptionMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredRevenue</link:label>
    <link:label xlink:label="us-gaap_DeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LongTermDebt-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LongTermDebt</link:label>
    <link:label xlink:label="us-gaap_LongTermDebt-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other permanent differences, amount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsForRepurchaseOfCommonStock</link:label>
    <link:label xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RetainedEarningsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312015Member" xlink:label="jynt_TheYearEndedDecember312015Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_TheYearEndedDecember312015Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Year Ended December 31, 2015 [Member]</link:label>
    <link:label xlink:label="jynt_TheYearEndedDecember312015Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information that applies to the year ended December 31, 2015.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_TheYearEndedDecember312015Member" xlink:to="jynt_TheYearEndedDecember312015Member-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312017Member" xlink:label="jynt_TheYearEndedDecember312017Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_TheYearEndedDecember312017Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Year Ended December 31, 2017 [Member]</link:label>
    <link:label xlink:label="jynt_TheYearEndedDecember312017Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information that applies to the year ended December 31, 2017.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_TheYearEndedDecember312017Member" xlink:to="jynt_TheYearEndedDecember312017Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LineOfCredit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LineOfCredit</link:label>
    <link:label xlink:label="us-gaap_LineOfCredit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdditionalPaidInCapitalMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" xlink:label="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" xlink:type="locator"/>
    <link:label xlink:label="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions</link:label>
    <link:label xlink:label="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Goodwill Related to Deferred Revenue from Previous Acquisitions</link:label>
    <link:label xlink:label="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of adjustment to goodwill recorded during the period related to deferred revenue from previous acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" xlink:to="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of treasury stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EquityComponentDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskCreditRisk-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The12MonthsEndedDecember312016Member" xlink:label="jynt_The12MonthsEndedDecember312016Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_The12MonthsEndedDecember312016Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 12 Months Ended December 31, 2016 [Member]</link:label>
    <link:label xlink:label="jynt_The12MonthsEndedDecember312016Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the reporting period for the 12 months ended December 31, 2016.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_The12MonthsEndedDecember312016Member" xlink:to="jynt_The12MonthsEndedDecember312016Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="us-gaap_CreationDateAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CreationDateAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Report Date [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_CreationDateAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementEquityComponentsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DefaultFinancialStatementsDateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Statement Filing Date [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefaultFinancialStatementsDateMember" xlink:to="us-gaap_DefaultFinancialStatementsDateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_LossOnDispositionOrImpairmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss on Disposition or Impairment [Member]</link:label>
    <link:label xlink:label="jynt_LossOnDispositionOrImpairmentMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing loss on disposition or impairment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LossOnDispositionOrImpairmentMember" xlink:to="jynt_LossOnDispositionOrImpairmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfClinicsClassifiedAsHeldForSale</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Clinics Classified as Held for Sale</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of clinics that met the requirements for the classification of held for sale.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:to="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherLiabilitiesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Rights and Customer Relationships, Reacquired [Member]</link:label>
    <link:label xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to reacquired franchise rights and customer relationships.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</link:label>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Anti-dilutive Securities (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic and diluted weighted average shares outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareBasicAndDiluted-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic and diluted loss per share (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease abandonment</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from abandoned lease obligations.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharePrice</link:label>
    <link:label xlink:label="us-gaap_SharePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, interest and penalties</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, interest and penalties</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability" xlink:type="locator"/>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_LeaseExitLiability</link:label>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Exit Liability</link:label>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Lease exit liability at December 31, 2016</link:label>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Lease exit liability at December 31, 2017</link:label>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of liability attributable to the exit of a lease agreement as of the balance sheet date.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LeaseExitLiability" xlink:to="jynt_LeaseExitLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OfficeEquipmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SoftwareDevelopmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Development [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred membership revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goods and Services Exchanged for Equity Instrument [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:to="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reacquisitions of Franchises Throughout California and New Mexico [Member}</link:label>
    <link:label xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to the reacquisitions by the Company of franchises throughout California and New Mexico.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BalanceSheetLocationDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets acquired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BalanceSheetLocationAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScenarioUnspecifiedDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScenarioForecastMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioForecastMember" xlink:to="us-gaap_ScenarioForecastMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:type="locator"/>
    <link:label xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties</link:label>
    <link:label xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross decreases - tax positions in prior period</link:label>
    <link:label xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of decrease in unrecognized tax benefits interest and penalties resulting from tax positions taken in prior period tax returns.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:to="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:type="locator"/>
    <link:label xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement</link:label>
    <link:label xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Minimum Interest Payment Over Life of Credit Agreement</link:label>
    <link:label xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The minimum amount of interest to be paid of the term of the line of credit agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:to="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementScenarioAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NonmonetaryTransactionTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NonmonetaryTransactionTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ForeignCountryMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill - component 2</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to the difference between the book value and the taxable value of goodwill.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DomesticCountryMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StateAndLocalJurisdictionMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill - component 1</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to the lesser value of the book value of goodwill and the tax value of goodwill.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxAuthorityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxAuthorityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CorporateNonSegmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateNonSegmentMember" xlink:to="us-gaap_CorporateNonSegmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and Other Accounts Receivable, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementLocationDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationConsiderationTransferred1</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationItemsDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_ConsolidationItemsDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementLocationAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationItemsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingSegmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_MaximumMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RangeMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OpenTaxYear-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OpenTaxYear</link:label>
    <link:label xlink:label="us-gaap_OpenTaxYear-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Open Tax Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_MinimumMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RangeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountingPoliciesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefits-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_UnrecognizedTaxBenefits</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefits-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, tax</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefits-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, tax</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfFinancialPositionAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross decreases - tax positions in prior period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross increases - tax positions in prior period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</link:label>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Write-offs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsFranchiseCosts</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise costs</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the franchise costs in the deferred tax assets, current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsFranchiseCosts" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsRevenueCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred revenue of the deferred tax assets current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsRevenueCurrent" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsAccruedExpensesCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the accrued expenses of the deferred tax assets current portion.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</link:label>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Recoveries</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfCashFlowsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the current portion of the allowance for doubtful account in the deferred tax assets.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LatestTaxYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LatestTaxYearMember" xlink:to="us-gaap_LatestTaxYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetDeferredRentCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred rent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred rent in the deferred tax assets current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarliestTaxYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarliestTaxYearMember" xlink:to="us-gaap_EarliestTaxYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetRestrictedStockCompensationCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock compensation</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the current deferred tax asset of restricted stock compensation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfStockholdersEquityAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RepaymentsOfNotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_RepaymentsOfNotesPayable</link:label>
    <link:label xlink:label="us-gaap_RepaymentsOfNotesPayable-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments on notes payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charitable contribution carryover</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred tax assets current for charitable contributions carryover.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</link:label>
    <link:label xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred tax asset net operating loss carryforward noncurrent.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment</link:label>
    <link:label xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset basis difference related to property and equipment</link:label>
    <link:label xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the asset basis difference in property and equipment for deferred tax assets.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ReceivableTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="us-gaap_ReceivableTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member]</link:label>
    <link:label xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to notes payable delivered as a portion of the consideration paid in connection with the Company's various acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromLinesOfCredit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings on revolving credit note payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State deferred tax true up</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the effect of reduced state rates on the deferred taxes in the effective income tax reconciliation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State deferred tax true up, amount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the effect of reduced state tax rates on the deferred tax amount, for the effective income tax reconciliation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions</link:label>
    <link:label xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions</link:label>
    <link:label xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of notes payable delivered during the period as a portion of the consideration paid in connection with the Company's various acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:to="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:label="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:type="locator"/>
    <link:label xlink:label="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executed letters of intent for future clinic licenses</link:label>
    <link:label xlink:label="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of future clinic's licenses that have an executed letter of intent.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:to="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersLicenseFee" xlink:label="jynt_RegionalDevelopersLicenseFee" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFee-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersLicenseFee</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFee-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers License Fee</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFee-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum amount of license fees that must be paid by regional developers.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersLicenseFee" xlink:to="jynt_RegionalDevelopersLicenseFee-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TaxPeriodDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxPeriodDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TaxPeriodAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers, Franchise Fees Collected Upon Sale of Franchise</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of franchise fees collected upon sale of franchise.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:to="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">10% Interest Bearing Promissory Note Maturing August 1, 2020 [Member]</link:label>
    <link:label xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information relating to a non-interest bearing unsecured promissory note maturing August 1, 2020.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:label="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Territory in Maryland/Washington DC [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to regional developer territory in Maryland/Washington DC.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:to="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-interest Bearing Unsecured Promissory Note 2 [Member]</link:label>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents non-interest bearing unsecured promissory note 2.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">10% Interest Bearing Promissory Note Maturing September 1, 2020 [Member]</link:label>
    <link:label xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the 10% interest bearing promissory note maturing on September 1, 2020.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-interest Bearing Unsecured Promissory Note 1 [Member]</link:label>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents non-interest bearing unsecured promissory note 1.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:label="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoryInMinnesotaMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Territory in Minnesota [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoryInMinnesotaMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to regional developer territory in Minnesota.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:to="jynt_RegionalDeveloperTerritoryInMinnesotaMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SegmentGeographicalDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementGeographicalAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">10% Interest Bearing Promissory Note Maturing October 1, 2020 [Member]</link:label>
    <link:label xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the 10% interest bearing promissory note maturing on October 1, 2020.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreement" xlink:label="jynt_RegionalDevelopmentAgreement" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopmentAgreement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopmentAgreement</link:label>
    <link:label xlink:label="jynt_RegionalDevelopmentAgreement-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Development Agreement</link:label>
    <link:label xlink:label="jynt_RegionalDevelopmentAgreement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount recognized for regional development agreements.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopmentAgreement" xlink:to="jynt_RegionalDevelopmentAgreement-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLossCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLossCarryforwards</link:label>
    <link:label xlink:label="us-gaap_OperatingLossCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</link:label>
    <link:label xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net non-current deferred tax liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateContinuingOperations</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total income tax provision</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision (Benefit), amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of enacted tax reform</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CorporateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateMember" xlink:to="us-gaap_CorporateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of (decrease) increase in valuation allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementBusinessSegmentsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchiseRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Rights [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchiseRightsMember" xlink:to="us-gaap_FranchiseRightsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SegmentDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PolicyTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_PolicyTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other permanent differences</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FormerChiefExecutiveOfficerMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former Chief Executive Officer [Member]</link:label>
    <link:label xlink:label="jynt_FormerChiefExecutiveOfficerMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the former chief executive officer.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FormerChiefExecutiveOfficerMember" xlink:to="jynt_FormerChiefExecutiveOfficerMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CreditFacilityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRentCreditNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred rent, net of current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevolvingCreditFacilityMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CreditFacilityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementClassOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AwardTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CustomerRelationshipsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LongTermNotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State tax provision, net of federal benefit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, net, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Expected federal tax benefit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of enacted tax reform, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of increase in valuation allowance, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for acquisitions</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilitiesCurrent</link:label>
    <link:label xlink:label="us-gaap_LiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquireBusinessesGross</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesGross-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsForProceedsFromLoansReceivable</link:label>
    <link:label xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments received on notes receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:to="us-gaap_PaymentsForProceedsFromLoansReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and administrative expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_AccountsPayable1Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable [Member]</link:label>
    <link:label xlink:label="jynt_AccountsPayable1Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing accounts payable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AccountsPayable1Member" xlink:to="jynt_AccountsPayable1Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected dividends</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseOperationsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Operations [Member]</link:label>
    <link:label xlink:label="jynt_FranchiseOperationsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the franchise operations segment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseOperationsMember" xlink:to="jynt_FranchiseOperationsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_CorporateClinicsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Clinics [Member]</link:label>
    <link:label xlink:label="jynt_CorporateClinicsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the corporate clinics segment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_CorporateClinicsMember" xlink:to="jynt_CorporateClinicsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillAcquiredDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GoodwillAcquiredDuringPeriod</link:label>
    <link:label xlink:label="us-gaap_GoodwillAcquiredDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRentCreditCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred rent - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred revenue - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected term (years) (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Remaining Contractual Term (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State tax provision, net of federal benefit, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected federal tax benefit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesPayableCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes payable - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</link:label>
    <link:label xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of fixed assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfUndevelopedFranchiseAgreementsTerminated</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Undeveloped Franchise Agreements Terminated</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of franchise agreements terminated for an undeveloped franchise.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:to="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, Number of Units (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Awards forfeited (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Awards vested (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GainLossRelatedToLitigationSettlement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GainLossRelatedToLitigationSettlement</link:label>
    <link:label xlink:label="us-gaap_GainLossRelatedToLitigationSettlement-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash paid for legal settlement</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Remaining Contractual Life (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:label="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional developer territories in Central Florida, Maryland/Washington DC, Minnesota, Texas, Oklahoma and Arkansas [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to information regarding regional developer territories in Central Florida, Maryland/Washington DC, Minnesota, Texas, Oklahoma and Arkansas.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:to="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationAcquisitionRelatedCosts</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_OptionToRepurchaseSharesChangeInFairValue</link:label>
    <link:label xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option to Repurchase Shares, Change in Fair Value</link:label>
    <link:label xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of change in fair value for options to repurchase shares.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:to="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Remaining Contractual Life (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for nature of operations.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:to="jynt_NatureOfOperationsPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsPayableCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Favorable leases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the favorable leases in a business combination.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Fair Value (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</link:label>
    <link:label xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payroll liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccruedLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillImpairmentLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GoodwillImpairmentLoss</link:label>
    <link:label xlink:label="us-gaap_GoodwillImpairmentLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FinitelivedIntangibleAssetsAcquired1</link:label>
    <link:label xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:label="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">10% Interest Bearing Promissory Note Maturing October 24, 2020 [Member]</link:label>
    <link:label xlink:label="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the 10% interest bearing promissory note maturing on October 24, 2020.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:to="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClinicsAcquiredDuringThePeriod</link:label>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired during the period</link:label>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquired or sold during the period</link:label>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of clinics acquired during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsAcquiredDuringThePeriod" xlink:to="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</link:label>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:label="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_AccountingStandardsUpdate201409201610And201612Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2014-09, 2016-10 and 2016-12 [Member]</link:label>
    <link:label xlink:label="jynt_AccountingStandardsUpdate201409201610And201612Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the accounting standards updates 2014-09, ASU 2016-10 and ASU 2016-12.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:to="jynt_AccountingStandardsUpdate201409201610And201612Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</link:label>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Undeveloped Franchises Reacquired During the Period</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the aggregate number of undeveloped franchises reacquired by the Company during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:to="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted at Market Price, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics</link:label>
    <link:label xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Reacquired Developed Franchises Operated as Company-owned or Managed Clinics</link:label>
    <link:label xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of the reacquired developed franchises that the Company is operating as company-owned or managed clinics.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:to="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net purchase price</link:label>
    <link:label xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Net of Deferred Revenue and Deferred Franchise Costs</link:label>
    <link:label xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, net of the deferred revenue and deferred franchise costs related to the acquisition.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Rights in Los Angeles County, San Diego, and New Jersey [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information about regional developer rights in Los Angeles County, California, in San Diego, California, and in New Jersey.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AmortizationOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AmortizationOfIntangibleAssets</link:label>
    <link:label xlink:label="us-gaap_AmortizationOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsIntangibleAssets" xlink:label="jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangibles</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets excluding goodwill.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsIntangibleAssets" xlink:to="jynt_DeferredTaxAssetsIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Number of Shares (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesCurrentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdvertisingExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AdvertisingExpense</link:label>
    <link:label xlink:label="us-gaap_AdvertisingExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Assets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label xlink:label="us-gaap_Assets-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice</link:label>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price</link:label>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the per share amount at which grantees can acquire shares of common stock by exercise of options.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:to="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreementMember" xlink:label="jynt_RegionalDevelopmentAgreementMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopmentAgreementMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Development Agreement [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDevelopmentAgreementMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the Regional Development Agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopmentAgreementMember" xlink:to="jynt_RegionalDevelopmentAgreementMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="locator"/>
    <link:label xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements</link:label>
    <link:label xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net franchise fees recognized upon termination of franchise agreements</link:label>
    <link:label xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The element that represents net franchise fees recognized upon termination of franchise agreements.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss and comprehensive loss</link:label>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PlanNameAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProvisionForDoubtfulAccounts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ProvisionForDoubtfulAccounts</link:label>
    <link:label xlink:label="us-gaap_ProvisionForDoubtfulAccounts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Recovery) provision for bad debts</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SellingGeneralAndAdministrativeExpense</link:label>
    <link:label xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total selling, general and administrative expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PlanNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other unallocated assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CapitalExpendituresIncurredButNotYetPaid</link:label>
    <link:label xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</link:label>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SellingAndMarketingExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and marketing expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</link:label>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RestrictedStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsNet</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Carrying Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WarrantMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeStockOptionMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_RelatedPartyTransactionAmountsOfTransaction</link:label>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Goodwill-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unallocated property and equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RevenueDeferredAdjustment" xlink:label="jynt_RevenueDeferredAdjustment" xlink:type="locator"/>
    <link:label xlink:label="jynt_RevenueDeferredAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to deferred revenue from previous acquisitions</link:label>
    <link:label xlink:label="jynt_RevenueDeferredAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the adjustment to deferred revenue from previous acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RevenueDeferredAdjustment" xlink:to="jynt_RevenueDeferredAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</link:label>
    <link:label xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Compensation, amount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity-based compensation costs.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Compensation</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the equity-based compensation costs.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConstructionInProgressGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressGross" xlink:to="us-gaap_ConstructionInProgressGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtInstrumentInterestRateStatedPercentage</link:label>
    <link:label xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TableTextBlock</link:label>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Tables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_TableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentFaceAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtInstrumentFaceAmount</link:label>
    <link:label xlink:label="us-gaap_DebtInstrumentFaceAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss per share:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract-label" xlink:type="arc"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>jynt-20171231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:32PM UTC 2018-03-09--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-document-and-entity-information" xlink:href="jynt-20171231.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets-parentheticals" xlink:href="jynt-20171231.xsd#statement-consolidated-balance-sheets-parentheticals" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets-parentheticals" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockShares" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity" xlink:href="jynt-20171231.xsd#statement-supplemental-disclosure-of-noncash-activity" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:label="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:label="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:label="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreementMember" xlink:label="jynt_RegionalDevelopmentAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The12MonthsEndedDecember312016Member" xlink:label="jynt_The12MonthsEndedDecember312016Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312015Member" xlink:label="jynt_TheYearEndedDecember312015Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312017Member" xlink:label="jynt_TheYearEndedDecember312017Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="us-gaap_CreationDateAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_RegionalDevelopmentAgreementMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreationDateAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="jynt_TheYearEndedDecember312015Member" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="jynt_The12MonthsEndedDecember312016Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="jynt_TheYearEndedDecember312017Member" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable" xlink:href="jynt-20171231.xsd#statement-note-3-notes-receivable" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:label="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:label="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:label="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:label="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:label="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration" xlink:href="jynt-20171231.xsd#statement-note-5-fair-value-consideration" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt" xlink:href="jynt-20171231.xsd#statement-note-7-debt" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity" xlink:href="jynt-20171231.xsd#statement-note-8-equity" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The2014PlanMember" xlink:label="jynt_The2014PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="jynt_The2014PlanMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_ForeignCountryMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions" xlink:href="jynt-20171231.xsd#statement-note-10-related-party-transactions" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareholderMember" xlink:label="jynt_ShareholderMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="jynt_ShareholderMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-significant-accounting-policies-policies" xlink:href="jynt-20171231.xsd#statement-significant-accounting-policies-policies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-significant-accounting-policies-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AdvertisingFundPolicyTextBlock" xlink:label="jynt_AdvertisingFundPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RoyaltiesPolicyPolicyTextBlock" xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-significant-accounting-policies-policies" xlink:label="jynt_statement-statement-significant-accounting-policies-policies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CooperativeAdvertisingPolicy" xlink:label="us-gaap_CooperativeAdvertisingPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionServicesCommissions" xlink:label="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-significant-accounting-policies-policies" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PolicyTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InternalUseSoftwarePolicy" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_AdvertisingFundPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CooperativeAdvertisingPolicy" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc"/>
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:type="arc"/>
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityTableTextBlock" xlink:label="jynt_LeaseExitLiabilityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="jynt_LeaseExitLiabilityTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-tables" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-2-acquisitions-tables" xlink:label="jynt_statement-statement-note-2-acquisitions-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-2-acquisitions-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-tables" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-4-property-and-equipment-tables" xlink:label="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-tables" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-6-intangible-assets-tables" xlink:label="jynt_statement-statement-note-6-intangible-assets-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-6-intangible-assets-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-tables" xlink:href="jynt-20171231.xsd#statement-note-7-debt-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-7-debt-tables" xlink:label="jynt_statement-statement-note-7-debt-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-7-debt-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-tables" xlink:href="jynt-20171231.xsd#statement-note-8-equity-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-tables" xlink:label="jynt_statement-statement-note-8-equity-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-tables" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-tables" xlink:label="jynt_statement-statement-note-9-income-taxes-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-tables" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-tables" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-12-segment-reporting-tables" xlink:label="jynt_statement-statement-note-12-segment-reporting-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-12-segment-reporting-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity-details-textual" xlink:href="jynt-20171231.xsd#statement-supplemental-disclosure-of-noncash-activity-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions" xlink:label="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:label="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized1" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:label="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis" xlink:to="jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxesPaid-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestPaid-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:label="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityAdditions" xlink:label="jynt_LeaseExitLiabilityAdditions-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfFranchises" xlink:label="jynt_NumberOfFranchises-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfMajorCustomers" xlink:label="jynt_NumberOfMajorCustomers-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfPCEntities" xlink:label="jynt_NumberOfPCEntities-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue-n2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersLicenseFee" xlink:label="jynt_RegionalDevelopersLicenseFee-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreementMember" xlink:label="jynt_RegionalDevelopmentAgreementMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The12MonthsEndedDecember312016Member" xlink:label="jynt_The12MonthsEndedDecember312016Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312015Member" xlink:label="jynt_TheYearEndedDecember312015Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheYearEndedDecember312017Member" xlink:label="jynt_TheYearEndedDecember312017Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="us-gaap_CreationDateAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts-n2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue-n2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit-n2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_DefaultFinancialStatementsDateMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_RegionalDevelopmentAgreementMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="jynt_AccountingStandardsUpdate201409201610And201612Member" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreationDateAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="jynt_TheYearEndedDecember312015Member" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="jynt_The12MonthsEndedDecember312016Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreationDateAxis" xlink:to="jynt_TheYearEndedDecember312017Member" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfPCEntities-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfFranchises-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfMajorCustomers-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilityAdditions-2" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n2" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFee-2" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-2" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-2" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseRoyaltyGrossSalesPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdvertisingExpense-2" xlink:type="arc"/>
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit-n2" xlink:type="arc"/>
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FranchiseRevenue-n2" xlink:type="arc"/>
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDeveloperFeesRevenue-n2" xlink:type="arc"/>
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FranchiseCosts-n2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-details-textual" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCosts" xlink:label="jynt_DeferredFranchiseCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCosts-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable-details-textual" xlink:href="jynt-20171231.xsd#statement-note-3-notes-receivable-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:label="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivableContractualTerm" xlink:label="jynt_NotesReceivableContractualTerm-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivableInterestRate" xlink:label="jynt_NotesReceivableInterestRate-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesReceivablePrincipalAndInterestTerm" xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfLicenseTransferAgreements" xlink:label="jynt_NumberOfLicenseTransferAgreements-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUnsecuredPromissoryNotes" xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:label="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:label="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:label="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:label="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDevelopmentAgreement" xlink:label="jynt_RegionalDevelopmentAgreement-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:label="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoryInCentralFloridaMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoryInMinnesotaMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_InterestBearingPromissoryNoteMaturingOctober242020Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesReceivableNet-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableInterestRate-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableContractualTerm-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivablePrincipalAndInterestTerm-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfLicenseTransferAgreements-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUnsecuredPromissoryNotes-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopmentAgreement-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-details-textual" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsClassifiedAsHeldForSale-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration-details-textual" xlink:href="jynt-20171231.xsd#statement-note-5-fair-value-consideration-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsFairValueAdjustment-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-details-textual" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RepurchaseRightToDevelopFranchisesConsideration-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-details-textual" xlink:href="jynt-20171231.xsd#statement-note-7-debt-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCredit-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-details-textual" xlink:href="jynt-20171231.xsd#statement-note-8-equity-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BinomialLatticeBasedModelFairValueTotal" xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-n2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_The2014PlanMember" xlink:label="jynt_The2014PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="jynt_The2014PlanMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharePrice-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount-2" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueSharePrice-2" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueTotal-2" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-2" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-2" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionToRepurchaseSharesChangeInFairValue-n2" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-2" xlink:type="arc"/>
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-details-textual" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_ForeignCountryMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLossCarryforwards-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OpenTaxYear-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions-details-textual" xlink:href="jynt-20171231.xsd#statement-note-10-related-party-transactions-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareholderMember" xlink:label="jynt_ShareholderMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="jynt_ShareholderMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-details-textual" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfOperatingSegments-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability-4" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability-5" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityAdditions" xlink:label="jynt_LeaseExitLiabilityAdditions" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilityNetAccretion" xlink:label="jynt_LeaseExitLiabilityNetAccretion-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_LeaseExitLiabilitySettlement" xlink:label="jynt_LeaseExitLiabilitySettlement-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilityAdditions" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilitySettlement-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiabilityNetAccretion-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details" xlink:label="jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-2-acquisitions-purchase-price-allocation-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-3" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-n8" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details" xlink:href="jynt-20171231.xsd#statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details" xlink:label="jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-7-debt-maturities-of-notes-payable-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebt-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-stock-repurchase-option-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExcercisePriceYearOne" xlink:label="jynt_OptionExcercisePriceYearOne" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearEight" xlink:label="jynt_OptionExercisePriceYearEight" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearFive" xlink:label="jynt_OptionExercisePriceYearFive" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearFour" xlink:label="jynt_OptionExercisePriceYearFour" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearSeven" xlink:label="jynt_OptionExercisePriceYearSeven" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearSix" xlink:label="jynt_OptionExercisePriceYearSix" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearThree" xlink:label="jynt_OptionExercisePriceYearThree" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_OptionExercisePriceYearTwo" xlink:label="jynt_OptionExercisePriceYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:label="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExcercisePriceYearOne" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearTwo" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearThree" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFour" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFive" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSix" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSeven" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearEight" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:href="jynt-20171231.xsd#statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-options-activity-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-stock-options-activity-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-options-activity-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:label="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-n9" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-n9" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-n9" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-5" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-5" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-restricted-stock-activity-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:label="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-warrants-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-warrants-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-warrants-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-warrants-details" xlink:label="jynt_statement-statement-note-8-equity-warrants-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-warrants-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-5" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets" xlink:href="jynt-20171231.xsd#statement-consolidated-balance-sheets" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue-n8" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsCurrent" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent-3" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets-3" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="jynt_CoOpFundsLiabilityCurrent" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent-3" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermNotesPayable" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities-3" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_TreasuryStockValue-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity-3" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-operations" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherSalesRevenueNet" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RoyaltyRevenue" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_FranchiseRevenue" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_AdvertisingRevenue" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_TechnologyServicesRevenue" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="jynt_RegionalDeveloperFeesRevenue" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherIncome" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues-3" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfRevenueAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_FranchiseCosts" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_TechnologyServicesCosts" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenue-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense-3" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n8" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_OperatingIncomeLoss-3" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-3" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit-n8" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_NetIncomeLoss-3" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-changes-in-stockholders-equity" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-changes-in-stockholders-equity" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-changes-in-stockholders-equity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-n8" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-n8" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod-n8" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-n8" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding-5" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod-n9" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsClosedDuringThePeriod" xlink:label="jynt_ClinicsClosedDuringThePeriod-n9" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsOpenedDuringThePeriod" xlink:label="jynt_ClinicsOpenedDuringThePeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ClinicsSoldButNotYetOperational" xlink:label="jynt_ClinicsSoldButNotYetOperational" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:label="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EntityOperatedUnitsMember" xlink:label="us-gaap_EntityOperatedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisedUnitsMember" xlink:label="us-gaap_FranchisedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisorDisclosureAxis" xlink:label="us-gaap_FranchisorDisclosureAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FranchisorDisclosureAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisedUnitsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_EntityOperatedUnitsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsOpenedDuringThePeriod-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsAcquiredDuringThePeriod-n9" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsClosedDuringThePeriod-n9" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-5" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsAcquiredDuringThePeriod-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsSoldButNotYetOperational" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:href="jynt-20171231.xsd#statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_TheJointRRCCorpMember" xlink:label="jynt_TheJointRRCCorpMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:label="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_TheJointRRCCorpMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:href="jynt-20171231.xsd#statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:label="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConstructionInProgressGross" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:href="jynt-20171231.xsd#statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:label="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-n9" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:label="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits-5" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-4" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-n9" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows" xlink:href="jynt-20171231.xsd#statement-consolidated-statements-of-cash-flows" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-n9" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-n9" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-n9" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_RevenueDeferredAdjustment" xlink:label="jynt_RevenueDeferredAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RevenueDeferredAdjustment" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-n9" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-n8" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n9" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-n9" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable-n9" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-n9" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-n9" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts-n9" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets-n9" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-n9" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-n9" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-n9" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromLoansReceivable-n9" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities-3" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable-n9" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities-3" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-3" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-4" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:href="jynt-20171231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-3" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:href="jynt-20171231.xsd#statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:label="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit-3" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsIntangibleAssets" xlink:label="jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:label="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent-n10" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent-3" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-n9" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent-n10" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:href="jynt-20171231.xsd#statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:label="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-2" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:href="jynt-20171231.xsd#statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20171231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20171231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract" xlink:label="us-gaap_DepreciationAndAmortizationAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_CorporateMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_CorporateNonSegmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DepreciationAndAmortizationAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_OperatingIncomeLoss-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepreciationAndAmortizationAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-2" xlink:type="arc"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>mission.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mission.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !\ ?8# 2(  A$! Q$!_\0
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M'AE<X\<I]\MO(W;%SIK)&CK0&SO9T!H=(/K_ .P[C%UIK]0(IMU ^:35WI)
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M!HJ&N^_Q#0\>H[CB;8ZJ>FBJDT_A&S5Y&ZCO\1 I[  [/;OQ[NJ-I@>]%((
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MU=_?OXUPQ55^$U?X1VJ/L/H//C?H>(-Z^*2.GJJ!J-(()&QXUH@$5;.]GI[
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M'OV&^,(PK5<)R%8BN:KQJA!(]BJUPU*Q7#XB.:J</>XCE:Y&M56KB<L,P/\
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MI2PH%I72Q6[H5S +-:D4TVFD6,2(?^5).(FZQU=O_?\ W_0 =R= #A.SV[[
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M-8LT"KJ-1/>H4TDFKL>Y/GMH\3[=JD @C6SO0! /8#N#OV^F_P"'!-/I1U?
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M[NY9C(_=V%:='D8V,9S>?M'N='0\G1T-Z V=:&R0![GL._$>[;->] U U:_
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MR?W1O?GO2!X\^> #T@5=- WWW73U;)[^:CY[>?S]">#AZ4AQ9G?HMC>PWF9
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L!PBFD$ GOY_K]/;7\^^^VAQ(AVX3*.SX\D_?896LSSRJIRZ)X8]?3[YY_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>clinic_map.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 clinic_map.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %X E,# 2(  A$! Q$!_\0
M'P !  $$ P$! 0            <&" D* 00% P(+_\0 4Q    8! P($! 0"
M!P8#! 4- 0(#! 4&!P ($1(A$Q0Q00D5(E$687'P@9$7(S)"H;'!"B0S4M'A
M&";Q)31#<S56<G2R-D1496AX@I:7HK34UO_$ !X! 0 !! ,! 0
M   '! 4&" $#"0(*_\0 2Q$  @(! P,"! ,%!0<!!@,) @,!! 4 !A$2$R$'
M,0@405$5(F$C,G&!D19"H<'P"20S4K'1X?$7)4-48G(8)C1$4U9C9'.#DI/_
MV@ , P$  A$#$0 _ -_C3333333]_O\ ?;WTTTTTTUB"^)9GO*6&<I;:G.+I
MJQ5B5BF.3+<H=ZL5SB^]IIEJM?6JEJK2#EN]LCF*2DBNU%1=Q"M>8V CV#>G
MFWB+V#GG!?Q'L 96"&KUOEU<1Y#>M$"N82\)'CJL_E/H2<-ZU?3"I5GY5US=
M4;&R4E%V-PW, C"]2*_1?2V[DYQE3*H25JM96TS&N),;6[3VIF6@$%/;*%2?
M<'J$.9%O;D8ZX=3ZY;!#U W-Z<9C*HV]G=OW,74K-S3TT<?G2R>(QN4!>.N6
M"4N+J3R(U9H/D&VNE=C'E<6QHUL@GK_/]?0?W^FK-JGOZVK6BQSU0=Y.:42T
MURV6&F24+DV.DL?J!,UN??UUTFWD+&W9PJH.GK!51FW"3+)"W40%ZP9N#';)
MW+OS0DLQ:6)FJ-A:&&+=PX1;MS)QCEPU=JGC)%FG%KJ-EBI.'(KNW:1')19M
MB*+%$K1,4]7[=[<W>0]T6=IR0AG$&+*ZJT4(5^^:R:J;/'K!I3TWBAF@*,D2
M3Y8PT^6/0</2-4Y0B2SHSGS"*-=MG!5<V^W7L%87VJ\-ARB4'9;#5K[9J8+"
M<)BPIF8[7;E<1)3+(B,2^(+U@SWI-B=LYK KPEZ<GFCQ]C%Y*GD+87\<S'V;
MD7JV3HW**<8^JVHI0*<.0BZN^302(TC(MJED^9231N_CGC608NTBKM'K)PDZ
M:.43AR19NY0.HBLD<.Y%$SF(8.Y1$-=KD/OK3BH]IN&+WBC_ !?<[;C5TL8#
M./P+89*MLG?!RJ"#^'8+IPDB4RA2J*$?QKDBIBAXI3AR WLT'XE^ZVE@BVGY
M*AY9C4S) J%TK!J[9C(D#@R3>R49Q#Q*9CEX$5G]*E5Q. F.N?J$1NEST_R"
MN2HW*UL?H#1*HZ9GZ1$RY/C_ )B>'TGB.9B(XVO\;.S+T+5N[:V=VW8+CKLX
MMU?<F+7$?O&QD!B<K'TF%U\1;F.9'K*8@BV1--8EJ+\6W%LCX2&3L6Y H:IA
M3(O)UH\?DB!0$Q@*=0Y(SY1;S)$#E02M*@]4 @"'28W2!KT<>[R=KN4C$1IV
M;J,N_44!).%L$@M2+$HJ(@ $)6KNVKL^<PB8  "QHB/(:Q>W@,S2ZILXVV(#
M^\T%2],?Q>CNIB?TZ^=;#[:]:/2G=Y*7@=^;=L6G\=G'7+PX?+-YXCD,/F1H
M90XB9B)(:DC!3 S,3,1-S&FOFDJ19,BR1R*)*E*HDHD<%$U$S@!B'(<O)3%,
M40$IBB8H@("!A 0U]-6C4GQ,3',3S$^8F/:8^^FFFFFFFFFFFFFFFFFFFFFF
MFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF
MFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF
MFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFL+_Q
M?WQ2M=ML2,9UG<V#)LL$X9N ^33BJY L30@.O"ZTE)LTXE(^3!5,CHM;46.F
MJ+ AT<+Z@$4*1 R"CLSM=NS08H-5GSI^]=KIH,F#)@W26<R#UZ[52;,V+9)9
MP[<K)(()**J$(.<+XLS>@R%;Q9\]R)(U6]5HUVL=&IOX&M%B@<BF<MH*'E(A
M[:(:+7B:;-MDUT"5]]/2K-@N9^_*X:.DB>89X?,76N6HN3J!;(.>K=4D8BUQ
M?3;K=5276!J+.26&)EK4ZK0]"\@YK\6\>R<<#%9M()2#=NHR<H+ 4Y9MV@R1
MVS6E:SEB1NSPP'K!K(LO8'0SLGU@42 $=8'0!]0]!-@USY'?$Y3%GK]N0+ER
MN-+)-VF,MIV,1>LT*9[?P>/M?-4XR53Y6VEB+5I5/.6L2=BN==\V$XVQ6N:R
MW;#4K1M\K%MK%UR0D,8A6K7?,AXBC&56LR.T9Q%(/EV$YD.VM+R[/7%K_78!
M-PVQ*R@A70G6\U*-VS4&%RDQQ*Y5NT'DW*V2\FUJ!EZS!9%N,E<6,'/2#63E
MVII=-L9VY>+,FK5JT/*NTEI4D0EYP85-Z6+4E)55J=\MD'S%FC9[B6B;D*;M
M->65Q9-TU3JS^4CZ,B1AA&G/YR""ISLVVB3MXV+J=UD:<W(YO\6UB'=DEY@(
M-M,$CY$THO'XNRE*0I2$*!2%*!2%#T*4H<%*'Y    ?IJKQ-91WLAEQ1:3-Q
M=10E;K11<V90FS;,Z8&8! 6F?*)83',8JI#6/:]UAS:/UFSU&EM[8WI;A,YB
M\YB=H#D[UEV,R_\ ::NBX5NWB<963N!D1U$6+K-R]W'4$X_'5;.="M6QM&A0
MQ.-QWZUP   <!P ?D !_@  '\@UVHV.?34M$0<2V%],3\S$U^&8%5:H'?S,Y
M(-XF)8E</%F[- SR0=-VQ57CANU3%4%'"R*0&4"?;YM)W,8NJ,[?,@8AE*S3
MJPW1=SLZK<,92R3!LL];1Z2HL("[R\LZ*=T[;D,#*/<'(F<RYRD1344)>FV:
MJ6*4ZU62U\P*5.>E37%)","E;#$VS)$(Q #,R10,1S,1,)T-O;ARM/(9'$[?
MSN5QV(43\MD,9ALED*&*0"F/-V3N4ZKJV/4"$N>;+;4@*5,;,P $46\<!_+T
M[CV]>P=^P=Q[>@>GIKXN&S9V3PW3=!RGW_JW"*2Z??@!#H5(<H<@' \ '(=A
M[#K[<]Q#@0$.?7CVX_/G@>0X'T'VUSKNB9CS$\3]XU9Y@2B8*((9CS$Q$Q,?
MK$\Q,:J"HW6_8[,!\<Y%R)CL.HAA:T>\V:N1"AB=P%S76,FG6GP<E*!BOH=P
M4Y2$ Y3 0H!=A+?$OW782PW4K6\MM7R9/7/,%CJE::Y&I;/P$J%BN@UM]=G#
ME_1W%+>OY&7M^4:7'M9)PJY59EK<D)BN!?N"ZLO[?WA  ]Q,(  ![B(CVX .
M1'\M1+NJD_!/@:BIJ#TU/!<%<Y-L!Q$$;'N G)C-!SJI&'^I?ACZQXOB'Y.
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MUP_F(0Y3$.0IR' 0,4X 8I@$! 0$H\@(" B @(=P$0'721BHMN<BC>.8H*)
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M63ET58N!LJ+)VHE*O[_7]_GK\F,4A3&,(% I1,8QAZ2@!0[F,8>Q0 .XB/H
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MX-E-6:HU["FVL6S(5AO45WT 1,JG<J$-FN+A FH*&A$A,%JD=!]!]M-?D3E
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M[M5D]-T5PN:=D9-1,9#!( 75;?\ 6' ^AC\?N =C5MY[YRF+?E-M9',90J^
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M'3LLS0+_ &>P-D'A&XE^DOTBD)>P=NVO16N5G<B'S"40FC<"7KL,!6; H//
M<BO,PSQR80Y .HJP& .H0$#<B''G]/Z\?Y3^OW_[/'Z_TY_AS/,?]-4YIKW/
MGJ2G9U3J Z]0,H6$G8=T8!#OPI6[9#M4Q'TY38AT@'TE* \:_(OJPMW7IK]F
M<>!ZX*^2B)0[!U=+:R0=H( B;N &<#P4!+R/J7G[?X_:/\_\-/\ 7'_IX_Q^
MDZ\776>&$C1T<O\ :(V7,7U]02/QZ??TU40#3#@7G^D)E_S"=:FV$I>Q1XZ$
M(RK*' !$1 !4 XASR(CP&@1]2? #<EIG&GCF00$)6D)MR@*QRD$GCQUPD>X@
M<.# V >X<$ .1!I_T\>?X_T_[?KKV[D[?QEPFF#"3E&*<.C6H1--E*/FA$S0
ME/KD:L4A6CA(A0!VV<&^D.>L3"(]7.O+);KBD'"=RMY"_P#)^)YPZ8]@#D4U
M'QTS#V#^V4WII;UA<72[N!$1%2ZVTH"(<")$)]^U2_/_ (+=/@.W >W/.J?U
MQ'M'/VB)Y\_37,_7W_G[^?K_ !GQYU4@W.X&Y ]E>N ,  8'[&!E^L '^_\
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M)MCD&S=FA%I8=0:JR\O,P=?B$G*62<EF6;B^FI)B11=,BB2BJ38CA0A5""8
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M<)<&$0-P58P]/J!3=M?0-F^X$W5RQQ0CP7D!6S73 ZN_'2'@"XZ3 '<>H"D
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MC,4S7/+N4+8Q?H)N31\I>["G!J%<) <#$K,6^CJPW Q%./#:0S=( ^D"
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MK]-B[BTY(T<=,[251CGQU731M+QSAG)LRG6726:.T'+1T[9K-W2U*:G(#%@
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M//R-KEK].5EY'2<,T0=.ZQ4D:U664G$QKMO!I-Y8C,C0&<8M&M7DJG(V. '
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M(9",).(,+U=M%MJ]=&JB:-A&/MY)V017AT$4[9NV)0[8LUYHC<@V=N21C12
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M:3Y+(]:L#AE>3R<BM,OG\XZ;M)1*95F7*KE>7;3T+(1,W$R*ZQE'$*_8 <J
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M$Y"]*&!<8-*JV]7BP"CCYBY=KX,VC @MV2)<1K;[X)?47;F!HV+FZM[X6O\
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M&#&?O"4I(@9 1$>>_P :E+"U<_L3(V#E5S.X3<>$R$5JM>73C,;:Q5RA>L6
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MLO/V!P[L3LBSQ JWFI]TM,N 4*=0%.L%7IP,)@ZA, B;OSKUB'*J7K2$%2B
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M#QIIZ<<]N?3\_P!--=^J#35:XT<':Y-QDZ3 IE&V2L?.4P. B05&]QA%TP.
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ME2@#GGICCSIJ>L8)*QV&]T]J*<I4E:=AW$Q1$Y .9[DK,T+?.A),5"F,887
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MD4J7L(!TJQR[50O'/;I,'' <<<:K:/R9EB(**</F7-T,D/;PH?-V6HE$ X[
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M,Q(C$[ASD\S,<<3!9"8GGVXF/.N\<K"B!K,7M(5I,7&2]@[$68BHA.2!BMM
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M^/=CSYGF.)EN63$3'/,=4<<<S'&WH*KM3?V1DX%=BC@=N"$'(FVQE,]5S01
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MH',DX('Y%6(<H?I[ZR*DVP#[%&TR'LK@EZK72"RL5K!. .\L(%86E,KL!_9
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M AS_ !X#V'GGL'80'OW["'<.1[Z[8]X^OF/'WU3ZDVU$,CAW;@43_0]#<O-
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M,;MA*!BB<N ;.)P 0$P ?=7N6%+JX[@!D^Y 'CZ>.GMJTS6SNQF$S:6"@O\
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MDD0S?(F4I6,>/8:NSM0\*F8X;*O;%"V>W6=W#+5" "$(F0B:92D33*5,A"@
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M-?4UE5JY5P\LO+14W&KODXUE74SMPLJU@62H%@HD[5[B9A,X#)/7R&K-PS-
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MPPA9P]_[,#%*IE8PN9FY;[WWD_57)XDXVQ1KYR;&2:\\+7;;R6>R6;91:Y8
MM,69I)?3(\-B/]_L5'Y'(_[];FV,+NSV#[=/Z=<R1MIEWD.I1L,66N6*UUI=
M4YYJ?DW,?8)6D@1J*"K4:XSLL T=3(NCD4?G;(QK=-1!2041V6-6@;.=K5>V
MTX^(*99H^1;["U"2RFYEIPLLW3LL7%K"M#0S=B",*RAX.0EIAHQ/'(&4>I*
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M;>9 7(\^(7M(V1Q/Y9Z@'\WM$QYU;\NB#A!9#JZ?'151ZPX^@%2&((\#P \
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M5ZK:%IV&<Y*@VCF1914]7X*U1*$?(*M"/&Z=9=&O K_(_) _SW[?-@V#MO\
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MIVDW%"+1NR@8EZ%RR?E2D@B0'HDNN.W&8C:F$MLRF(P=JEE"HY"@LQS3W8Y
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MD-D0L:)9NN8K?X\QVTLLVQ<I/7-*(7RCJ(;L7;F-!#GU^W'';@>?X<Z ''^
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ML6A5Z+41@K;8Y>9>EQW2EL"8@AXVEP=DN"%4R/F"^(JOGU=@G:24O<)R7?\
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2---------------------?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>support_map.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 support_map.jpg
M_]C_X  02D9)1@ ! 0$ 7P!?  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &: G<# 2(  A$! Q$!_\0
M'P !  (" P$! 0$           @)!@<$!0H# @$+_\0 0Q   @(#  (! P0
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M*PR*2NO90M25LN>Y!W\4K;I=T_Z@E^W/.3<9!B_K=UU5YWV"-53LL/247;2
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M05*\*OWWHUD,'8HAJJ.5>.LZU V9 JBB!(T%UJY5 !9E:Z&PR.G[(%O8&!!
MW[PW+BP/%K@V4M0KUC@>D*TV'%0RP>L348@1?^U2OQ_W"5+%HCUGQ^Z?S?\
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M$ 2 AM%%SUL_54X/WOI9W%[(I;\9Z?#9[/5$@-T=U:>H7ER@M<E6$442T0M
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M3620.1$O6WQSY)^(O:T12M8^2/>L>U/,>;=7,@09)!ZBK4DUG]TT];^+>O\
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MXHSL!ZZKL;0[X?UUD>Q6Y=\YYVV*M!DR(DTU_8)I9!UU0L3F/4[,O,\[FP:
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MKUILN!"E$*#(B3(G$L^Y&H"J/(]>/L4!T;LB&E<#JUHNU\LE1KIMHK7KPG:
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MCO,>A1VK,34@[6I:)B8G\^.MAV<#F*#2"PV[2D4[#-J(IAMK Q50RRW!NNV
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MM=7*RVLDZ_WJT;6>R7V6K261]89+187$[MG-I3:^&MF93%:(EB\50CB7J@P
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M52Y4F&#K=W-K"_[HJES15MB2I_W$TE>M,I[Z2M6K*X \TK55$4!;>=ZZ"*]
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MQMC'QB7"%KK'\?'S]F7Y^?C'QAG\95!1AM<[=+"K3Q$V'%9FY!BB/:@1V_\
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M1]J'K2*-!/G?&,ZY%LMNTM(GTYQM(54==M/G2*3XG3[S^_J7G:7IO#.3B](
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MM%] TQ'M'(-54$*_FM;C*EEBBSO*P(I[ZRPZ1RRCPK["%]&_WI"==;"\9_\
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M\^XWS;II%CM&*6A<,*RA;WRG[7RCN+QCBS(,_09.QLL_$T'CF4JSL[YZ$@3
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M>=)HQ:M9Z!3^<I6UJK(VHA;6U5.&OEVXMS" :O'LH%J=@/ W(S2:;)BAN3%
M0+/]@J+9&9KH-].)%]1LFN,Z_7*L8MJ89+IG/QMF%.ZAN*[!&NN,YQI-<!1Y
M=LXQF4;7.,Z_PB]5D3$DKQM/6OC?;[TUR7M:B'')MG.VVNS=^*"BFSMMM_\
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M*(,:@>/VSUV^Y7_L_/0D7S]KZNN^ )3!4QUSTN;9_N1686,A8;2,LR+[-F5
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MB,XYQ)#&% _6JM-],]G[+!3$VZKB/7;50+F1U2Q5JPPTNVV^G](:5)47T+6
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MNTOO3JN#QL*ZIT/<"U<O7:K4>K<MC>WFHH%H)A==>X+H5H+F&KT;XYB<H-E
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M\27VM,Q%8M^8ZP&]SSC/%,J-CDVC.8E!P*D/".D[%&&/;XJ?#G)N,36WI?\
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M0U9J#&V)N5VN=D37&F .?N7;1!2L@#E8K[:<8!7JR+&Z/OWL\Q]4Z3P.[O\
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M\D;9/+=GC'&-G#7H$61RU#]$Y)1Y&QW;?")XZ32%Y(&PJK,-'-2][S\GH*A
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MW+P^DVQAS"Q(V+^R)(45<1+3^@\]N,D$12ZW)*:H:FY3"/0US(1%920 S1Y
MF&D1NI$7E23KD-?JO(*3T]L4@<)K98NEU*:K[4Z0]O-I^[V\Z4<UL4U.*L;$
MC>@31Q0X4Q3D;E1;Y+^O3;.]XUA?^M7:/6SCGM%TP_C9J+CO7N7D=!KU'Y#T
MF5"ZN#H2IG=2]?ZCS_LUQWF+IKA9>55H81I:^:LL<U,CLQ6LV(&> =AQ:>B_
MLWR!=ISCFO,TU7J?6A2'U*KM(J/%+XJ@7J+=M(Y9)>6SJ[6LJUBC;F'#'DF#
M!NX(FVY.NLP)N!_O@W=H?;#@W&L 7 ^0D2X_RMW)Y]R53#HBF;79TFV"YC4:
M&<H-G=_1XQHI1S12:E1%)4S% 4%/7:Y[VF+W'Y]IZ>9W!QODVL+,U.)X;CY&
MG+90,I90C *+M,E0Q/UNVK?[":#JPS-M'$,[$FFWG6K?->BWQR76Z+1^FW6Q
M:<ZORX"4%"&U/1*&QZ,#>6RVBHE-Y*[3X?W,14^LMV,4UV)5!'EV=+)B:6:T
MWD7Z:;RO,^W$>RU>*TJO."-CZ;1^-O&;6*TVA$AYM?5[)O8TE?6K >>P""'+
M=T8SZOW!@;,7DI>E#"!.;6Y#>J7,N-$S2\9X:EI;F^5/I_*6K[9K; 2"5%AJ
M1=@BT8VBQ[7 V0 1K3!#MH!AYI-IX8YHX]LZ9SYB#GKW/[#T%KQW/8J1'WB^
M=%M=?L'.%W3;PJ KR>EUI@T7II\5)0'*7BTTVJAQ'MW.J4J>"W,BQAY-0$J+
M;#<X_J4Y1R]=\' 4MG#XT9 WZF^DM!N8*CS:KE,V?20<97RD0ALR,C((B0*G
M+!&QD(.1[3PG^G?BG% XNOW!;!M:L:1P))P< >,RZY;PDFOGZ:JY=%IOTH?X
MC3/SLJCD2TQ6\$@[[,^K_"*=T0>7FO 7-2.BYD%8ZVC$QT!X.TL5,L5L:S6
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MHXE./Z%$SPH8>5JTT,VQF$6'AU$X4<T4NJ1!;=N&]LN1\HW^'J+HO"P]C37
M7?4I%\]&R8CN;JYGE '6'MY<9FA $VQK$EA4!I*Q1D6@WZ\^(IK/7.,<BKUV
M'$$N:'F%!36X1>7(> +9U=44@OQPCIM=93!(&L!<0Q<NNLA$.NDV^N-M\X\V
M?X\>><E8]:Q6/XB(B/\ PCQUZN6GVM:T_P VF9_\Y\]/'CQY^]?G3QX\>.G3
MQX\>.G3QX\>.G3QX\>.G3QX\>.G3SY3P1$P3#SQZRP3Q;PS1;?\ =DCDUSIO
MIGXSC/QMKG./ZSC./G^LXS_?GU\>.G5(7ZW.:3IR;U61=%4E0<Y)]HJ>1?>D
MCJ*K;;%1J)7JO96-NT2K+D"^V9N7-=A8-,[RIGH!4%5+%<+F91RL WR;G(0"
M*<:@&8T'NBJK1&(:G>")ML;/F2W66HIV^Z*93:IQ2&[36.?00UY"RT#81J7<
MDIXA9Y'L _6;]3.E>SGK[4&G+,6]]8.26\YTVYQ3\"DM[S4;@DGJ+Z5"L.@)
M$,MU2R8#8E.=8MF,B >W*$NLS9R(*1Y$KF'#-I>ZA<:\J6=)K;(A!;Z^V 3I
M;.OL [&.!P=& _(1D@MPB0V4FRYS,NW$L:,Y*;OM^!M-)>+^G >87BCA$GA6
MU[2VCK8\2"YS0JR1[);D%_F9@=1Z30!D^"R3)"V&"%W$6R-^>G]51=<7,T1/
MYI:XE:I:.+N3#-5PW<6%G[2,'I\"EB7)EI,D##-'E1A&5F64M!(:/?:O144B
M6O5N8=BVK;.FC*5^H;29,/FJ-5)N@QC(&#"Q?^* CFSN+EA ;!MI'C,.DNT>
M-K=JF:%?DP;:FJ9:KS!J.,P@D6#1HFEMD)CVU:IXQ%T2YA65M<<P$(WC"7$;
M:R,0C!EN1$6G[F\J-"8%O10BTF=*Y6"URXU1B58/NW(#.TU-'V'6Y)W6(5^
MIQ]8(3!"F6\V9OO  :11Y(N2_2MIG*;%5?9'_%9'6;;GGS'G%E@:=:RI.JM)
MI5S6]!B>,E0+V$&F4D8NP54\ZQ65:,N:'$$B;-F6V!EV==Q[U^F5QK_6-52,
MSD%41,,'A>AL[1<$LK%RVL>]8 ^R.HY@5*,5<GQ'B*Q>#>V7#R<_Y8APVFJ#
M)-H5T6Z-.B(Y8;2.==UJ1+AA:I#%42FTUEB(7@)9N3VB*5W%QJX+>96JA!.W
MMIJW$49S(AA5:W,?FBU^P;.U=MI[YC4@<RCHJRJOX.+-9&M97P$#'3[,[#K)
M6R+43I,Y+P>MT7O<-Q#82+4YL]K>5.H#J@8TRZ]NE3P6WJA&L9F)@XOQ6MAN
M2!5JOD'(T9/%X&5H52%B85,>V?L?ZP56OL.>^LE<7WIO(*G/==^LG2^FLZQ5
MUTVV^YU*J1KM\0?9,L44DH#AE//_ !Q4:R$81Q6JS(H]5ERO'.C5WV5X+SOI
MZ0XF,2XU>L,&4N&FSY_SWIBI>M(>IG#"<%5+-<*/:M=]#OW!8JE<:::E%+8U
MKC,$E1>=9&[FIH\M'AZW&LOE8W,PU'H05L]2M1&J1C.7*1M6^A$LDK+XZ$:J
MI=I>\T+:UKN]EP9+%FNWO(N1<8Y]J=NWLCD>"]EGW-&<1KW96NHGK:05EVE\
M*0Y=1#S(A-2VC5!H-B*#@6TWT*>=$VAL9,85=E5RQ.C9C=%T80.^N?K,U829
MQJ"4+)]L@$K&?NP&QCR0XVFUTQGI*B]GL":.=AB71V!-NJ?1SJC4,LC"#3$X
MS?"9C *<M"M28A;;%@1$$<P:]X."3'"8*2/#P:V.8[EW9W284ZV5QIL)*D$"
MD7UBI,H8=-PVM<4DDG%'9>KI1G:BTO#&)\(ITP2G]CVC9KM>Q9XD!M==8C8C
MVQ:-BZJ\'^<8EFPH062WH'>,8UVTVW396N4I6?KBVG'L8GW)9,K0AMH&WT89
M1DT1$&3BQ(G\?N#/B34_G^?6*EK_ )F1^D?DG5C=1>" ^6/$7!YM_MYI;Q[Q
M/^\Q^+5_F?,3%?\ KGSD^F^T>V-M-LQ[?YO\VNWTY_[NV?\ O8SC/^O_ (^=
M$ZKJ2R:Q;.EHI98^\!"]Q@876P)CA9M"0V:-W(/*>K9 E10E!D#2ZXTGBU^Y
MI+%MO'MW6/C;Z?\ US_Y9QKMG'_VS\?_ )_.+@T/!>B_)P'[AM#'/JN_-$PQ
MV@EVFCBGP!M-@O,,TD$ND4V(?M2;PRZZ[YVTWUUT&)]9B];7K:D^T6K^)IXF
M/%JVBT368G_,3'B?'B?/6LQ/BWG^)B(F)_B8\3,^8G_$Q/B8_P"//^.NK3M#
M?S/XZ_VAVL40TQ@9\,.HP=O4B9'TG=KAHM-8@6(<A$$-D01[[Y6E21G!Z[HV
M $N,GTCS+)I%'C&V\F^D>NNN,9VSM)OC37&,?\\YSG&,9_W^/C.,X\PZTKH&
M9M00,8)\QDVG=R1B,M@J.%%K-<?L\$"'K2@&H6\[C*!21, 8-),"S)$EVW'(
MFBWXU@!,KU>L3I5<+@OV1UNP.!8#&:ZT#X(5*#6 ^-B+DDLKW?&\P\4/TZM]
M]_C;&L.OW/H\DC%<,ZC4QXCY*7L*;_Q\U:5I,%FL?BLV]IK:(GUFU+6K%:VB
ME=KSSD86BY8CVK>P_:/_ -R*UI/O,>(B)F;36T1YCVK:8\1/K'.JFT#:N3&[
MQQ'K;+8+:^'C*'C*$,5,+*RA0D[B$Q2121%5D1++'K+%\;#[1Z[8^?G'G]BH
M]2$^O*Q!"@Q)))-OI426]*BWED^<R2YBJ#!%%]V3.?F2;.F9=\YSMMMG;.<^
M<15*[K:M(@/I+*:!$C3H]2ZF]KC\.*-$M$4QZ3B/S*2]QOF,;7?& $K37'QO
MC.V-OC7/(*N]86#S&6 PZHKQ8""C7%RKMAJZ  02/>4HH^S-E8]8#''BTWFF
MGG<Z0Z0QR2XWS'KG;S*3$S_,UG_FLS_M_P#V_P#7X_V_/>ZZQT2[IAE;; G7
MMY797>Z>PIM=JY92=,/%9B.H0KBGVJRWZD,;XQK*R0V2TGK0@B"97PXRK)3E
M=A'0Z0FZ!7[^5?:"G;V2];0<VJ,-W24'HS&MJV\*>K5HR(1L58Z:%JLM9C_I
M1OXC">;5?OM^6004)$NAS66%E?)0I8\VNJ4E?'7+"(?(ADKKNV6+4TEVMU!D
MM"R>8*NUJ-:A:331)\2/VK6$+!L0B5F&?^C5K4>QT6":UL'(.[UJ>0M;)JS@
MG:--3;-G0^%F@65_:#45HS31R:SKS(I)"(M,9AFWBDQB=!9QDRE0V#58;"Y6
M+UN034?&6/,#M$^D4K2)O6//O\L5F)B*QYZ#H#M10']N4[7I+ [3;V)6+3%Z
M6K,2.XYI/_3/F9M$3,>(CSJOGO)^1<P_<V]>XUGB5RM:ZO#W\_CM2NZ"O6-A
M6LM<ADZ_X8RV"K3J1CGCTY$,_'_*$#=30F#YE_)UQWD+\1ITNE "]5%:KJ^D
ML5M9I[<-25CV6=X$;1:PO4P )J"_CG(U)MS PYLOL'XPR:,'(ND[J)D)OC7&
M?JQ]/U8VSMC&N?JQKG&?G&,8QG[>,XS]7]_/^OU9SGY^?->4D^*X37^Q&AN)
MAF%X8TY</:%,\:Z6J\S()K*J5!JSD)!;H6M@WN%IB8 P08U86$Q2>/JQ3SXQ
M^/9S3MCD-MZQB'I%"V?:N_[UH*@ATF2DH2U1AH,0XN2TC%2E:SXI6.NH##73
M6JGGDLBG7W]$P4'10<$+8Q*B7#4 Z00MR$O,1YN0E[W]KWM,NGO5%3I,[VSD
MD+:[_(Z O:L8E3ISM&M9WVM0LM8@$"UJU+S*IP=IM@( G;6':2;?3[.DF^O0
MR>S'#ON2:;]>0Z[?1B>;:42WPBPZRRR:ZQE&35V( 2?.V-\Y#**@+TCVUEW@
MTCDTWVAC^I:U"Y9P>AMJ*JK%6MK_ +Y5E@;5;5:ON1JO7<[Z?8'>=1IU<PV^
MLNRU6'/-M!B73)<>(Y=-M]=LU A>UG75OSNQWH#L>/7YWV;UADMEBUCUWDWW
MV.KEI2"PXVQKC?;,BZ;37XQM]K./JUS.W:GL+H\IXJ;;7;N23;+B@1A(HO8H
MEE<^M;11N/3S]@AZ^WV_%O7T@=)K\EZR=U^_.KVIY?'%\[+QM1><7.U&6'ZZ
M(SB;:9?J4$2JU47PPDNJ4?D,W&0U[W(6DU#3T!6CV ];CC;$"YJ>.B1II3Q8
M6"_G=5M:*W& A1RX7H++J:;+B(TW:9)JY9C+%(QT!<Q1L(<6I>^A^7>RAJO7
MINEX5-]R8TJQ'5Q:$D1Q) +'E.[L)R_8$R\A?,:\>T4U.$X'1#;$:AEX*DEP
M/B3-='%^\7SM%O5UA-RB!B!EPN6W._5M_8V-0YHN/B.(DL]\-DJ3 &NI5J]:
MS<GQFV##'*-0Y/7",,*BH\S]F]7.TU^-T;E=1K*$4X:NI2ZGT$?'XP$ @\&9
MYH[LGH8\GXP"F/!'X1QN=<Z8QIKMC7;?')RG@W;[BYC<3YAL2AKM*(,$^72S
M;LI4J2"1<#2JK:.=9V:5(51XI&OHD#>:PNP$Q8_IW;[\\UHGR; XJG?CZ+NN
M%5=#+T2)ZU2U'2 : S[%']FV56PZ!<RQ)+?>H;Y!R<95PS(K G >RBHVNG/Z
MI9F92(E0!/T'DH0MA<J:2=O3V<<!=KKF=K."@9!["SX 8N(E.A0Q.V!(6(FY
M'G$]^10ZK[0]^O>_\BY3S&T](L1U2<6&FJZI1;2QIU<J"+K[6I-;)72P'L,_
M6A+HV.F0V":4F5]$RV 5;M10HKF^1<[NC.M],I3:IWJOMK>+0+=0P['*N#H-
M-FL%:O"POHMGUKMT<S'R64*#=':N=SJM-+<K1)4CD6'9BV:(H*?K":E5]SQ>
MIU_2J(7[?F?7Y%L545/4M;F?WAK0Z'6W#*B_R;]C'D$TH1Y1Y"4@9I+7D\\1
MAY ZX/&F6["Z1<;N^SCYEJ.I:BN_D"T((2RY<U=&W)U615"=>K+0[XJ^<8DW
M&K8IFK+6K%Z5%(W>VKO,.P:W(>693'&]O%?XUL-9)TX5M&HUH4XHT#X]"KCJ
M2-J;S&C0=ZE9J,2=#6+:IZ=5,5E\EQ6Z\1M.VART5AMY9G*6TA%$EMX]&!QI
M.72^*6'\HTB>7XFWCAATDUAACBABTUT])/H5)Z\V#U)XS3K@W]=;8U/VZ 8^
MJ]V/X_8'T6S_ *E=F^1&-?LTIKG3.J/\0C(Q >F\8$6FVT.L,6,8HX]3O0CM
M?>%G1K7SVY4O=W3W*JNOGE]N]E62L!++LZ>HJ]61#.9]$@4**^F3*1BA,N!M
M2B,0,9=Y"29<:V"^JGHU[+\&]J^-]1ZI6T+BG5\WI<<A%/MG-;2TPV:\:Z0I
M4RPCZM*DYS!J8=M)OM(JSC2/$>98])LZ?$J_U Z/!^9\7:XAH<_R^/<JX<[_
M *A'AU%0KK^TGQW1IFY%*LZ244*Z/6'ZD1+H7!<M:CJW-9]H)[#8_+N/\NS=
MQ#B&CL<<YC0''+[LV)59#(>W\[]0V/5=)F2B2MGWO(7?T^IZ!M)2)S:/6WFN
MKLJ^3!6,"PVA9J+SP^X#AICTA*073*0ZVB"*UCNN/5XJT;66,80,..(70'6,
M6'3472"*/[V>IV1!S*]!A]%LQ9,'/^J%[Q.$7--X2K"\0V=R?/.8EY\G<"Q3
M61N62/$(7KL%%+&-'I+K!!IYSKI8\NZO=:TM27G=T3785LH>*6Z,D@@MWYZ@
M63>1? Q#ECV$$:2S:0S2[CP#[;D1Q8W@^YV'1[.D:UBU@$A6[42QX_CLNAW-
M>D:BRC6]^NK<L!,F]2_%U'G'=;#[2S31PXUWSOK)\:?.*4!476\2!9<5IK%+
M7$*@KVI$1/B]J4\S$S6LS$S,3,1Y\]>D P"%/F@QTO-8K:]!UK:T1X\^UHCS
M/F8B9\S/F?S_ #^>OOT*:^"U:Q"3URJDZZ0KP(M,WZSB:2_<<+ ,QY@)Y*=B
M+0C,F((,?=(UCS)I][;?3&?GKGNK8ZW5_5KS:KE9_$O^\<&+0J>0$?&U.Q^0
M3^[41+I'+!MOM##IF$G._P"3C;$T.<[:>8S:9^-!EUR"=NJK"YE?-]V,)ERN
M'/@R,CURUMA<'Q'/:U'IC9RJ33C:3:Q2$F"@YC^YC6+7SG3'<[*M5/RLZ7IO
MF-)T(C&5_?WS/333,W/]-]98RNA,H=M9-S,2XP1%OG3.GU1YBQICX[?7+UQ=
MJ^I?7*3??AE,*65,@L!QO^W<FE9N+([K->.#S\&DK1]U:NNM ?@TB8@[<^60
M2$,> *,F;6FG+J#8%O$#W'#&YK!K7:Y Z8"6BJ!%M5P/%;&:(*64M[&G)W'P
MV(&9PY(S%F$R&#3ZM9-\:^;@0#*_W"_S"=$>RQ[6P<@/0>\I7'W<#<OY[C;.
M)F8C@@K7,L$N_P!.Y,T>--LZ:ZZ0XUCQQUJ<F&N<G(@O5GV)$TYZKTTTWH!4
M6L36KB*&NF(\TF3&)-E.3\1222;;08VDDTSG?73;7D$4H"08!2 -6)BI0WL(
MM8GQYB"4FMXB?$>8B8\^(\]=1W/0T@RMHHI:"UIBUEWE0.+VM7_IM8+(R"M-
M?\3-9F/\=:R@YES-8A:& <!,5D"];32!'11TJ=L'D7LM/3:D1,ANJ,'4QFL8
M<FGY&2R"\SYSMKG.OVOJV!."C@8=+QK2^ACQ8IM<DVS&6VTTQKHNZ1OMG?\
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MVW$N?0^%=;[LJKE:6UF3N5-62KZ_T\N:56Q-DIJMA\% 4\(N8,B.Q;1':97
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MC;\)=^WF4I[<2K"=:7)]@4U>04)'JG6,643RPZ)/Y&)C:0_K'5NPP!)/3;V
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MSUWIJ'ISQQ5E8L8T</4=,;QG2]1)D)WFDVVCV AQ%I_VF7:/]Z==2J*62']
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MK;[V\1'4##U"YS3Y8\0P5T6(0:>5OIZG>S<Y_L;.[;C(\K%KS5K"M>NM;4:
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M "QYG>=<PY7W$7XXOR;8AS_35M25&(2 !IH>O;*ED3UU)6">!QD@J EEY/\
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M?&<_7C$>?Y2NEQC'T[;;8TVDVSC$>=;3?5U4S/Z<[8JV*]=,DYLX@WE9(9[
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MJWIZ6 %<$BD=Z1-?+M[9\JMG!?8CI- =X+ND1+ 6_H[BO7I:K'9$G21]K?\
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M^F&C&:[;8_<X\;9QIG>3YS\[29BSB/@\?B(CQXCQX_V\1_'^)ZVJ?YGS^?\
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M2#)0EI62OZ_)'K68_P"G]WM&V\TYJ7@'"N2<G757=8S%D;KKM7)1<C#6BGF
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M:M*=38=X!A.9";1::5_ .=M8Y=8]C(Y#,Z8WFWTVPOXC_,1$?]_X_P"?_/\
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M2WJR6X6K?DRZF-:F#4Z(A;O$?YO/%@U\3O.C3V6M-M1*"<:3:%2YI7"7:(Z
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M@;(>ZZFD(IX#21N_9@H[7U?9_:,0V\4ADEY8:BM52YS8UCX3]X$.'S7CG5>
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MB';Y&)TUTVWW^Q/IF7?J5ZR$^L8W3J)5.AB7-?9K_4[&4TMU!)6L8)\4=8)
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MVW-75I=IJC8]H7@O[+5J^FVS4:RU)L*R$[,U<)U$)<0%$V+:/RRU<((XVHZ
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M[8U'!TKX  5I]VSTK8]ZP 5?VUL2U*5BL^9@IDX/%./V%EY6+Q;!S&[,F67
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M3J%;TL5*((Z6JIKOG-S;SW"S]94'87:!#-XMUE=LV:P@?WNR4[-D$T364:!
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M(-+-RR>-2],:,GSO?[&I+9EB'2.#27.!H(0 18X5J9>*"K4#"+@1((L4K*>
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M:[A4*Z<)TCI%0;<[-OMG)<UD$F@UZXTF$=)3;G98Q8-*WH([H5V:K:744;3
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MPR_@Z_+>_N0OP'?JAV_X+Q@S1FM96K9M>=?#2(N#(:SSZ*D72S\W2)9I*^<
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MUJ,P@+ R_(6F[]W0W-P(Y[#5FR1ZVZ),'.?L8$SO@:\J8V!^1YG ^1(:6_\
M=U!<AK=$H./'5HMFT*RW4.F=!\+;+#%K#H)N1DC/@7SFH$-J*P0LT<&X_P!Q
M^,&X[Q3?C)V>*9X=1,6XDZ>= "2X8+B+O*_1S(I:*UA*YZ2\0EP"N5GRQX'R
M_9[V/:>OU)QPY#9.L6KVTC6JF-;6UFD<^OE? <-;,<67V=ZZVYG+,V >3:7*
MPI:;LD+?G/-XD[^I**R1J[S]?4"\];Z=P@.R]9OW0;7T>S^R%WTJF*Q5VE0M
M/-*>)4ES:Z6QI6><K*"NDCP?:[%)7WS*M'*U3WJM/6LXVHY XJK?(/0^K>P"
MMPR]&^L\P9=(Z!RMTHUL9?.NC3\MHKY(784=6MEVNDC4N(*W4VT37M0C39H]
MA4W=A5F5?=#Z"5D3>"?4/J C0@;'4GI_65=_)#5#.[E?;LZ[5%:\*QU8^1['
M7.C%,4X(K"-2)AG-S*'F#DG,461FP&D \4.L5:SE>,,X>?P_)MKEUP;%^8:S
M8='9+(QF%.4A/Z0$N1DU^6IR!"Z9IIP'RM/,"*,:FX"XKN"YF?DU^0L,90,L
MN?E\6K4ZN6-AAA-FVP_:N@Q&GK ^!E8+)EUQA78K18("4,PS7Y2^'<'IO;K$
MXX]RU3SR[W"KV"2Y3V6;N"4W>>"X5MX8'5U\M\7)V\=Y_D:]R[_CTFZE1)54
M+?"IP2P(&"U(B#4/?::[5N[4]HX2W$CK7/"Z3_(;CVK11 NIY&Q9RDL^K)6B
MROGS5TLI3B9+I%3\W;0".P1B&!BP31UKMBL?0;#1[C0:VI;+J_4,VB*YUAC9
MTNL^UJZ!7J[<.=NE+($-@GNBA<:X6SPVE)>Z9"K6J[0J4/)=(1Z8?<J#K%(4
M</[-SV]]]_=+M7+\S]@;&IKM[05];:A$W'E*9>Z8A54).;1'U=0N!3JV\8V:
MJ64ZJG6)Y(X9LS"Y<UPA-[FVX?!VMA55KE/'7L/./O.E5!FZJ5%2IQ=TM'6)
M6E?-8$E2HV)JQ?/66!>A8O73>Z<.<>XYA<CSU+@Q^,\RRN1\APL#.4'I.H7G
M0S]3]/7B T999>U0M.D,R"E4KNN&,7X?4L6?U ;9<6'L5=BG&\]QJP(5&N-;
M8'KUE0-= 6^@4L)Y<XT&D;<(\TK587 ,W:-U )-<5Y+#($&;'DF7[_HD>Q4/
M4?6)GP]U%&LO7K58I:_JJV/'-)-Y#?#W=JX_8]-1"3@1@!P]+)S.$9>P-"C/
MYBRD$W@#G$&A\\U<[OS_ +ET1S>?9[HV_1[0E4T6AI!8*;$OK02/!%PDC:=$
MEYG6Z^FTBK^TV%@NC_0$,.OEAF%KF08([)=L#UA]DZIZ&>[SGJLEA1;<$ASK
MR^_!5#?#Q>OXEU&QI7E&LNKE:VL M@BY _D'.7#+1<.%]5@Z B#TW->?1/;+
MDG#G]+M4AV^.E'^JN#X:VJ)E:T3E[3V".$]RV0T5=%K3EY%DS%?=41)<&-8B
M@2"K(ZH=N>YN=B]\=3E5KM+\:YWL:"KA'PS1Q(?)W!:6:30H,C*P+*;%@"9.
M(U@44.RP-FPK>I?;IX\^ I0QHHQH1$!@9D$)0A8LL<XI0Q$>LT!(T\6V\4T$
M\6^LL,T>^\<D>^N^FVVNV,Y^_E+?Y_CKTB_C^>GCQX\=.GCQX\=.GCQX\=.G
MCQX\=.GCQX\=.GCQX\=.GCQX\=.GCQX\=.GE5OZQ'+;]U#T]GS0%+&PS<\Z7
M4.DVNO*!B#FC6F)%]C5-I0EHNDDS'->*?+K>2-IIOOJ#72RHM=YAH],VI>/-
M@XKR!CBG(\7D:H!-'QM%9^BQIFHF(#>)N&UZ^;#^0<VI4M(FX;3!:1-J1'6L
M\SXPMS3BG(.*.,&47WLMK.NTO$6,M)Z3 STI:8J7X2Q0E@WM%#UK85YBMYGK
M_//3 &7]FLI=* ENMJMY$2*N55#KAFU?-FN?Q!0!@A_KE^)9)M?R)Y=(QQ!\
M2$ERP#PR2:>]WA=0L//N)<=H5M8ZN+72.6<^J%F;ZS;D:M+#6JDH2NF.I$G_
M !)\&L@B2<328^N7$OU[_P";;/F1I^>4"O/65GK]&IZ.RN<28;V%/64JQXUQ
M+)K++ADW""@/.Q)+KK+)@HB7ZY-==]OG;7&?,P\E'O!WD_\ :@'%26POT5'(
M(PU;YW:OM,-M""*W@M%5*!7#04UK6M+7/:WR%FOH,0X<[%]AO_8^??T&^11O
MZ6V)5.LKH7S$E44RF-7R$CCI#M'(6+7)8E:+TI\(:V]RE)1A[W^F/LMVGWFY
MWV;F%*A?4U%4/2A:EN$U]J-3AH5AXM[KV#M':I3BB9M>JU4.U\8,$KDC7B\&
MSR\X(DI-HWQ6]),8ZZD\V_6:7@\_-O\ VMY:K.#[(T.>^U9'4O62G\[;<R@,
M!$Z8S"Z)FSV:\C<G8K2C'5)!@Y3_ (I+&2>5&[YBQ#L +JKWP>/(.ZL3U#OT
M'YWV?DGJKS7F?L"YNMEZM2";T@L-HO\ =D'1+#:0Q>A6K:LV7%NKP:Z-DG>5
M:1*Q0#.%JZSIDQ 22S!PN5QF,S$\>/'3IX\>/'3IX\>/'3IX\>/'3IX\>/'3
MIX\>/'3IX\>/'3IX\>/'3IX\>/'3IX\>/'3KKG"A98%#5"[!'9IG:TY0W6EZ
M8E%8+&0LH1X),6?ZD'+%GE@FTS_6\<FVN?\ 7R 8Z>T4B=3SV][F&6D%)+JN
MM.V^25W1U->U6KI[2(=KG[D#_:(Q:3;:^SA$8@-RS9UN7J# U@,L-\Q>V4NK
MWE=&KM*B%H,,7&P FQ*4"S4LX8Y886J-RNG#<(FT,$\\$+5.<"QA@(GAC)UB
MGETW_/$3XF8_,?Q_Z_\ 7^/]NG4"ZOG$B]H3K\Y_,O'3R,9^J3^X].E6P(?;
M&=LYS].11(,1_&-=?MZZYUUUQG'G<RE,=#T"I #HTL]D;PI:ZKE8R*12"HX3
M&S0UFVT7-LJTZ5"M:-V)F5ITLWXL"I>&:W:+0B.[LO*;CR<:'"$*R=1H.S1I
M]J)0%&UZG4,6.SS.<%O,M;*%KT.J*=F[>(A@E#VZ4" (FTD0=%8DNGHFQ>&T
M.Q3/9NI6T#9'#.A(04"H,0V@MC1)V#7!KNRV>(AAH"&\ND:RN;15Z5'JXJ*=
M0,$:TB:.;&F#_/$1,1^?_.?$>/'_ 'Z=:S1< [8@4S[@3\IABV)Q"JY?AQ:<
MUJJ+=5H6FO\ '>E:5"%UJ)LVC9$9JY_.258()X8%>8( %.B\S"[&CZ)R-(ZM
MW2ZC5%5)CLSQS;+A7>C[V!;2DC)CB)6_<"OZ/2C9*^M!T7XM+.'77-;US.PW
M#+0+CW UD?G$/ !:@FJV@0C)8R$) 8KCQH3 3P3(=QRPC1"-)!RA"AY)("1I
MXY(9X9-XI=-M-MM<]1Y$+X( ;VBM;_)2U+3$U)%+TK;_ /MXB\SZS^)GQYZZ
M[2U&A_'>;5\3[5FOCS%_6U8F8F)\Q'M/X_'G_?JN*Y$B+50<K(T%8)I=^7QE
M&L#15X0^FO4*<1G:<PN886/7;$'QKM)+C7;/Q]/UYSC&>BN%_K,->CU4WFL[
M$OK7SZFQE)KXA@+"@NG0*Q66IP[$!E-,%.M0-VIXY$>X\VD\$&HQ(Y4H\N-F
M=CYVQYBVI[A,=KIR6>_J26L4HM@:N:$;JL/AJR-/HK#:Y)I+^[_QX*#!NH>]
M.**U6"3GHVJ\.KZQ<W6D$6*H9+LM<QM%_*Y]\MY(@I(]8TD ?S)JY&'DUCUR
MRS]S&=--=,R1[2;:_5'C;$(")C(NP>M"&J<A1"H7UL<7QAK2U?\ KO'O:MHG
MS29B:S$UF(\ST%:WSUV(+%;D@DWI2+Q$DI%!5B:^(M:(M:+S'FGF/$Q,?QYB
MU=?7=O:>F= -J%VINJ=D?6KH/'9;O=#[% \L$9\S7;9Y#!8S="8+34C;*"2*
M=%@#1J&, ,%HOB^>+K:JWP1/THGW-Z(_KM<;*0(J>=)U'IMNTOP80MOS=0N8
M+JNZWLUGL6@;*OX-J\]=%>P[D+IR56J^70V:2KUYR(ME18IW7(YX,VQI/+&8
MSH6VF-!>9]'UUSO&1/B/&(BBQ\ZXDQG&F\NDFF/J_O%>_P"HCQXKI=4Y?IZY
M<[2WUQ6GW1KW?U/'(:V\M4*"*M\^J2]B+4JPPV;NHY23!!2%M73LFQDPXA/[
M?/@>6;7:^-;1N>[_ !_A?,=='$XP^9;/MMN+8ZKO'TT12T&JN\V%7X+M&2 C
M-W[G%>&HI81"33S O)N*YO"XY/W$X=@:I>22;0VRX"&CMM9N[I:M[+N7;PPD
M8&:%[:#.D.B"RA $':P[B!'I%1_MQ[8L/::[Z=$:)X6M,2(=^74>H 1R1W&2
M5 _:M-FKH#!, NEUN#PH)E:X$>JT"@SAK-X61Z-)*^'LEYOZG(./\EYGUWGO
M0@>_,^L59-HYLR[ 8!P&K(V$K M4 E_$F'Y^@*F!6]0?V<9:\K#A#)9[U(N0
M:[KJ;&_UQ_37NO<JJ\[F]OX?"%K(IL@5@W*B'-2[2-59R$U@N%C%9/*HPH0*
M)RG_ (V/)_\ 6L&@3DYXMP.HKI)EQ?KQSBC\:X@OY+Q2OC:]$,JS"+HME/39
MJC67H3Y7/*QN_4GL:K#6.!H4; QYHG^P>>UI.*M,E%AK$)#T*RO=?N7Q3CN3
MB<.[;<PH"."ZK.=R+ #F'=PM%.J][^S^\U]<CK0=>QRR#+T&Z$V&=$S-H.CG
MDO#G;?M1N]QW^5\L[L9!A+\ORTM5'DA-!=+D"3TL4&("&*O\@%0%S%P J32S
M@VC,5SEE5R5=<H#*$W+K+S_GE#KN;8<WZ57V1]BYF F+T2TU!:FK5G9;%)M'
M]G>.S51>ML3ZK&V^WA,XQ43?62KH$;]Z" 5@O<R]" Y;BRZG!02U5$['14=L
M[4IY@I6<<[AL!0^@\H(&%=5K-1):74A 8LU8MI;0EN%5%(1I?W2)UK'YMEIM
M4Z(D%LG/:/.NLR,")(5S^J)U0;:2MJS5P%@07D$8Q<F3)ZMC[#72ZF;R:JY!
MA6%=S8ESG9'8=!^[7KYOVGU_N;71BC#Z:K9UOH=.D"))9IK.+1%E@C2<D6'"
MK<,W^7ZFT61E6R@$TI3#HAZB>,>)%C6$:EV28.WRG(8Y/JQGYVONJ5U]ME$#
M:Z236B&NH].?:LJ,K)!,<Y$JTE:\5N&XY'>U)L_HB:Q^-,!PLUAUC)XZ57C^
M55QA<KELK,D&3EBTKWNR$A+!64HW\LL#M>#03YO!>O,8C"_/3KV26U/8M"01
MH9-91TA08\.L6,869K^B<18A8J<2$#X_;Q%IFA6?H>PMHQ818[=O4E'8NU<H
MJJ4#*B4RBW@3C,4[&X93O3'7/*4EZ55RLDDIFX4;(CG.!RMYF\\43\NOVB&,
M(K[)@N*>]PY;0,?8,?N-5B+K.TZABI8E1/3"2U7Y\%@<2T]M,,U'308"B2J2
MHF<^I'[IG>/:.0*/>[?]*WF/LOW_ )9GFRFK]:]>>#@] L_5(?;[]I1\YZH_
M<6NA+*98Z-R^MO:V-F[W#]Q);X&]A;]0'R;F56AN/*JH$:W/18YCZ;?U$:;&
M-P],^83,0V*;=1I#TF;^;HPJT+2HKGEK=DL#9G+LU\41>E?B)8Q+R.AO/_L1
MP)#N%RMO.V!ZK.4#$,T9G,6FHAZ-V%?TRNAJAI9=<1P1I_!\M+R6R]UP@#6"
MD7J<[U6+]!U!I3.O7:I-.KT&T.^<;D='L]?QRW1F:77DDL4Q/X=4JU2J^C)+
M6&K:WID"N<*$$MLX&9[[&:$7MUC])3UH2I%*H:P>U5NA7Q2ZROJ[7Y J^^-(
MF)-,:)(PN$MA!DI# HDE..*Y90P+]A1?W([7'WI;O^+^KO#N![.&'.Z.+%;[
M026==.FV<YE=^L7IBP(P6>;<NF6TMQ<WV"3,9)C6EN,I5F=L#)5BT&*$6.0/
ME;.5][^1ZRN GQDSO#QY>6-?5+B.PA&WJ$71JX]]=, )07AE8ME%(99\4-)2
M$@UK1%Q^ ?TX\2XS^N$Y0ID\RMHZ,FR5M7,AL6!F!.[95&A7#&IH'N!D?W')
M22][C@5 ?%6)MY];MZ_T3D/K(YY+1ND]BE15GI%$N!]0N-F!CMHS-UT2I0P:
MRC-J,DN-*KP33<.SJ$E1TIU;,?B3L316^KJQQ.("..'5.QVLNPHZ)8WO0N5H
M6'>K?90GCNHO[&E#26:O"?MUHF-2U^Y]'(LBQ(OJ%'K^=W"XC9$L$&K-490[
M[^M.Y\YY]T<*!9T*BTZ]K1I=9Q@+E6$MG#'GTE@GTG'&=!&PP3:3C#SZRQ1Z
MR:S#P2Z[8WACVUCQ;_1#U*N-1>5,OA/-U>S:)KNLM:BG5K6\4APS4SIX[)S^
MT,U+0^H/%(Q$FZ:55]L$.3>>/9?,(:>,5J7'>=,8B>U$W:OK;FJWHO:L_P!\
MC%M.BH],CE986*Z=FHC3>#,_$:2U&;R*+5GY[B]A%^9<EX_I(D1S^/87&!85
M>/*G+D26^>;59S!KN S=0&>E!'% ,6%G&8&LN205^:16IY]5.O0.(7MR5J=>
MZY+1FBX#K?*DW2WM=R@3*-4M_6TNV.MNC%+RUKNEVPZ1DY@A8LT<]IFWK$PH
M'W08M!6[WN6\O?V3E?J'S3FG+>#X-BVHCP*M.*W8[&=8:@!!;4R[H=2O*HS8
M,=T?9$M'<N$S!CE!+'+7CF D<:\6^OWP_3NC[AZYK^;^M]7X97KM1*'7><\X
M4]55OD=2'JU5-7$U)9+T_G*P[KM;@I!8?[\F3X_FG/+*?@M??.<V++2%VD\S
M5T])_=Q/V&I>LC7@:^3J5W(G<.;0!MT'JWK=4N5)K6\RWM=HZ/S2D&V578W=
M,0QD4RD&TL2W:VRRU6$U3$M)%/,DS@\]H>5$U.1=Q?HJMYF9/S83;#"N7O%0
MLL=36&LHY1C1ULZMG$,K/+5AF0:K803HC7K12)>3=N^\G;RH.,]O&=#<Q-W9
MI3/U% A9U^+KZ$,+MYC;S*0UT<Y^*J.ZVNM1!&#XZ[91XYWO4^U_5JB<9]D?
M=XU$:S+'%;T)/>:WR>[@* *HZZ,$[ F)H%F;K\V$R5&H6:O#434A(77;(X+6
M*WU2L2K0--=)"^K_ #Y)^K![C\B]CS.1Q<9YC^D[[2]$YE=^AWB]T8_H?=K9
MPBI#U'D--@YYSHVL+O7Y;QCJ*V/IC.LW3FL8-H3,5)549JX[-:TT,7O7O]"'
MNWM?TCE;WV9*S5>+UOD]D(LG1]^8R\XZ?9K#W;B->KQ@E'H/<.4K.J5GK?!K
M3^3'3>M=&I/-,I7?.^1=7SRN>^KC:13K"OU1_5SW8]=U->N/Z9S._6SV4]A>
MOF+C2J'UY3QN_.V-<XUT"R'6GJG,+KHP]*/8^*6CT6"H-[QT+D- [6-(CYT'
MGIE_L30:=5&?=O>6Y%R]5O(TM33XZGB8ZN4NV_0HT/5*LV@:E**A3,,)Z*ZB
M_J4\Z2K1;,,@*O0,\=CN"Z/!N(43UT5@;-]74MI2JM]<IKKM74"P9HAKVU &
MBC#.:W7Z]9R&4PV6HQ1CY;^^.55F):^V]+,8L9U77KO7+#45QL",;0&J5[FU
M-J !\4*@ 4OYL)R9FX@VLAC6R:)YTPS"=9H,/6T>^OC_ *_^_P#M_I_O_>?]
M_P#?R-_J ^]E[3ZR\6LWN)6^<4WV8L5'7/.O5'DT5B'HE6LC:2<^"NJA[4T>
M.X&"9,0L76>"=TW#AM0SJ)0T8)]0"Y9(>1]U.73QX\>.G3_K_K_K^_\ ?S2/
M7/6WA'>?L;=@Y94;].*H)1!'/5WULUZPENGL&8ES4:0=DNG%>(5+=8>$4.>H
M8B8,5%!SS$;S;N\>.G6&TKG]0YXO+6U)1A=HR/F:N6!1S)W8+"VGQKI*WL]H
M?&,[)9V^\,<(W[K8&K)AJ&.*%J3@04:&+,O^O^7_ +>/'CIU'[O?K^L[2@)F
M1VQ]R#KJU?\ 9Y]W.B"I9[O1CQR]6(.) +  SK=UJ>Y^N<NZ!=%;BJNQ"#-=
MPA&6XC8*G/V:]F>L>H7$ZW3NT<61<XZEU;@ZQ!QR*BV-MVWB;SK*FOY$ZOPZ
MUO6Z/E^U6<HZ1'FT5']\;N N@5V"\,$C1Q+S.R9,]!OE-WZZ/+:5>O1O%\L
M3"2Z<([OP+HG*&*8V !P#:[)TZO\:L8@^Y&N83P'_,.IWQ(T5$;:"30F:,9)
M1B%(IHF7XUB9&_RWB6=M*G=0:Y'C)L+KFJ$I0.Z:8#"K\@6 D^6OBEQ$ 22T
MFPJ6%<D%IIW< C2O"^5Z>>P-33R>-;^CG-F@U@K-)YC#0RDJ$Z]XBM@5F"P2
M/@F(-ZWBDTMY-@;)J,($M'5VTB5.0HKDD!N40\P)LL40P/Y<A5AUCE%+^F/:
M-HJC8+2OF3(T\_VYL:8XIU#0,EX X&CG.G\N+V5*U6]H9T<)<\_-&'4L=<%$
MQJHH72I235EV)-5S*>.5,..OW(&U^K6)^GFA8QA-R0VSZGB?@NM@FUM/+1F$
MM@AT&Z<O9<(OAU7R[E#-69,6-#7C22-9K^4:3RLZ;FM3US"HB[%2M#F5>DN#
M%>#'NN.7UK+8-46@"M^L\VK<:<DY;@B.>;&89YHOQX\[:>K]BEO>"7DD%@L>
M+DI?^;F@GFTTK-JV+0-8\V\^2VB:4CR*]/'6M!TI-*0*12/\TI>L_B@9'-8J
M2:UO 2GO/[?7P*MX)>T06E[\OT9OU&X4%A6>BW:G1D52GB_"]2+_ &38<65>
M0KFW@M/J_<923\FKR:7.8CCX8V-#C5NT3*7D$)T3ZFTF&]>GS_K_ *_^V?/\
MV2\)FJ@(PE0'+J#D^H7ZP4.@C[0L+NIY/=:^^NE>2;SGU[5?=[G3&,H-9LZN
M1(\56FK5,R!IKM%M\?Z.E*N=5Z-3ZMT"C/5]HI=WKJ:V5.R*9L$*WU<L*\=J
ME;KY_C7[HC!>4.5!MMKKM]N77Z]-=OG7'GSWYX4#B7+I;25(JAR/[.D$0QTK
MGA8BP?NKIWBT6':#F^T5&1P-(#B=0$D1864]-_Z<.?L\VX/5/0<$YI\6E;(8
M,0E[:1U9H:<]MZDT]"5LL+Z0WX))'VL]^YQ_**S3>3^/'CR#^K"=/'CQXZ=/
M'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/(K>XO7['QGCD[NH;QC
M6>R6-534K66&(G1%*R&9,S6^!9])(2B8%*9A$NCFTV@C9$!$$1$002C32I\U
M7V;D=;[=0&U!LVY(HQT@IZUJ#]O\]&\6R_D+&X7W,9CDD'EQF(D:7XB.7S%@
M2YUB*DVQDL<J0-3/-HC^9$38;M#FGR18-;Q-O8?_ .[2/^JXI_!:Q(YB8MXZ
MUCFJ6[H\2Y$CQEJ4M]O(=!DLP:5[C<(&U1_&S'Y5+?S(PMUF+*EO1BLUD<3%
M"-=]@>Y4Y_!;5O5>@-F(D^AI*RU7&QV2MNM(ML;2KFB%NR*6:B%1XV&S* *"
M6!#)MNL*"FCCDT]#-&M$%WI5/N@HTH8UOJU?M X<^V-YA(+ I$;0C2[XUUQM
M)!&7K%OMC77&=M,YQKC']8K"K?Z:C?\ DD&MWZBH94L8J*4L6O5I@M?6,&*:
M/[BZ:8MT4-6M3A\;QDE!SNR8M=MXQ-HI-M"X;7 00U@(:U>/$& O$'!"$@U^
MW"*&)#H.,/#IC^M(H(8](X]<?]W37&,?Z>;GSW5X]I?IT8\A,P*"RPPNM=:D
M M47P@O\@@V+:MHM:L>LP")M7S%KWI6#/Z>.(]RN,?ZDMS:'DLUJ4ZYV9HZ:
M^F>SPKL?<?#]9QX:HKCL,)+?+6SY(H6:6H 125]^SGZA-2]<.J&<QEH6MEBI
M%-Y%T7M%ZLW9>%<*HO,:AW?H-_YSRF"&Q=SZ!1%ERNUP:<CZTU!JBDL4<5)S
M]AEH_ =/Z:ELG=%?J9>F@[%XFAZ-<FSM-9YJF$BK7!/82V/KT<(1UT5BVY"B
MK'+6S?M=.3R<#['*ZO?) [I2U(//W+1@^'63JC&.U.X^F7K;['V91<.P\[FL
MEA55W:EE&JKMT.C17"A[/PK5CG74%U ME76=>YK'8P8W<'.>IAW"D#LB6A4"
M".5RWV.UJS_35]+FTMK*(Y&R%/M]FWMI3=-UKM=>>5EI.;U5B:'R]Z@Z,L<<
M;J[4SN78Y'E(Y*;2J6]CZ==QW" X>QLHIXZZLUUR.9_J!<![;WVE\)XR?8>C
MZ6_F?6^D_P"*2BIVQ;RD<?D\_KI@M&BO5AKZFK]#9-0O9&K$S[\Z=6B"IF*&
MZ*X93/=< 1SB\BMS+TF]8>-=1U[%R[E\5*NT%>L556:);;?(J37D5O7<J5VT
M2I<LFM$W+J?+: ^(<IQ8V%6IRAD[)I:PYF64=*>29*GQTZ>/'CQTZ>/'CQTZ
M>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ?]?]
M?\__ %\?]?\ /_W\>/'3IX\>/'3K!NE4W6_T>Q53!6X!C(+29*TCFGAD3652
M4,YJSR/<?.-\R([&O5MXX\ZR13;!8AG@('DE@DK^Q:71[BDL14;B4W*WK8+M
M)$U4"&H'U8?T:L6%7O.S:+EYG[99!V:G[PA>T1/V8S!]LB28VULZ\I\_48QW
MOUD3%^TG"\T*T45>P-"ZIS^]TE\_GI\?0SZ6&PZ35G-;Z)32H4&;#3ZQ%::U
M(E<;B&VJQ7[=H&L'=1#_ $CQYCD.]A)(V4H\P]"8)<9$F A&AD$N&S)IJ$=R
M-R 0K&(,5;%M[WK$]:_R)]7#0/R)VC-T\5=AU^$E2NLU1"*Y#F&JO0C#$K4K
M8UA@I<OQ06:4O;Q6=GM[/8?Y!1,R4ZZ;;X9VGXQASS_?.DG\(=Z9VVS)T#3X
MQK#M-]6V<9UQ]W&FOQ)MIKGCF/6V]V2[9IEQVS#1;SC'T%<_WVQ^3;N49UVS
MOF^X^GX_!V^C&)/C&<[;?&V-?G6I7C7ZHY[GH8&?9-'3*A0%%<MYJYWRBB=$
M=/I;H;^P*4BPQ63=[3OLGF1F6V<@R(2+&A<(.DI&GU:ZRSZXS[7\E]B+G8-N
M0!],L\5&I T=EPPI(%2R#M<+0-LIWCUM=M3[GZ$8J)^-\A:D;"_9Q]W37,\?
MSM_,.UO-N.+NBY%QO86S@C5LUKJ+$=QPT9. :];;:@V<L9",$"O(KL?)4Q:!
MM2I"4B=7XQW3[=<_$NK@<MRF'=&[(EL8S@<[D1I1I9EBP\'0D.K855P$8^:$
M;!NL,AJ7F@[7KGC1@41<U;*"DV9LA:69K76M;<OZDG +Z<E1%NEUI!43.\I&
M\H8M;G2%[6)_@ VRS5YU75.SY*6UG^6XEMLU+Z@PH_49^09$+OC$/ =7H=]M
M=%L,6C FT$]%B>?O 4C69DO;MZTJ#.BF3C&K#-;+94XZU,'R[-9<K*)UG)=1
MO$)Z*6W7C;'T4P$9?..=/=:<[(?E7/%:6Q+OVM,[+V:L8HA<BSPFQYVD_'DB
MY_\ %W4+7/3^QE\6L=KJ ]!TL S+F=Z7VK:P&RSZ.DN=$TT52@NU4KH<C!E7
MQ3HF[E8^:%FC57]U4!R$Z!F<><<GZV3EAVL_.GY7?$)-,H-14UQE;2O,RT,P
M:V%0=D[CM I'>)K%:V[>]RSA_%&\O*Y'L(9HM:QZ*$>,PG2S(K#$>;Z8:"56
M+$-@I7Y&ECB]ZGI>D"^2M:/Z<W6.UU>\WCV &3W_ *9QDZ"!?[;NECI7868E
MTLT<1]6L\Z^SV5:\LO5E-QG7 $;+X&#2&GN;$&YR&'@28.UWG'LPE!9 69[Z
M\=^H;RWQJ;#QRD$4-G?NGVA-:[$+5LR\JYC4Y&[JF\Y#,KSGH70+7<$_+UJQ
M'::XV;@[)A2C%NE>%_\ Q ^_WL1?.C4"6+B\?+*:+R5;[T<W)3-OY'3[A>..
M=(N''JXFMU+EQT"U; <WL2VX[N1HQN/"=6JD]?NZ7KG/GE8/O']</6CF/JWS
MM7SSF\=D9X%"#&?7SH5F;7[J5\*"W+E'9WOH%BG*?6(D7=@;&I#G(B25H C"
M6K*4B(<59!M7</DE>Y>^QM'P<KCJEU\Y=5+%BU?-$ 67J1J]ZRL<E@30%"*+
MIKP@!);ZM2K78/T.W? )X1Q8'%[\@V.0!6T&]&FEJV%#5"N%^4RRM(@]PI26
M2,^IFW37<:<8EF(+19>HSG'Z-/-.CWW_ !2[!3GW).6.]I#&/IO+;%%\TF/^
M^Q%<#W#I*%H>$-2[?C4)T7S&I,W@(>I1JS^<Z(6,M-37P)$B>MIE-<KJA6@K
MR!: E0H4@ JI,D3*A8@5:E2L!B@!7+5P0\ @  <$ @8L,0P\4<,6FN.T\><>
MKR'=W198=O7T-:F,@/-S9T&+LD63'%8J."$F;D):*4@K!K$9/ Q08I/CIZ[5
MQ[B7&N*1HQQW&1R/U=Z^CI2D&!2XY?SY*3Q^*TK[7D*XXHLO)"_ $7RD]GCQ
MX\P_6Q=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/*-?
M_P!8#3VTCTEK%H1QO(JE0^[U6S]>?)9+//K2^:XHG25<-S9):Y9ZP,U6H>EL
M.<2'&6(G=#60"3+,T-K2]49:T=Y7F&=$HJ/IU$MO/;+IMNBN2!E7V?TB)V&\
M8S(;<?)&B^PJWE>82#;[:$: 6!(Z1&[Q:BN4[1;*4"1E<+5+A;61MA%0YLC2
M2TA!)>XZ$(DR-FE+7',7I$V'$>U?/B?S-;QYK;#<BQ0\CP-KC[!B+K[>6_E'
M,*@R$$%]8JI;UH6MAWF*%M^VT1YCS$6I;Q>O^>_?:KIS2U7"IW%/3$E^I-IK
M^\H@9Z)M:\Q1YKMK&4M8@'-N+2WG"AA*LM-&6VNW251X275"G;!N"RBTV#T7
MB=_5TZ"Q=#Y#UJOT[-G4 )K.ZYQ=:^)#=!LGM4.ZE@U2K8=V$.5!A<69?N+9
MXAY1&/W12<CD9)[5<"[KZ:=;O_,>H67:]O@2FO0U74C=%BMWW6NW6:P.Y.XN
MWC*RKE"VZN^F9=QW^I?C0_L=B@80I)#ZX=56;.YWW>ZUS;NWK;_&*K[!4#J/
M6;I:N$V6C\JY\53W-FLMFL]QK"W"(-&C,N%A&<#++FTS^'N\"VVE&FC(TS%)
MF+-X-CNIMX->RP5U$.3Y'<65P<HY(1(X 9BXV<%;8TH!G0L@D%2-EZ[!'Z!I
MG4RCU>!Y$:]?-:G;')TM/O"*]M'C&GP%EN>,<:&\-MA\EP[!<7/@^A]I]T[L
M9*/U:HW+?1MK L@;P0-;5/\ (_2?VP]@.=J.O\\Y]!+78+)>E"8K2XT"L62]
M8KYS"LG04]!8BG ^A67PD"XF)N8G$W9*&6@C?$,$&9K,OT)/:PRMVZQ^EUK.
M<Q4.XIW?8_6;^43)-9$;N(S+;M7(54RYC-]0S#+B#L=/KF0XC@L;=HDASBO(
M%X*GD>E_(NI^F/+ND>TG9K;=N<55/&=9KCZY;U76RY/JU7?J09+NU T._+0=
M./$#FVI_\9WQDQ,0H%N<A<&^BU-1>4VL.E^0]/HD71*-9Z+UT;M7*=HK6@KX
M5$LJ*SG6.I*6<"K5>7=$ 8AFM8LJ*V5ERCM*/=F S5Y$/WC\UT]MGO.SW:X<
M9C V,7CSV8[V]Y;E)MK++:-RZ%"9>BV=E_[Y+)K#SVM/) 9$XKFUJVJ)S,67
MW'+L#L(QVGYD9/>Q=#DN9H*\]XIIN*L.-8]JI37052$!+Z-EW3SIJ9>J8#X"
M47RB5^5?2,;_ $1_'D?_ %7[VF]GO7OE?=$HL2W%\K>)WR.&4LB*L7A"P.JW
M1:?&8:$NG9:TZ^H[)5\-=0H!FW[1^Y!8W#*'DWD!Y3-E8Z;+"C0K!95.59@-
M_'N(X"6$85_$S'L,E;4MXF8\Q/B9Z]"5&EWE5G5"T.HXN%I4XYF:&78'4P2T
MF8B9H0=ZWK,Q$^+1^.GCQX\X.NQT\>/'CIT\>/'CIT\>/'CIT\>/'CIT\>/'
MCIT\>/'CIT\QRUV0.II2G)D<D^L.T4 XL.=<2E%DR:Q#P:[;?Y=-<[[?7-+G
MZOM0:2RXTDSIB/;(_->=.K9UGK&PJS&)#P#AF@PVVVNF#,CQSP2CXDVVQKI)
MM 5-O!]><:[3Q1Z;9TUWS)KUG+G&HQ=:OL>HKV%7Q[3-XK/CQ7_YIC^:U_/M
M,17Q/GQUQ'L2H2V%'L2*6FD>/,S:(_Q'Y]IC^8KXGVGQ'B?/6K0>Y-8SM9'"
M5?\ M6^^/NZKI2OSQ(?JQC:778B3<<S:'3.V^\6L0?W?IS].^F?C&9(0RQD0
MQ3P[ZR0SQZ312:?]V2.77&^F^O\ ^3OKMC;'S_?QGR$ =2M+0S1<-7W,)$N^
M(9)#EAH(8N,Y^G>4HLF"*'6*/Y^O;&DF^\N-?B&.7?.NN9IJ%^JE2K5:29ET
M6+@E^LNV/C:34(:(;$FV/G/QG?$6-LX^<_WG_7/F$X^UH,_8AR27'6:_&0E(
MI,$F9]Z1XK7VCQXF8_/I/B(\1:(C'YAFB_+\\VM2/7TO>L5F+?GVK$Q%?:/'
MB9_$^LS_ #XM$1K&X^PG!.=WZH<IO_;>1T;J/0I%L5!YO<.CT^M7R\2N69"5
M1%3Z@Y<!6"S2,W A2L#1*O-V+8#SAP8W(BWCUS6:\TX>[K>:SV9+%T!Q57=Y
M5TW=@/BQG4ZMMZ^@?6895]?Y<B52[M5<5&L,1_CPG.@!MM_NSZZ^0SZ/Z:V"
M\^UU]]GU/6;)2FQWJ_S3B_-%5:M/3*\K2]&Y]>_8*Z07CIU8I5\IM?[#389N
MN5O5?SZW:D 8D0V*/<@>*P[;QP9YS^E=[(K:Q2*KTGVN(=5E-<0&]CIJ!WTY
M2I,J!7:?1_JMTI*AA6+#01P55JT];NSKB10:NG59_P =3P3%ABV:QZ-MDZRO
M5[GCS\ZXUUUQKKCXUUQ].,?Z_&-?\N,?ZY_TQC_S_P"?]^?KQTZ>/'CQTZ>/
M'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQTZ>/'CQT
MZ>/'CQTZ>/'CQTZ>8Y<*A6+_ %6QT>ZHUUFJ%N2LJY9J\W'T+6.D;@24%FM.
M'W_RRC%B3RPR:_.-L:[_ %:;:[XUVQD?CSZK:U+5O2UJ7K:+5M69K:MJSYK:
MMH\3%HF(F)B8F)CS'YZ^;5K>MJ7K6]+UFMZ6B+5M6T3%JVK,3%JVB9B8F)B8
MF8F/'7B:_4#]8:#Z9^Q8_':/?6UFK%AYN@Z6C7W5RJ*NE8C>6F[U^:ME%K0U
M&[Q,%'589Z\Y8"3/B!I"Q'IC,P##II*+])%[74]F]C=G#] GE9I.&K%F'#M:
MME/*F?=6S@,+]P,@W(DEFE$CTBA^YM+/N/'C&V^\>NM^WLGSA VN%8N%GH=(
MN-9;H].?.I+'3:W92%SO+^)G0YV6CQ2RR:DE,8V1&MVQMIO77]CB_%&E'M+@
MM?%9(AX>B2];IBL;E?-XKRWO%.N$5>K]2IV30AI7* (9L,J$2QN(TFAS+\ ,
MJ22.(F4V ?,4DDVN)XY!WT9Y%VR-P37RVF-5@.:%CE#6R,UG+9^TCJP5A*<P
M)/FN%.$_-GSWO-(:+<A"$K%;N/?T])\4[MK]Q\C<23Q%V-4ZO$5\6ZHD?U/C
M^ABRNJ_^KF#(1F<L]6E<Y>@ZVLH$0Q"'><?]B^66CM5#[)PBMMD=7<]75)$L
M+FSJ'3)<%M6E50M< <L24P0X*%P: .H8-=!7.ZI>;,9"C<;Z8"GHAK/J9VBB
M]-YTKXE;?2[H74.M6"ETF! \K78.BTN>A]:N?5>>](NAZE[R[E"B:S\R2\5[
MI8<[@7-9?JTZHL@! 7XMGC#<WO+G?#+JYY4J36CDQE_?O<FW"I4'J*H6[C3B
M<*Z&ULJMFGIMRTNP(:=PB5"/%I>-/MPJ(5SS7<:&:#?3]"J=*5_JT\70UGC"
MCGM6YWQ&W7,WH\"!VGCZGWKOJ[K$E?4('1V,(W^*5S#F7=6MN#1?=.B>7?5I
M89YR=Q=!8CP>6<PXQD[_ !O/>2'Q_DS$Z3B3>,BV63G4HE+BK;2]F5C?5"#Z
MK"QHD!PC8!%"02Q)%VNVG%^5<IRN8/00^I@WH!,RFBZ(4B"Y+9<]Y1=FJ3:Y
M+D.-I=D)(9"R1=JI%YJ.+AO6KUVY7ZE<$Y1ZV\2K\=9Y;QNFJJ74EF-1,%RB
M+]-I#G;J<(0 =C9K.VG866U.-0QY'=E;-6Y$6I!TOF\/'_X?]?\ AX\P/4G=
M/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=/'CQ
MXZ=/'CQXZ=5J?JE>E:#W$]<C]A$VI?8.+S3]+Y"? S4)"SSE.HYEKYR6V?4C
MI"*)%TRO+YJ_+^_4*XJ$]FTJ=TVKQS.HJ\Q>*;C_ +&5ZQ] _P 7JG-O0JYS
M[I._44/.ZZ<OLA*573_8JS#*%G.+<?4ZW)T?F]5VIPG-ZC?8%84MO?@2C,8Z
M^T7'J]_](3_?Y_\ ^_[_ /Z?_?\ Y^4Z?K4^L]J[=ZS5_IO+N4,>O]9]<[I%
M>%M,J"D9QU&V\U>"_L_3:?S4$LL$5K8]I8:?T@2LREP36EERY4F5;Y?$*--Y
MD[1=P)XSKQA[39/])[X6<?1@[CE%LL6G2P[O#$*]@C'#%@D<M(?,@J6WN.+&
M^2">]_;*.88-]W 3'7FG'C*[641=1*6]4V7>A*(%8)0;%B2O4HT/#,5&Q(O[
M1;5# \,XG>N1>]=&[A7:(@[1,L$&8\V;8[*^-;$:;7^FM84=D!1+>C7NK@@
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6CQXZ=/'CQXZ=/'CQXZ=/'CQXZ=?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exh1053.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exh1053.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $S 5<# 2(  A$! Q$!_\0
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M;;P)_P (8FD06_A;[*+$:9;;H8A !CRQL(.TC@\\Y.<Y-3&\:;BGKK^+;O\
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MM:L]W%',^_3Y$\X+]G1%A_>/MX" BBV^5[_\"^^VWS>Z5KM%]+K;_@VV]?\
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M0J1Y#"0%@08V(Q71B%R5G"&UI_>E=:^3TOLSFP[YZ//+?W/QDD]/2^FZ/?\
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MOW2>I\):E8Z?-XD\4:Q^RG+I8T*Z^'NIC4(/!9C33QJP,9T_;'$!&E]M:;C
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MJBN:\<?$70?AU96UQK=S<*]U)Y-K9Z?8SW]Y=.!N*PVUNCRRE5!9MB':H+'
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M\WB"> V7G0/J>I6-S!8R/;QN]P%OI(UMY'C6*4R!)"4,;AL%2 ]+73NOZO\
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M?A/0O^$7\*Z-HWG_ &G^SK*&S\_9L\SRXU3=MR<9QG&3C/6B'VN;RM_Y-?\
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MXD>!?&T/A>ZETB+5O#ET9+[4&62UD9\26]S*D4'.599TB1<*"G"TE[U[=O\
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M2]N+AYWGM[ Q2>>%::4+&T\)"JH\SYB1]"45/*N7EZ?\&_YN_?[D.[OS=?\
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M_8+2'1KRYNK![K&YKB222".2-&8!1$JN44$EY"0%\)_:-T_XJ^,/B=%:>%_
M/_"1Z['X1_LGQ7!X)\:V%@8[>ZGE*VEP^H6;&1"D9:.2..&53)*05#K7W;7&
M^-O@O\/OB9?07WB_P)X9\5WMO'Y,-SK>CV]Y)''DG8K2HQ"Y).!QDU,ES-/^
MM4T_OOJNVFVA47RIK^MT_P +:>>N^HOP=U!M4^%OA:9_#K>$F73XH3H;7270
ML?+79Y2S(2LJ+MPL@X=<-WKL:AM+2#3[6&UM88[:VA18XH84"I&@& J@<
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MJ]QJ$T=_IYB#%9YV>18YEG7=&&**8P45=S[KV@SZ[\(_%GP6N9_$VM>))?B
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MEI)%R755W,P!^?\ QY^Q1INI_L^VNE>$_ 7@30/B];Q6;V_B<E1-;WL,B/\
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M^ /$L'Q#M]*^)WA19;=O$$&A%K#4[68IY\%Q8M<YVN(HCE9@592RE> O"_\
M# O_ %<;^T!_X7/_ -HH_P"&!?\ JXW]H#_PN?\ [15MN4G)[MW^?_!6C6S6
MCNB+))1Z)6_K]'NGJCK-:^#7BCP?XGN?B98?$_2=&U]]':T\37GB#0S<:1<0
M1.\T<J1"[A>U6'S)0,SN-A^?<P+GRG]EWP/+\6OV<_@QXC\'>-=%L_%'@G4-
M3;[3)8G4[)FG:YCEAE@CN8G1BDL<B_O00-N=P:NJ_P"&!?\ JXW]H#_PN?\
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M#ZJHKY5_X8%_ZN-_: _\+G_[11_PP+_U<;^T!_X7/_VB@#ZJHKY5_P"&!?\
MJXW]H#_PN?\ [11_PP+_ -7&_M ?^%S_ /:* /JJBOE7_A@7_JXW]H#_ ,+G
M_P"T4?\ # O_ %<;^T!_X7/_ -HH ^JJ*^5?^&!?^KC?V@/_  N?_M%'_# O
M_5QO[0'_ (7/_P!HH ^JJ*^5?^&!?^KC?V@/_"Y_^T4?\,"_]7&_M ?^%S_]
MHH ^JJ*^5?\ A@7_ *N-_: _\+G_ .T4?\,"_P#5QO[0'_A<_P#VB@#ZJHKY
M_P#A;^R'_P *O\=Z9XG_ .%U?&#Q;]A\W_B3^*?%7VW3KC?$\?[V'REW;=^]
M>1AE4]J* /7/B+XN7P+X+U36A$+FY@C$=I:[@IN;J1A'!""2!F25XT'NPKY
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C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785940528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Mar. 02, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">JOINT Corp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001612630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">jynt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,586,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786688672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,216,221<span></span>
</td>
<td class="nump">$ 3,009,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">103,819<span></span>
</td>
<td class="nump">334,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">1,138,380<span></span>
</td>
<td class="nump">1,021,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">42,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Notes receivable - current portion</a></td>
<td class="nump">171,928<span></span>
</td>
<td class="nump">40,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCostsCurrent', window );">Deferred franchise costs - current portion</a></td>
<td class="nump">484,081<span></span>
</td>
<td class="nump">748,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">542,342<span></span>
</td>
<td class="nump">499,525<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,656,771<span></span>
</td>
<td class="nump">5,696,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,800,466<span></span>
</td>
<td class="nump">4,724,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Notes receivable, net of current portion and reserve</a></td>
<td class="nump">351,857<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCostsNoncurrent', window );">Deferred franchise costs, net of current portion</a></td>
<td class="nump">812,600<span></span>
</td>
<td class="nump">836,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,760,042<span></span>
</td>
<td class="nump">2,338,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,916,426<span></span>
</td>
<td class="nump">2,750,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits and other assets</a></td>
<td class="nump">611,808<span></span>
</td>
<td class="nump">707,889<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,909,970<span></span>
</td>
<td class="nump">17,054,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,068,669<span></span>
</td>
<td class="nump">1,054,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">86,959<span></span>
</td>
<td class="nump">299,997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_CoOpFundsLiabilityCurrent', window );">Co-op funds liability</a></td>
<td class="nump">89,681<span></span>
</td>
<td class="nump">73,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll liabilities</a></td>
<td class="nump">867,430<span></span>
</td>
<td class="nump">750,421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable - current portion</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">331,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent - current portion</a></td>
<td class="nump">152,198<span></span>
</td>
<td class="nump">215,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue - current portion</a></td>
<td class="nump">2,553,818<span></span>
</td>
<td class="nump">3,077,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">48,534<span></span>
</td>
<td class="nump">60,894<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,967,289<span></span>
</td>
<td class="nump">5,863,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent, net of current portion</a></td>
<td class="nump">802,492<span></span>
</td>
<td class="nump">1,400,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">4,693,441<span></span>
</td>
<td class="nump">2,231,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred tax liability</a></td>
<td class="nump">136,434<span></span>
</td>
<td class="nump">120,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">411,497<span></span>
</td>
<td class="nump">512,362<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">12,011,153<span></span>
</td>
<td class="nump">10,129,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2017, and December 31, 2016</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 20,000,000 shares authorized, 13,600,338 shares issued and 13,586,254 shares outstanding as of December 31, 2017 and 13,317,393 shares issued and 13,020,889 outstanding as of December 31, 2016</a></td>
<td class="nump">13,600<span></span>
</td>
<td class="nump">13,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">37,229,869<span></span>
</td>
<td class="nump">36,398,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock 14,084 shares as of December 31, 2017 and 296,504 shares as of December 31, 2016, at cost</a></td>
<td class="num">(86,045)<span></span>
</td>
<td class="num">(503,118)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(32,258,607)<span></span>
</td>
<td class="num">(28,983,374)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">4,898,817<span></span>
</td>
<td class="nump">6,925,413<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 16,909,970<span></span>
</td>
<td class="nump">$ 17,054,861<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CoOpFundsLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of Co-op funds liability (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CoOpFundsLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred current net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred noncurrent net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount representing an agreement for an unconditional promise by the maker to pay the Company (holder) a definite sum of money within one year from the balance sheet date (or the normal operating cycle, whichever is longer), net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82891408&amp;loc=d3e4531-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date more than one year from the balance sheet date, net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786352736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Series A preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Series A preferred stock, shares authorized (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Series A preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Series A preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">13,600,338<span></span>
</td>
<td class="nump">13,317,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">13,586,254<span></span>
</td>
<td class="nump">13,020,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">14,084<span></span>
</td>
<td class="nump">296,504<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786228016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Revenues and management fees from company clinics</a></td>
<td class="nump">$ 11,125,115<span></span>
</td>
<td class="nump">$ 8,550,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyRevenue', window );">Royalty fees</a></td>
<td class="nump">7,722,856<span></span>
</td>
<td class="nump">5,973,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseRevenue', window );">Franchise fees</a></td>
<td class="nump">1,442,415<span></span>
</td>
<td class="nump">2,286,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingRevenue', window );">Advertising fund revenue</a></td>
<td class="nump">2,753,776<span></span>
</td>
<td class="nump">1,866,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TechnologyServicesRevenue', window );">IT related income and software fees</a></td>
<td class="nump">1,137,363<span></span>
</td>
<td class="nump">932,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesRevenue', window );">Regional developer fees</a></td>
<td class="nump">583,550<span></span>
</td>
<td class="nump">617,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">398,929<span></span>
</td>
<td class="nump">296,084<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25,164,004<span></span>
</td>
<td class="nump">20,523,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseCosts', window );">Franchise cost of revenues</a></td>
<td class="nump">2,996,797<span></span>
</td>
<td class="nump">2,717,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TechnologyServicesCosts', window );">IT cost of revenues</a></td>
<td class="nump">315,397<span></span>
</td>
<td class="nump">221,918<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">3,312,194<span></span>
</td>
<td class="nump">2,939,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">4,473,881<span></span>
</td>
<td class="nump">4,419,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,017,323<span></span>
</td>
<td class="nump">2,566,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">18,117,533<span></span>
</td>
<td class="nump">22,086,321<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Total selling, general and administrative expenses</a></td>
<td class="nump">24,608,737<span></span>
</td>
<td class="nump">29,071,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on disposition or impairment</a></td>
<td class="nump">417,971<span></span>
</td>
<td class="nump">3,520,370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(3,174,898)<span></span>
</td>
<td class="num">(15,007,976)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(64,455)<span></span>
</td>
<td class="num">(1,467)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax expense</a></td>
<td class="num">(3,239,353)<span></span>
</td>
<td class="num">(15,009,443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(35,880)<span></span>
</td>
<td class="num">(164,429)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (3,275,233)<span></span>
</td>
<td class="num">$ (15,173,872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (0.25)<span></span>
</td>
<td class="num">$ (1.20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">13,245,119<span></span>
</td>
<td class="nump">12,696,649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of regional development fees revenue recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from the sale of advertising time (such as television and radio) or space (newspaper or magazine pages). May also include advertising, marketing and promotional services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generating franchise revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchiseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period from consideration (often a percentage of the franchisee's sales) received for the right to operate a business using the entity's name, merchandise, services, methodologies, promotional support, marketing, and supplies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 952<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058139&amp;loc=d3e68564-108043<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchiseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TechnologyServicesCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred in providing technology services. The services may include training, installation, engineering or consulting. Consulting services often include implementation support, software design or development, or the customization or modification of the licensed software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 605<br> -Section 25<br> -Paragraph 76<br> -URI http://asc.fasb.org/extlink&amp;oid=68047459&amp;loc=d3e132428-111767<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TechnologyServicesCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TechnologyServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from providing technology services. The services may include training, installation, engineering or consulting. Consulting services often include implementation support, software design or development, or the customization or modification of the licensed software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 605<br> -Section 25<br> -Paragraph 76<br> -URI http://asc.fasb.org/extlink&amp;oid=68047459&amp;loc=d3e132428-111767<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TechnologyServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786843744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2015</a></td>
<td class="nump">13,070,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2015</a></td>
<td class="nump">$ 13,070<span></span>
</td>
<td class="nump">$ 35,267,376<span></span>
</td>
<td class="num">$ (791,638)<span></span>
</td>
<td class="num">$ (13,809,502)<span></span>
</td>
<td class="nump">$ 20,679,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,123,481<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,123,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of vested restricted stock (in shares)</a></td>
<td class="nump">162,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of vested restricted stock</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">37,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">70,893<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">70,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of common stock, offering costs adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,042)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,042)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (83,391)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(83,391)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock under employee stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Sale of treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(161,911)<span></span>
</td>
<td class="nump">$ 371,911<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">210,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Sale of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">46,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">99,953<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(15,173,872)<span></span>
</td>
<td class="num">(15,173,872)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2016</a></td>
<td class="nump">13,317,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2016</a></td>
<td class="nump">$ 13,317<span></span>
</td>
<td class="nump">36,398,588<span></span>
</td>
<td class="num">$ (503,118)<span></span>
</td>
<td class="num">(28,983,374)<span></span>
</td>
<td class="nump">6,925,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">594,371<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">594,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of vested restricted stock (in shares)</a></td>
<td class="nump">76,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of vested restricted stock</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">206,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">364,043<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">364,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (2,655)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock under employee stock plans (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Sale of treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(127,057)<span></span>
</td>
<td class="nump">$ 419,728<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">292,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Sale of treasury stock (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(283,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,275,233)<span></span>
</td>
<td class="num">(3,275,233)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2017</a></td>
<td class="nump">13,600,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2017</a></td>
<td class="nump">$ 13,600<span></span>
</td>
<td class="nump">$ 37,229,869<span></span>
</td>
<td class="num">$ (86,045)<span></span>
</td>
<td class="num">$ (32,258,607)<span></span>
</td>
<td class="nump">$ 4,898,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79507207&amp;loc=d3e4534-113899<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=96864182&amp;loc=d3e11149-113907<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=96864182&amp;loc=d3e11178-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of treasury stock (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787090048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (3,275,233)<span></span>
</td>
<td class="num">$ (15,173,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">(Recovery) provision for bad debts</a></td>
<td class="num">(40,000)<span></span>
</td>
<td class="num">(10,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights', window );">Regional developer fees recognized upon acquisition of development rights</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(138,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RevenueDeferredAdjustment', window );">Adjustment to deferred revenue from previous acquisitions</a></td>
<td class="nump">133,943<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements', window );">Net franchise fees recognized upon termination of franchise agreements</a></td>
<td class="num">(73,665)<span></span>
</td>
<td class="num">(342,259)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,017,323<span></span>
</td>
<td class="nump">2,566,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of fixed assets</a></td>
<td class="num">(14,525)<span></span>
</td>
<td class="num">(2,191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on disposition or impairment of assets</a></td>
<td class="nump">417,971<span></span>
</td>
<td class="nump">3,520,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">15,734<span></span>
</td>
<td class="nump">120,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">594,371<span></span>
</td>
<td class="nump">1,123,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Cash paid for legal settlement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities', window );">Restricted cash</a></td>
<td class="nump">230,575<span></span>
</td>
<td class="nump">50,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(124,108)<span></span>
</td>
<td class="num">(999,522)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">42,014<span></span>
</td>
<td class="nump">28,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(42,817)<span></span>
</td>
<td class="num">(133,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_IncreaseDecreaseInDeferredFranchiseCosts', window );">Deferred franchise costs</a></td>
<td class="nump">269,719<span></span>
</td>
<td class="nump">361,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposits and other assets</a></td>
<td class="nump">96,081<span></span>
</td>
<td class="nump">71,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(36,751)<span></span>
</td>
<td class="num">(953,084)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(213,038)<span></span>
</td>
<td class="num">(75,532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_IncreaseDecreaseInCoOpFundsLiability', window );">Co-op funds liability</a></td>
<td class="nump">16,435<span></span>
</td>
<td class="num">(127,832)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Payroll liabilities</a></td>
<td class="nump">117,009<span></span>
</td>
<td class="num">(742,954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(734,321)<span></span>
</td>
<td class="num">(19,130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Deferred rent</a></td>
<td class="num">(410,964)<span></span>
</td>
<td class="nump">824,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">1,170,691<span></span>
</td>
<td class="num">(896,195)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">156,444<span></span>
</td>
<td class="num">(10,847,312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(839,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights', window );">Reacquisition and termination of regional developer rights</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(325,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(449,204)<span></span>
</td>
<td class="num">(1,567,727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromLoansReceivable', window );">Payments received on notes receivable</a></td>
<td class="nump">76,351<span></span>
</td>
<td class="nump">35,905<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(372,853)<span></span>
</td>
<td class="num">(2,695,822)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings on revolving credit note payable</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance of common stock, offering costs adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,042)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="num">(2,655)<span></span>
</td>
<td class="num">(83,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfTreasuryStock', window );">Proceeds from sale of treasury stock</a></td>
<td class="nump">292,671<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">364,250<span></span>
</td>
<td class="nump">70,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments on notes payable</a></td>
<td class="num">(231,500)<span></span>
</td>
<td class="num">(436,350)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">1,422,766<span></span>
</td>
<td class="num">(239,852)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash</a></td>
<td class="nump">1,206,357<span></span>
</td>
<td class="num">(13,782,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at beginning of year</a></td>
<td class="nump">3,009,864<span></span>
</td>
<td class="nump">16,792,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at end of year</a></td>
<td class="nump">$ 4,216,221<span></span>
</td>
<td class="nump">$ 3,009,864<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_IncreaseDecreaseInCoOpFundsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the increase (decrease) in co-op funds liability during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_IncreaseDecreaseInCoOpFundsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_IncreaseDecreaseInDeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the increase (decrease) during the reporting period in deferred franchise costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_IncreaseDecreaseInDeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The element that represents net franchise fees recognized upon termination of franchise agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the reacquisition and termination of regional developer rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of regional developer fees recognized upon acquisition of development rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RevenueDeferredAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the adjustment to deferred revenue from previous acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RevenueDeferredAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as operating activities. This may include cash restricted for regulatory purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3095-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of an equity stock that has been previously reacquired by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130534-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82913847&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777012944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Non-cash Activity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Cash Flow, Supplemental Disclosures [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">During the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> cash paid for income taxes was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,315</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,250,</div> respectively. During the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> cash paid for interest was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$108,016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,262,</div> respectively.</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">Supplemental disclosure of non-cash activity:</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company had property and equipment purchases of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50,474</div> which were included in accounts payable. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company had property and equipment purchases of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,059</div> which were included in accounts payable.</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">In connection with the acquisitions of franchises during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company acquired <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$293,014</div> of property and equipment, intangible assets of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$339,000,</div> goodwill of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$269,780</div> and assumed deferred revenue associated with membership packages paid in advance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$45,072</div> in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$839,000</div> in cash and notes payable issued to the sellers for an aggregate amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$186,000.</div> Additionally, at the time of these transactions, the Company carried deferred revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,000,</div> representing franchise fees collected upon the execution of franchise agreements, and deferred costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,450,</div> related to its acquisition of undeveloped franchises. The Company netted these amounts against the aggregate purchase price of the acquisitions (Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>).</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">In connection with the reacquisition and termination of regional developer rights during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company had deferred revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$224,750</div> representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;In accordance with ASC-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">952</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605,</div> the Company netted these amounts against the aggregate purchase price of the acquisitions.</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">In connection with the sale of the regional developer territories in Central Florida, Maryland/Washington DC, Minnesota, Texas, Oklahoma and Arkansas, the Company issued notes receivable in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$559,310</div> with revenue to be recognized over the anticipated number of clinics to be opened in the respective territories. The Company has recognized <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,967</div> of revenue related to these notes in the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div>of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into a settlement agreement, whereby it resolved a pending litigation matter. Under the terms of the settlement agreement, the Company agreed to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time settlement amount comprised of cash and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46,948</div> shares of common stock. The fair value of the total consideration related to common stock was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000.</div> The fair value of the common stock was measured using the closing price of the Company's common stock on the settlement date.</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div>of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> the Company recorded an adjustment to goodwill related to deferred revenue from previous acquisitions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$166,088.</div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942274464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Nature of Operations and Summary of Significant Accounting Policies</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Principles of Consolidation</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly-owned subsidiary, The Joint Corporate Unit <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> LLC (collectively, the &#x201c;Company&#x201d;), which was dormant for all periods presented.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from general and administrative expenses to other expense, net, as well as certain balances from other revenues to revenues and management fees from company clinics for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>to conform to the current year presentation and align with the segment footnote presentation.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Comprehensive Loss</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;Net loss and comprehensive loss are the same for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Nature of Operations</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Joint Corp., a Delaware corporation, was formed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 10, 2010. </div>Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold" nowrap="nowrap">Franchised clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened or purchased during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired or sold during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" margin: 0">&nbsp;</div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold" nowrap="nowrap">Company-owned or managed clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">399</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">370</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Clinics licenses sold but not yet developed</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Executed letters of intent for future clinic licenses</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div> <!-- Field: Page; Sequence: 53; Value: 1 -->   <!-- Field: /Page --> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Variable Interest Entities</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&nbsp;variable interest entity&nbsp;(&#x201c;VIE&#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> hold the controlling interest and are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> the primary beneficiary are accounted for under the equity method.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Certain states, in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice.&nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have the power to direct the activities of the PCs. As such, the activity of the PCs is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the Company&#x2019;s consolidated financial statements</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Cash and Cash Equivalents</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company considers all highly liquid instruments purchased with an original maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> cash equivalents as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Restricted Cash</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentrations of Credit Risk</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> PC entity and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> franchisees represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%,</div> respectively, of outstanding accounts receivable. The Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have any customers that represented greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its revenues during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounts Receivable</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which the Company performs management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had an allowance for doubtful accounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$131,830,</div> respectively.&nbsp;During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>the Company recovered <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40,000</div> of accounts receivable that had previously been deemed uncollectible.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 54; Value: 1 -->    <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company determined that certain working capital advances from its PC entities in Illinois and New York were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$47,000</div> of accounts receivable to loss on disposition or impairment related to these entities during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>The Company wrote-off <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$731,857</div> of accounts receivable to loss on disposition or impairment related to these entities during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Franchise Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Property and Equipment</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in the consolidated statement of operations.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Software Developed</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Intangible Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&nbsp;&nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> years. The Company amortizes the acquired regional developer rights over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. The fair value of customer relationships is amortized over their estimated useful life of&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>&nbsp;years.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$38,185</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>related to closure of an acquired clinic in New York. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impairment was recorded for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Goodwill</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div>&nbsp;&nbsp;Goodwill and intangible assets deemed to have indefinite lives are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> day of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter or more frequently if events or circumstances change that would more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> reduce the fair value of a reporting unit below its carrying value.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 55; Value: 1 -->    <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$54,994</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impairment was recorded for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Long-Lived Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> long-lived assets have been impaired. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impairments were recorded for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.3</div> million during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>due to the sale or closure of clinics in Illinois and New York (Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>).</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Fund</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&#x2019;s consolidated balance sheets.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Co-Op Marketing Funds</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&#x2019; officers. The marketing funds are included in restricted cash on the Company&#x2019;s consolidated balance sheets.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounting for Costs Associated with Exit or Disposal Activities </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Costs to terminate an operating lease or other contracts are (a)&nbsp;costs to terminate the contract before the end of its term or (b)&nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.</div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Lease exit liability at December 31, 2016</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">338,151</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 10pt">Additions</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">883,146</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 10pt">Settlements</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(891,991</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net accretion</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(29,906</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Lease exit liability at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299,400</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company recognized a liability of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million related to operating leases that will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer provide economic benefit to the entity, net of estimated sublease income.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company ceased use of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> clinic locations from its corporate clinics segment and recognized a liability of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.9</div> million for lease exit costs incurred based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company recognized the resulting expense of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.4</div> million in loss on disposition or impairment in the accompanying consolidated statement of operations.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 56; Value: 1 -->      <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Rent</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include rent holidays and rent escalation clauses.&nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&nbsp; The Company records tenant improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Revenue Recognition</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Franchise Fees.</div>&nbsp;The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;The Company&#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> financing to franchisees and offers <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> guarantees on their behalf.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Regional Developer Fees</div>. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under the historical program, regional developers paid a license fee ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,250</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the then current franchise fee for each franchise they received the right to develop within the region. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the program was revised to grant exclusive geographical territory and establish a minimum development obligation within that defined territory. Regional developers receive fees ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,500</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,950</div> which are collected from franchisees upon the sale of franchises within their region and a royalty of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3%</div> of sales generated by franchised clinics in their region. Regional developer fees paid to the Company are nonrefundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. The franchisor&#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&#x2019;s license.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company entered into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> regional developer agreements for which it received approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.1</div> million, which was deferred as of the respective transaction dates and will be recognized on a pro-rata basis over the estimated number of franchised clinics to be opened in the respective regions. Certain of these regional developer agreements resulted in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, the revenue associated from the sale of the royalty stream is being recognized over the remaining life of the respective franchise agreements.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Revenues and Management Fees from Company Clinics.&nbsp;&nbsp;</div>The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&nbsp; Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&nbsp;&nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&#x2019;s PC.&nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&#x2019;s PC in return for a monthly management fee.&nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;"></div></div> <!-- Field: Page; Sequence: 57; Value: 1 -->    <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;"></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Royalties.</div>&nbsp;The Company collects royalties, as stipulated in the franchise agreement, equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7%</div> of gross sales, and a marketing and advertising fee currently equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> working days after each sales period has ended.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">IT Related Income and Software Fees.</div>&nbsp;&nbsp;The Company collects a monthly fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon receipt of equipment by the franchisee.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Advertising costs are expensed as incurred. Advertising expenses for years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,397,076</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,279,572,</div> respectively.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Income Taxes</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> likelihood of being realized upon ultimate resolution.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Loss per Common Share</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: left">Net loss</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,275,233</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,173,872</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,245,119</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,245,119</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.25</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.20</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 58; Value: 1 -->    <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63,700</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,003,916</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Warrants</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Stock-Based Compensation</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Recent Accounting Pronouncements</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers,</div>&#x201d; which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The standard also calls for additional disclosures around the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>): Identifying Performance Obligations and Licensing,</div>&#x201d; to clarify the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> aspects of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606:</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identifying performance obligations, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>): Narrow-Scope Improvements and Practical Expedients,</div>&#x201d; to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has performed a review of the above revenue standards updates and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the adoption of the updates to have a material impact on its revenues and management fees from company clinics, advertising fund revenue, or IT related income and software fees. In addition, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the adoption to have a material impact on its franchise royalty revenues, as they are based on a percent of sales. The Company expects the adoption of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> to impact its accounting for initial franchise fees and regional developer fees. Currently, the Company recognizes revenue from initial franchise fees and regional developer fees upon the opening of a franchised clinic when the Company has performed all of its material obligations and initial services under the respective agreements. Upon the adoption of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> the Company expects to recognize the revenue related to initial franchise fees and regional developer fees over the term of the related franchise agreement or regional developer agreement. The Company has finalized its accounting policies, and has selected the full retrospective method as its transition method.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 59; Value: 1 -->    <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company quantified the impact of adopting this standard, and designed internal controls during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>to be implemented on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018. </div>The Company estimates the cumulative catch-up adjustment to be recorded to retained earnings as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2015 </div>to be an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.3</div> million increase to the accumulated deficit as the Company has adopted the full retrospective approach. This is made up of a decrease to franchise fee revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.5</div> million, a decrease to regional developer revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.4</div> million, and a decrease to franchise cost of revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.6</div> million. The Company estimates the adjustment to be recorded to retained earnings as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>to be an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.8</div> million, with a decrease to franchise cost of revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million. The Company estimates the adjustment to be recorded to retained earnings as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>to be an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million, with an offsetting increase to franchise cost of revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million. The impact to regional developer revenue for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> material. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impact to the Company's consolidated statement of cash flows is expected as the initial fees will continue to be collected upon execution of the franchise agreement. The Company will comply with the increased financial statement disclosure requirements during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;<div style="display: inline; font-style: italic;">Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>).</div>&#x201d; The ASU requires that substantially all operating leases be recognized as assets and liabilities on the Company&#x2019;s balance sheet, which is a significant departure from the current standard, which classifies operating leases as off-balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>While the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet quantified the impact that this standard will have on its financial statements, it will result in a significant increase in the assets and liabilities reflected on the Company&#x2019;s balance sheet and in the interest expense and depreciation and amortization expense reflected in its statement of operations, while reducing the amount of rent expense.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div>&nbsp;<div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification of Certain Cash Receipts and Cash Payments.&#x201d;&nbsp;</div>This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>Early adoption is permitted. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;<div style="display: inline; font-style: italic;">Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Restricted Cash&#x201d;</div>&nbsp;(a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within those fiscal years. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;<div style="display: inline; font-style: italic;">Business Combinations (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">805</div>): Clarifying the Definition of a Business,&#x201d;&nbsp;</div>to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within those fiscal years. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued ASU&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04,</div>&nbsp;&#x201c;<div style="display: inline; font-style: italic;">Intangibles - Goodwill and Other (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>): Simplifying the Test for Goodwill Impairment</div>.&#x201d; This update simplifies the subsequent measurement of goodwill by eliminating &#x201c;Step <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2&#x201d;</div> from the goodwill impairment test. This update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2019. </div>Early adoption is permitted. The Company is currently evaluating the impact this standard will have on the Company's consolidated financial statements and related disclosures.</div> <div style=" font-size: 10pt; margin: 0pt 0; background-color: white">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div>&nbsp;<div style="display: inline; font-style: italic;">&#x201c;Compensation&#x2014;Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>): Scope of Modification Accounting,&#x201d;&nbsp;</div>to provide clarity and reduce both (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) diversity in practice and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) cost and complexity when applying the guidance in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,</div> Compensation&#x2014;Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718.The</div> amendments are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017 </div>and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777162384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Acquisitions</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Franchises acquired during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div></div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company continued to execute its growth strategy and entered into a series of unrelated transactions with existing franchisees to re-acquire an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> developed franchises and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> undeveloped franchise throughout California and New Mexico for an aggregate purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,025,000,</div> subject to certain adjustments, consisting of cash of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$839,000</div> and notes payable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$186,000.</div> The Company is operating the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> developed franchises as company-owned or managed clinics and has terminated the undeveloped clinic license. At the time these transactions were consummated, the Company carried <div style="display: inline; background-color: white">a deferred revenue balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,000,</div> representing franchise fees collected upon the execution of the franchise agreements, and deferred franchise costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,450,</div> related to an undeveloped franchise.&nbsp;&nbsp;The Company accounted for the franchise rights associated with the undeveloped franchise as a cancellation, and the respective deferred revenue and deferred franchise costs were netted against the aggregate purchase price.&nbsp;&nbsp;The remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$997,450</div> was accounted for as consideration paid for the acquired franchises.</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company incurred approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$75,000</div> of transaction costs related to these acquisitions for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>which are included in general and administrative expenses in the accompanying consolidated statements of operations.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Purchase Price Allocation</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following summarizes the aggregate estimated fair values of the assets acquired and liabilities assumed during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> as of the acquisition date:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">293,014</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,728</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269,780</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,042,522</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,072</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">997,450</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets in the table above consist of reacquired franchise rights of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$181,000</div> and customer relationships of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$158,000</div> and will be amortized over their estimated useful lives ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> years and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> years, respectively.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill recorded in connection with these acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities. All of the recorded goodwill is tax-deductible.&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Pro Forma Results of Operations (Unaudited)</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table summarizes selected unaudited pro forma condensed consolidated statements of operations data for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> as if the acquisitions in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> had been completed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2016.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Pro Forma for the Year Ended</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">December 31, 2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">December 31, 2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Revenues, net</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,985,277</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net loss</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,483,492</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 61; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">This selected unaudited pro forma consolidated financial data is included only for the purpose of illustration and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicate what the operating results would have been if the acquisitions had been completed on that date. Moreover, this information is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> indicative of what the Company&#x2019;s future operating results will be. The information for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> prior to the acquisitions is included based on prior accounting records maintained by the acquired companies. In some cases, accounting policies differed materially from accounting policies adopted by the Company following the acquisitions. For <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> this information includes actual data recorded in the Company&#x2019;s consolidated financial statements for the period subsequent to the date of the acquisitions. The Company&#x2019;s consolidated statements of operations for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>includes net revenue and net income of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.5</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.7</div> million, respectively, attributable to the acquisitions.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The pro forma amounts included in the table above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2015, </div>together with the consequential tax impacts.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942480032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Notes Receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Notes Receivable</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2012, </div>the Company sold a company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$90,000</div> unsecured promissory note. The note bore interest at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> per annum for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifty-four</div> months and required monthly principal and interest payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">forty-two</div> months, beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2013. </div>The note matured in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017 </div>and was paid in full upon maturity.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the Company entered into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> license transfer agreements, in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,925</div> in separate unsecured promissory notes.&nbsp; The non-interest-bearing notes require monthly principal payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> months, beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 1, 2015. </div>The note was settled in full in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2016, </div>the Company entered into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> license transfer agreements, in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> separate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,500</div> unsecured promissory notes.&nbsp; The non-interest-bearing notes require monthly principal payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months, beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2017. </div>The note matured in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 2017 </div>and was paid in full upon maturity.&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 29, 2017, </div>the Company entered into a regional developer agreement for certain territories in the state of Florida in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$320,000,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$187,000</div> was funded through a promissory note. The note bears interest at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per annum for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42</div> months and requires monthly principal and interest payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div> months, beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2017 </div>and maturing on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2020.&nbsp;</div>The note is secured by the regional developer rights in the respective territory.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 31, 2017, </div>the Company entered into a regional developer agreement for certain territories in Maryland/Washington DC in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$220,000,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$117,475</div> was funded through a promissory note. The note bears interest at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per annum for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div> months and requires monthly principal and interest payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div> months, beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 1, 2017 </div>and maturing on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 1, 2020. </div>The note is secured by the regional developer rights in the respective territory.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 22, 2017, </div>the Company entered into a regional developer and asset purchase agreement for certain territories in Minnesota in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$228,293,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$119,147</div> was funded through a promissory note. The note bears interest at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per annum for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div> months and requires monthly principal and interest payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div> months, beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2017 </div>and maturing on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 1, 2020. </div>The note is secured by the regional developer rights in the respective territory.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 10, 2017, </div>the Company entered into a regional developer agreement for certain territories in Texas, Oklahoma and Arkansas in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$170,000,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$135,688</div> was funded through a promissory note. The note bears interest at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per annum for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div> months and requires monthly principal and interest payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div> months, beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 24, 2017 </div>and maturing on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 24, 2020. </div>The note is secured by the regional developer rights in the respective territory.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 62; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The outstanding balance of the notes as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$523,785</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40,826,</div> respectively.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5066-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5162-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777123600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt; min-width: 700px;">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Property and Equipment</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment consist of the following:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2016</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Office and computer equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,137,970</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,083,039</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Leasehold improvements</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,117,379</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,085,366</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Software developed</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,066,454</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">891,192</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,321,803</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,059,597</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Accumulated depreciation</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,928,349</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,566,172</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,393,454</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,493,425</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Construction in progress</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">407,012</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">231,281</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,800,466</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,724,706</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Depreciation expense was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,438,443</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,818,403</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016, </div>the Company determined that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> clinics from its Corporate Clinics segment met the criteria for classification as held for sale. Accordingly, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016, </div>the Company recognized a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.4</div> million impairment charge to lower the carrying costs of the property and equipment to its estimated fair value less cost to sell which was recorded in the loss on disposition or impairment line of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> consolidated statement of operations. The Company completed the sale of the property in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> for nominal consideration.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942335360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Fair Value Consideration<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Fair Value Consideration</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#x2019;s financial instruments include cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying amounts of its financial instruments approximate their fair value due to their short maturities.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> levels based on reliability of the inputs as follows:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 1%; text-align: justify">&nbsp;</td> <td style="width: 6%; text-align: justify"><div style="display: inline; font-size: 10pt">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div></div></td> <td style="width: 93%; text-align: justify"><div style="display: inline; font-size: 10pt">Observable inputs such as quoted prices in active markets;</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</div> <table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr> <td style="vertical-align: top; width: 1%; text-align: justify">&nbsp;</td> <td style="vertical-align: top; width: 6%; text-align: justify"><div style="display: inline; font-size: 10pt">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2:</div></div></td> <td style="vertical-align: bottom; width: 93%; text-align: justify"><div style="display: inline; font-size: 10pt">Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&nbsp;and</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 63; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></div> <table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 1%; text-align: justify">&nbsp;</td> <td style="width: 6%; text-align: justify"><div style="display: inline; font-size: 10pt">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:</div></div></td> <td style="width: 93%; text-align: justify"><div style="display: inline; font-size: 10pt">Unobservable inputs in which there is little or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> market data, which require the reporting entity to develop its own assumptions.</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> </div>have any financial instruments that are measured on a recurring basis as Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company had non-recurring fair value measurements. As a result of the sale of certain clinics subsequent to year end, the Company recorded the assets at the lesser of their carrying values and their fair value less costs to sell, which resulted in a write-down of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.5</div> million. The inputs used to determine such fair values were based on the offer price provided by a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party in connection with the sale, and are classified within Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> in the hierarchy.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777128416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Intangible Assets</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2016, </div>the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in San Bernardino and Riverside Counties in California. The total consideration for the transaction was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$275,000,</div> paid in cash.<div style="display: inline; font-weight: bold;">&nbsp;</div><div style="display: inline; background-color: white">The Company carried a deferred revenue balance associated with these transactions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$36,250,</div> representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp; </div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 1, 2016, </div>the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in Virginia. The total consideration for the transaction was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50,000,</div> paid in cash.<div style="display: inline; font-weight: bold;">&nbsp;</div><div style="display: inline; background-color: white">The Company carried a deferred revenue balance associated with these transactions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$188,500,</div> representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consisted of the following:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">As of December 31, 2017</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Gross Carrying<br /> Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Accumulated<br /> Amortization</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Net Carrying<br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,673,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">657,943</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,015,057</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Customer relationships</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">674,667</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,333</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,162,000</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">443,348</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,652</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,536,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,775,958</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,760,042</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" margin: 0">&nbsp;</div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">As of December 31, 2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Gross Carrying<br /> Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Accumulated<br /> Amortization</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Net Carrying<br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,673,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">410,688</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,262,312</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Customer relationships</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">509,042</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">191,958</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,162,000</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,348</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">884,652</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,536,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,197,078</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,338,922</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Amortization expense was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$578,880</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$747,733</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company evaluates the recoverability of finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of intangible assets is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recoverable, the carrying amount of such assets is reduced to fair value. The Company recorded an impairment charge as a result of the closure of a clinic acquired in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$38,185</div> related to certain reacquired franchise rights and customer relationships during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>which is included on the loss on disposition or impairment line of the statement of consolidated operations.&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impairment was recorded for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 64; Value: 1 -->  <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Estimated amortization expense for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and subsequent years is as follows:</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">2018</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">439,590</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">348,034</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2022</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">133,693</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,213</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,760,042</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942421744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Debt</div></div></td> </tr>  </table> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Notes Payable</div></div>&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> notes payable totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$800,350</div> as a portion of the consideration paid in connection with the Company&#x2019;s various acquisitions. Interest rates range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.5%</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.25%</div> with maturities through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February </div>of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> notes payable totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$186,000</div> as a portion of the consideration paid in connection with the Company&#x2019;s various acquisitions. Interest rates for both notes are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.25%</div> with maturities through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May </div>of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The outstanding note will be paid upon execution of a final settlement and release agreement between the parties.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maturities of notes payable are as follows as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017:</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">2018</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Credit and Security Agreement</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 3, 2017, </div>the Company entered into a Credit and Security Agreement (the &#x201c;Credit Agreement&#x201d;) and signed a revolving credit note payable to the lender. Under the Credit Agreement, the Company is able to borrow up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,000,000</div> under revolving loans. Interest on the unpaid outstanding principal amount of any revolving loans is at a rate equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per annum, provided that the minimum amount of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$200,000.</div> Interest is due and payable on the last day of each fiscal quarter in an amount determined by the Company, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$25,000.</div> The lender&#x2019;s lending commitments under the Credit Agreement terminate in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2019, </div>unless sooner terminated in accordance with the provisions of the Credit Agreement. The Credit Agreement is collateralized by the assets in the Company&#x2019;s company-owned or managed clinics. The Company is using the credit facility for general working capital needs. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company had drawn <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,000,000</div> of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,000,000</div> available under the Credit Agreement.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777128416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Equity</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;<div style="display: inline; font-style: italic;">Stock Options</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 15, 2014, </div>the Company adopted the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Stock Plan (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x201c;2014</div> Plan&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Plan is designed to supersede and replace the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012</div> Plan, effective as of the adoption date and set aside <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,513,000</div> shares of the Company&#x2019;s common stock that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be granted under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Plan.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">660,000</div> stock options to employees with exercise prices ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.23</div> - <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.11.</div>&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">295,286</div> stock options to employees with exercise prices ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.65</div> - <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.51.</div>&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#x2019;s stock trading price is the basis of fair value of its common stock used in determining the value of share-based awards. To the extent the value of the Company&#x2019;s share-based awards involves a measure of volatility, it will rely upon the volatilities from publicly traded companies with similar business models until its common stock has accumulated enough trading history for it to utilize its own historical volatility. We use the simplified method as to calculate the expected term of stock option grants to employees as we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term of stock options granted to employees. Accordingly, the expected life of the options granted is based on the average of the vesting term and the contractual term of the option. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-year yield curve in effect at the date of the grant.&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has computed the fair value of all options granted during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> using the following assumptions:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: right" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Expected volatility</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%</div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> - </div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Expected dividends</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Expected term (years)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Risk-free rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.98%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> to </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.20%</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.19%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> - </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.68%</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Forfeiture rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summarizes the stock options:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Number of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Weighted<br /> Average<br /> Exercise<br /> Price</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Weighted<br /> Average<br /> Fair<br /> Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Weighted<br /> Average<br /> Remaining<br /> Contractual Life</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">477,459</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.30</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.01</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.7</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">660,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.22</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37,824</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.88</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(146,560</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.34</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.66</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.86</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.9</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">295,286</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.31</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(206,875</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.76</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37,570</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.11</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,003,916</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.18</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.87</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.1</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">287,230</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.37</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.38</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.4</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 66; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The intrinsic value of the Company&#x2019;s stock options outstanding was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,306,260</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> stock-based compensation expense for stock options was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$380,067</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$561,559,</div> respectively.&nbsp;&nbsp;Unrecognized stock-based compensation expense for stock options for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$840,826,</div> which is expected to be recognized ratably over the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.7</div> years.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Restricted Stock</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company granted restricted stock awards to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> members of the Board of Directors. The awards have been granted under The Joint Corp. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Incentive Stock Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for each to earn <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,345</div> shares of common stock. The estimated fair market value of these shares was valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.10</div> per share, based on the Company&#x2019;s stock trading price, totaling approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$268,000</div> to be recognized ratably as the stock is vested.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company granted restricted stock awards to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> members of the Board of Directors. The awards have been granted under The Joint Corp. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Incentive Stock Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for each to earn <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,950</div> shares of common stock. The estimated fair market value of these shares was valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.02</div> per share, based on the Company&#x2019;s stock trading price, totaling approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$240,000</div> to be recognized ratably as the stock is vested.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summaries the restricted stock activity:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid" nowrap="nowrap">Restricted Stock Awards</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Shares</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,288</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,415</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Awards vested</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(162,440</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(170,848</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Awards vested</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(76,070</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,345</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63,700</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> stock-based compensation expense for restricted stock awards was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$214,304</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$561,922,</div> respectively.&nbsp;&nbsp;Unrecognized stock-based compensation expense for restricted stock awards as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$143,240</div> to be recognized ratably over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.7</div> years.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Modifications</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company accelerated the vesting of all unvested stock options and restricted stock awards granted to the Company&#x2019;s former chief development officer in connection with his separation from the Company. In addition, the Company modified the post-employment exercise period of the stock options previously granted, extending the exercise period to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company modified the post-employment exercise period of stock options previously granted to the Company&#x2019;s former chief executive officer in connection with his separation from the Company. The modification extended the exercise period to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 13, 2020. </div>In addition, the Company accelerated the vesting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,733</div> shares of the previously granted restricted stock awards that were scheduled to vest in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016. </div>The remaining unvested restricted stock awards were forfeited upon separation.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 67; Value: 1 -->  <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">These modifications resulted in an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$412,000</div> increase in stock-based compensation for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016.</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Treasury Stock</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2013, </div>the Company exercised its right of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> refusal under the terms of a Stockholders Agreement dated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 10, 2010 </div>to repurchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,000</div> shares of the Company&#x2019;s common stock. The shares were purchased for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.45</div> per share or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$240,000</div> in cash along with the issuance of an option to repurchase the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,000</div> shares. The repurchased shares were recorded as treasury stock, at cost in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$791,638.</div> The option is classified in equity as it is considered indexed to the Company&#x2019;s stock and meets the criteria for classification in equity.&nbsp;&nbsp;The option was granted to the seller for a term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> years.&nbsp;&nbsp;The option contained the following exercise prices:</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div> <table style="; border-collapse: collapse; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 86%"><div style="display: inline; font-size: 10pt">Year 1</div></td> <td style="width: 1%">&nbsp;</td> <td style="width: 1%"><div style="display: inline; font-size: 10pt">$</div></td> <td style="width: 11%; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">0.56</div></div></td> <td style="width: 1%">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 2</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">0.68</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><div style="display: inline; font-size: 10pt">Year 3</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">0.84</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 4</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.03</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><div style="display: inline; font-size: 10pt">Year 5</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.28</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 6</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.59</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><div style="display: inline; font-size: 10pt">Year 7</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.97</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 8</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">2.45</div></div></td> <td>&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Consideration given in the form of the option was valued using a Binomial Lattice-Based model resulting in a fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.03</div> per share option for a total fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$551,638.</div> The option was valued using the Binomial Lattice-Based valuation methodology because that model embodies all of the relevant assumptions that address the features underlying the instrument.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016, </div>the option holder partially exercised the call option and purchased <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250,872</div> shares at a total repurchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$210,000.</div> The Company reduced the cost of treasury shares by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$113,000</div> related to the transaction, reduced the value of the option by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$259,000,</div> and reduced additional paid-in-capital by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$162,000.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 2017, </div>the option holder exercised the remainder of the call option and purchased <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">283,128</div> shares at a total repurchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$292,671.</div> The Company reduced the cost of treasury shares by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$127,000</div> related to the transaction, reduced the value of the option by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$292,000,</div> and reduced additional paid-in-capital by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$127,000.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Warrants</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In conjunction with the IPO, the Company issued warrants to the underwriters for the purchase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div> shares of common stock, which can be exercised between <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 10, 2015 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 10, 2018 </div>at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8.125</div> per share.&nbsp; The fair value of the warrants was determined using the Black-Scholes option valuation model. The warrants expire on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 10, 2018 </div>and have a remaining contractual life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">.9</div> years as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 68; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The information below summarizes the warrants:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap">&nbsp;</td> <td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap">Number of <br /> Units</td> <td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap">&nbsp;</td> <td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap">Weighted <br /> Average <br /> Exercise Price</td> <td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap">&nbsp;</td> <td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap">Weighted <br /> Average <br /> Remaining <br /> Contractual Term (in years)</td> <td style="font-size: 10pt; padding-bottom: 1pt" nowrap="nowrap">&nbsp;</td> <td colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid" nowrap="nowrap">Intrinsic <br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2015</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.9</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.9</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Exercisable at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.9</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Issuance of Common Stock for Legal Settlement</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016, </div>the Company entered into a settlement agreement, whereby it resolved a pending litigation matter. Under the terms of the settlement agreement, the Company agreed to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time settlement amount comprised of cash and newly issued shares of its common stock. The amounts paid by the Company in this settlement was determined by the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to be material. The fair value of the total consideration related to common stock was valued using the closing price of our common stock on the settlement date.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942480032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Income Taxes</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Income tax provision reported in the consolidated statements of operations is comprised of the following (in hundreds):</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Current provision:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt">Federal</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,800</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">State, net of state tax credits</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,100</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,900</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Total current provision</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">43,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred provision:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Federal</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">97,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">State</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,000</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,300</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total deferred provision</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">120,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total income tax provision</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,900</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 69; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following are the components of the Company&#x2019;s net deferred taxes for federal and state income taxes (in hundreds):</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Deferred revenue</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">756,900</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,509,400</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred franchise costs</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(281,000</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(553,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Allowance for doubtful accounts</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">51,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Accrued expenses</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Goodwill - component 1</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(136,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Goodwill - component 2</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55,500</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Restricted stock compensation</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(17,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,800</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Nonqualified stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">152,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">182,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Deferred rent</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">257,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">629,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Lease abandonment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Net operating loss carryforwards</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,061,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,924,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Tax credits</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Charitable contribution carryover</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,200</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,500</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Asset basis difference related to property and equipment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">377,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">201,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Intangibles</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">368,100</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">429,600</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,739,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,496,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Less valuation allowance</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,875,800</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(11,617,100</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Net non-current deferred tax liability</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(136,500</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Tax Act was signed into law on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 22, 2017. </div>The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Tax Act significantly revises the U.S. corporate income tax by, among other things, lowering the statutory corporate tax rate from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34%</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21%,</div> eliminating certain deductions, imposing a mandatory <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time tax on accumulated earnings of foreign subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> completed its determination of the accounting implications of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Tax Act on its accruals. However, it has reasonably estimated the effects of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Tax Act and recorded a provisional tax expense in its financial statements as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.9</div> million. This amount is a remeasurement of federal net deferred tax assets resulting from the permanent reduction in the U.S. statutory corporate tax rate to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21%</div> from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34%.</div> As the Company completes its analysis of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Tax Act, collects and prepares necessary data, and interprets any additional guidance issued by the U.S. Treasury Department, the IRS, and other standard-setting bodies, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>make adjustments to the provisional amounts.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company has federal and state net operating losses of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$26,527,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$32,030,000</div> respectively. These net operating losses are available to offset future taxable income and will begin to expire in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2035</div> for federal purposes and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2025</div> for state purposes.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 70; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following is a reconciliation of the statutory federal income tax rate applied to pre-tax accounting net loss, compared to the income tax provision in the consolidated statement of operations (in hundreds):</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For the Years Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percent</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percent</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Expected federal tax benefit</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,100,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,106,100</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">State tax provision, net of federal benefit</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(140,200</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.33</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(735,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.90</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Effect of (decrease) increase in valuation allowance</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,741,300</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(84.73</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,042,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40.24</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Other permanent differences</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.72</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Stock Compensation</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(131,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.08</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Impact of enacted tax reform</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,946,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">121.97</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">State deferred tax true up</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">185,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.72</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other, net</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,500</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.05</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(145,700</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.97</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Provision</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,900</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.11</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.09</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The state tax benefit stems from the resolution of various voluntary disclosure agreements with multiple states where the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet been in compliance. In addition, the Company is responsible to pay certain minimum and franchise taxes to jurisdictions in which it does business.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Changes in income tax expense related primarily to changes in pretax losses during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>as compared to year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>and the effective rate was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.1%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.1%,</div> respectively. The difference is primarily due to state taxes, stock compensation and the impact of enacted tax reform which is mostly offset by the valuation allowance.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded a liability for income taxes for operations and uncertain tax positions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40,000,</div> respectively, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$27,000</div> respectively, represent penalties and interest and are recorded in the &#x201c;other liabilities&#x201d; section of the accompanying consolidated balance sheets. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Management made a determination that the Company was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> in compliance with several state and local tax jurisdictions in which the Company was doing business. Accordingly, management undertook to analyze its tax exposures, both income and otherwise, with respect to jurisdictions in which compliance was deemed to be inadequate and has entered into Voluntary Disclosure Agreements (VDAs) with the taxing authorities.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table sets forth a reconciliation of the beginning and ending amount of uncertain tax positions during the tax years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (in hundreds):</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Interest/<br /> penalties</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Interest/<br /> penalties</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Uncertain tax positions - January 1</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,200</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"></td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,800</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,600</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Gross increases - tax positions in prior period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Gross decreases - tax positions in prior period</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13,200</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(26,800</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,400</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6,200</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Uncertain tax positions - December 31</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,200</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,800</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#x2019;s tax returns for tax years subject to examination by tax authorities include <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013</div> through the current period for state and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> through the current period for federal purposes.&nbsp;</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942394496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt; min-width: 700px;">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Related Party Transactions</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company entered into consulting and legal arrangements with certain stockholders related to services performed for the operations and transaction related activities of the Company.&nbsp;&nbsp;Amounts paid to or for the benefit of these stockholders was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$205,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$461,000</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942332528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt; min-width: 700px;">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Commitments and Contingencies</div></div></td> </tr>  </table> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Operating Leases</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases its corporate office space and the space for each of the company-owned or managed clinics in the portfolio.</div> <div style=" font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Total rent expense for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,808,837</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,389,971,</div> respectively.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Future minimum annual lease payments are as follows:</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">2018</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,119,305</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,808,476</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,544,978</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,411,126</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2022</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,283,865</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,060,963</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,228,713</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 27.8pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016, </div>the Company ceased use of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> undeveloped clinic locations from its corporate clinics segment and recognized a liability for lease exit costs based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company classified all of the approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$338,000</div> lease exit liability in other liabilities, and related expense in loss on disposition or impairment.</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Litigation</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material adverse effect on the Company.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942394496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; min-width: 700px;" cellspacing="0" cellpadding="0">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Segment Reporting</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> operating business segments. The Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company operated or managed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div> clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the franchise system consisted of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div> clinics in operation. Corporate is a non-operating segment that develops and implements strategic initiatives and supports the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> operating business segments by centralizing key administrative functions such as finance and treasury, information technology, insurance and risk management, litigation and human resources. Corporate also provides the necessary administrative functions to support the Company as a publicly-traded company. A portion of the expenses incurred by Corporate are allocated to the operating segments.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 72; Value: 1 -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The tables below present financial information for the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> operating business segments (in thousands):</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center">Year Ended</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Revenues:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,125</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,550</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,039</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,974</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total revenues</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,164</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,524</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Segment operating (loss) income:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,704</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,730</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,243</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,561</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total segment operating (loss) income</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,539</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,169</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Depreciation and amortization:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,608</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,186</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Franchise operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Corporate administration</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">409</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total depreciation and amortization</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,017</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,566</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Reconciliation of total segment operating income (loss) to consolidated loss before income tax expense:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Total segment operating income (loss)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,539</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,169</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Unallocated corporate overhead</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,714</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,839</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Consolidated loss from operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,175</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,008</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other (expense) income, net</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(64</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Loss before income tax expense</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,239</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,009</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Segment assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,998</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,936</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,362</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,003</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total segment assets</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,360</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,939</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Unallocated cash and cash equivalents and restricted cash</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,320</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,344</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Unallocated property and equipment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">765</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">781</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other unallocated assets</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">465</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">991</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; padding-left: 20pt">Total assets</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,910</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,055</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&#x201c;Unallocated cash and cash equivalents and restricted cash&#x201d; relates primarily to corporate cash and cash equivalents and restricted cash (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>), &#x201c;unallocated property and equipment&#x201d; relates primarily to corporate fixed assets, and &#x201c;other unallocated assets&#x201d; relates primarily to deposits, prepaid and other assets.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6937024912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Principles of Consolidation</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly-owned subsidiary, The Joint Corporate Unit <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> LLC (collectively, the &#x201c;Company&#x201d;), which was dormant for all periods presented.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from general and administrative expenses to other expense, net, as well as certain balances from other revenues to revenues and management fees from company clinics for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>to conform to the current year presentation and align with the segment footnote presentation.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Comprehensive Loss</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;Net loss and comprehensive loss are the same for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NatureOfOperationsPolicyPolicyTextBlock', window );">Nature of Operations Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Nature of Operations</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Joint Corp., a Delaware corporation, was formed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 10, 2010. </div>Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold" nowrap="nowrap">Franchised clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened or purchased during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired or sold during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0">&nbsp;</div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold" nowrap="nowrap">Company-owned or managed clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">399</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">370</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Clinics licenses sold but not yet developed</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Executed letters of intent for future clinic licenses</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Variable Interest Entities</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&nbsp;variable interest entity&nbsp;(&#x201c;VIE&#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> hold the controlling interest and are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> the primary beneficiary are accounted for under the equity method.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Certain states, in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice.&nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have the power to direct the activities of the PCs. As such, the activity of the PCs is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the Company&#x2019;s consolidated financial statements</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Cash and Cash Equivalents</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company considers all highly liquid instruments purchased with an original maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> cash equivalents as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Restricted Cash</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentrations of Credit Risk</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> PC entity and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> franchisees represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%,</div> respectively, of outstanding accounts receivable. The Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have any customers that represented greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its revenues during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade and Other Accounts Receivable, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounts Receivable</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which the Company performs management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had an allowance for doubtful accounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$131,830,</div> respectively.&nbsp;During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>the Company recovered <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40,000</div> of accounts receivable that had previously been deemed uncollectible.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 54; Value: 1 --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company determined that certain working capital advances from its PC entities in Illinois and New York were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$47,000</div> of accounts receivable to loss on disposition or impairment related to these entities during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>The Company wrote-off <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$731,857</div> of accounts receivable to loss on disposition or impairment related to these entities during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionServicesCommissions', window );">Revenue Recognition, Services, Commissions [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Franchise Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Property and Equipment</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in the consolidated statement of operations.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Internal Use Software, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Software Developed</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Intangible Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&nbsp;&nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> years. The Company amortizes the acquired regional developer rights over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. The fair value of customer relationships is amortized over their estimated useful life of&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>&nbsp;years.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$38,185</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>related to closure of an acquired clinic in New York. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impairment was recorded for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Goodwill</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div>&nbsp;&nbsp;Goodwill and intangible assets deemed to have indefinite lives are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> day of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter or more frequently if events or circumstances change that would more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> reduce the fair value of a reporting unit below its carrying value.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 55; Value: 1 --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$54,994</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impairment was recorded for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Long-Lived Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> long-lived assets have been impaired. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impairments were recorded for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.3</div> million during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>due to the sale or closure of clinics in Illinois and New York (Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>).</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_AdvertisingFundPolicyTextBlock', window );">Advertising Fund, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Fund</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&#x2019;s consolidated balance sheets.&nbsp;</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CooperativeAdvertisingPolicy', window );">Cooperative Advertising Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Co-Op Marketing Funds</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&#x2019; officers. The marketing funds are included in restricted cash on the Company&#x2019;s consolidated balance sheets.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounting for Costs Associated with Exit or Disposal Activities </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Costs to terminate an operating lease or other contracts are (a)&nbsp;costs to terminate the contract before the end of its term or (b)&nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.</div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Lease exit liability at December 31, 2016</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">338,151</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 10pt">Additions</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">883,146</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 10pt">Settlements</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(891,991</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net accretion</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(29,906</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Lease exit liability at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299,400</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: center; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Company recognized a liability of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million related to operating leases that will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer provide economic benefit to the entity, net of estimated sublease income.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company ceased use of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> clinic locations from its corporate clinics segment and recognized a liability of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.9</div> million for lease exit costs incurred based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company recognized the resulting expense of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.4</div> million in loss on disposition or impairment in the accompanying consolidated statement of operations.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Rent</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include rent holidays and rent escalation clauses.&nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&nbsp; The Company records tenant improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Revenue Recognition</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionServicesFranchiseFees', window );">Revenue Recognition, Services, Franchise Fees [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Franchise Fees.</div>&nbsp;The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;The Company&#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> financing to franchisees and offers <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> guarantees on their behalf.&nbsp;</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesPolicyPolicyTextBlock', window );">Regional Developer Fees, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Regional Developer Fees</div>. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under the historical program, regional developers paid a license fee ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,250</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the then current franchise fee for each franchise they received the right to develop within the region. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the program was revised to grant exclusive geographical territory and establish a minimum development obligation within that defined territory. Regional developers receive fees ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,500</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,950</div> which are collected from franchisees upon the sale of franchises within their region and a royalty of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3%</div> of sales generated by franchised clinics in their region. Regional developer fees paid to the Company are nonrefundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. The franchisor&#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&#x2019;s license.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company entered into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> regional developer agreements for which it received approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.1</div> million, which was deferred as of the respective transaction dates and will be recognized on a pro-rata basis over the estimated number of franchised clinics to be opened in the respective regions. Certain of these regional developer agreements resulted in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, the revenue associated from the sale of the royalty stream is being recognized over the remaining life of the respective franchise agreements.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock', window );">Revenues and Management Fees, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Revenues and Management Fees from Company Clinics.&nbsp;&nbsp;</div>The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&nbsp; Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&nbsp;&nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&#x2019;s PC.&nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&#x2019;s PC in return for a monthly management fee.&nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.&nbsp;</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RoyaltiesPolicyPolicyTextBlock', window );">Royalties, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Royalties.</div>&nbsp;The Company collects royalties, as stipulated in the franchise agreement, equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7%</div> of gross sales, and a marketing and advertising fee currently equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> working days after each sales period has ended.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock', window );">IT Related Income And Software Fees, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">IT Related Income and Software Fees.</div>&nbsp;&nbsp;The Company collects a monthly fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon receipt of equipment by the franchisee.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Advertising costs are expensed as incurred. Advertising expenses for years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,397,076</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,279,572,</div> respectively.&nbsp;</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Income Taxes</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> likelihood of being realized upon ultimate resolution.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Loss per Common Share</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: left">Net loss</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,275,233</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,173,872</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,245,119</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,245,119</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.25</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.20</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 58; Value: 1 --> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table style="border-collapse: collapse; min-width: 700px;" align="center" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt" nowrap="nowrap">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid" nowrap="nowrap">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63,700</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,003,916</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Warrants</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Stock-Based Compensation</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.&nbsp;</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.</div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Recent Accounting Pronouncements</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers,</div>&#x201d; which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The standard also calls for additional disclosures around the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>): Identifying Performance Obligations and Licensing,</div>&#x201d; to clarify the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> aspects of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606:</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identifying performance obligations, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>): Narrow-Scope Improvements and Practical Expedients,</div>&#x201d; to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has performed a review of the above revenue standards updates and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the adoption of the updates to have a material impact on its revenues and management fees from company clinics, advertising fund revenue, or IT related income and software fees. In addition, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the adoption to have a material impact on its franchise royalty revenues, as they are based on a percent of sales. The Company expects the adoption of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> to impact its accounting for initial franchise fees and regional developer fees. Currently, the Company recognizes revenue from initial franchise fees and regional developer fees upon the opening of a franchised clinic when the Company has performed all of its material obligations and initial services under the respective agreements. Upon the adoption of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> the Company expects to recognize the revenue related to initial franchise fees and regional developer fees over the term of the related franchise agreement or regional developer agreement. The Company has finalized its accounting policies, and has selected the full retrospective method as its transition method.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 59; Value: 1 --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company quantified the impact of adopting this standard, and designed internal controls during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>to be implemented on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018. </div>The Company estimates the cumulative catch-up adjustment to be recorded to retained earnings as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2015 </div>to be an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.3</div> million increase to the accumulated deficit as the Company has adopted the full retrospective approach. This is made up of a decrease to franchise fee revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.5</div> million, a decrease to regional developer revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.4</div> million, and a decrease to franchise cost of revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.6</div> million. The Company estimates the adjustment to be recorded to retained earnings as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>to be an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.8</div> million, with a decrease to franchise cost of revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million. The Company estimates the adjustment to be recorded to retained earnings as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>to be an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million increase to accumulated deficit. This is made up of a decrease to franchise fee revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million, with an offsetting increase to franchise cost of revenue of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million. The impact to regional developer revenue for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> material. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> impact to the Company's consolidated statement of cash flows is expected as the initial fees will continue to be collected upon execution of the franchise agreement. The Company will comply with the increased financial statement disclosure requirements during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;<div style="display: inline; font-style: italic;">Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>).</div>&#x201d; The ASU requires that substantially all operating leases be recognized as assets and liabilities on the Company&#x2019;s balance sheet, which is a significant departure from the current standard, which classifies operating leases as off-balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>While the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet quantified the impact that this standard will have on its financial statements, it will result in a significant increase in the assets and liabilities reflected on the Company&#x2019;s balance sheet and in the interest expense and depreciation and amortization expense reflected in its statement of operations, while reducing the amount of rent expense.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div>&nbsp;<div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification of Certain Cash Receipts and Cash Payments.&#x201d;&nbsp;</div>This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>Early adoption is permitted. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;<div style="display: inline; font-style: italic;">Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Restricted Cash&#x201d;</div>&nbsp;(a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within those fiscal years. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;<div style="display: inline; font-style: italic;">Business Combinations (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">805</div>): Clarifying the Definition of a Business,&#x201d;&nbsp;</div>to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within those fiscal years. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued ASU&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04,</div>&nbsp;&#x201c;<div style="display: inline; font-style: italic;">Intangibles - Goodwill and Other (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>): Simplifying the Test for Goodwill Impairment</div>.&#x201d; This update simplifies the subsequent measurement of goodwill by eliminating &#x201c;Step <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2&#x201d;</div> from the goodwill impairment test. This update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2019. </div>Early adoption is permitted. The Company is currently evaluating the impact this standard will have on the Company's consolidated financial statements and related disclosures.</div> <div style=" font-size: 10pt; margin: 0pt 0; background-color: white">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div>&nbsp;<div style="display: inline; font-style: italic;">&#x201c;Compensation&#x2014;Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>): Scope of Modification Accounting,&#x201d;&nbsp;</div>to provide clarity and reduce both (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) diversity in practice and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) cost and complexity when applying the guidance in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,</div> Compensation&#x2014;Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718.The</div> amendments are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017 </div>and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted the standard on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate this amendment will have a material impact on its consolidated financial statements.</div></div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AdvertisingFundPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the advertising fund.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AdvertisingFundPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income and software fees related to information technology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NatureOfOperationsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NatureOfOperationsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for regional developer fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the revenues and management fees from the Company clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RoyaltiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the royalties from franchises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RoyaltiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054294&amp;loc=d3e8384-108330<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84159346&amp;loc=d3e8275-108329<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75027168&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=75032840&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75027451&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75032840&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77990344&amp;loc=SL6759159-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=77990344&amp;loc=d3e5728-111685<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=77990344&amp;loc=SL6759068-111685<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CooperativeAdvertisingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for offsetting cash consideration received from a vendor arising from cooperative advertising arrangements against advertising expense when such consideration represents a reimbursement of a specific, incremental, identifiable cost incurred by the entity in selling the vendor's products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 50<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68069731&amp;loc=d3e63739-111659<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CooperativeAdvertisingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6389767&amp;loc=d3e17916-109280<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionServicesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for commission revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 20<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=68047264&amp;loc=d3e48393-111629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionServicesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionServicesFranchiseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for franchising fees, which is consideration or a share of proceeds paid to the entity by another party for the right to operate a business using the entity's name, merchandise, and supplies. Furthermore, discloses whether the installment or cost recovery method is being used to account for franchise fee revenue if no basis exists for estimating the collectability of specific franchise fees, the sales price of such franchises, the revenue and related costs deferred, the periods in which the fees will become payable by the franchisee, and fees originally deferred but later recognized because uncertainties regarding the collectability of the fees have been resolved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 952<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68064525&amp;loc=d3e68593-108044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionServicesFranchiseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables.  If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5212-111524<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5093-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942287824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock', window );">Schedule of Franchisor Disclosure [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Franchised clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened or purchased during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired or sold during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Company-owned or managed clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics open at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed or sold during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">399</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">370</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Clinics licenses sold but not yet developed</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Executed letters of intent for future clinic licenses</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiabilityTableTextBlock', window );">Lease Exit Liability [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Lease exit liability at December 31, 2016</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">338,151</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 10pt">Additions</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">883,146</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 10pt">Settlements</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(891,991</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net accretion</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(29,906</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Lease exit liability at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299,400</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: left">Net loss</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,275,233</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,173,872</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,245,119</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,245,119</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.25</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.20</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63,700</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,003,916</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Warrants</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lease exit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of franchisors that are included in the discussion of the nature of an entity's operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6714725264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">293,014</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,728</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269,780</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,042,522</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,072</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">997,450</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Pro Forma for the Year Ended</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31, 2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31, 2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Revenues, net</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,985,277</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net loss</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,483,492</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6609566864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2016</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Office and computer equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,137,970</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,083,039</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Leasehold improvements</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,117,379</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,085,366</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Software developed</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,066,454</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">891,192</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,321,803</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,059,597</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Accumulated depreciation</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,928,349</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,566,172</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,393,454</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,493,425</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Construction in progress</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">407,012</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">231,281</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,800,466</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,724,706</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6940538128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31, 2017</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Carrying<br /> Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Accumulated<br /> Amortization</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Net Carrying<br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,673,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">657,943</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,015,057</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Customer relationships</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">674,667</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,333</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,162,000</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">443,348</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,652</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,536,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,775,958</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,760,042</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31, 2016</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Carrying<br /> Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Accumulated<br /> Amortization</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Net Carrying<br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,673,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">410,688</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,262,312</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Customer relationships</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">509,042</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">191,958</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,162,000</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,348</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">884,652</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,536,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,197,078</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,338,922</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">2018</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">439,590</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">348,034</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2022</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">133,693</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,213</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,760,042</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942308336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">2018</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6936937888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Expected volatility</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%</div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> - </div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Expected dividends</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Expected term (years)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Risk-free rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.98%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> to </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.20%</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.19%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> - </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.68%</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Forfeiture rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Exercise<br /> Price</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Fair<br /> Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Remaining<br /> Contractual Life</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">477,459</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.30</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.01</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.7</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">660,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.22</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37,824</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.88</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(146,560</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.34</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.66</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.86</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.9</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">295,286</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.31</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(206,875</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.76</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37,570</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.11</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,003,916</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.18</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.87</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.1</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">287,230</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.37</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.38</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.4</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Restricted Stock Awards</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Shares</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,288</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,415</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Awards vested</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(162,440</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(170,848</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Awards vested</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(76,070</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,345</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63,700</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Class of Treasury Stock [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 86%"><div style="display: inline; font-size: 10pt">Year 1</div></td> <td style="width: 1%">&nbsp;</td> <td style="width: 1%"><div style="display: inline; font-size: 10pt">$</div></td> <td style="width: 11%; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">0.56</div></div></td> <td style="width: 1%">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 2</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">0.68</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><div style="display: inline; font-size: 10pt">Year 3</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">0.84</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 4</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.03</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><div style="display: inline; font-size: 10pt">Year 5</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.28</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 6</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.59</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><div style="display: inline; font-size: 10pt">Year 7</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">1.97</div></div></td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td><div style="display: inline; font-size: 10pt">Year 8</div></td> <td>&nbsp;</td> <td><div style="display: inline; font-size: 10pt">$</div></td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 10pt">2.45</div></div></td> <td>&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: center">&nbsp;</td> <td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Number of <br /> Units</td> <td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Weighted <br /> Average <br /> Exercise Price</td> <td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Weighted <br /> Average <br /> Remaining <br /> Contractual Term (in years)</td> <td nowrap="nowrap" style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Intrinsic <br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2015</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.9</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Outstanding at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.9</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Exercisable at December 31, 2017</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.9</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6776971936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Current provision:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt">Federal</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,800</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">State, net of state tax credits</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,100</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,900</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Total current provision</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">43,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred provision:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Federal</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">97,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">State</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,000</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,300</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total deferred provision</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">120,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total income tax provision</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,900</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Deferred revenue</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">756,900</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,509,400</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred franchise costs</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(281,000</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(553,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Allowance for doubtful accounts</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">51,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Accrued expenses</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Goodwill - component 1</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(136,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Goodwill - component 2</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55,500</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Restricted stock compensation</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(17,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,800</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Nonqualified stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">152,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">182,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Deferred rent</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">257,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">629,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Lease abandonment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Net operating loss carryforwards</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,061,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,924,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Tax credits</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Charitable contribution carryover</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,200</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,500</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Asset basis difference related to property and equipment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">377,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">201,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Intangibles</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">368,100</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">429,600</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,739,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,496,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Less valuation allowance</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,875,800</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(11,617,100</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Net non-current deferred tax liability</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(136,500</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For the Years Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percent</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Percent</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Expected federal tax benefit</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,100,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,106,100</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">State tax provision, net of federal benefit</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(140,200</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.33</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(735,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.90</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Effect of (decrease) increase in valuation allowance</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,741,300</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(84.73</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,042,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40.24</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Other permanent differences</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.72</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Stock Compensation</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(131,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.08</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Impact of enacted tax reform</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,946,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">121.97</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">State deferred tax true up</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">185,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.72</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other, net</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,500</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.05</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(145,700</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.97</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Provision</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,900</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.11</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.09</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">%</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Interest/<br /> penalties</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Interest/<br /> penalties</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Uncertain tax positions - January 1</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,200</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"></td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,800</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,600</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Gross increases - tax positions in prior period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Gross decreases - tax positions in prior period</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13,200</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(26,800</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,400</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6,200</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Uncertain tax positions - December 31</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,200</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,800</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=96868398&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6606153136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">2018</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,119,305</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,808,476</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,544,978</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,411,126</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2022</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,283,865</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,060,963</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.25pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,228,713</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942339920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center">Year Ended</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Revenues:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,125</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,550</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,039</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,974</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total revenues</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,164</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,524</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Segment operating (loss) income:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,704</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,730</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,243</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,561</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total segment operating (loss) income</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,539</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,169</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Depreciation and amortization:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,608</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,186</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Franchise operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Corporate administration</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">409</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Total depreciation and amortization</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,017</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,566</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Reconciliation of total segment operating income (loss) to consolidated loss before income tax expense:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Total segment operating income (loss)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,539</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,169</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Unallocated corporate overhead</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,714</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,839</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Consolidated loss from operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,175</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,008</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other (expense) income, net</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(64</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt">Loss before income tax expense</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,239</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,009</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Segment assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,998</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,936</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,362</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,003</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total segment assets</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,360</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,939</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Unallocated cash and cash equivalents and restricted cash</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,320</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,344</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Unallocated property and equipment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">765</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">781</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other unallocated assets</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">465</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">991</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.25pt; padding-left: 20pt">Total assets</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,910</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.25pt">&nbsp;</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,055</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8813-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787391504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Non-cash Activity (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,315<span></span>
</td>
<td class="nump">$ 11,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,016<span></span>
</td>
<td class="nump">15,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,474<span></span>
</td>
<td class="nump">11,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions', window );">Adjustment to Goodwill Related to Deferred Revenue from Previous Acquisitions</a></td>
<td class="nump">$ 166,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis=jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember', window );">Regional developer territories in Central Florida, Maryland/Washington DC, Minnesota, Texas, Oklahoma and Arkansas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Noncash or Part Noncash Divestiture, Amount of Consideration Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseFeesMember', window );">Franchise Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice', window );">Deferred Franchise Costs Netted Against Aggregate Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=jynt_AccountsPayable1Member', window );">Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of adjustment to goodwill recorded during the period related to deferred revenue from previous acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AdjustmentToGoodwillRelatedToDeferredRevenueFromPreviousAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred franchise costs netted against the aggregate purchase price of acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest. Includes, but is not limited to, payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis=jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestituresByUniqueNameAxis=jynt_RegionalDeveloperTerritoriesInCentralFloridaMarylandwashingtonDcMinnesotaTexasOklahomaAndArkansasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=jynt_AccountsPayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=jynt_AccountsPayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6789064352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash Equivalents, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for Doubtful Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">131,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Allowance for Doubtful Accounts Receivable, Recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Allowance for Doubtful Accounts Receivable, Write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="nump">731,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">54,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of Long-Lived Assets Held-for-use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage', window );">Franchise Monthly Marketing Fee Gross Sales Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease Exit Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,400<span></span>
</td>
<td class="nump">338,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiabilityAdditions', window );">Lease Exit Liability, Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Gain (Loss) on Sale of Assets and Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(417,971)<span></span>
</td>
<td class="num">(3,520,370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersLicenseFee', window );">Regional Developers License Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage', window );">Regional Developers License Fee Current Franchise Fee Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage', window );">Regional Developers Royalty Sales Generated by Franchises Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_FranchiseRoyaltyGrossSalesPercentage', window );">Franchise Royalty Gross Sales Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,397,076<span></span>
</td>
<td class="nump">2,279,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,258,607)<span></span>
</td>
<td class="num">(28,983,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseRevenue', window );">Franchise Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,442,415<span></span>
</td>
<td class="nump">2,286,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesRevenue', window );">Regional Developer Fees Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583,550<span></span>
</td>
<td class="nump">617,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseCosts', window );">Franchise Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,996,797<span></span>
</td>
<td class="nump">2,717,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=jynt_AccountingStandardsUpdate201409201610And201612Member', window );">Accounting Standards Update 2014-09, 2016-10 and 2016-12 [Member] | The Year Ended December 31, 2015 [Member] | Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="num">$ (3,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseRevenue', window );">Franchise Revenue</a></td>
<td class="num">(4,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesRevenue', window );">Regional Developer Fees Revenue</a></td>
<td class="num">(400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseCosts', window );">Franchise Costs</a></td>
<td class="num">(1,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=jynt_AccountingStandardsUpdate201409201610And201612Member', window );">Accounting Standards Update 2014-09, 2016-10 and 2016-12 [Member] | The 12 Months Ended December 31, 2016 [Member] | Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseRevenue', window );">Franchise Revenue</a></td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseCosts', window );">Franchise Costs</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=jynt_AccountingStandardsUpdate201409201610And201612Member', window );">Accounting Standards Update 2014-09, 2016-10 and 2016-12 [Member] | The Year Ended December 31, 2017 [Member] | Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseRevenue', window );">Franchise Revenue</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseCosts', window );">Franchise Costs</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_RegionalDevelopmentAgreementMember', window );">Regional Development Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer Software, Intangible Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember', window );">Development Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember', window );">Franchise Rights and Customer Relationships, Reacquired [Member] | Loss on Disposition or Impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise', window );">Regional Developers, Franchise Fees Collected Upon Sale of Franchise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise', window );">Regional Developers, Franchise Fees Collected Upon Sale of Franchise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfPCEntities', window );">Number of PC Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfFranchises', window );">Number of Franchises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfMajorCustomers', window );">Number of Major Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross sales a franchise pays for monthly marketing fees as stipulated in the typical franchise agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_FranchiseRoyaltyGrossSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross sales collected as royalties from franchises typically collected bi-monthly two working days after each sales period has ended as stipulated in the franchise agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_FranchiseRoyaltyGrossSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability attributable to the exit of a lease agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additions associated with lease exit liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfFranchises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of franchises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfFranchises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfPCEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of PC entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfPCEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of regional development fees revenue recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of franchise fees collected upon sale of franchise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of license fees that must be paid by regional developers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of the then current franchise fee regional developers pay as a license fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of sales generated by franchised clinics in their region regional developers receive as royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recoveries of receivables doubtful of collection that were previously charged off.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68075217&amp;loc=SL9156395-115594<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generating franchise revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchiseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period from consideration (often a percentage of the franchisee's sales) received for the right to operate a business using the entity's name, merchandise, services, methodologies, promotional support, marketing, and supplies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 952<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058139&amp;loc=d3e68564-108043<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchiseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13777-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 225<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84241808&amp;loc=d3e92212-112881<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68055307&amp;loc=d3e2420-110228<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84176398&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=jynt_AccountingStandardsUpdate201409201610And201612Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=jynt_AccountingStandardsUpdate201409201610And201612Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=jynt_TheYearEndedDecember312015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=jynt_TheYearEndedDecember312015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=jynt_The12MonthsEndedDecember312016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=jynt_The12MonthsEndedDecember312016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=jynt_TheYearEndedDecember312017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=jynt_TheYearEndedDecember312017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_RegionalDevelopmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=jynt_RegionalDevelopmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787081936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics open at beginning of period</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the period</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsSoldButNotYetOperational', window );">Clinics licenses sold but not yet developed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent', window );">Executed letters of intent for future clinic licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember', window );">Franchised Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics open at beginning of period</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsOpenedDuringThePeriod', window );">Opened or purchased during the period</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired or sold during the period</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsClosedDuringThePeriod', window );">Closed or sold during the period</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the period</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired during the period</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember', window );">Entity Operated Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics open at beginning of period</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsOpenedDuringThePeriod', window );">Opened or purchased during the period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired or sold during the period</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsClosedDuringThePeriod', window );">Closed or sold during the period</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the period</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired during the period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsAcquiredDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of clinics acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsAcquiredDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsClosedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of clinics closed during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsClosedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsOpenedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of number of clinics opened during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsOpenedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsSoldButNotYetOperational">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of clinics that have been sold as franchises, but are not yet operational.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsSoldButNotYetOperational</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of future clinic's licenses that have an executed letter of intent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_FutureClinicsLicensesWithAnExecutedLetterOfIntent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942492032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Lease Exit Liability (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease exit liability at December 31, 2016</a></td>
<td class="nump">$ 338,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiabilityAdditions', window );">Additions</a></td>
<td class="nump">883,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiabilitySettlement', window );">Settlements</a></td>
<td class="num">(891,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiabilityNetAccretion', window );">Net accretion</a></td>
<td class="num">(29,906)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease exit liability at December 31, 2017</a></td>
<td class="nump">$ 299,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability attributable to the exit of a lease agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additions associated with lease exit liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiabilityNetAccretion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net accretion associated with lease exit liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiabilityNetAccretion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiabilitySettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements associated with lease exit liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiabilitySettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786839392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (3,275,233)<span></span>
</td>
<td class="num">$ (15,173,872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">13,245,119<span></span>
</td>
<td class="nump">12,696,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Stock options (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">13,245,119<span></span>
</td>
<td class="nump">12,696,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (0.25)<span></span>
</td>
<td class="num">$ (1.20)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1757-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6773873136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive Securities (in shares)</a></td>
<td class="nump">63,700<span></span>
</td>
<td class="nump">92,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive Securities (in shares)</a></td>
<td class="nump">1,003,916<span></span>
</td>
<td class="nump">953,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive Securities (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6773824240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions (Details Textual)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember', window );">Franchise Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember', window );">Franchise Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member}</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod', window );">Number of Undeveloped Franchises Reacquired During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,025,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics', window );">Number of Reacquired Developed Franchises Operated as Company-owned or Managed Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCosts', window );">Deferred Franchise Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts', window );">Business Combination, Consideration Transferred, Net of Deferred Revenue and Deferred Franchise Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, net of the deferred revenue and deferred franchise costs related to the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred costs incurred and are directly related to generating franchise revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of the reacquired developed franchises that the Company is operating as company-owned or managed clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate number of undeveloped franchises reacquired by the Company during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6774402096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions - Purchase Price Allocation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,750,338<span></span>
</td>
<td class="nump">$ 2,916,426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member}</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">293,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases', window );">Favorable leases</a></td>
<td class="nump">140,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">269,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">1,042,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred membership revenue</a></td>
<td class="num">(45,072)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts', window );">Net purchase price</a></td>
<td class="nump">$ 997,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, net of the deferred revenue and deferred franchise costs related to the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the favorable leases in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777014032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions - Supplemental Pro Forma Information (Details) - The Joint RRC Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 20,985,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (15,483,492)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_TheJointRRCCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_TheJointRRCCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6788883040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Notes Receivable (Details Textual)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 10, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 22, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInCentralFloridaMember', window );">Regional Developer Territory in Central Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopmentAgreement', window );">Regional Development Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember', window );">Regional Developer Territory in Maryland/Washington DC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopmentAgreement', window );">Regional Development Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInMinnesotaMember', window );">Regional Developer Territory in Minnesota [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopmentAgreement', window );">Regional Development Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember', window );">Regional Developer Territories with Texas, Arkansas, and Oklahoma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopmentAgreement', window );">Regional Development Agreement</a></td>
<td class="nump">$ 170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote1Member', window );">Non-interest Bearing Unsecured Promissory Note 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote2Member', window );">Non-interest Bearing Unsecured Promissory Note 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member', window );">Non-interest Bearing Unsecured Promissory Note Maturing October 1, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfLicenseTransferAgreements', window );">Number of License Transfer Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUnsecuredPromissoryNotes', window );">Number of Unsecured Promissory Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member', window );">10% Interest Bearing Promissory Note Maturing October 1, 2020 [Member] | Regional Developer Territory in Central Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableInterestRate', window );">Notes Receivable, Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivablePrincipalAndInterestTerm', window );">Notes Receivable, Principal and Interest, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member', window );">10% Interest Bearing Promissory Note Maturing August 1, 2020 [Member] | Regional Developer Territory in Maryland/Washington DC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableInterestRate', window );">Notes Receivable, Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivablePrincipalAndInterestTerm', window );">Notes Receivable, Principal and Interest, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member', window );">10% Interest Bearing Promissory Note Maturing September 1, 2020 [Member] | Regional Developer Territory in Minnesota [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableInterestRate', window );">Notes Receivable, Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivablePrincipalAndInterestTerm', window );">Notes Receivable, Principal and Interest, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_InterestBearingPromissoryNoteMaturingOctober242020Member', window );">10% Interest Bearing Promissory Note Maturing October 24, 2020 [Member] | Regional Developer Territories with Texas, Arkansas, and Oklahoma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="nump">$ 135,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableInterestRate', window );">Notes Receivable, Interest Rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivablePrincipalAndInterestTerm', window );">Notes Receivable, Principal and Interest, Term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CompanyOwnedClinicMember', window );">Company-owned Clinic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="nump">$ 523,785<span></span>
</td>
<td class="nump">$ 40,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableInterestRate', window );">Notes Receivable, Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivablePrincipalAndInterestTerm', window );">Notes Receivable, Principal and Interest, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfLicenseTransferAgreements', window );">Number of License Transfer Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NotesReceivableContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The contractual term stated in note receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NotesReceivableContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NotesReceivableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the per annum interest rate stated in notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NotesReceivableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NotesReceivablePrincipalAndInterestTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the term over which principal and interest are to be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NotesReceivablePrincipalAndInterestTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfLicenseTransferAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of license transfer agreements the Company entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfLicenseTransferAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfUnsecuredPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of unsecured promissory notes received during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfUnsecuredPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopmentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognized for regional development agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopmentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor's statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor's rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInCentralFloridaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInCentralFloridaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInMarylandwashingtonDCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInMinnesotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoryInMinnesotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_RegionalDeveloperTerritoriesWithTexasArkansasAndOklahomaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingOctober12020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingAugust12020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_The10PercentInterestBearingPromissoryNoteMaturingSeptember12020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_InterestBearingPromissoryNoteMaturingOctober242020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_InterestBearingPromissoryNoteMaturingOctober242020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CompanyOwnedClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CompanyOwnedClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6937154480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 1,818,403<span></span>
</td>
<td class="nump">$ 1,438,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember', window );">Loss on Disposition or Impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of Long-Lived Assets to be Disposed of</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfClinicsClassifiedAsHeldForSale', window );">Number of Clinics Classified as Held for Sale</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfClinicsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of clinics that met the requirements for the classification of held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfClinicsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=68055307&amp;loc=d3e2611-110228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6774257456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 4 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 7,321,803<span></span>
</td>
<td class="nump">$ 7,059,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(3,928,349)<span></span>
</td>
<td class="num">(2,566,172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,800,466<span></span>
</td>
<td class="nump">4,724,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">407,012<span></span>
</td>
<td class="nump">231,281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,137,970<span></span>
</td>
<td class="nump">1,083,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,117,379<span></span>
</td>
<td class="nump">5,085,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,066,454<span></span>
</td>
<td class="nump">891,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember', window );">Property Plant and Equipment, Excluding Construction in Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 3,393,454<span></span>
</td>
<td class="nump">$ 4,493,425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6600225984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Fair Value Consideration (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial Instruments, Owned, at Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueAdjustment', window );">Assets, Fair Value Adjustment</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42546-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786567968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Intangible Assets (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 02, 2016</div></th>
<th class="th"><div>Jan. 02, 2016</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,880<span></span>
</td>
<td class="nump">747,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember', window );">Regional Developer Rights in Los Angeles County, San Diego, and New Jersey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RepurchaseRightToDevelopFranchisesConsideration', window );">Repurchase Right to Develop Franchises, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember', window );">Regional Developer Rights in Los Angeles County, San Diego, and New Jersey [Member] | Franchises [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember', window );">Regional Developer Rights in Virginia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RepurchaseRightToDevelopFranchisesConsideration', window );">Repurchase Right to Develop Franchises, Consideration</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember', window );">Regional Developer Rights in Virginia [Member] | Franchises [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">$ 188,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember', window );">Franchise Rights and Customer Relationships, Reacquired [Member] | Loss on Disposition or Impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RepurchaseRightToDevelopFranchisesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration paid or payable for repurchasing development rights to develop franchises in certain areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RepurchaseRightToDevelopFranchisesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786246368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 6 - Intangible Assets - Intangible Assets Acquired (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3,536,000<span></span>
</td>
<td class="nump">$ 3,536,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,775,958<span></span>
</td>
<td class="nump">1,197,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">1,760,042<span></span>
</td>
<td class="nump">2,338,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember', window );">Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,673,000<span></span>
</td>
<td class="nump">1,673,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">657,943<span></span>
</td>
<td class="nump">410,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">1,015,057<span></span>
</td>
<td class="nump">1,262,312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">701,000<span></span>
</td>
<td class="nump">701,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">674,667<span></span>
</td>
<td class="nump">509,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">26,333<span></span>
</td>
<td class="nump">191,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember', window );">Development Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,162,000<span></span>
</td>
<td class="nump">1,162,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">443,348<span></span>
</td>
<td class="nump">277,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 718,652<span></span>
</td>
<td class="nump">$ 884,652<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786886432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 6 - Intangible Assets - Estimated Amortization Expense (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2018</a></td>
<td class="nump">$ 439,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2019</a></td>
<td class="nump">413,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2020</a></td>
<td class="nump">413,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2021</a></td>
<td class="nump">348,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2022</a></td>
<td class="nump">133,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">12,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,760,042<span></span>
</td>
<td class="nump">$ 2,338,922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787082976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Debt (Details Textual)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 03, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions', window );">Number of Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement', window );">Line of Credit Facility, Minimum Interest Payment Over Life of Credit Agreement</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest', window );">Line of Credit Facility, Periodic Payment, Interest</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember', window );">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,000<span></span>
</td>
<td class="nump">$ 800,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember', window );">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember', window );">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount of interest to be paid of the term of the line of credit agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of notes payable delivered during the period as a portion of the consideration paid in connection with the Company's various acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payment applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786285904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 7 - Debt - Maturities of Notes Payable (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2018</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787772752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 14, 2014</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>May 15, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,286<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,306,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury Stock, Retired, Cost Method, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 791,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BinomialLatticeBasedModelFairValueSharePrice', window );">Binomial Lattice-based Model, Fair Value, Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BinomialLatticeBasedModelFairValueTotal', window );">Binomial Lattice-based Model, Fair Value, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 551,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 551,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Stock Issued During Period, Shares, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,128<span></span>
</td>
<td class="nump">250,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292,671<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292,671<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClassOfWarrantOrRightIssuedDuringPeriod', window );">Class of Warrant Or Right, Issued During Period</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 8.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife', window );">Class of Warrants or Rights, Outstanding, Remaining Contractual Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">328 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Stock Issued During Period, Shares, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,128<span></span>
</td>
<td class="nump">250,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000<span></span>
</td>
<td class="nump">113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 419,728<span></span>
</td>
<td class="nump">$ 371,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Stock Issued During Period, Shares, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionToRepurchaseSharesChangeInFairValue', window );">Option to Repurchase Shares, Change in Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(292,000)<span></span>
</td>
<td class="num">(259,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,000<span></span>
</td>
<td class="nump">$ 162,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (127,057)<span></span>
</td>
<td class="num">$ (161,911)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,286<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 380,067<span></span>
</td>
<td class="nump">$ 561,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 840,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 255 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,304<span></span>
</td>
<td class="nump">561,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">255 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Former Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.65<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.51<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=jynt_The2014PlanMember', window );">The 2014 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,513,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=jynt_The2014PlanMember', window );">The 2014 Plan [Member] | Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,950<span></span>
</td>
<td class="nump">12,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="nump">$ 268,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BinomialLatticeBasedModelFairValueSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the fair value share price derived from the binomial lattice-based model.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BinomialLatticeBasedModelFairValueSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BinomialLatticeBasedModelFairValueTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total value of the option determined by the binomial lattice-based model.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BinomialLatticeBasedModelFairValueTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClassOfWarrantOrRightIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of warrants or rights issued during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClassOfWarrantOrRightIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the remaining contractual life for warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionToRepurchaseSharesChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of change in fair value for options to repurchase shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionToRepurchaseSharesChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional share-based compensation cost recognized as a result of an occurrence of an event that accelerates its recognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of compensation cost was accelerated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized and expensed compensation cost from equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of treasury stock (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=jynt_FormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=jynt_FormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=jynt_The2014PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=jynt_The2014PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6774515088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Fair Value Assumptions of Options Granted (Details) - Employee Stock Option [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate', window );">Forfeiture rate</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) (Year)</a></td>
<td class="text">5 years 182 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">1.98%<span></span>
</td>
<td class="nump">1.19%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) (Year)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">1.68%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the forfeiture rate in determine the fair value for the share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6774895952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Stock Options Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted at Market Price, Number of Shares (in shares)</a></td>
<td class="nump">295,286<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Number of Shares (in shares)</a></td>
<td class="nump">953,075<span></span>
</td>
<td class="nump">477,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 3.66<span></span>
</td>
<td class="nump">$ 4.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Outstanding, Weighted Average Fair Value (in dollars per share)</a></td>
<td class="nump">$ 1.87<span></span>
</td>
<td class="nump">$ 1.86<span></span>
</td>
<td class="nump">$ 2.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted Average Remaining Contractual Life (Year)</a></td>
<td class="text">8 years 36 days<span></span>
</td>
<td class="text">6 years 328 days<span></span>
</td>
<td class="text">8 years 255 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted at Market Price, Number of Shares (in shares)</a></td>
<td class="nump">295,286<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted at Market Price, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 4.31<span></span>
</td>
<td class="nump">$ 3.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, Number of Shares (in shares)</a></td>
<td class="num">(206,875)<span></span>
</td>
<td class="num">(37,824)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 1.76<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled, Number of Shares (in shares)</a></td>
<td class="num">(37,570)<span></span>
</td>
<td class="num">(146,560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 5.11<span></span>
</td>
<td class="nump">$ 4.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Number of Shares (in shares)</a></td>
<td class="nump">1,003,916<span></span>
</td>
<td class="nump">953,075<span></span>
</td>
<td class="nump">477,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 4.18<span></span>
</td>
<td class="nump">$ 3.66<span></span>
</td>
<td class="nump">$ 4.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, Number of Shares (in shares)</a></td>
<td class="nump">287,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 5.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue', window );">Exercisable, Weighted Average Fair Value (in dollars per share)</a></td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted Average Remaining Contractual Life (Year)</a></td>
<td class="text">7 years 146 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average fair value as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942409424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Restricted Stock Activity (Details) - Restricted Stock [Member] - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested (in shares)</a></td>
<td class="nump">92,415<span></span>
</td>
<td class="nump">339,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">59,700<span></span>
</td>
<td class="nump">86,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Awards vested (in shares)</a></td>
<td class="num">(76,070)<span></span>
</td>
<td class="num">(162,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Awards forfeited (in shares)</a></td>
<td class="num">(12,345)<span></span>
</td>
<td class="num">(170,848)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested (in shares)</a></td>
<td class="nump">63,700<span></span>
</td>
<td class="nump">92,415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942389888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 8 - Equity - Stock Repurchase Option (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExcercisePriceYearOne', window );">Year 1 (in dollars per share)</a></td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearTwo', window );">Year 2 (in dollars per share)</a></td>
<td class="nump">0.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearThree', window );">Year 3 (in dollars per share)</a></td>
<td class="nump">0.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearFour', window );">Year 4 (in dollars per share)</a></td>
<td class="nump">1.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearFive', window );">Year 5 (in dollars per share)</a></td>
<td class="nump">1.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearSix', window );">Year 6 (in dollars per share)</a></td>
<td class="nump">1.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearSeven', window );">Year 7 (in dollars per share)</a></td>
<td class="nump">1.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearEight', window );">Year 8 (in dollars per share)</a></td>
<td class="nump">$ 2.45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExcercisePriceYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in the first year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExcercisePriceYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearEight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year eight.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearEight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year five.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year four.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearSeven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year seven.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearSeven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year six.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year three.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year two.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786826784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Warrants (Details) - Goods and Services Exchanged for Equity Instrument [Member] - Warrant [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Outstanding, Weighted Average Remaining Contractual Term (Year)</a></td>
<td class="text">328 days<span></span>
</td>
<td class="text">1 year 328 days<span></span>
</td>
<td class="text">2 years 328 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, Number of Units (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="nump">$ 8.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber', window );">Exercisable, Number of Units (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms', window );">Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested equity instruments other than option outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for exercisable equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:durationStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of exercisable awards on equity-based plans excluding option plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6773823616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income Tax Examination, Penalties and Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 27,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Liability for Uncertainty in Income Taxes, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,527,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember', window );">Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6669084944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 22,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State, net of state tax credits</a></td>
<td class="nump">20,100<span></span>
</td>
<td class="nump">20,900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision</a></td>
<td class="nump">20,100<span></span>
</td>
<td class="nump">43,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="nump">97,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">23,300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred provision</a></td>
<td class="nump">15,734<span></span>
</td>
<td class="nump">120,700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">$ 35,880<span></span>
</td>
<td class="nump">$ 164,429<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775975344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Net Deferred Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 756,900<span></span>
</td>
<td class="nump">$ 1,509,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsFranchiseCosts', window );">Deferred franchise costs</a></td>
<td class="num">(281,000)<span></span>
</td>
<td class="num">(553,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">51,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsAccruedExpensesCurrent', window );">Accrued expenses</a></td>
<td class="nump">45,300<span></span>
</td>
<td class="nump">57,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsGoodwillComponent1', window );">Goodwill - component 1</a></td>
<td class="num">(136,500)<span></span>
</td>
<td class="num">(120,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsGoodwillComponent2', window );">Goodwill - component 2</a></td>
<td class="nump">55,500<span></span>
</td>
<td class="nump">86,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetRestrictedStockCompensationCurrent', window );">Restricted stock compensation</a></td>
<td class="num">(17,900)<span></span>
</td>
<td class="num">(30,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent', window );">Nonqualified stock options</a></td>
<td class="nump">152,900<span></span>
</td>
<td class="nump">182,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetDeferredRentCurrent', window );">Deferred rent</a></td>
<td class="nump">257,100<span></span>
</td>
<td class="nump">629,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsLeaseAbandonment', window );">Lease abandonment</a></td>
<td class="nump">80,600<span></span>
</td>
<td class="nump">108,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent', window );">Net operating loss carryforwards</a></td>
<td class="nump">7,061,300<span></span>
</td>
<td class="nump">8,924,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent', window );">Charitable contribution carryover</a></td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment', window );">Asset basis difference related to property and equipment</a></td>
<td class="nump">377,800<span></span>
</td>
<td class="nump">201,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">368,100<span></span>
</td>
<td class="nump">429,600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossNoncurrent', window );"></a></td>
<td class="nump">8,739,300<span></span>
</td>
<td class="nump">11,496,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent', window );">Less valuation allowance</a></td>
<td class="num">(8,875,800)<span></span>
</td>
<td class="num">(11,617,100)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Net non-current deferred tax liability</a></td>
<td class="num">$ (136,434)<span></span>
</td>
<td class="num">$ (120,700)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the asset basis difference in property and equipment for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetDeferredRentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred rent in the deferred tax assets current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetDeferredRentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred tax asset net operating loss carryforward noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetRestrictedStockCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the current deferred tax asset of restricted stock compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetRestrictedStockCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsAccruedExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the accrued expenses of the deferred tax assets current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsAccruedExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the current portion of the allowance for doubtful account in the deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred tax assets current for charitable contributions carryover.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the franchise costs in the deferred tax assets, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsGoodwillComponent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to the lesser value of the book value of goodwill and the tax value of goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsGoodwillComponent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsGoodwillComponent2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to the difference between the book value and the taxable value of goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsGoodwillComponent2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsLeaseAbandonment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from abandoned lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsLeaseAbandonment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from non-qualified stock options and carryforwards classified as non-current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred revenue of the deferred tax assets current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31928-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775913408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Expected federal tax benefit</a></td>
<td class="num">$ (1,100,000)<span></span>
</td>
<td class="num">$ (5,106,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Expected federal tax benefit</a></td>
<td class="num">(34.00%)<span></span>
</td>
<td class="num">(34.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax provision, net of federal benefit, amount</a></td>
<td class="num">$ (140,200)<span></span>
</td>
<td class="num">$ (735,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax provision, net of federal benefit</a></td>
<td class="num">(4.33%)<span></span>
</td>
<td class="num">(4.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effect of increase in valuation allowance, amount</a></td>
<td class="num">$ (2,741,300)<span></span>
</td>
<td class="nump">$ 6,042,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effect of (decrease) increase in valuation allowance</a></td>
<td class="num">(84.73%)<span></span>
</td>
<td class="nump">40.24%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount', window );">Other permanent differences, amount</a></td>
<td class="nump">$ 16,700<span></span>
</td>
<td class="nump">$ 108,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome', window );">Other permanent differences</a></td>
<td class="nump">0.52%<span></span>
</td>
<td class="nump">0.72%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount', window );">Stock Compensation, amount</a></td>
<td class="num">$ (131,900)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent', window );">Stock Compensation</a></td>
<td class="num">(4.08%)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Impact of enacted tax reform, amount</a></td>
<td class="nump">$ 3,946,100<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Impact of enacted tax reform</a></td>
<td class="nump">121.97%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount', window );">State deferred tax true up, amount</a></td>
<td class="nump">$ 185,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent', window );">State deferred tax true up</a></td>
<td class="nump">5.72%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other, net, amount</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="num">$ (145,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="nump">0.05%<span></span>
</td>
<td class="num">(0.97%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (Benefit), amount</a></td>
<td class="nump">$ 35,880<span></span>
</td>
<td class="nump">$ 164,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Provision</a></td>
<td class="nump">1.11%<span></span>
</td>
<td class="nump">1.09%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the effect of reduced state tax rates on the deferred tax amount, for the effective income tax reconciliation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the effect of reduced state rates on the deferred taxes in the effective income tax reconciliation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the equity-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationSharebasedCompensationCostPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32059-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6774242768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Uncertain Tax Benefits (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax benefit, tax</a></td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="nump">$ 32,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases - tax positions in prior period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases - tax positions in prior period</a></td>
<td class="num">(13,200)<span></span>
</td>
<td class="num">(19,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax benefit, tax</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Uncertain tax benefit, interest and penalties</a></td>
<td class="nump">26,800<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Gross increases - tax positions in prior period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties', window );">Gross decreases - tax positions in prior period</a></td>
<td class="num">(26,800)<span></span>
</td>
<td class="num">(6,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Uncertain tax benefit, interest and penalties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 26,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits interest and penalties resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777068928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Related Party Transactions (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jynt_ShareholderMember', window );">Shareholder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related Party Transaction, Amounts of Transaction</a></td>
<td class="nump">$ 205,000<span></span>
</td>
<td class="nump">$ 461,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jynt_ShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jynt_ShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6937272704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies (Details Textual)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">$ 2,808,837<span></span>
</td>
<td class="nump">$ 3,389,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease Exit Liability</a></td>
<td class="nump">$ 299,400<span></span>
</td>
<td class="nump">338,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease Exit Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 338,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUndevelopedFranchiseAgreementsTerminated', window );">Number of Undeveloped Franchise Agreements Terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability attributable to the exit of a lease agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfUndevelopedFranchiseAgreementsTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of franchise agreements terminated for an undeveloped franchise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfUndevelopedFranchiseAgreementsTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942726112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2018</a></td>
<td class="nump">$ 2,119,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2019</a></td>
<td class="nump">1,808,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2020</a></td>
<td class="nump">1,544,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2021</a></td>
<td class="nump">1,411,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2022</a></td>
<td class="nump">1,283,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">3,060,963<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 11,228,713<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6942371072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775589664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 25,164,004<span></span>
</td>
<td class="nump">$ 20,523,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(3,174,898)<span></span>
</td>
<td class="num">(15,007,976)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,017,323<span></span>
</td>
<td class="nump">2,566,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(3,174,898)<span></span>
</td>
<td class="num">(15,007,976)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(64,455)<span></span>
</td>
<td class="num">(1,467)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax expense</a></td>
<td class="num">(3,239,353)<span></span>
</td>
<td class="num">(15,009,443)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">4,539,000<span></span>
</td>
<td class="num">(5,169,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">4,539,000<span></span>
</td>
<td class="num">(5,169,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(7,714,000)<span></span>
</td>
<td class="num">(9,839,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(7,714,000)<span></span>
</td>
<td class="num">(9,839,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">11,125,000<span></span>
</td>
<td class="nump">8,550,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(1,704,000)<span></span>
</td>
<td class="num">(9,730,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,608,000<span></span>
</td>
<td class="nump">2,186,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(1,704,000)<span></span>
</td>
<td class="num">(9,730,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">14,039,000<span></span>
</td>
<td class="nump">11,974,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">6,243,000<span></span>
</td>
<td class="nump">4,561,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">6,243,000<span></span>
</td>
<td class="nump">4,561,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 409,000<span></span>
</td>
<td class="nump">$ 380,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6774366000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 16,909,970<span></span>
</td>
<td class="nump">$ 17,054,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Unallocated cash and cash equivalents and restricted cash</a></td>
<td class="nump">4,216,221<span></span>
</td>
<td class="nump">3,009,864<span></span>
</td>
<td class="nump">$ 16,792,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Unallocated property and equipment</a></td>
<td class="nump">3,800,466<span></span>
</td>
<td class="nump">4,724,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,360,000<span></span>
</td>
<td class="nump">11,939,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Unallocated cash and cash equivalents and restricted cash</a></td>
<td class="nump">4,320,000<span></span>
</td>
<td class="nump">3,344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Unallocated property and equipment</a></td>
<td class="nump">765,000<span></span>
</td>
<td class="nump">781,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other unallocated assets</a></td>
<td class="nump">465,000<span></span>
</td>
<td class="nump">991,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">8,998,000<span></span>
</td>
<td class="nump">9,936,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 2,362,000<span></span>
</td>
<td class="nump">$ 2,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M?_A=A9TW=F__L?%%4';PZR[D%U!+ P04    " #L@&E,F5R<(Q &  "<)P
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M$'B 0#TB4K9[ 0P);+!'Q\\"6Q^1/"-V/B*%EY" /B:&G@SH&4Q/07IJZ.F
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M L[ P S,E(&YR" SN9XU?M+L)\T5D[?$G-4&"+75GH,O5,I"3Q94*N(,',S
MR4H9E55JUMASKT:EOZQ*0*958(7M>&C' SLZLR,U9_TX6_' "@>K"EX"]!*
ME[R_@RA(,T>3][;,JC3T(K02@96LC'64=?;LG,VL !D;(EL8-5IA(BCI*!\0
MZZ/HO"Q2:8Q3WCQ(:)W3[ JF"IC2H)E,;DJ#L6$LY>V$=*1C 6H:4NU>$W!D
M<T<D2C+:1Z]S1U+'EA3[PJC6F(.:@2>7>V(YL*UGDUL",E*^-,\T!JL&9#5B
M?3&B*)LFFFPEJ=.:V(12SV&P:@L\A=R3% D4'347?M0%/2_M8$QK)T%O2E,6
MHU4#;HJA*,%)K*P7DT/JK JAP#2-^:H!8*U@B"3LE2:3%I;<$A#&&"T5UE.-
M2:LE:F6H(QEJ$MC$Y) R"M%Y[(<P:$F"5BR()/%Y92CHS'>%=&FY,K'01(0Q
M2P"S5GB2^"27F!9S3U+'3KO2]"#,69*<%9.5)#ZC4R'G!Y!Y;4MSC3!C23)6
MMI!DYQ4[G^LJI(N653 %2QBR)"%K\VB&)#O3FL=*0 T)O;6E@)PP8TGBT^91
M#0%\.I.#JP*RA D?BHXP9DF&PS8/($C&N5JG)4^,;! />T/1EOH-8YLDMIVP
M!.+=M%@SB;&$ N.H2S$Z87 3 K<82X#'"=LQ-U\!82##L>0)<YM B"P'DR3R
MV'4NBG8"47)"MXX6FV(,;P91LAA/+*FLK3-YX%H!W;B_,IYU:1^,^<U:QA*V
M5#',6P9QK<UC2" 2(&%)VZN0^K[$?R[L[4%,:_-E&XBD'P1ELF4_&+8,(EJ;
M+T@,(&K28JQ$SP-A:F[OJ1!+,.8M@YC6QMR5)*EW+%8E(&,;56D88=PR.'UP
M>03(@*/L*>2SNT+"%'/84 H!&1.7O9P?KK![8$Q(!H1T.2$9'!XH!0Y60&ZE
MXP/&=&1 QWS'NP8B.3\ &+4RA08V&(L&8)%R>AB .W(V7_B1+#"7]ND&(]&
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M/=>4S,5_A0LH'QZ4^!PE*AM74@[6H9Y9O!0M7J9==G$?IYOTXPS;!O 9P!?
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M%%0^F/=HVW'-1L>;;GI!;'[&^5]02P,$%     @ [(!I3 Y#M2.W 0  T@,
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M]_YLIC&;#(?]_(/8\HV+WU!+ P04    " #L@&E,?G@]8[<!  #2 P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6QU4VUOVR 0_BN('U 2XJQ19%MJ
M.DV;M$I1JVV?B7U^48'S ,?MOR]@U_,Z[PMPQSW/<W<<Z8#FV38 CKPHJ6U&
M&^>Z(V.V:$ )>X,=:']3H5'">=/4S'8&1!E!2C*^V7QB2K2:YFGTG4V>8N]D
MJ^%LB.V5$N;U!!*'C&[IN^.QK1L7'"Q/.U'#$[@?W=EXB\TL9:M VQ8U,5!E
M]&Y[/"4A/@;\;&&PBS,)E5P0GX/QK<SH)B0$$@H7&(3?KG /4@8BG\;OB9/.
MD@&X/+^S?XFU^UHNPL(]RE]MZ9J,'B@IH1*]=(\X?(6IGCTE4_'?X0K2AX=,
MO$:!TL:5%+UUJ"86GXH2+^/>ZK@/X\T^F6#K #X!^ PX1!TV"L7,/PLG\M3@
M0,S8^TZ$)]X>N>]-$9RQ%?'.)V^]]YIO#[N470/1%',:8_@R9HY@GGV6X&L2
M)_X/G*_#=ZL9[B)\MU2__8]^LDJ01(+DKQ*3#R6NQ>P_B+!%3Q68.DZ3)07V
M.D[RPCL/[!V/;_(G?)SV!V'J5EMR0>=?-O:_0G3@4]G<^!%J_ >;#0F5"\=;
M?S;CF(V&PV[Z06S^QOD;4$L#!!0    ( .R :4QA\-W+MP$  -(#   9
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M\/<PR3T(X!\\TD0.GN3803D(X1\]%$7.GD2<2D (__2A*'+\!-KUD5 0P@<
MBB($$.QKPL(0+"@]2!2!@&#[$^!MYF, 13$.< 4@P-XLX ")8AS@(D" PUG
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ML7Y[[_9Z?LMS8-6PC"E9_RO*WU!+ P04    " #L@&E,L6"15[<!  #2 P
M&0   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6QM4^UNVR 4?17$ Y2$N,D6
MV9::3M4F;5+4:=MO8E_;J&!<P''W]KM@Q_,Z_P'NY9QS/[BD@[$OK@'PY$VK
MUF6T\;X[,N:*!K1P=Z:#%F\J8[7P:-J:N<Z"*"-)*\8WFSW30K8T3Z/O;//4
M]%[)%LZ6N%YK87^?0)DAHUMZ<SS+NO'!P?*T$S5\!_^C.UNTV*Q22@VMDZ8E
M%JJ,/FR/IR3@(^"GA,$MSB14<C'F)1A?RHQN0D*@H/!!0>!VA4=0*@AA&J^3
M)IU#!N+R?%-_BK5C+1?AX-&H7[+T348_4%)")7KEG\WP&:9Z[BF9BO\*5U (
M#YE@C,(H%U=2],X;/:E@*EJ\C;MLXSZ,-_L;;9W )P*?"<D^UC(&BIE_$E[D
MJ34#L6/O.Q&>>'ODV)LB.&,KXATF[]![S?G'^Y1=@]"$.8T8OL!L9P1#]3D$
M7PMQXO_1^3I]MYKA+M)W2_IAMRZ0K HD42#YI\3]NQ+7,(=W0=BBIQIL':?)
MD<+T;9SDA7<>V <>W^0O?)SV;\+6LG7D8CR^;.Q_98P'3&5SAR/4X >;#065
M#\<#GNTX9J/A33?](#9_X_P/4$L#!!0    ( .R :4RNO#6#Z@$  &8%   9
M    >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;'54VXZ;,!#]%<0'K DD@8T
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M>LN!0:7M-C9[.;7^=-"BGZ<:649K_@=02P,$%     @ [(!I3&";0[7? 0
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MJ9G+^5;.@1;#\N"0]=4K_@)02P,$%     @ [(!I3)X"Z@:T 0  T@,  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL;5/;;IPP$/T5RQ\0@]DFZ0J0
MLJFB5FJE5:HFSUX8P(HOU#9+^O>U#4OHEA<\,YQSYN)Q/FKS9CL A]ZE4+;
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M=?&RX%!;/]V[N9[>\K2PJI_;E"S_BN(?4$L#!!0    ( .R :4SH0(8,:0,
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M;PZ@*!8>G#\)\I>1:08W!^T.)/+H"\=4@01FD00JG$"%$AB:1:+80QR%8ZI
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M# 2("-)FJZJ56BG:JNW9(9. UL;4=L+V[6L;0BDX%VR/_YEOQMA3]%R\R1I
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MSGJ'#Q^K(_I,!!NL-K/40;-WYIUR*U3TDH<HS+R+)AHQQ8!!,TPP(3S%/I5
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M7O:3J0^T:(>AB\;)7_P!4$L#!!0    ( .R :4S!'G86+ ,  -X-   9
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M;6+W:NS_T3"RFT:;S/^7_#]02P,$%     @ [(!I3#F>^8=U @  W@@  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULC5;OKIHP%'\5P@/<4J!0;Y!D
M>C5;LB7F+ML^5ZU";J&LK7KW]FNA$H42_2)M_?TYY[2GD%VX^) %I<K[K%@M
MYWZA5/,*@-P5M"+RA3>TUO\<N*B(TE-Q!+(1E.Q;4L5 & 0)J$A9^WG6KFU$
MGO&38F5--\*3IZHBXM^",GZ9^]"_+KR7QT*9!9!G#3G2GU3]:C9"ST"OLB\K
M6LN2UYZ@A[G_!;ZN86P(+>)W22_R9NR95+:<?YC)M_W<#TQ$E-&=,A)$/\YT
M21DS2CJ.OU;4[ST-\79\55^WR>MDMD32)6=_RKTJYC[VO3T]D!-3[_SRE=J$
MD._9[+_3,V4:;B+1'CO.9/OK[4Y2\<JJZ% J\MD]R[I]7JS^E>8FA)80]H2N
M.).$R!*B9PFQ)<3/$I EH&<)B24D P+HBM56_XTHDF>"7SS1':"&F',*7Q.]
MOSNSV&YG^Y_> *E7SSF"00;.1LAB%ATFO,/ >\S2A0GO,6]CS "Q&B.B 63M
M,HIZ#-#)]AF'SHS#5B"^]1B:K#I,VF+J+M(P3E'@]HF</M'(!\%X4)%HY(-2
MC/%@ U8=#-W TCA-HXFT8V<X\3AME ["B4?A3&2,G!;(D3%R"R1.@<0AD P.
M6C+>&KTQP42@J=,G=?BD;@'L%,"/S] 2CP*-DG#J",V<-C-'G-@M  -W>P>/
M2[JPH+MC&$R6%$Y<)-#A-)N0<'<F?*(U%W#<FQ!C-!FMNSGAN#LC/%5:=T/!
M)SIJ!<<M%6&(T?!2>P3K @(WM[IY\_\@XEC6TMMRI5\0[35^X%Q1+1F\Z&XL
M],=&/V'TH,PPU6/1O7&[B>*-_9H _2=-_A]02P,$%     @ [(!I3.H'W7W)
M @  HPH  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N>&ULC99OKYHP%,:_
M"N$#7/J'MG"C)M-EV9(M,7?9]KIJ57*!,JAZ]^W7 M<!/4[?""W/.?T='GOH
M[*+KU^:HE G>BKQLYN'1F.HYBIKM416R>=*5*NV3O:X+:>RP/D1-52NY:X.*
M/"((\:B061DN9NW<NE[,],GD6:G6=="<BD+6?Y8JUY=YB,/WB9?L<#1N(EK,
M*GE0WY7Y4:UK.XJN6799H<HFTV50J_T\_("?5YB[@%;Q,U.79G ?N%(V6K^Z
MP9?=/$2.2.5J:UP*:2]GM5)Y[C)9CM]]TO"ZI@L<WK]G_]06;XO9R$:M=/XK
MVYGC/$S"8*?V\I2;%WWYK/J"6!CTU7]59Y5;N2.Q:VQUWK2_P?;4&%WT62Q*
M(=^Z:U:VUTOW1/ ^# X@?0"Y!N#XOP&T#Z"3@*@C:TO]*(U<S&I]">K.K4JZ
M/P5^IO9E;MUD^^[:9[;:QLZ>%XR@671VB7K-LM.0@8:,%2M?0?])(@MPI2 @
M!6GCXQ$%GE!T&M%JRFX-1CE"$]K5?=T(B() % ":%+WL-&RP$!:"I2R9  $Z
MG HD$A@H!H%B (A.@&( R!8>3]WR=832)"4W+&,@$ . 8C@!!Q/P!SSG?D5<
M4-_S^[H1D "!Q .>"V\ASD0:3YQ8^;(8(Y[<<#P!<9(''$_\NA%FB(D)#Z C
MG%!\P_$4!$H]()IP. %&<+-!#WC>BX:P F'?\_NZ,=*-_H<?<+T7C6P7,>?3
MUPSH&$J'&W",!#=##'7#J?.]:+2).:73/R(@PRD>]J@Q$=P-L=\.:7)CLV.X
M?V&H@7G6 QT,<P)X?U\XAH)[&(::F&<^\S=S3&D\;?. C@@QU(V1X*Z(H;;H
MF<^];YS "6?>9]G7)4D\U'5(T>"TX(YOWV1]R,HFV&AC#Q[M\6"OM5$V)WJR
M!1[MB?$ZR-7>N%MA[^ONV-0-C*[Z(V%T/9<N_@)02P,$%     @ [(!I3&MQ
M\SX4 @  "P8  !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL?93=CILP
M$(5?!?$ :VSSEX@@-:FJ5FJE:*NVUTXR"6@-IK83MF]?VQ":!7=OL,><,]\,
MV"YZ(5]4!:"#UX:W:A-66G=KA-2Q@H:I)]%!:]Z<A6R8-J&\(-5)8"=G:C@B
M492BAM5M6!9N;2_+0EPUKUO8RT!=FX;)/UO@HM^$.+PO/->72ML%5!8=N\!W
MT#^ZO301FK*<Z@9:58LVD'#>A!_P>I=;O1/\K*%7#_/ =G(0XL4&7TZ;,+(%
M 8>CMAF8&6ZP \YM(E/&[S%G."&M\7%^S_[)]6YZ.3 %.\%_U2==;<(\#$YP
M9E>NGT7_&<9^DC 8F_\*-^!&;BLQC*/@RCV#XU5IT8Q93"D->QW&NG5C/^:_
MV_P&,AK(9,#QNP8Z&NC,@(;*7*L?F69E(44?R.%G=<SN";RFYF,>[:+[=NZ=
MZ5:9U5N9D*1 -YMHU&P'#7G0D+>*W5)!_TF0*6"J@GBK(,Z?.'\[$"*<S\H8
M1-F#**:K9!7Y0=0+HC[0:@9:BF),29+Z0;$7%'M ))J!EJ+W0(D7E/A > 9:
MBFB<1S3V@U(O*/6!9AMANQ1A2M,5]8,R+RAS.>(W6S*=<;(EAQ#\'TSNQ>0+
M#,;9#),OMAS.TBB*Y_M_J2.4YBLR/P3HX5C::_(;DY>Z5<%!:'/"W3D\"Z'!
MY(R>3'>5N9FG@,-9VVEFYG*XGX9 BVZ\>M%T_Y=_ 5!+ P04    " #L@&E,
M=7SY 7("   3"0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6R-5N^N
MFR 4?Q7C UQ%1>V--5G;NVS)EC1WV?:9MK2:J^* UKNW'R UK1Z[VP\5\/?G
M'.0 6<?XFR@HE<Y[735BZ192ML^>)_8%K8EX8BUMU)LCXS61JLM/GF@Y)0=#
MJBLO\/W8JTG9N'EFQK8\S]A95F5#M]P1Y[HF_.^*5JQ;NLB]#KR6IT+J 2_/
M6G*B/ZC\V6ZYZGF#RJ&L:2-*UCB<'I?N)_3\@K F&,2ODG;BINWH5':,O>G.
MU\/2]75$M*)[J26(>ESHFE:55E)Q_+&B[N"IB;?MJ_IGD[Q*9D<$7;/J=WF0
MQ=)-7>= C^1<R5?6?:$V(>PZ-OMO]$(K!=>1*(\]JX3Y=_9G(5EM550H-7GO
MGV5CGIW5O])@0F )P4 (T$-": GA1PF1)40?)6!+P"."U^=N)G-#),DSSCJ'
M]^NA)7K9H6>L/M=>#YJO8]ZI^11J])+C(,F\BQ:RF%6/">XPZ3UF/<6$&-UC
M-A FN,>\0!A_P'@JER&A $PH, +17;"+4; ]!AM,8S"C,#93! K@*$(PBG :
M13B31@0*1(# :#Y74TR41K )!DTP8#*:B56/26YF OOF!QO%H%$,&(4CHWCZ
M41[X)*!/ OA$(Y]DDE" 9VU2T"8%;/!H(:<3&_1HWA:@T0(PBF$!Y,/U[0,2
MR;AX_6FP:7P;JRW@*2[U_=D"13-;#OK_VEZ#H'3&!]X)$+ 5A(L9";B,$53'
MDVT- $5S4P)7.P+*/4(S$G M(ZB8)Z$"H&B\L7DW9X>^+GPG_%0VPMDQJ8XA
M<U@<&9-4"?I/2K!0-Y2A4]&CU,U$M7E_3/<=R5I[!?&&>U#^#U!+ P04
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M(V'PP=RC;=/-2(XWTW+IV?KRVG]02P,$%     @ [(!I3,H^&9\:!0  NAH
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M84/)4>KE4JUY-T"[C61-_W'@#5\HR3]02P,$%     @ [(!I3)OSU#U/ P
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MG/=-KU](U@[]W!M_*OE?4$L#!!0    ( .R :4P62_U2 0(  /@%   9
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M<K'& _,DRIY=;(88_(S8#A$1AJ.(P$0C:Q_WHXA#)PH(@YPXIC%/@<1@(#%
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MJL>BZ7F:B>)UV\\%75.Y_ ]02P,$%     @ [(!I3,P+*3=9 @  <0<  !D
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MJB?QO:GX;_B*B90K$IFCH83K7Z^Y<$'[*8I$Z=&+N7:#OM[,DRR9W-P.8'(
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M6)X.%,Y2;U.UY\-P&@Z2=>/<1=/P+_X 4$L#!!0    ( .R :4RS2E\%" (
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MNQL._Z%C33M>;++I=K7Y"U!+ P04    " #L@&E,8!OW%[U6  "9<P$ %
M 'AL+W-H87)E9%-T<FEN9W,N>&UL[7UI<]M6MN#GF5^!ZI'GR5400VQ<E'Y=
MI<AVCS->5):3U*M7\P$B(0EMDE #I&V]FOGO<[:[ /<")&4G4Z\FU9V$(H&[
MG'ONV9>_-LTVV&W*?^Z*RVJWV?[K7Z;)Y"_!U_5JT_SK7^ZWVX?S'WYH%O?%
M.F]&U4.Q@5]NJWJ=;^'/^NZ'YJ$N\F5S7Q3;]>J'>#R>_+#.R\U?_O;7IOS;
M7[=_>U$M=NMBLPTN-LO@Y69;;A^#UQL>H:PVP5GPR_6+X/3D>7 2E)O@;;E:
MP=?-7W_8_NVO/^ 0/$P4!V^KS?:^@3&6Q;+[\XMB,0J2* SB<33M_O@VKT?!
M.*8?9]T??]YMX,VQ_TV]>'O%__ZFW!3!ZVVQ;OY7]P79X(?BKFRV=0YOOLO7
MA3/G^]?O/@:75?W0\_XES%GG*YAV67P-_F?QV'WN8YTOR\U=</VXOJE6W5__
M\;C9=K^[W-4U[N15V2Q@Y'\K\AI!&;S(M\[ZSLZB^"R)>A;WJEP5=7 )[]U5
MM;.RZW6^PM\_% ]5O<4U7E;KAWSC/*BV*NLRSU]O\^W.08!_*YRO9(1?JQ7@
M;5[+RIS'WE4]+_Y6K%9GGS;5ETUP7>1-M2F6P>NFV15UWUJK]1H0X'I;+3Z%
MP?5]7A=-\'ZW;;;YAH[C%#"XH:^?]PQQM;M9E8O@U:K*G2/2V/;Q\<$YDVA\
M]C][7[@JZK):]IZGNAW_];_\ET$LMW'C%7SI@++[I,SK??;5OW6_N8!7E_SZ
M*K_K_GJ;KQIGY9= "JI5N81-+8.?\E6^610 >" VC:$<0\1@TG</\J:!0<Z=
MG_/F/H#3#!;XH?CGKOR<K^!Y9WL?"KC@Y0+7A8\Z>UTLD)HV05TL"ACC9E6$
MP:9PSOSU9E&MBV";?RWL9SN/(3D^;Q[R1?&O?P%ZVQ3UY^(O?PM<3-^V1@$0
M+62[=+FJC0NJVP(>6 :W0*P6]V53!(NJ(>#N>?.J+A[R<AD47X$G-# M JW:
MWL/57[1 [)"N:@N8,_S,50V<IH;K@H/B(3P@VG@!V-TS/114M]WUTU "ND.A
MT#>6>XA  .Y*A#COQ[O2OU?5\@NP-W?VAZHIMS8$AR#G_TVA]:K,;\I5N2T+
M%[<U3C[DCQXDP]_K76&.U+V,9]5#<+O;+!L]CT/6K_+'NEJM[(7XCTP6<02.
MTD/'//ZYV.P.F.!]"VL'%MY&W4-W>"@6M?;YA)=HMT>_!Y2G_S 9,GLA,O
MLLQRB[>7\7L!0AQPRF*S\#Q,C/6^6BV!B_\+W?OMHX/%U\!S +@7 1!"V4/#
M#/ED/!J/(P!['0#1WA4_!MDX'(_'PI*#?+>]K^KR/XIE&(R#$CG]DB^=8>$A
MW"\$'_"08GT#FU="94A/=K]VV0N+"+TKBFE%?:N*DG "OR;)3/UJK1)^S&:3
M,,Y2]:.U[KYEJS<3V$$R3_S#CF%5L]G\@/&<_5XLER7B%V !LH,S$( 6^4,)
M6.&*K"!C[4!*(]@$41J.9WHG0ZN/YY,P&^]Y= +GLR6J[:%JN_5N11+$LK@M
M%Z7S"&-QX\&^O?A.*SSDS2%)YO0JQ[MZ7VQ+D*J:YT"R3H(?9,.'X[]&,Y)#
MET"%\QJH$ ")1G+DI/Z1'-0<DFSW#B/(]BU#5(<)V>W;=RP\VF\?!0/OJ_OW
M[7WMP+VV[Y-^>W V"P51RRJ8+L-U>@]0(>UV0*S^P!S&E2O4#W07UODFOZ.!
M@]L"OKNMJS7<2U(!@\6JW)0+5Y:N'O,52'OX@J-&:)',]^O%\C/(B66#L$+!
M1+%!1T+["+\P#2A9XJ9[6]UNOP"HO$.C#D]T;0E#KE >]3[&+%*F[>&/?;]>
M KE"Z-=]D'W5DD?M1ST;W/>(2"][GKH&I9CH/YUE_:D@G;Q/) 39%43O,M<2
M=KY&>>,_<I_,\?=B4Z!5@YY;K@$5T$:R+3\7O>,+9>8UA<'=\2.\J1K <+C^
M94-B-BZTJH,2$+*L$4V]+Q#65OI2^ ]=IO0*^S3*37%; 7:56L=3K_1K@7U/
MO .I;H5CLA"U!K#?PW.X<_S:.[VF= Y>_90WY8*&6I:K'=Z*5>N% PFF.\R7
MHKR[QP\YW$N@ T?3[UX*=7D/*A825;&_:';[DMAM/]FRC3;!O[\EJ<&QVUEB
MS)6(,9<LQO2^HNGO\,@?BFU>HF7I95YO8/M-_X"51VI2DH(%-!1T;!-'UO?.
MON=HX6<W>5,P2@$^\47NPU+@9S0P',?GHMF2UJ&M("S6#1SN :\[1K.O1;U
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M:I5KAC7\MWT+[S!;HU&&0U&O-TAF\9KO:C;SW< ] B6>-ML]7T1U%60BT%H
MFQ#K MHP*,Q%!8VQ@F#,RTH]:%\SEASPDJX>%>'7JZ3[!S>:-8IJ@U8)EI0-
M&X0C76K7"OWD6391_>4.SDI&!F[V:=1GC;+L!DWY-8B29T&</@OIZD;C9[T7
M2%O\/Q@[AL<+ !\?6*<7\P;:>,2K8R\>Q1ZX1UO<9=N)$PJH'^6O7IQI1Z\[
MLR%H<!8/B54GX:/52IFHE=D7H?BEJC^1O"!A!; *TA9'?31M@V2M^D(W"$=<
M5KN;[>UN931I]NI4C*I\<##+]IXQU#EN9%";'$4?EH5XYK8O;[=1*$O![ *0
MLI&XW1VA(7K6BB\2/LJ^<49Y3/PB!D^RCEX]D/H<F"Q(M'I_^/(2&'7.I(\<
MBTJ&90F%5V<&*6U8:_IX0X(C2%YK' FV[-] SA3*8D :=LU#L4"A*X!EP191
M_-*F)0 ;VOF00]HRE\.\@.0L/C7";:O-784'3;R6=R$RUV[%ZUSA.>]0(RDQ
MS@"Y$-QR JVB.ZA6X5J-K*6VHC9+1%9M2.DU&ES[[NX)V@GANUGB-6:?I!RB
M;*/F%V"4)"'<&@RT+BV(?BB!DW1--&C=/0N2S9 IL)/U,\=\5O[AE/MVQ1.#
MGD,SJUE$1N6)E'PU9">9(GF"?4UI7Q[;Z,D4P9&Y=E,@7-J%:!C8)06&]*;/
M&!*&$0\ER8L-(PY*A>3V8[O5/P!*?O-S;ILR\*;5VBRU9$ PD4$,)IN5\G^7
MMA<[%.H%7XJY"T#*GFU4&6 X4;MS$4M&02O[YJ7R# ;^I!Q:%HFU2Q6!C0"S
MP@)+MKN04+%K%*JBI0TUCK,59E.NB^T]*,A$!DAWUE@.\@02O16=MA;3&MPJ
MR""D 6M%B%*2:A:\42^[8[(D0$/IO=Q07L3R1]9LT&%<?,E70B'62 R5Q0C'
M8%J-8!P%OS'J(7;;WE,8I ,+U)]IZ"WJJZ&<$LL%%'U)A]F*2K>#*,E2N:X^
M*R-ERVQ+KZ*T0B$&-9OS2FWC72H"TK(*:TT8%VZ"&D%34?&O+[2YH<6,]/:-
MD5.'S-I1&H3S1.J:%M!4^%2M=.R2N(<6D1"(0 1(/M4#DP!YTS:"5FU;.OQJ
MDU_%;RU>W-DHWU9U^ I( '6V(I.[EY3.3OA)Z\I9Z#,*WC/.!?G#PTJQ#-1Q
MT)%U7[ !Q1Z)Q@_9V*%DVN*K_"')9N6MV K"+O;AW!)6 6L'L($VV* "N"U7
M?)L4]$JVEV]!F&6.@E=O!6Q"+DB^9'B5--26B26 ?*3B'<73 @=. 6E$*60,
M$2)1V[+F #Y%KOVV( -WJFHCD-!%??B:\>X>0/9>B@Q6;.[Q.FMS E'[DG2;
M&V(,1!WP2$#:(3<OIM0A%03N2GJ'B>2\%=*:KTC:N>Z@;K%4E+)>,H@?\GK;
M'QHQ<N@-DK"-%2;8BRVOU;'OFO992;@TBR)YARB2!,$TL6QQ?DT3;XO0HNI9
M8"4B7C"Z.*F)+((!%3(WDMRK9[DRIK:Y3K_CE710D/VJ-3DZC/;?D6G5'D4S
M 0HM61F]\\H$FAL /=2 1OUNL=T1WM5K+>8.#B3B&BE_\KSE;E8<LL98)HD&
M ;6&(IF%T8!<W=J209J-':K%/(>\L<DLC&:9QUWSSF-@& 4J-]1\D&/2&RR^
M+BRI7MDT\!31&*8@U8:N.7KD;B+?*J-K!RTT])3X;H<-8-S"KA'-GER=\8C4
MO5M@MVB WH':05\<!Z4L#>=S3U!##Y3>@&Q]]H:BD 2]V].A6M+075GADRMZ
M4O9WVXZJ0])2(-3P?+=DO%N88+9%60-[1@JWH"]0 =]:@O\BKVOROAK_.\$,
MIP(V]*@M6?Y]G,2CQ+/I-+#36<BLTK6X 0V \RN;>X9JWDU_N24=CXG>#_KJ
M]NN_&+ED;'^WI)@!=T40"O_EN[S&VANK1VLDT*R1@,7/_ 8EH+;KPHXU(=>M
MO?RV08H/R%X:RL.,BR7*.0MAFIU-=6B-TD ;%&>1-BU+RK^Q3)-=JZFU)5JX
MZ"P%"]Q- :SVCJ7;S9*%$R5OP"5\J,A]PZRLL"03W))HJ0A8 '"M0-F9+^<,
M$2V^U1VSHDCJ7<M@2\(3UW- 95B:D1U5@(ME\0>N3(52IC*$OOP*K!5^?4&A
MIP"F"^.=Z%YCTB40J#I56$.!1=K.V&1UYN&7:G@5Y<37"/5Y"K6C79<BK> /
M>%D-&5.R&GO06AX#LY;29K:\6[3 20@1"6K&T+:BP#B4*LD"IU@*GP1Z;Q;N
M -H?ABX92>NQ?'RX9E+7853TQL@(N$]%S-%Z4HB-5 NBC(NMP95P9G@>#8Q0
MK79;XP02;XRR-"J3SD7GA(Y;2?Z=UH&Q]##936&'4RO:B> _0T$(<9=T=SY<
MEEQ!W)*X;F7;$S3A"A"*2,MT9K-X>!JAC)JI+*7*2H6&S;-;5"%K3=$Q+H$N
M-IJP>(@N?BD$Y2LLJAO%B0#17&Q%?Z:UB2Q*=P]EB9P84R->N:(DI!-QA$AP
MW8GD,G+>PH3$>@'*5L)6,'QWW?;ET<X=7"9P4[H'=$TM,&X]C.DD2%">R:)
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M4*I<H/19_0L0/,PBII-KB=LXW ,XF2CKX2@F]WX4C0Y\&[V_\RR,9Y@(,)K
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MTAD"#07X9@1S3?5SI0_J("5GM%P@V).4)FJ'):JV+F["6E?&W%"+B5;.-V7
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M38$P;[0W^JF7X3^-/WV(/O@LK\;:I<R3WX%>_&DY/-AR.'1>%\ ?]"ZN]2X
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MO.*:2K/8F1*K\+NEZIVJ_/VGV7W2<SKCF0N H7+^?9,-O>,(9=0'P+.SOIX
MP_CJ>\,Q"OM :1H+#)Z@-Q\,>Q X U(C A>>'L[>-^%5'TO$1@8>N_+8M4OW
MD2]3>[_5U.  ZM2NVJ]I"/SAJG)'M1OPOWYPUX$#UZE3AI#=/"A!W0NV:$QT
MGCD5%J1]Y%2??-&3Y-\/-+(=<E>P@?C4GIE4M(BT3-/?^Q=]0/^#O3F*G<X&
M&,>PT?J+/Q%L./O?+MZ#:C*J2JY?[= -M)(+GM*I83BZJZ\+PCZP&1B8"668
M@<IE5DV.X8HT_E7YOK/#[_TIL7N27OL1HE4?W[55#/4:Z!]4 6D@'4B26MAC
MJSM)['L\V/?DL9!ME13H9!H,TLPGEI4?&N@PP;FON+QY[H>FV?[M_P)02P,$
M%     @ [(!I3'!Q[:U9 @  7 P   T   !X;"]S='EL97,N>&ULU5=;;],P
M%/XKEHO0)J'F4IHQED2"29.0 $U:'WB;W,1)+/D2'*>D^_78<2YM4 <K ZTO
M]?%W?+[SV3ZM3\-*;2F^*S!6H&&45Q$LE"K?.TZ5%)BA:BY*S+4G$Y(AI:<R
M=ZI28I16)HA1QW?=P&&(<!B'O&8W3%4@$357$5P.$+#QUR+%$;P_>_V]%NKJ
M%;#C[,ULYL[=^_.KJ>>L<YU#8'D^I1'T@K?0^7/B@[03TN532.>N^YA>=TH>
M/)'\,>X)]<4!ZO%4#YSB.Q/H=%<6AYG@X\TMH 4T,V(8;!"-X#6B9"V)B<H0
M(W1K8=\ B:!" J5+1F?V#%(]6+=G9Z::.AY&N)!M;IO!?JZ[Y1-'/S,"":6#
M0!]:( Y+I!26_$9/VL4M^(L+=/9J6VJ%N41;SU_",: ==)*UD"F60QH/]E <
M4IP9.9+DA1F5*!WC5$HP;:0$Y8*C5D,?T1F:-L&4WIFOVK=LC[O)@%UCKL2%
MP*CH3;WKSAQOS6TE[[)9[EU:_RA>4)*-4!]KO1W>SDW1X5N),]*T\R8;!&AV
M5)9T^X&2G#-L-_/;A-Z1">,0]7E (21YT'RF5!(-8 G!!DM%DEWDAT3E"C>J
M+Z<F.U:S?X*:G_N<<\RQ1'17M*[]EWS*_UGQXN+O);>_*E/!SZC1/)HG(')Y
M"B*#4Q!Y C6YN'SY&DV;]&]%.MW[O=,D[+4( PK6-:&*\$YN0=(46SVF1XO@
M5]/\T;V'>NP4-+U":]WJ[_'KV!1GJ*;JUFRQ=49PM#\;X5XPK%H-%!$<[2\X
M)36[;!.._R?BGU!+ P04    " #L@&E,[OHMA; $   W*@  #P   'AL+W=O
M<FMB;V]K+GAM;,6:76_C*!1 _PK*T^Q#-[$-[H?:2MUF5JJTVXF:[.PS)21!
MM2$+I-/Y]P/.9'K=Q%?[8OP4&Q/[" /G<O'U-V-?GHUY(6]UI=W-:./]]FH\
M=F(C:^Y^-UNIPY65L37WX=2NQVYK)5^ZC92^KL;Y9%*.:Z[TZ/;Z<*^9'=]>
MQX.O2GYS[^7QE'#AU:M<\.>;T604ZHU!Q>:FA]\]T97]/TQFM5)"3HW8U5+[
M/925%??*:+=16S<BFM?R9G2H0N[TDGS67OGOY$'O;Q7JCDCSZ(?ES2@+QY[[
M\)]7Y=1S)4?$7JEPP3XLLPC>'^1].#>56H:G+\D?O.):2#)OV@8 Y@A@/A@@
M^33C +) ((N$D/,($?_@B%F1+UMI 21%(.E@D/<;#OLC0R#9<)#<;0!DB4"6
M_4+.=]MMU8#QBDR5$Y5Q.RLCY*/19P#R'($\[Q?RT7A),G)&'KG_"1?[XKXB
M@0/G H&\2 "9!\@[\=\N/+RI - N$;3+!&A%;+]PX,B3%%*]\@;A?>*>8#/W
M) $@#8 S&VYC@UUX%$UHQVW\)\1$!=.S81I,%C#_Y,J2K[S:21)'N5HVG1%B
M8IK)>O9,@UD&S(<PJO4Z/IW<.=?V8(8Y)NM9,@WA>2"<RN?6V\6<DO4LE0;J
M(D#%?N>_0RS,(EG/&FFP+INW*4PMR8*_R=:+Q.R1]:R/_<P\"71/\7(0W8S'
MX;NP7#LN(";FCRR)0*)![DU=*[\7<9QCPO!M#US,(%D*A631(7.Y;N+M)[DU
MUBN]AHB82;*>53)7:ZU"71X7 T*8G8YT9!8"':%:_3+'A)*G$$I7Q)!G$!,3
M2IY"*!]C!O)I$=WL?H.4Z+(EA4^Z[)P7$!.32IY"*B>UU[0HQ,0TDZ?0S,%]
M)]\U9IL\A6W>)7B2#Q-.GD(X'VUXDA+S33ZD;_(+B(GY)A_.-[%)(2;FG+QO
MYV!KU&("\R:8<XHAG5- YQ28<XH4SNG$S"$F)ITBA70Z,:%T"C1;ED(ZG9@4
M8F+2*5)(IQ.304S,/D4*^QS'0U/IN:H<@9B8A(H4$CK"#/'1SHH-AT%P@5FH
M2&&A$Y@_YU.(B5FH2&&A4]FI_8N'F)B%BA1)M*XHF$(+4<Q"=,A4&H46HIB%
MZ)"I- HM1#$+T<%2:4WGA)B8A>AP2Y]8!C'179L4%NK"_ SG38I9B*:PT/L*
M[6"?A7SS.U[!10;%+$136.@7YAGY.ZH]3/*RV6)ZA)B8A6@*"\$59;L](29F
M(9K"0@"S-3/=M?HF9B&:PD(MS+DWXB5$<Q_WFQAF(9;"0BW,)^F\56*_%PHQ
M,0NQ%!8ZT9IA&1Q#.8B)68BEL% +\U]N+=?'%F*8A5@*"QWG9DY$[PRS$$MA
MH2/,7Z<0$_UZ8(A]GQ@EA^=-Y0IB8A9B@R3DXG@71@NXM<(P"[$4%CJ!^8\6
M(4B&%F*8A5B2C%S'?AJ[A)B8A5@*"W7E-TNX%BHQ"Y5),G)=F' M5&(6*I-D
MY#K2L%/XD4:)6:A,DI$[C1G*("9FH3))1JX#LX09N1*S4-E8:-Q4=K?72[E2
M6BX?PR-<*!>\$C-+XL_^<P_*XK;L:E=5]Z'LB_[+\%C>W./P(>?M#U!+ P04
M    " #L@&E,M]#"#R@"  "E)@  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QSQ=G-;MI %(;A6T&^@ QS?B9)%;+J)MNV-V#!@%' MCRNFMQ]739U
MI<1?%^AC@X6PSGDW/++&3]_RJ1Z/75N:8U]6;^=36S95,X[]EQ#*MLGGNMQU
M?6ZG7_;=<*['Z>MP"'V]?:T/.<AZG<(PGU$]/\UGKEYVFVIXV<5J]:,>#GG<
M5.'M%'YUPVMI<AY+N%SBW;1@NN6]S_^SOMOOC]O\M=O^/.=V_*#B[X(J?!PD
MRT%"#]+E(*4'V7*0T8-\.<CI06DY*-&#[I>#[NE!#\M!#_2@Q^6@1WI07 ,9
MU_PDA#5?ZPBXCGRO(P [\L6.@.S(-SL"M"-?[0C8CGRW(X [\N6.@.[(MSL"
MO"-?;P%Z"U]O 7K+#9ZUT<,V7V\!>@M?;P%Z"U]O 7H+7V\!>@M?;P%Z"U]O
M 7H+7V\!>@M?;P5Z*U]O!7HK7V\%>NL-SDK080E?;P5Z*U]O!7HK7V\%>BM?
M;P5Z*U]O!7HK7V\%>BM?;P-Z&U]O WH;7V\#>AM?;P-ZVPW.NM%A-U]O WH;
M7V\#>AM?;P-Z&U]O WH;7V\#>AM?;P=Z.U]O!WH[7V\'>CM?;P=Z.U]O!WK[
M#=Y5HI>5?+T=Z.U\O1WH[7R]'>CM?+T=Z.U\O1/0._'U3D#OQ-<[ ;T37^\$
M]$Y\O1/0._'U3C.]2U,/>?=]'([MH5R[Y)_AG];,X"[C^RE?/^,R]=/],Z7'
M:4L.E\^K_Y\N4_]$A'E%>?X-4$L#!!0    ( .R :4S>GY_G\@$   8F   3
M    6T-O;G1E;G1?5'EP97-=+GAM;,W:RT[#,! %T%^ILD6-ZU=XB'8#; $)
M?L DTR9J$ENV"^7O<<)# A6IB%:ZFZ;).#,WJ756O7Q\=10FVZ[MPSRK8W07
MC(6RILZ$W#KJ4V5I?6=B.O4KYDRY-BMB8C8K6&G[2'V<QJ%'MKB\IJ79M'%R
M]7Y]:#W/C'-M4YK8V)X]]]6/IM./AKFG=EP3ZL:%D[0@F]QL4Y>0KLVS5 T9
MVV/"SQN'\W3?W3-YWU3TIVAVN6Q*JFRYZ=(M>7">3!5JHMBU>:B-I^HA^J9?
M?>2]-S[>FBXU9MN6?5N0'R]'?&UI=X"Q<LC),6T+VC5J++Q_\G\-_-P-I?4T
M=3Y5?6QV/%Z*=)^J@0T+#_F(-&R=BJJ]AJ?6Q_MA7ZQ?C]]WO?"O8F#CX7]O
M_7 Y!$@."9)#@>30(#D*D!RG(#G.0'*<@^3@,Y0@**)R%%(YBJD<!56.HBI'
M896CN,I18.4HL@H4606*K )%5H$BJT"15:#(*E!D%2BR"A19!8JL$D56B2*K
M1)%5HL@J4625*+)*%%DEBJP215:)(JM"D56AR*I09%4HLBH4616*K I%5H4B
MJT*15:'(JE%DU2BR:A19-8JL&D56C2*K1I%5H\BJ4635*+(6*+(6*+(6*+(6
M*+(61Y1U/.:=:?K?DCQ9N_Z<S\:_?RW> %!+ 0(4 Q0    ( .R :4P?(\\#
MP    !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( .R :4QF\PM@@@   +$    0              "  >D   !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ [(!I3 !8N-;N    *P(  !$
M     ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ [(!I3)E<
MG",0!@  G"<  !,              ( !M@(  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    " #L@&E,Z0J]\:@"   #"@  &               @ 'W
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ [(!I3(3#
M35PO!0  9!D  !@              ( !U0L  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( .R :4SH>/3 50(  /D'   8
M  "  3H1  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #L
M@&E,HI!GVC4$  "=$0  &               @ '%$P  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ [(!I3-(>8<XW!0  #QL  !@
M         ( !,!@  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( .R :4SP!LX-H 4  ,4;   8              "  9T=  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #L@&E,]ZH\>+8!  #2 P
M&               @ %S(P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ [(!I3#:?(S*R 0  T@,  !@              ( !7R4  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( .R :4P.0[4CMP$
M -(#   8              "  4<G  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " #L@&E,,C:.GK8!  #2 P  &0              @ $T
M*0  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( .R :4Q^
M>#UCMP$  -(#   9              "  2$K  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ [(!I3&'PW<NW 0  T@,  !D
M     ( !#RT  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .R :4QGZ<0MM@$  -(#   9              "
M ;0V  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ [(!I
M3-'+@=BW 0  T@,  !D              ( !H3@  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " #L@&E,6K*8X[<!  #2 P  &0
M        @ &/.@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( .R :4R)]&9#)0,  (P/   9              "  7T\  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ [(!I3-K^273; 0   04
M !D              ( !V3\  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " #L@&E,W^<Z>\(!   W!   &0              @ 'K00
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( .R :4RL71S<
MN $  -(#   9              "  >1#  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ [(!I3&YWRR?! 0  -P0  !D
M ( !TT4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #L
M@&E,L6"15[<!  #2 P  &0              @ '+1P  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( .R :4RNO#6#Z@$  &8%   9
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M  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ [(!I3.A
MA@QI P  50X  !D              ( !U5$  'AL+W=O<FMS:&5E=',O<VAE
M970S,"YX;6Q02P$"% ,4    " #L@&E,9@LC;&8%  !''0  &0
M    @ %U50  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M .R :4S67>?M7P,  +T/   9              "  1);  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ [(!I3&&C<>O_ 0  -P4  !D
M             ( !J%X  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " #L@&E,RC3 2D,"  "F!@  &0              @ '>8   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( .R :4P=/3WQ&@(
M  4&   9              "  5AC  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ [(!I3,$>=A8L P  W@T  !D              ( !
MJ64  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #L@&E,
MQR7F'54"   P!P  &0              @ $,:0  >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( .R :4S':$!-[0$  +,$   9
M      "  9AK  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ [(!I3+/*I]L!!   !!8  !D              ( !O&T  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #L@&E,%G& \@4"  "'!0
M&0              @ 'T<0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( .R :4P'2/-)C (  )P(   9              "  3!T  !X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ [(!I3+WX9XS7
M 0  :P0  !D              ( !\W8  'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " #L@&E,.9[YAW4"  #>"   &0
M@ $!>0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( .R
M:4SJ!]U]R0(  *,*   9              "  :U[  !X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ [(!I3&MQ\SX4 @  "P8  !D
M         ( !K7X  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    " #L@&E,=7SY 7("   3"0  &0              @ 'X@   >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( .R :4SNWA0*IP$  (4#
M   9              "  :&#  !X;"]W;W)K<VAE971S+W-H965T-#<N>&UL
M4$L! A0#%     @ [(!I3,H^&9\:!0  NAH  !D              ( !?X4
M 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #L@&E,'1VZ
MDF0"  "M"   &0              @ '0B@  >&PO=V]R:W-H965T<R]S:&5E
M=#0Y+GAM;%!+ 0(4 Q0    ( .R :4R;\]0]3P,  *T-   9
M  "  6N-  !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
M[(!I3$.$"/DU @  8 8  !D              ( !\9   'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " #L@&E,%DO]4@$"  #X!0  &0
M            @ %=DP  >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( .R :4QDXXM[C0(  *X)   9              "  965  !X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ [(!I3#.F )^X @
M8 H  !D              ( !69@  'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " #L@&E,S LI-UD"  !Q!P  &0              @ %(
MFP  >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( .R :4P;
MFGYU*P,  !@-   9              "  =B=  !X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ [(!I3 O&ET\S P  E@T  !D
M     ( !.J$  'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .R :4R,U^+' P(  +<%   9              "
M >>M  !X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ [(!I
M3%&'ZT6V P  >!$  !D              ( !(;   'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    " #L@&E,N9R,/YL"  !I"0  &0
M        @ $.M   >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( .R :4Q@&_<7O58  )ES 0 4              "  >"V  !X;"]S:&%R
M9613=')I;F=S+GAM;%!+ 0(4 Q0    ( .R :4QP<>VM60(  %P,   -
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64$L%!@    !) $D \1,  +,9 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>201</ContextCount>
  <ElementCount>415</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>71</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-consolidated-balance-sheets-parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-operations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-changes-in-stockholders-equity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-consolidated-statements-of-cash-flows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - Supplemental Disclosure of Non-cash Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity</Role>
      <ShortName>Supplemental Disclosure of Non-cash Activity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Note 2 - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-2-acquisitions</Role>
      <ShortName>Note 2 - Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Note 3 - Notes Receivable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable</Role>
      <ShortName>Note 3 - Notes Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Note 4 - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment</Role>
      <ShortName>Note 4 - Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Note 5 - Fair Value Consideration</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration</Role>
      <ShortName>Note 5 - Fair Value Consideration</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Note 6 - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets</Role>
      <ShortName>Note 6 - Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Note 7 - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-7-debt</Role>
      <ShortName>Note 7 - Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Note 8 - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity</Role>
      <ShortName>Note 8 - Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Note 9 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes</Role>
      <ShortName>Note 9 - Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Note 10 - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions</Role>
      <ShortName>Note 10 - Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Note 11 - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies</Role>
      <ShortName>Note 11 - Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Note 12 - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting</Role>
      <ShortName>Note 12 - Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-significant-accounting-policies-policies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Note 2 - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-tables</Role>
      <ShortName>Note 2 - Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-2-acquisitions</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Note 4 - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-tables</Role>
      <ShortName>Note 4 - Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Note 6 - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-tables</Role>
      <ShortName>Note 6 - Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Note 7 - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-7-debt-tables</Role>
      <ShortName>Note 7 - Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-7-debt</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Note 8 - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity-tables</Role>
      <ShortName>Note 8 - Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-8-equity</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Note 9 - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-tables</Role>
      <ShortName>Note 9 - Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Note 11 - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-tables</Role>
      <ShortName>Note 11 - Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Note 12 - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-tables</Role>
      <ShortName>Note 12 - Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Supplemental Disclosure of Non-cash Activity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity-details-textual</Role>
      <ShortName>Supplemental Disclosure of Non-cash Activity (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-supplemental-disclosure-of-noncash-activity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Lease Exit Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-lease-exit-liability-details</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Lease Exit Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Note 2 - Acquisitions (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-details-textual</Role>
      <ShortName>Note 2 - Acquisitions (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-tables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Note 2 - Acquisitions - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-purchase-price-allocation-details</Role>
      <ShortName>Note 2 - Acquisitions - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Note 2 - Acquisitions - Supplemental Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details</Role>
      <ShortName>Note 2 - Acquisitions - Supplemental Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Note 3 - Notes Receivable (Details Textual)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable-details-textual</Role>
      <ShortName>Note 3 - Notes Receivable (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-3-notes-receivable</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Note 4 - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-details-textual</Role>
      <ShortName>Note 4 - Property and Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-tables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Note 4 - Property and Equipment - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details</Role>
      <ShortName>Note 4 - Property and Equipment - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Note 5 - Fair Value Consideration (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration-details-textual</Role>
      <ShortName>Note 5 - Fair Value Consideration (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-5-fair-value-consideration</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Note 6 - Intangible Assets (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-details-textual</Role>
      <ShortName>Note 6 - Intangible Assets (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-tables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Note 6 - Intangible Assets - Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details</Role>
      <ShortName>Note 6 - Intangible Assets - Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Note 6 - Intangible Assets - Estimated Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details</Role>
      <ShortName>Note 6 - Intangible Assets - Estimated Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Note 7 - Debt (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-7-debt-details-textual</Role>
      <ShortName>Note 7 - Debt (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-7-debt-tables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Note 7 - Debt - Maturities of Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-7-debt-maturities-of-notes-payable-details</Role>
      <ShortName>Note 7 - Debt - Maturities of Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Note 8 - Equity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity-details-textual</Role>
      <ShortName>Note 8 - Equity (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-8-equity-tables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Note 8 - Equity - Fair Value Assumptions of Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details</Role>
      <ShortName>Note 8 - Equity - Fair Value Assumptions of Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Note 8 - Equity - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-options-activity-details</Role>
      <ShortName>Note 8 - Equity - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Note 8 - Equity - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity-restricted-stock-activity-details</Role>
      <ShortName>Note 8 - Equity - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Note 8 - Equity - Stock Repurchase Option (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity-stock-repurchase-option-details</Role>
      <ShortName>Note 8 - Equity - Stock Repurchase Option (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Note 8 - Equity - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-8-equity-warrants-details</Role>
      <ShortName>Note 8 - Equity - Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Note 9 - Income Taxes (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-details-textual</Role>
      <ShortName>Note 9 - Income Taxes (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-tables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details</Role>
      <ShortName>Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - Note 9 - Income Taxes - Net Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-net-deferred-taxes-details</Role>
      <ShortName>Note 9 - Income Taxes - Net Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details</Role>
      <ShortName>Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - Note 9 - Income Taxes - Uncertain Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details</Role>
      <ShortName>Note 9 - Income Taxes - Uncertain Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - Note 10 - Related Party Transactions (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions-details-textual</Role>
      <ShortName>Note 10 - Related Party Transactions (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-10-related-party-transactions</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-details-textual</Role>
      <ShortName>Note 11 - Commitments and Contingencies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-tables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details</Role>
      <ShortName>Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - Note 12 - Segment Reporting (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-details-textual</Role>
      <ShortName>Note 12 - Segment Reporting (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-tables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details</Role>
      <ShortName>Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="jynt-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20171231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details</Role>
      <ShortName>Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>jynt-20171231.xml</File>
    <File>jynt-20171231.xsd</File>
    <File>jynt-20171231_cal.xml</File>
    <File>jynt-20171231_def.xml</File>
    <File>jynt-20171231_lab.xml</File>
    <File>jynt-20171231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2017-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>88
<FILENAME>0001171843-18-001818-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-18-001818-xbrl.zip
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M'K#V%_G9BD.N3OAOSP%KR_0991HMLG[R\9N7GVEEK-6I_B".\W]=[]F](V8
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M8!7[.BM99 K;G8%Q%Q:?=#T?!!E;<_D?!7(#Q PR(3 =$H.7D"@@CX TR*M
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M2RNOA'XR"JV=,3&=Q+!^\,+0F_\"=N#D^Z/O@=+"&3S_@^ _/KR3174@*\9
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M ?\.%N8D^9M>8P,@!',73Q(0'K!:I#_$TE3F(H"1DT_8(<D=LO\^VU8X^R#
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MEZ3E('+#6Q9=!!0?F.J,B;D)!YFY5G1,K:YJY<D,L*6]RH-HGDC++)4K7W4
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M9#[V3$T/A&>8@CPL,98.=K3G/&&A"(&F=E";(+0?F>TU-T%G^:?"[[!!F,Q
MRRR-NBL?O>"GP:]9;?T>2..YA2#&(3U1YH%D@AF+%F&E?XN*N^0HO7OPU-%@
MK!9Z&@K!S/29'Q: F@/%@]";?&<"-5>M(Z9W2'NP%1O)Y\1;?HC^KL[$]>-]
M.?1KX,V)R2(D,4_L,:Z%XM'/!<,G9J;_%12'B$W4W/K2VF)'*7J4HK6DJ,X5
MHFFE+G2;9>5[8(L]9DU*TFVW=K:CY7#@D/5$@[Q6/>U];,K1:" :1JV8JV+4
M3YU(GI7X'\?$4BU_F+X/]N2U?XM ?GXA_@0D[ UNX_3'(/XUD-9#E]2A) TE
MM2)T21MSDGV&8/\/7QY\QQXR<7KRT3B59"V'V38PKJ )DL=F]9(POLRCQV?B
MTBI/_%BQ+/-/EWFU<H27X(-K.[^>A'Y$3MZWF'94-BTO)FW;:4NJ(#4+[3)V
MER;$*G5M:-20S%DF(->:0%#1L*& ,\C3BJKLNK)X:1"]NT4(\WJ@<$_^44GZ
M4$?"T,]5M;;UA$(UZB"7Q 7W3=W<YF"I3OGM49<(5=6)\VJ=H\3W&$U>;O?4
M/L<>'D)I JWP)6O0WAJMUU@+,;%_6*-Z>MF3Q<9[TRG:Y"A967(5-;[I7WC#
M2,S)+&?IXSA#[QE]1_ C2&T3JQ$FOJ78^8)=U::>8WLMZDS2BX"#;OA%#VU8
MTHCVFJ/>]EPAU1\P]+/HJ^PI&'A@B,; 4(I&?T]!GLI ,<:#L2YM&^=9SI"[
M9??-G'W)"F&#U63/HSD0$Y,_F?# D(180_H8Y2&PLLU!=1SGMH!TL:V3-D M
M*M%GYDIJA^;MSE6[U"SV%XNA;-2CK(YYVDEO(7U4NQ\*['!CH\EW8"UK9/&@
M6M8,)&D\4,1"[D*']#C8CC685L?'<UM^:4N4 ^RA(E%MINJC>ARR;[:H(VCJ
M<H@L'CFD%H=HJ@HFA_$Z.*2UX)"E(UO48@M5D@:2_",*#OG((;4X1#:4@3&J
M:7SLFT/J"XZU#J/Q.M_C9;@Y!1N\ 9:\P>HL=7FCT:3-:'LCKJ.9^F0Z92".
MQ,%XI-1CNEU3<"]B:Y6E9#A[)BR*+J06W)D;:FNV86,(EA?!V;:#DU?K27H5
MBB 596.@2VT8="L*;F;2LAN$O;E =C/18;AWVKB'9?W4*+_LN')[=?U6AZI/
M"*U&%P4]!:A/[:=BV;E\,@F[+!"<N'QXP.(JBI<2R85"P&J?4H=N+OC4%)RX
MDC1KP<A\D^3%#N.<FK3Y'8MNQ=IO- 2./N?'J>D1P;Y95C1A=7<(+/"<=4K#
MG9Q[,JER@0V9)K0A$XV\-0//A>VY%+R'N+!<VL.-Y1"NQ=!.,&#!GF*6D\F2
M]^*&4_TV,5- ?ZUFG^5(F-'6=@6/]EYRLL+=@W@Q6)Q,<O4!3V)/8B0Y0NPE
M>40^[<UD^[B*#7WA>[] ?',WHE_2"-!N$#K<R[DKMO,9U^.>]9GH>XA+UZ_&
M_8-IA2F_H9>/DJ5RB<::8HPY_%O<S$E!2;SV#"*?IL'0:$V,PY_ ]C=IYCN3
M<;AG'HAC@Q0,F""A$;II#DX036;YN6DPVNY%P6J_5-IHSDS[>+)*7R@7IE/L
M7^<5.ES6:+?6+.!H/5C)<^\P)O3&]*_].^Q?:=%253?$O\.0L&UJS.L*I^9Y
M2;R9>"J*4A&;#1!U@,+F<O.ZPNF=L5L4Z*_!613./)^JX:VHGZ_P7P255F(O
MEBGG3]X"RAH$5L5>H+QB"4?;T%&5N!!*RD@40<=70,@FWA*Z.O23*Z!3). "
MI2UTUU$8A"9+;=B*@$H%B)HQDC6U L3<[&W@K$-*M0).418-8]P2SJW;=>@*
MM^H@Y<%2N,IJ#6Z$I8Y,Y+9NH1S7 ):%3V9@U,(9YHH:_JS,9.LJ^J-CP=X=
MC7B IG:!C01L>]JKR?VZ#TK=Q%A^(R$[D[):P/GU8%_[),Y GO_PH7N[**!>
M4Y"NBE]W0G.\:5<Q._A^3AL*X*?F)=*EH\3M3>(>9HGT CO1-"W&3P(RU Z%
MU6%X02Y7'1A%M\<C38Q*6G;8&UPF.,9JA?6;\V E#S\I-I)4>/&6IH->0_HX
M\R5FG3;BQ+H5)VFAN0?\@;VL4RA-UW26@<W&2[N1%%N,@)RP['QQDS*P 5SF
M^TU&]H$C]ECR\3#J]>Y^SI5<;E@+S&VWXWI[NY\_L%\*\^=Y(RVATXOREY1_
M%"#I:<W5?_"CU0?(_%[NP)H6[LRJH10WJV7WT_"FS$V)%RH@$<&P\%.?:K:
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M-N;L 4+<%$-)&NNBWA-&N9<^L]#NLVE(?"RP>XF1"5M(.TWD2SM9EFKJ^@V
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MEI5CW^TWT7=[_$/VW68[0:![J2[.;['G3DR'T'QA/0H"FS;ZQ$O++/P PQ]
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M\3-B=AP&8%$?# ;*?,GO"(%H-I_#8ES"'%!Z(N:@>^'"_E 8W+9/4B8 &6
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MPC0VOL%G04)0I%[L^"%"V!KV7<0$^.^]ERR,)2+5KGPQ"'P(NYL9>=3()F
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MU$Z\[)F5P4C3M(9EG-Q"%#":>=_H+%OC2F@R&E4M9CU[N'G [<'FT:CR-FV
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MN7,KS6-"_V?! \W77;]3V($9>X8G\L'9RM#",5V+ \=JUL*;(ZN^DFZ2BZT
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M5*/N0L\HHV<KXX">824]0VMDU28'#/WO,;L-Y\F]';%]SV7#]ESVS,]E4H)
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ML)S?S(>!_Y ;C^*&A3?+YN2&#JTO#9MX%M[.#0Y!#Z'52F.6]3VG-AKP9/*
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M0,@C@BGA,OV5AM1%@Y 8"6%8H(W@>RO?EBO;%6_"']!YNGOK+$)$]1-M!B3
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MJ6,'2P=$'0(6-:*HY?>(.DL((:S8C!&;"T>I]K84%WS"(Q+EVE+D><1]!8K
MLU4JC[T,H\3[;[YV/QO9X_.LV":TDWU\WDT=Z4CI)2J!&OWHUT_/+\'Q.KT#
MNEK_HM$<Q^%Z^IX2KGV<"]U!N=5WU0V>JM[3J:HQS\/JYW!N7KTV;M;JCV]$
M9B+1A[6IWDKH*OKDLS!E5[JC4KX'*3+$\WLPBP9T$UKZ17B?93_B&[U 5'[!
M$&&:R#(PEOD+;JGUUHZE8)29CY5F.)0J  ,R6!1C69V'>964J<E$P$J0Y14+
MN>P@P/)T4?\,W%R*VG>1UN]A\=PYK2L(*(4-\];UG1VA*RC3-3S*$5EZB4I\
M5%@OVFV4,G-GN=)<"_Z<*:4*70''6W%P%G1O9;:G9OTK4ZNVXB"T9O!@N?F(
M&=<H^JTA;-(03HY_T+Y ^_<EPXM"@G)&K=0/>&G3I@<7-U7 2R2"[Y8,]\>=
M\0%E,3:^VO&?QOLP<MBK#AHHK!SP7):5( LG7\_@+R!8D86C%+/\1Q@-^&;[
M$D-F@V7DRE]+8(\7!+@RH\0#'TTKASZRMZ72BUORB!4,YL4<.Z5AS&N(K(9"
MFG-IQ#&23,Q#N!E]%JW!?%(&\WE'J:4,K>^,9V0[QPW;SIYY?-OY!O4TG*!0
M,<WPH$-!T>9BUKUAP7+>\$HV&05ZR^:>*&&C# !);V?[.;%0N>X6WC23,U=W
M?R%!@:$%HGQ34N_*K&*> AP;,0Z&>"@>$S]D CL0GKU?@$G#0*P>7]8LXUH$
MU@&#*X"UC)>(( 8,#F/;CU\1!3R<!Y]+4ED=P[O*S"T6&K3FM36O3]6\/F>C
M>E (\1'8ND%5P/0(1N^#@B",C:[Q=QV=\!-I\,;L7W]8/#G>8E& 9@"_XM4+
MJFQ%Y@>%K:C_]*IPPYL%(V/^1D]D,.(U+Y6P)' $LS&790VF<?:@XIZ$])*+
M-;-5(U C%2?F[#I84:MA32; K"<2B9WN&8F%;QQ99J@[)[D;R<K+R VY6Y5P
MK+*03:OFW]$<Y!1N6<>(>]73Y>EJ?X$[TAZGS@3@>-P[N1SJO_I\(-H+Z=\V
M9VS&YJ1H; A^!%3_;QJ"AP8A6N^4)4.0=-I*'H12<%,X-<U"."*];""LG)M8
M^14=T=4 +068+,KMSC!1OA,F-Y9?XX%-F7D=0;)!><@'%.H++86>;<,A]'V9
M](O5S71>!;OABF,M';5+FC_P9@T9X*:0H3ACA#T+TT2F>.51_G<?2*:ZY3%1
M:05RZ#5ZZ32LQ/7M33/K< 5\R!_7\N P%WYZ7SOD;@E+$/,#L32<_SP]"1TT
MFD4.)@ =D"MC@PND=Z?('L#,I$( H8T27$R40/_[?WY,X^Z=;:]>?XKN[$#D
MD=VH]\$_K@/WLW:E]6FNL+'5]5_\5GF@\/1MEBF7&;3/ @[A*WA^;WS0:K_\
M[_]E&/^C1L?3WS6/NV&Y 3SUA<U_?N']&Z6\:UK=OOGO'%G41>#ZNQ=W/\D,
MT5MV1]3\1GOD!18M><#P^.<7W?X+PW-_?N%8X^%X.K7&+XPT\,00<3BP8(PT
M=E_\,A@->[V>QI6,KAT('AV=X$D5P=.IN0/!'S@PCDZPRSG<,^%_&K-U8CY\
M?*]1,QF/>U74]*>3J34M4,,'W8&:44;-J 8U9A4UUG34FPSJ4O-KEKDIX&(J
M)7$3.;UAI6Q-AOTB->N#[DE9#4;U1E64 9NFAU+V,0R< ]AF5F])TQQ,Q]74
M90/O3V -[IF56W!H6OV1M2>!\*7*<.>B^4[D\!ZX2:?]*GJ[H\%@."S06TG'
M833OMI6G@TJ:S<&H* .[D'R+H%<"F_(C2PYE[K!2&$S3M(:F661O8?Q]*-R-
ME<-I%863X; WG11-QD8"98[H^S#Z'(4.8V[\/@J7OX9V$%-&Z3=L?'@@4Z>3
M2LW9'8_Z0S.CN!X]QYG#3FR?3BIU;+<_G/:&1YO#%R;[]GR:WU"_-WY6/' -
MJG>@-1J64U]!R>&4[\;Y::7T3/K]:;GP[$3ZISE]B=E@>$R^H59TM=BM4VE5
M4&E\CU\'GO_SBR1*V8L?#R%A1[Y5V@FS-[#6V59&0SFU7\-KA\[^;]0M^M_A
M+%J+XG_+WUQG5_7D.W]A^N4]'$9DL7'\=1&%Z1T<?Y,;.)#!:3WP;#B-?&3W
MO['OGA.N.]EY5DS[@TI/<M*?YKSL;5.LS1!0M2!Z=KP0W[BUF/-6=/X2^OHZ
MZVGV]6'%B$^*+^\9*SE?%*;>LZKD<I>IKTWFF&S8LK'&5?:NUL8ZULIL- V5
MIZ83LOBSJ'3\[.-I/'#?P:>K9=$'WL=85ZJ-P6!J]08;9E-)T_'FLN/*5!H]
M<S@:CZWQ$283B2U+RO.S'7V**'KB$HSA9_"_%E0AL\?)J2J8T06ZNM]GD>]U
M>>?<%[_TKGH]W1+6(NHX$ZGALE8%.9J8"#T07Z?)(HRH"'BOE=!U4)Y@C"KU
MJ@@N#GX8H34XW>\U1>@'?GFZ#S?[9B616PCD@^Y/7!T.6J<F[E.:4&2<MPO8
M@WW]?2G41CZ0S#J,')R83%(!&SBH[]^J(\1F'Z+.<*.RX:K.BMN&6]F>*T(=
M8'&TB.\!<<M1=1AU.+#ZN9/ =@J.0/)VV1F-*YW6 1P'K>%!)&M'<O2]P.N"
M)?8.]INFE5X@QO$+NK>"AKU)+7.+=-JJ1&"+0&;C8Q3IT_QK1.EM#\>)2%1&
M5*RI!5);SJ\20@ZD>L=3=64XVS*K5WDWJO'K3[Q9];OO+'(XS/R!W*X,;/9'
M VM817<9*0=3OB/'*P.>X]ZT7R4FM0@O=_"S.T]UIUG_U!I/>N:D-WGQ2ZV;
MYKF]]'SX,/&P4RFV+P7:[4#>+JML.P4?GO!8)O/]>&4CL,?/+T#OX+]7O+R"
M_BW&7'L-0A &W7O/31:OC7&OM_HN[L[I7CR)Y ^I&8=C^S*]+PE7+U366N+*
MQ^2+^JOOBL#ME^OKD]KZF_4VUA_#I E@N,'KJOOUM;\3=P.')(/R^5ZE/RE)
MJVR:N7)G4(Z5VA9U9_]C$F4R]2,)[ $)I9=1K9#C"-/#$U2_)/$192?/C0TN
M'W_M1ME(F20K#:5KI*+&HI%!Q2-2?Z04U@QQ?R-,4?;M50RTRK_V55RS,$G"
M94YW!>%]9*]^?L'_JX8NW3XUMNL:8]?WE"$8T>74P(-79IT1BI0",X"%P+5^
M%=6EH^LKS?G]DR$8+0EZX]M@XX@L@_):B#@=)PQ)FD7&CT2?RBQN.9)Q9%2E
M!R],0D_!Y4=$RRZK4E8W$=W-7EJ]0<?J3SK6</AJ@U\T&ORMQ /3A<]G<T[O
MI_E<IE-C3G.*^9HL9W@WN1?6^CBU5T2\PJQ-Z@_;W[5UW@3?N(-7<U >>\?L
MCSO3<:XJ[(C\V(')[3IM7*?>I-_I]:>-K].A*N$/54JUS1*6$D:@M@LP3)C[
MJYK6'E&'[D3-P6]J4F:&'=,<=_KCFC)S,@X\[S7H38:=_FC4S!HT8;^WTKC)
M@;V5?4EE-P=W!V;LZ1?GCT^5/NPQ3=J!8S5L64:CSF XJ">A37*Q%8 F!& R
M!2=P:EW*\C?E;[36;(_"P4[?,CN37K^>L+0>Q4G6H#><=H;3<3-K</$>Q76N
MF5>&$M^:E?/*Z<M^9VI-.OU!S>/'L=CXJEWX,R^\U1F"1VF.&W8IUA:^]20N
MUXKU._UIO_ZIH_4D3G%]WQG@&EC#9M;@XCT)+%M/HM218 ZK*+S#9@^M03FS
MG/; YS4OYH#:+G^SRV_US8XU,2]E^9N[#RE*DW4U/,1@'?:Z4L;2*PPW3&?^
M>H[5[C=OAX[1K ,SZ?4Z@[J!_:.QKUWZLR_]H#.VX/][E[/TFY(*SY?T=KDI
M?3*MZ>(F]U9O<RB[&C;3VOL'LS, SWHPR/>6;Z:=.0P^,6'P?&39N) &[^MP
M<PUX/=@D*L<,.(HH/+L6_OR8RUS>D$N"]KD,X1]A4)>W5CT]968N*F(X\%[/
MB3D2->+>W831*HP0,^]&?!5S1#7L<<1;"</[$3&/=I"3[XT(VF3!?-X4(K9]
M=D7XJQ$Z"-B_P;LDWNO-GYM00]95GO5+S_<I&I!!?CL+$%>"(/7#>P$<Z=A1
M],!+01&:1"2\K\K3XN&7N(@,ML22(Q?"JXUO5$#I,\()B>FIF/F^P"-%$X"\
MB-RLB:2/F"((5DE-/$2CD4@G%=DBB6E&8^7E5H=GW-BP6BXW1ZQ5")D@G&N\
M%),__73F7A3GL2K_2NT(4T^!I$:X.5ZSA4&(&/D^KZQP!0]K@%SN4LQ5LPQL
M'=(FAUE9^;LW#PJKA:?UJF^VHK4,K&K,'K,_GHY[-69<AE.SXQQ')YUC-2A'
M;]+O]:?-S'&7=50IFA^T#,T:,ZU$KAJ:YAC6\_)6<]^95M;R#GN387\TNKPU
ME7EZ;WF:7DW9K:S^-7NCT6 XN+P5W6^>E=7"DZEI3JU&EW,CH=7%P7W+G/3Z
MC2[()DK[E?@ X]YP.M2!4(]":1%JLC9<1*72ZD]ZO4&MK;R.,[D3E740(BH5
MSF!L#<:]!JC<1=E4/O/NNP!9UZ_F/@2?Q<7<]IW:K_08^OUIOYY&.LYRG9L1
ME6[%8 ",R(.&G%8BCH<.7KD7QP4X\U.O[?&F5+EQQQ/SV%,B;/J'/5 <D-B)
M:8%,G0C'X=F_L68XK3Q4O0>FP1[G6?K='E@(AP40+R,^60%X@'4M%.=P#3NA
M,,Z5D8OH8Z\T7L J^Y7S3B"1C0O2I7@-;U-NP.F"QY:R.%$:LWGJ&[[WC<7-
M!"&21<3R;6*2L(%A8\1WS0TK.JZ6%P,2W^TEMM3[[PZ,C1>A#.=0. W?39U^
MC+"2\W,5D.+-<I]X'/XW&[O9!+P]$C79PM@B9SB/@[HH$?*BRHZQ+0[BBKGX
MMO\ 'R,&B@\L'>]_6%PTQUZ1A/P7FPK^@3VJ/#2>R&,5\ NCX@[#]:=7)X@$
MVZ'ED#T!5?,KNR(MG%X1L270X6:]'447)DXF1B+O8.8X" 59O5BT^\F"K[5B
MFW7TX '!NX+]KFGU]['W7:M_>LBFHP.B5,*BU$G=R67HM*@H+2I*BXK2HJ+L
MF?+7HJ)L?]>%H6VTJ"B/8YU:5)06%64WF6E142YA#5I4E!85Y9*+3EI4E&<N
M "TJ2FO-6E241[0&+2I*BXIR^6:E145YK@O?HJ*T5JQ%1;G\-6A145I4E,=@
M4%I4E&>]_"TJ2HN*\O^W]ZZ]C1M)N/#W YS_P#.;!28 I>%%)*5D,X#',Q-X
MWYFQX7$VR*> )EL6-Q2I\&);^^O?ZB8ID1(I\7Y3 [G($B_=54]55U=55_6O
M- :MBG*QK.]O593@<U04)3Z\'$EV1=/K?B.IHE]PIFB._+H_[U7K*3C[\=6P
MC+6_CHX([ \%\#S_YOV=^$>.P>Y?WOAHU=>LT0HP6J7B:)\-%\S-S[;S$;#@
MP55748)FQ4:?V2?B)K.C!J69HZ@RWF+M/;//Q4W(>> RX[U',"C-, ./X.TR
MZ =,^H(&YU0>[.M8>FNIA%&QA1Z?/4X8K7M;G5#%."'Q_*-JRW-,S6(<P[A+
M)ULVSMV4/5.>YS>>VII(;&T@H[>7DZR4I-N8RR;(&PG+_@2'47X:@W^ORT%U
M/X(NR=+8%KY0:O->*^"_8GS9%[T*ZV%E4X*FSN;(;V$7BWF^K1I-;^Z(1PMV
M(>;<3O<HM;FIB,0F6S=\=E1+6QDNBIV^J^*@KNR>;L\YW4?7-"O*E>(2W40E
M*-.K,9W+FP#7-/6Z.YN12VL)D=9ZL('2N]*=@0T_*  7]5SW$;<\#]HJYSFO
MB]96(V'V(N]AL;YKJ1)F%MT74W=!_]T%Y5T$OUFJ:=I:4 A$=5?!V6C\ 9^+
M?E9-%)7X<)#K.8867=@5RT_HU-[HS!DK"CG7QZ%(VA#(+K+BK*4TT)YM^$\(
M=7I%]3$H[,;QI,@M);12ZJ=1/V^F7M>RW/#>=X>#6P\HQO@QV1[@_G=4#IQ9
M7@5QT;O@4;%\L:B4/SSHO7 >!29,!>FL_ZZRW@K>4C7O5&@C\33_2UKUZLCL
M@J_BPBM%O9I2CBGOJ_$>'_RNLG#5S/LB.<=E\S /LSG)*>\[%?9%#XYJN2HY
MJG6U)IF?M\O8=_ER?-.?YW[8QG\)FF>L5(=4H4+.V0KT<TG(RF05N&2U]@(S
MJI$4QWFYS9$BLRO!3.8;)86;TO I?UJO.^?XN=!"9F\\D_<PTS=\9XJH9B3O
MGK$J/'MS(FE)$3>O!539\:1*%&/_9GMM-#CCN9^.]&;6YU,Y)TI$H1P+6%R;
MAL6HVZ9N*!D,$0TF+AMY*7"JV^Y0*]K'N_"1[%A2ZMJS2:%KW\1-+(C3S41/
MV.9U''P2)"CD_6)X*Y!2Q\,ELUT/-$J@!]U=46[2R]!Y-C30 QOD+ &$*.@_
MB4MI[U-VR!N\F)*.'H#_?#8\ ^UZ*X9CG<9HM?L4:D<PM@SR;GA/]*Y'9*&E
MX85/<5%RO+C+HKK9./8KJ?MN;EN0PA]@]6-!YR=8W5+375AMCEY-6^[&B)'9
M<C?+H,N]Z!ZNUAMU2Z3I=HFUOWNG;H/%,,_2G&EH &\S;2Z1EY*&1OH(RHZS
MR"DG&">?:1")LBB5&&<4WKM6W=651?[W:1\#O/*NPXZM_R%M5\MT I,SQ\QS
MXIQ?Q,=<:#0U3R5'NS YTS07Q9FXF-4V%;Q$(/V3ZEAPA1NK4?41M+)FI'18
MFD\X$9OB5SI>T0CC/]O.-_02'FV#Y]PYM@4?M6 Y(M;X_L?O'N@.U='=WS9X
M$P5/G'$+3!6>@]&3#T)@L/]Y[2"R#'V$Z\A38$W\ [3@)ZP#(_TD\G"/%-[Q
M/>K[\%U#ENH8=K 5"/^ <2)-=<_W$^3GF7T3)Z+(<0<[@G-$'#S1X4<8T<H]
M)KQ<,^$7F3(\D2^/[NE@5^JF>68GNHG0 <W/:WI%RD:)* C27.:4=L=\7J4K
MV=Z6B3!?S$51F549\S.R?'0?-&?',*K:2FY&6\DU]<04/TG77>-"_# Q .7Q
M1#2[ ^YZU_T$6U-\O UOFP/R>"O']I]60$X@$>RZE[M3+DN$7!:N>P+*P0]1
MU7 G^L'>JB;>+;.,JA-_%VF)MO1)YAMY.,O</.RVUX:EV6OX*M%*Q(UJD@?/
MQ+^1=EF&%S2Q@S%/[!<+[\[A)T"CBKN!A6?S:FI]=5;1G--+WT.W Q!Y;;@N
M<3(4;G/96.^KBW]B>1=9NPH+5D&$N]HQ^X-FU[;KG?885M,@_5!0NXGO=0_N
ML(=UU,9!+CZWHL5$RUNI08\^XGHS2)3EOV"M$F<>\1.2QHNP5\0>.#7V5-)W
M#VX,6PGJS ON!AAT]HM\,#O%:.#W$QG_'^[_][(RM!7^,E"AIKEE_(UM1<Y%
M;-($KPN44V.Z*479Y-5/.UQ]!F5;W'J2J(;J5D/EM3%*ZI^]VL'X2 )XIQ7B
MQH2#DV-!<H(^IA9NE,E8MC5Q$#8"B,LNU:K [O+'4'R)#*%7I/E$? \%]LE!
M9#L8R9^WW>"P&@C?"KO1K=T+@I:JK;2K3>\:>Y-J/X6-0",U@IN71OIEIWLB
M<N(9N?ZC"_MK_"28([: 3$2,)\_=3747Y0 BAUUF<U',A@V7XP84CVDLTF@T
MU%DI<8X8P\F7_W@%_;#XV<TYC*BGZ4\XY&)$[]Q=B()P#,QYN609U_! <2,3
M$5W.DK!05!7V'5!-MYW0!@P.,\*=MO5DDX?NXSNNO]G8CC=EXEC%_:L,'5[7
M/$ L.QGK,'!K6](MV#Z:N+U<XIA0ZX-Z\E48B8>'$:QAA@,BN5+-Y33= FAB
M"4NL1ZF+6-5*;(J2G0\B\?*,XV9' \T]DD(UUA0E,QU#X"1!A+&4'TE*@LW.
MD?8!=ZI&KAMF^P3>O%V9D^M@)W7L4)N(B622>>;H>9X7#C-KJM*Q]M%G>@/G
MDG3H#6R8]#O0W^XTUOGQ2YG4GW'BHEWJEYJ G V?A3++,P'B;=A&3IV*:D'.
M#%F"QA#FDAP;3N+%Q0953$-DQ_JDA2)RRB+?H+YK*Z3[)KI=7H$=H1NFC[<U
MW\'"<DARPZ?7H,DX3@&\)GZ8,#,P<LS>(8<DFI4JR2AP%UV2<00]O)5V.E;C
M.!!# D%X0+M^U8V44AP!5UKJ(WZQ#=2[*L%8O"/W;]8S<O&>,':\G"28G<VA
M;+4,6I&']JH>FBRR"G=I/;D'RZV%P,[XG$<S>E2^KF)G[N]8WAE[4ZP&W26?
MC<8YJ"*[X%MJ!DUYD":KDLARRGA;7I%+?B=IZP7.:EXT(KC#U' JDJ-E0)%3
MB_4[,;*<)/ANVPIRO6](BLJ#^OHI"!!_" YR/."QEO*&B,)%>T.ZV&<7JN[?
ME*\CL;6DW2$:(RWM#M&>=9.A[Z]]Q\'!V$W4&8@VB!BO/3+DBH\G/&U!^@O2
M<5Y7O_PR0VLF,+DPO]G0^",(N'?FX-QES75["-UIJH=8,+O)F6T7_\5XZBNC
M.4@W:+FX#N'*L7Q>N-**<2/B^J(O7._8T1]4?],.;>PQV)*]4AZ7:,PWSH!9
M@4AJUW)*&QUT/:CN1S#*;6^^@>V.8%$W#L5S'_!<5A^?]>(,ATN-K\^\F-\9
M<(EBTC@#%@H[&XJ!E'^!.>EEH;OJSK9#^2/]U)4R&J:+K-@7KO?""1SSJNA'
M-B]=M/)8#1*U&KIE@, -QZ]2W6R@RT@=^SFZI%\.+WJQT)YL0Q(LP$%%,!)I
M+;X$TS8G]7>#E"K&W6B+F\'RGI=G^7T1?>MQ4R&;.RLM/'*(P^U!QYPK2_]B
MJ(^&2?+/*Z2$-U;HCZ:$TY3P7I.6IH37.,E**>&=1K?/DZK'[^YG38!=^#8L
M+I=-,9HDFZ./LB3G-X1I*G-G)[HE;I'?9NU1-G-=N1H'Y7*I\S0':MX*\Z-V
M5%4)\".E?![*2Y*87ZV6I'PO7%_DIBO3M%] /A&#FYWA7;&W]$U&#?JH4&&M
M\301C3(U0'N)'V-N2KJH:IKCPWH:EH6GLIDKN5O*GUE !;0) 1U0\EA]R^JO
MMJV_&*;)3$AU=.+K97@*F#P&&"_*L&>BIF\'E*\_9:-VT[?B(IHJF *%1QY-
M+M4MEG0I+<2 N=Q>2EM_EM+[@_JQ1&[! %8]F@J95Z\KC7LT*.'3""]R=4ML
MW];3;[;UMP]?+HV=?-)ZKT6RE(6Z19,NJL4X,!?:.W_?GU4U%HJU/ J4/&=4
M)(46:NB4 [*P8.6AB&K%=?4+4G%_ND?5TFUK364TYPZ):P\@E %IJRDW;\^>
MZ<]J^@V79 OZC%E/C&F[+J.ICK-=VLZ+ZNC4%LZ5S\1R,D^C-=TJ4'8AS(;C
M9:I:MJQ$\<1+1@<_HWT0+H8!_5E=KU<J4"4X-@(W.,9CT(6;++$VC(AB)T_X
MAA6H[':Y>VTO>M9UHA(^B0:/=0V7T0W<.ASA!$,'F2J.XG@V/D<+UK*W)<W%
MT=^^L:%;W+RG7Q6%%K;HUA'(M;A+Z605SCI:=F-YJO5DP$),BXUWIP#D.:TV
M?GELGQ5Q?O>]=$=> X,N3V5<.(JXH&ZT;O?I/#M;R!>6^)RM\K\@UV6>5=,G
M.5N,&ITYHJM)9YE)<W:N%*B05P\)\V>-48;7G@/(LS)?((.A(8YWYYHX68T)
M!_ LVYI$+4QV13=QU2\S+*BSK0!?6OFI,H"+' NICWY5=!9E>F6F%SF1TB#3
MRY7Y*E2=*ZO$UV&KZ ^J:VCPH(^XVS1^=MD27_SBHDM\6?:+HVY^>1/\O^X:
M/P=(SRC9-,UEU1R.M/$B8--D&:<_D.HPGRP=Z7A CP[SCHRND>I@(^!*4Z6U
MIHU7$!O,Q.NK*M8LWIH@YH#&TF85LGGNBDG8UL<I>MF4ZVE=JY3Q='FVB144
M"5@CYC/."A/DA.%-^9/'=)987A'9N2*TQ2 :%2CMD>YR4-V/H$NR=-4![G<B
MR$AG5'B7^H13V]9KVV)<O,=S&=OW7$^UL'W&3$@NC38&AC:N]GA8EF:@^?A%
M/JUWB5+5/!,$5E[(K#QKB0D=Y[M]6BZ1YC'VDM&Q3\9X1HR+--\A3A[:H'2\
M@C3.Y2E79!?OR?=?XXMBW/I>J@Y :8?$R8C5M,6X7^YW]; Z99O4HXR_*,9W
MUYQ-F$IES&T]"*U4 /#^Q14"?\TT*:KZLCY;\ZT2DH*@G[N)%@C9E=. FL]T
M5]&'747%#3-)82!GO\*5-BB9L$%.L!YWQ<43/O[>:,.WW%20ZG2K=%;*;Q#4
MYJ=">_7[\F<6%4H*RLPL(GXKXQGM6A#>JQZZ1YIM:89ID&3M"AT$9Q>=7M1%
MXDJAUF*\U$8+N,^VPW@KQ. <(C=((FHF<:CW]&ZE8V/7;07;FF1?VPHV0-)6
M.C5>K7&[G]%/$Y9+K4BA@:'.\[+9V6+:V2Q_VAEN[TRJF"\1S$LUR=&2QZ#9
M<S:GLK-R.DUUXOJ5ZH2/->6OC-1 *EJK_"GRT'XQ2IQ-FV/2/_O%I<%)D012
M).<_($BEZ#*DJ&-?X7=/]1!9*S>._6RXAFVQC(5(NDVTDIY=18?C_&UAL9QQ
M=5>"H]U <E%^-LV;+$_)7B/9%;'VQE64\CD!O^AW\YOZ:I3N<T#?ZDAS</7^
M'X%"P2?X4*G\R46#2&"56>T%]Z@ YZL2,YLJ=,EJG>XRR\UH7ZAN>3#CIL*L
M'?IWO,.Z]8 4./EBK9)NJ/N2O;0J?J[\-+GNIKE45 LQ@)M*.<^X4O(WU/.'
M5J3N5@#R'O+N>JFJ;\,5G#&ZIKV B[K_1)XV ^[(&\+-*=E[>@J*KDO#I7W'
M^Z>;]48-7'_(4DF&!XY6.6@)E* PR=/1@%W,"@2>J:@V<LB*GRX4RH"QZTI*
M^^&N4W5NGG!21:+(M>?XB/$W%"]YE.5<HHTP.^6 U)K'@Y*?+E:72/L^-6J(
MCAZ02!7)_BLP;]I(I-ZUKV(3AOY1;XQO:C?ZP.4\D$Z[$8Z%YV_YF52Q,4>=
MW:,&PJ&18H'+[3GJ:5.I6IKDQIK]W$4G%2HH*-H[J*I76<H?YZR/>NWR:H1O
M:]66G?)\VP Y<4J1ZH3F4_5F^9NR#DQPQORV=I4"5ZW08!U*H615J,(%G;)*
M0WUV5$M;&:[M?#1<S;1=WT$5.LTI%UT**E^/J4S$-U6%9M#-Y_9C[K -7<I,
MR5,BZ4$ZHP&Z#:U %X!6>$=;U#4^\4H5JJHV0YOE.>^?6;[_.L L8V^0Q:@>
M\XB># N7&\0Y3AM8/>T3I;&[Z,U5Y*%G2=/J'C6OJ=$D22BK\K!*D',ZN6LD
M21]B<(%N$")0W().@&7-=IB-[V@K%:]QNN]@Y8#+/)[3#C2.NP/4+*?K@0;1
MF\@?D=LA?B]2OC*%^4K[VS><0)S!>*&27/*X-A7D[H)/M1*_LY:FN;)@TGIN
M"7NCW79KD63:C:FAXU\5G(HER)?_=!AE>*>:J3&&]\SVR-<Z,/(]&!9V/SAA
MQ22/*#)DZ=@#075:7R NYJV[0)L+CH[UE8)DC;473(^5Y2('C3W1V-,(8D^X
M(H9J;2?V2^BG PRK3S0212-1K1J&-!)U]J&]"F_(.;W1-!#5-:=F.7.M+R(.
M11W6/3Y"2&F?0OM:2T -/O!$Y9?*[[!H/Y# ,0T\44]=&(?@:>3ILCB><WEH
MUS/; R.$1J!&!_6\FV$:@!H;Y_,ZK/JOY<J9:I6"-#TVX+L<5/<CZ)(L/5VM
MA6ETYOG!!DT1Q;$:7Y_W[ZUPQ+75\[2]/$XK+JJ=IFV&@I3[+7%?J7;8ODX*
MTG5Z8 L2)4M_U^G$5AD4 [)<Y 8>P$?? QW@,5L$LHN>D0G+-/7KY^NDU%+'
M.4K]-.KS.4]X=BW %?M5?'I%FH_;5)C(\Y#C8HO9L#S<^F]I.\S2]WP'A6;V
M3K0I@OH3VZ6T[RXF6JXPS_ER.IF%>(@T?@597/OK>Y!1U;Q3MVOXX'ZVG=M@
M VP]?<%MIMWR%7I$^=(J]%1,;%3DW'E50.UY-B"[R'T[4<XM&@[7IY0W@>7Y
M!2OF+3,\BLRW"#H+JOUS526?<W-VI@PD.Z.^+9C "1Q%2+ZZ];,9NU &DG]7
M67$(/(5%+EC,>)[EA4M4' )%2"Z$"'.1G><M_]0U0O(KCJR6" ] $*0NP1 O
M,$O:7Z'FEIB<S+$+6<P'NJ8IV+<"^R027 &=M)!V95\I*PAS5N&K +3F>M,E
M73/E'2Q9/IL;>(CU9,"E5ZZ+//?*TG^U;?W%,,WR'AIA=FD>FH22R'<HNKQU
MD8!_,R=^>;Z=([]7Q*,?/YK.I!U_;OA\>J]9T=+AZU\=VW69:]5QMC!Z/*A=
M#8&K-:R/1=K8C8<J5YKFKWU3]0[**@!) 'O_(PE=%TF8;\A+!\M_5--'O;#)
M4I?DD'%(QV'$<.5C5++TY:\VT>,M)DUUH63I%5D:\Q&$EIJ4$HW*&.0]4J.S
MO,NHZT% C1,I _V,>?%G9]VNVTE6Q/Q=QD=3EV-H?)(EA5W,<FZ#*9<ZDR:.
MEUA.&E[ME!JS-7T7W@$[0@>9Q,AV5\:&)G;E@8_"\?E5\24:/<VK667&RG).
M\:4<:*0!"BN*.=>YKI5F[=4O#FW=,*\=NXG/6KOG8V7T/' =*SPO"_F5-#T0
M/C8 S&8B*\YRIO=0]H^-_0H_9^7^U"/O2<2\2)2[YL?5=J*S>,R\ER%SD95$
MN>("=6G'H4?">IY5%(E=2%46)\KZH;)>YEAN5F5A:NX8/&V7,+[<AF[33"H5
MFQ\;*VB:"4TSZ1]A:)I)/SVX-)^"DJ579*%I)I<0&*=I)D/@TXSG6'F>TX%
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M<_RBCAAY7CJ,A.SYT"YDKIU33FA*S_22ZFTJ=R%[5>5X?D')WA#8L]=4>/L
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M6('TL)!UB@^T2I+H@^&9Z'9Y8Q%]XJLFN?:S[:R1<[TRT!),1<W'(G&[!.V
MG!QUX[-=]@M%/"RI4"=5:B)Z_')<BKZ]BO$GI#Z[VX,\/XY3UC+M]LC9?LIM
M9AL*8982]NT3.?>)'EGI8$3#!=04BVYE8S2:XQH9\\-"_'4,N29*G#J6A4_;
MEP%:B1,C\1-1(I!,^H.?"X<%"!J9W]#IF#P"$J<C;I>AU &]'M.PBMLO3BME
M:+0ZF\"<53ZC5B F"RIPA(C\3*Y#<,M/L%X*%R]0(N2JXU2&PN*,K":")-5(
MX1(3["&%:U($$L:PG%;GZ.(I7).6D&6"8;%.)=$Y@?]3HM9?9<5P(FR5NP7
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M@S>;Y=$5Z?,=*]?#OG&QE*!P?5%C24*WR_T&YV'EV/[3RO:]:]4TEK8#^XG
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M!V!SIE-OTAW!()WH#I2B?)!LWV.>C8^_D&W:@KLUG1[IYMB59*S^%F2&]Q6
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MK,>4-1/7LG8O;*36"STU;TK0/^JTLP*-9]/)QT-4B?0G9.K!G_\/4$L#!!0
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MP:@JH9!+3,V7T63;;C#E>#W852"ZZ;$#:+<8Q7_D1)#2:'_VZ+TXX:W2@I6
MVO33"8S*B.:N4 =/_(TF93LES3I,'77:"<#"K-M,]4'R6RZ*7,UJQ@V-0[E2
M_09SPI*7*UISGM"D"W^7&]NE2@"I_LZ7.U!&EWHI[LX%"-O;#S30[(A]@_M_
M2%<K.2WK3N_9M=3)TV**W>$L2S%@,$&T7G*N7M@[+RJ]-;# ="%!@MR$#28-
M!-B+NR%L@&E(0P#VHO@1C$I#%P:DXLZ8G6N^+%#I2$, IJ_*!P,T=Q$"4,L[
M]6VH0X!73*_- M+Y\TW)@P'X](+&!O/4V$,(,,N;!3=#47G#(!BQ36<A@']^
MF>D5>QJM09R1I=UPVW3F)=]<L26]@R5)</)Q]54H%^^*4$1C"&#[#H(!.:1+
M.38M0-9T$ Q(^-2U[^#O\H@:5C<OZI4K7HHTQC@ICD5>W).IP6!'[!7<+5[D
M/)Y)73>:[-ST8 9F(/0':C0I&!D*D:N7 -=E0$-(_ &Y9T7PE^./N2 4RWU6
M7<PHI:W"E.M?$@,PFRX" *J](Q0*T]B!E]<R/"D -092^L7M43I,IO9^(:S#
MD<]NX@  J:'R#$>Q,EH4Q]N?'C&/B= O*BB=%TA+(B0S4C%?LGR<3?)T$[;2
MHS&2^*C86FQU,N"U5Z;F'NJ+9DAJ6[DK)G)35(Y2W0%&?>-6U2L'38VQ-319
MMQY68&DU+:0!F0!!942V@]O@("2H/,FNI[Y]9"6D*IUVTJCQ\QK4[H0VYBT2
MB1I4_82&OOE9&A3\FV,$W^$;4;X/?GW;'S="L;\-%KM-;A38B'&1,M^IDC,E
M=H*1]\-=Y)WG6(*%<@1FGOWI-1B]BRKJ=N#A?C48=/C&G&4J$!AYZ!9>QPF\
M8+FXJ/CN>D9 D@/  C@"^\]-'63_&"W!VA0M,/)P[< -M572-3C.$ZY!V#Z[
M"RR$\&-[AZM:/W=1KG\0]6_.FP++X @"?DV2^$.K@K5-G&&=E6LUB/*')HFV
MY]3'$/IO*@)P1L(QG !8"L$F+RBDFQ4:9 L^]XSA"0%'<,;7!+8Y;> 8UCP4
M.3B]ZAC6N"5H:(K<$9SH-9CHU_K,I6,XW0,BAJ6?A*3!&Y4XLU8&<7#J_$ R
M,.;,-]#LQR8#8TK]DPP.?_<+E2LRZD?2Z<@Y?OY6H C1)"KDQ%?J%T&FE$Q(
M+*WQ"*TCUQ)$M& I46^GBG#YKK@HE>Y<)+N)XD*?1T(E\$2)>J5<:G&/C#?6
MG-Q)XQD=['Z;#JN/%&B4ECN\XDL,LHR3<9ZIS>">7: T+8T^N>9^09PC?5YF
M!SVZSWK\I=!7.!DLY4!/\9=\/L9\-+DD:2Z_72,8Y9F<(C21PZF!WK"78.#N
M<?@1"1+;@:WO(\P+S9N.V\MX81>S/B1#HP.YM)@ESK?:MQ$ISCFB3&4X[7R(
M%ILS\6B\/OEHN&.V>(*[C:\UDR[WK_*EWU<X45>70B\3 E)YN 1JS9C=U4@P
M(F]@[M3TDOKN6C[:=H1@M/[NL"IG4+.KK&#$?U_0U1&<9W.I&3:;+O["[Y[S
M&/Z!J3K64-6'9'PUAFJC,T,*[4$52$5^BOVZ#&FD6P"WV4)"&NL&4(]N6.U7
MKB5$/VX1Q<KL7X])^54GSI"Y7V\N$)2U5A=3%TF5R@T6EV0BGX5IC+=UAIM\
MBYH[!=IUTL$%O)N%*N=OP<93DB3-R@E>Q;(%V0&85+D;VYPN)L0%XGPU8?P!
M\:2X#![.N&57!P#S5(E<G-/NEN1:# "\EP- $&615:D!A07?!M*#,)NF[$&E
M!%342EAQ#N_G$#!4 C<I8I3JK0E%P%(-MIJ_;(FY#1*[K@X!QGP_/I#D$,S]
MQ%CR0%(5(UXP*B71!S&H)W/"Y'DS)L\/R>209HA.B9QHE;<!VA$=@L%K=?0\
M&".:,*K;KL%$AV!0;DE_Y"@E$U)J^O)HPF[7L^CF$"#*"@P;%55-XB\N];2
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MU#498.8 <7TT_H%>'TVMOE#U^=;U2VU^R9),F.87<6'2__/[E,[E#]J(#UR
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M-C _ 'PFNR=HO[#AV;]VMS]+FP&46@\$;^_2G:Z?W$@.M=U1,7@B@CE_Z$Y
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M#,!UO^T/N.B(KP?ARQ.HA$0QD@,J3^#3Y'V:O$^3]]?#^F1M;!A/)[NUR6_
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M(2!=$ !I+&0#Z#%P& B6/:=E!I*PQ55+HZ:9 X$W+L4WHZH^)F&]W,%Y%:\
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MXN!AR;RHU5#6HGA@9[2<"32<SFI0:/=W3N^^EJ^.F.IJ14 /-#"49$90GQ.
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M-[D;RJ.'H 5[E<C356YG=6Z"]@_"#%KH2V9 'S\(,>A"!3:"^NV3,,-^9F9
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M]H$=3. :^2M:.!53,GRD>K-@<4AY6OKNFF57=G,*2+WA8-IAWLK28.4T=W
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M/8#N,X+!=C*#T"6X@&'#"63H<D_ & &!)W1I(&!PFJY@="D<C4!UV;#HTBK
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M+LO1RN"83#%!EQYI:QO3YRNCRZJT-51M^,_H4C#=#)8NBQHX;+^>W+!II40
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M/<2609,.;[ 6,>DLHTT2]R3G7$A^2<5D)W%MV<HW40I0+Q<!ET*PAB*<U6A
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M7C.:7)0W$<N'Q,_D4ZS_J@'"E^6E@PLJT,?)&C'!/ZWVM@TF"R)QD>&;@$[
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M9ZJZUZ1PKN:2"&$>1.P<&?WG*GJ#/1>#I<)CI.\A>K>XYT+-[<;>VS6^P):
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M.:J_*\+&B/;RQTDECDE-V>R&A%7IL<U_8OZ<L7_2Y'PD&&STNXEA8+WS^PX
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MG->+,/S)L3 @5^)!&@K ;#[B<,A*(_+0057/]A6\EMXM?XD@4ZF\RQ\@L?8
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M/N JJ! #XW0KC=+6#5'Q+W5%9'K@NK\X0O'41"U[GT-7B7)W+_:WO,@DDAO
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M67]5HG0GDU2*ZR\TCUE!D[XG%MWO\,5)A^?W4)54(J ./5J!A3-5/32H9)Y
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MA#D'^2PV>3YQ5L5Q0 PBO*IW#@=152>P7&L-H_C;)QFT,N=(JOZ]T@R@&MD
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M1<AL;G>8$Z^%6%&OYB,M56>+][SH"_$S_G[B"34*Q_?),XK0E!/%P6H1)X6
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M,D=<UT=+KDF@^6J+DS*'?XW2K1QQD:;\%3*3+*@0 R@>](H&-G-4-AIHN]9
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MZ[MZBMJK!\147M&-J7L(=K7Z&X84V5*2=E?P-K"HE;W9Q/VWXCH3=_/"BT
M\07G%TWD8_Y^TT2&P_(=K'\MR,5@1A:O_K=/UK(+3EP4+?5Q7%$@2K(;4A2W
MV=>(E>B\RUD=DG)_1W6O9(QNG_N/2*:]#*TRH$3$6;T!)32@R@.F^=3IW,S
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M;' :.TY#@[8E;=PI?H/YQL Y:2* J//YO1=,YPV>BH3]4<9=SDE1]M4=G#Z
MN<+I/81<&2YU1!#;8Y-?@/GHJA@O^YD)1$A"0@H<NRL:/Z:+PX7CE00^6P?)
MSK7W,3K^G9Z97&/O ^[9D8%*3]=E:?+Q.-(9)^2-SA [+HC_N]6ZS+1*RUS3
MO6Z2%4ELY0JK*CU/MJP7UUQL6B\#/FR;06E":C<S:&<\G([:^%&+ ?2X1^WG
M)!.(<[% D@_ZAW;II9H7I"#90$WD^ 0T:"H5]4#S@$(0>R#W>$LUXHEB$<O9
M^1.#>9WU7<N'O0PY)% FXN3*F#*:R9%YBWQ">DQP-"RPWN"1GLX""4@L>LY
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M$Q$+<C<4H6MMA$]WR:(\&XL7ROC [<\,KV[SWZ*,SLN5/&D?"ML9'%XGEF<
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MA]M<:F:6M+1,]@/.>+UY+II^P=F"AM*:;I"NL+TSK,1P7VW#5]NHBXM4-3C
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M?[#&#43(7VYVY#5;OVQCI'A"TRR5$ 7JT!IA[$X.=&E[W\="_<0@H#G;\^Q
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MMDO0WS\U7$&;JDL#Q%WG?*]OYKLE <]P3_\DV6(<7[WA@&>9WN(LX\FHO#)
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MNO2($;Y@I$9JC9[>XF[" IUEKTQYN&0*4$35IYBRO7<:>*?!V3L-&I3"O??
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M@I)DS6@MXI($2(#ZVO0GM<^<15]3-8&E;'MZH6GQ6#W$Z$=[K&Y/F@-1M%"
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M&CVYNXS@@'SH\3:Q]G'+SU%C0=A' R./XM_ZC0Q3ON,Y:P 0<6N@I#&+S1!
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M,#$W,3(S,2YX<V102P$"% ,4    " #L@&E,IO]XLBT1  #M" $ %0
M        @ $M8@$ :GEN="TR,#$W,3(S,5]C86PN>&UL4$L! A0#%     @
M[(!I3$:( ..@9@  +=0( !4              ( !C7,! &IY;G0M,C Q-S$R
M,S%?9&5F+GAM;%!+ 0(4 Q0    ( .R :4Q$#,":AI   %D."  5
M      "  6#: 0!J>6YT+3(P,3<Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #L
M@&E,U)"XRP!I  #J4@D %0              @ $9:P( :GEN="TR,#$W,3(S
?,5]P<F4N>&UL4$L%!@     &  8 B@$  $S4 @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
